<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
     version="2.0">
   <channel>
      <title>Wiley: The Laryngoscope: Table of Contents</title>
      <link>https://onlinelibrary.wiley.com/journal/15314995?af=R</link>
      <description>Table of Contents for The Laryngoscope. List of articles from both the latest and EarlyView issues.</description>
      <language>en-US</language>
      <copyright>© The American Laryngological, Rhinological and Otological Society, Inc.</copyright>
      <managingEditor>wileyonlinelibrary@wiley.com (Wiley Online Library)</managingEditor>
      <pubDate>Wed, 20 May 2026 07:38:40 +0000</pubDate>
      <lastBuildDate>Wed, 20 May 2026 07:38:40 +0000</lastBuildDate>
      <generator>Atypon® Literatum™</generator>
      <docs>https://validator.w3.org/feed/docs/rss2.html</docs>
      <ttl>10080</ttl>
      <dc:title>Wiley: The Laryngoscope: Table of Contents</dc:title>
      <dc:publisher>Wiley</dc:publisher>
      <prism:publicationName>The Laryngoscope</prism:publicationName>
      <atom:link href="https://onlinelibrary.wiley.com/journal/15314995?af=R"
                 rel="self"
                 type="application/atom+xml"/>
      <image>
         <title>Wiley: The Laryngoscope: Table of Contents</title>
         <url>https://onlinelibrary.wiley.com/pb-assets/journal-banners/15314995.jpg</url>
         <link>https://onlinelibrary.wiley.com/journal/15314995?af=R</link>
      </image>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70631?af=R</link>
         <pubDate>Tue, 19 May 2026 21:15:26 -0700</pubDate>
         <dc:date>2026-05-19T09:15:26-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70631</guid>
         <title>Race and Ethnicity Affect Symptom and Endoscopy Associations in CT‐Confirmed Chronic Rhinosinusitis</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Among adults with chronic rhinosinusitis (CRS) symptoms, hyposmia, and higher Lund–Kennedy endoscopy scores were associated with CT‐confirmed CRS overall, though these associations were not significant among Asian and Hispanic patients. Symptoms alone had limited predictive value when nasal endoscopy was negative, suggesting that the diagnostic utility of symptoms and endoscopic findings may vary across demographic and clinical contexts.

ABSTRACT

Objectives
To investigate demographic differences in the association between chronic rhinosinusitis (CRS) symptoms and endoscopic findings with CT‐confirmed CRS.


Methods
Consecutive adult patients presenting to outpatient rhinology clinics with chronic cardinal sinonasal symptoms who underwent nasal endoscopy and a sinus CT scan were included. Demographics, cardinal symptoms, SNOT‐22, and Lund–Kennedy (LK) endoscopic scores were extracted from electronic medical records. Logistic regression was used to assess associations between predictors and CT‐confirmed CRS (CT‐CRS) with prespecified stratified analyses by race and ethnicity.


Results
Among 314 included patients (mean age 48 ± 17 years, 51% female), 228 met criteria for CT‐CRS. Hyposmia and LK endoscopic scores were associated with CT‐CRS. However, in subgroup analyses, the associations of hyposmia and LK endoscopic scores with CT‐CRS were not significant among Asian and Hispanic patients. Among patients with a negative nasal endoscopy, 62.6% had CT‐CRS. In this subgroup, patient‐reported nasal discharge and the presence of ≥ 2 cardinal symptoms were associated with reduced odds of CT‐CRS.


Conclusions
Associations between symptoms and nasal endoscopy findings with CT‐CRS were not significant among Asian and Hispanic patients, suggesting limitations of symptom and endoscopy‐based assessments in these subgroups. Among patients with a negative nasal endoscopy, symptoms demonstrated limited ability to identify CT‐CRS. These findings suggest CT imaging could be considered earlier in selected clinical contexts.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/dfb61ef7-a033-43c0-a47a-cabef70cb4af/lary70631-toc-0001-m.png"
     alt="Race and Ethnicity Affect Symptom and Endoscopy Associations in CT-Confirmed Chronic Rhinosinusitis"/&gt;
&lt;p&gt;Among adults with chronic rhinosinusitis (CRS) symptoms, hyposmia, and higher Lund–Kennedy endoscopy scores were associated with CT-confirmed CRS overall, though these associations were not significant among Asian and Hispanic patients. Symptoms alone had limited predictive value when nasal endoscopy was negative, suggesting that the diagnostic utility of symptoms and endoscopic findings may vary across demographic and clinical contexts.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To investigate demographic differences in the association between chronic rhinosinusitis (CRS) symptoms and endoscopic findings with CT-confirmed CRS.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Consecutive adult patients presenting to outpatient rhinology clinics with chronic cardinal sinonasal symptoms who underwent nasal endoscopy and a sinus CT scan were included. Demographics, cardinal symptoms, SNOT-22, and Lund–Kennedy (LK) endoscopic scores were extracted from electronic medical records. Logistic regression was used to assess associations between predictors and CT-confirmed CRS (CT-CRS) with prespecified stratified analyses by race and ethnicity.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 314 included patients (mean age 48 ± 17 years, 51% female), 228 met criteria for CT-CRS. Hyposmia and LK endoscopic scores were associated with CT-CRS. However, in subgroup analyses, the associations of hyposmia and LK endoscopic scores with CT-CRS were not significant among Asian and Hispanic patients. Among patients with a negative nasal endoscopy, 62.6% had CT-CRS. In this subgroup, patient-reported nasal discharge and the presence of ≥ 2 cardinal symptoms were associated with reduced odds of CT-CRS.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Associations between symptoms and nasal endoscopy findings with CT-CRS were not significant among Asian and Hispanic patients, suggesting limitations of symptom and endoscopy-based assessments in these subgroups. Among patients with a negative nasal endoscopy, symptoms demonstrated limited ability to identify CT-CRS. These findings suggest CT imaging could be considered earlier in selected clinical contexts.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Corey Karp, 
Mitchell Figueroa, 
Jaynelle Gao, 
Joshua S. Lin, 
Zara Mubin, 
Sophia Albanese, 
Kevin Hur
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Race and Ethnicity Affect Symptom and Endoscopy Associations in CT‐Confirmed Chronic Rhinosinusitis</dc:title>
         <dc:identifier>10.1002/lary.70631</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70631</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70631?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70630?af=R</link>
         <pubDate>Mon, 18 May 2026 22:24:23 -0700</pubDate>
         <dc:date>2026-05-18T10:24:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70630</guid>
         <title>Management of Absent Upper Esophageal Sphincter Opening After Neurological Injury</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study evaluated the effects of swallowing therapy and cricopharyngeus (CP) muscle surgery on upper esophageal sphincter (UES) opening, oral intake, and airway protection in patients with absent UES opening following neurological injury. CP‐targeted surgeries were associated with improved bolus passage and oral intake, but persistent aspiration risk remained despite improved mechanical opening. These findings highlight the importance of multidisciplinary management of this rare condition and suggest that earlier surgical intervention combined with continued swallowing therapy may optimize recovery following neurological injury.

ABSTRACT

Objectives
To evaluate the effects of swallowing therapy and cricopharyngeus (CP) muscle surgery on upper esophageal sphincter (UES) opening, oral intake, and airway protection in patients with absent UES opening following neurological injury.


Methods
Retrospective review of seven patients managed between September 2021 and July 2024 with absent UES opening confirmed by Modified Barium Swallow Study (MBSS). All patients underwent swallowing therapy followed by at least one CP‐targeted intervention, including balloon dilation, botulinum toxin injection, and/or myotomy. Swallowing outcomes were assessed using the Functional Oral Intake Scale (FOIS), Mann Assessment of Swallowing Ability (MASA), Penetration‐Aspiration Scale (PAS), and pharyngoesophageal segment (PES) opening scores from the Modified Barium Swallow Impairment Profile.


Results
CP‐targeted surgeries were associated with improved FOIS, MASA, and PES opening scores. PAS scores did not change substantially, with six patients demonstrating values greater than or equal to 7. Patients who underwent CP‐directed intervention within 6 months of injury demonstrated greater FOIS improvements than those treated later (3.25 vs. 0.33).


Conclusion
CP interventions can facilitate improved bolus passage and oral intake in patients with absent UES opening following neurological injury. However, persistent aspiration risk remains despite improved mechanical opening, highlighting the need for continued swallowing therapy. Finally, earlier intervention may optimize outcomes, though further research is needed to refine treatment for this rare condition.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/b7f65924-19a1-4463-8ca3-e917029974a2/lary70630-toc-0001-m.png"
     alt="Management of Absent Upper Esophageal Sphincter Opening After Neurological Injury"/&gt;
&lt;p&gt;This study evaluated the effects of swallowing therapy and cricopharyngeus (CP) muscle surgery on upper esophageal sphincter (UES) opening, oral intake, and airway protection in patients with absent UES opening following neurological injury. CP-targeted surgeries were associated with improved bolus passage and oral intake, but persistent aspiration risk remained despite improved mechanical opening. These findings highlight the importance of multidisciplinary management of this rare condition and suggest that earlier surgical intervention combined with continued swallowing therapy may optimize recovery following neurological injury.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To evaluate the effects of swallowing therapy and cricopharyngeus (CP) muscle surgery on upper esophageal sphincter (UES) opening, oral intake, and airway protection in patients with absent UES opening following neurological injury.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective review of seven patients managed between September 2021 and July 2024 with absent UES opening confirmed by Modified Barium Swallow Study (MBSS). All patients underwent swallowing therapy followed by at least one CP-targeted intervention, including balloon dilation, botulinum toxin injection, and/or myotomy. Swallowing outcomes were assessed using the Functional Oral Intake Scale (FOIS), Mann Assessment of Swallowing Ability (MASA), Penetration-Aspiration Scale (PAS), and pharyngoesophageal segment (PES) opening scores from the Modified Barium Swallow Impairment Profile.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;CP-targeted surgeries were associated with improved FOIS, MASA, and PES opening scores. PAS scores did not change substantially, with six patients demonstrating values greater than or equal to 7. Patients who underwent CP-directed intervention within 6 months of injury demonstrated greater FOIS improvements than those treated later (3.25 vs. 0.33).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;CP interventions can facilitate improved bolus passage and oral intake in patients with absent UES opening following neurological injury. However, persistent aspiration risk remains despite improved mechanical opening, highlighting the need for continued swallowing therapy. Finally, earlier intervention may optimize outcomes, though further research is needed to refine treatment for this rare condition.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Radhika Rawat, 
Cyrus W. Abrahamson, 
Kelly Rogers, 
Jonelyn Langenstein, 
Jaymie Bromfield, 
Arjun Seth, 
James A. Burns, 
Andrew P. Stein
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Management of Absent Upper Esophageal Sphincter Opening After Neurological Injury</dc:title>
         <dc:identifier>10.1002/lary.70630</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70630</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70630?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70626?af=R</link>
         <pubDate>Sun, 17 May 2026 18:24:23 -0700</pubDate>
         <dc:date>2026-05-17T06:24:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70626</guid>
         <title>Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach for Maxillary Sinus</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
The prelacrimal approach (PLA) is a minimally invasive approach to maxillary sinus lesions. When compared to traditional osteotomy, the piezosurgery ultrasonic device (PZD) was associated with less bleeding, pain, hypoesthesia, and epiphora in comparison to traditional osteotomy. It also allowed for precise cutting with no bone loss; however, the procedure was time consuming when compared to conventional osteotomy.

ABSTRACT

Introduction
The prelacrimal recess approach (PLA) is a minimally invasive approach to maxillary sinus lesions, especially those of the anterior and inferior wall. Innovative advances, for example, the piezosurgery ultrasonic device (PZD), have been developed aiming at facilitating surgical procedures in terms of efficient hemostasis, dissection, safety, and reduction in surgical time. The current study aimed to evaluate the efficacy of piezosurgery versus conventional osteotomy while performing a prelacrimal approach.


Methods
A prospective randomized controlled study was conducted in the Otorhinolaryngology Department, Mansoura University, Egypt on 40 patients diagnosed with different maxillary sinus pathologies amenable to a prelacrimal approach. Patients were randomly allocated into two groups: Group A underwent piezosurgery while conventional osteotomy was used in Group B.


Results
Operative time was significantly higher in the PZD group (16.30 ± 2.16 vs. 9.05 ± 1.88; p = 0.001) whereas the blood loss was much less (14 ± 3.84 vs. 42 ± 16.81; p = 0.001). Postoperative pain, hypoesthesia, and epiphora were transient, significantly less in the PZD group (p &lt; 0.001, p = 0.006, p = 0.002), and spontaneously resolved. Both groups witnessed a significant improvement in their NOSE and SNOT‐22 scores in the 3‐month and 6‐month follow‐up visits compared to the preoperative ones (p &lt; 0.001). Other complications were comparable in both groups including cheek swelling, minimal epistaxis, dry nose, wound dehiscence, alar collapse, and recurrence of the original pathology.


Conclusion
The PZD was associated with less bleeding, pain, hypoesthesia, and epiphora in comparison to traditional osteotomy. It also allowed for precise cutting with no bone loss; however, the procedure was time‐consuming when compared to conventional osteotomy.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/ac18adfa-f6ff-4780-936b-5c43e0c5334e/lary70626-toc-0001-m.png"
     alt="Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach for Maxillary Sinus"/&gt;
&lt;p&gt;The prelacrimal approach (PLA) is a minimally invasive approach to maxillary sinus lesions. When compared to traditional osteotomy, the piezosurgery ultrasonic device (PZD) was associated with less bleeding, pain, hypoesthesia, and epiphora in comparison to traditional osteotomy. It also allowed for precise cutting with no bone loss; however, the procedure was time consuming when compared to conventional osteotomy.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Introduction&lt;/h2&gt;
&lt;p&gt;The prelacrimal recess approach (PLA) is a minimally invasive approach to maxillary sinus lesions, especially those of the anterior and inferior wall. Innovative advances, for example, the piezosurgery ultrasonic device (PZD), have been developed aiming at facilitating surgical procedures in terms of efficient hemostasis, dissection, safety, and reduction in surgical time. The current study aimed to evaluate the efficacy of piezosurgery versus conventional osteotomy while performing a prelacrimal approach.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A prospective randomized controlled study was conducted in the Otorhinolaryngology Department, Mansoura University, Egypt on 40 patients diagnosed with different maxillary sinus pathologies amenable to a prelacrimal approach. Patients were randomly allocated into two groups: Group A underwent piezosurgery while conventional osteotomy was used in Group B.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Operative time was significantly higher in the PZD group (16.30 ± 2.16 vs. 9.05 ± 1.88; &lt;i&gt;p&lt;/i&gt; = 0.001) whereas the blood loss was much less (14 ± 3.84 vs. 42 ± 16.81; &lt;i&gt;p&lt;/i&gt; = 0.001). Postoperative pain, hypoesthesia, and epiphora were transient, significantly less in the PZD group (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001, &lt;i&gt;p&lt;/i&gt; = 0.006, &lt;i&gt;p&lt;/i&gt; = 0.002), and spontaneously resolved. Both groups witnessed a significant improvement in their NOSE and SNOT-22 scores in the 3-month and 6-month follow-up visits compared to the preoperative ones (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Other complications were comparable in both groups including cheek swelling, minimal epistaxis, dry nose, wound dehiscence, alar collapse, and recurrence of the original pathology.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The PZD was associated with less bleeding, pain, hypoesthesia, and epiphora in comparison to traditional osteotomy. It also allowed for precise cutting with no bone loss; however, the procedure was time-consuming when compared to conventional osteotomy.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Ahmed Gad Esmail, 
Eman H. Salem, 
Aya Mohammed Abdel Aziz, 
Yasser W. Khafagy, 
Asser Abd Elraouf Elsharkawy, 
Ahmed Salama Abdelmeguid
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Piezosurgery Versus Conventional Osteotomy in Prelacrimal Approach for Maxillary Sinus</dc:title>
         <dc:identifier>10.1002/lary.70626</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70626</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70626?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70615?af=R</link>
         <pubDate>Sat, 16 May 2026 07:03:59 -0700</pubDate>
         <dc:date>2026-05-16T07:03:59-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70615</guid>
         <title>Partitioned Internal Auditory Canal: Association With Cochlear Aperture Anomalies</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Partitioned internal auditory canal (IAC), defined by a bony septum separating the facial nerve from the cochleovestibular nerve, occurs significantly more often in ears with stenotic or atretic cochlear aperture.

ABSTRACT

Objective
To investigate the association between partitioned internal auditory canal (IAC) and other inner ear abnormalities.


Methods
The temporal bone computed tomography (CT) and magnetic resonance imaging (MRI) findings of ears with partitioned IAC were retrospectively analyzed. The IAC was considered narrow if its mid‐portion diameter &lt; 2 mm. Cochlear aperture (CA) was classified as normal (diameter more than 1.5 mm), stenotic (diameter &lt; 1.5 mm), or atretic. The MRI images examined the cochlear nerve (CN). The CN's diameter was compared with the ipsilateral facial nerve to determine if it was normal, hypoplastic, or aplastic.


Results
Partitioned IAC was observed in 1.1% of ears with normal CA, 14.9% of ears with stenotic CA, and 20.9% of ears with atretic CA. Forty‐eight right and 37 left ears with partitioned IAC were examined. The most common CA anomaly accompanying partitioned IAC was CA stenosis, while more than half of the cochleae were of normal size. IAC was mostly narrow in ears with partitioned IAC. When the CN was examined, partitioned IAC was almost always accompanied by CN aplasia (more frequently) or hypoplasia.


Conclusion
This study demonstrates that CN deficiency, associated with CA abnormalities, may cause the aberrant location of the meatal segment of the facial nerve in a separate bony canal. Partitioned IAC is an inner ear malformation characterized by CN deficiency.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/1573acfb-583a-41dd-9a28-d13ee81f8f0e/lary70615-toc-0001-m.png"
     alt="Partitioned Internal Auditory Canal: Association With Cochlear Aperture Anomalies"/&gt;
&lt;p&gt;Partitioned internal auditory canal (IAC), defined by a bony septum separating the facial nerve from the cochleovestibular nerve, occurs significantly more often in ears with stenotic or atretic cochlear aperture.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To investigate the association between partitioned internal auditory canal (IAC) and other inner ear abnormalities.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;The temporal bone computed tomography (CT) and magnetic resonance imaging (MRI) findings of ears with partitioned IAC were retrospectively analyzed. The IAC was considered narrow if its mid-portion diameter &amp;lt; 2 mm. Cochlear aperture (CA) was classified as normal (diameter more than 1.5 mm), stenotic (diameter &amp;lt; 1.5 mm), or atretic. The MRI images examined the cochlear nerve (CN). The CN's diameter was compared with the ipsilateral facial nerve to determine if it was normal, hypoplastic, or aplastic.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Partitioned IAC was observed in 1.1% of ears with normal CA, 14.9% of ears with stenotic CA, and 20.9% of ears with atretic CA. Forty-eight right and 37 left ears with partitioned IAC were examined. The most common CA anomaly accompanying partitioned IAC was CA stenosis, while more than half of the cochleae were of normal size. IAC was mostly narrow in ears with partitioned IAC. When the CN was examined, partitioned IAC was almost always accompanied by CN aplasia (more frequently) or hypoplasia.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This study demonstrates that CN deficiency, associated with CA abnormalities, may cause the aberrant location of the meatal segment of the facial nerve in a separate bony canal. Partitioned IAC is an inner ear malformation characterized by CN deficiency.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Levent Sennaroğlu, 
Emel Tahir
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Partitioned Internal Auditory Canal: Association With Cochlear Aperture Anomalies</dc:title>
         <dc:identifier>10.1002/lary.70615</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70615</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70615?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70625?af=R</link>
         <pubDate>Sat, 16 May 2026 04:29:47 -0700</pubDate>
         <dc:date>2026-05-16T04:29:47-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70625</guid>
         <title>Ambient Artificial Intelligence Scribes: A Scoping Review With Implications for Otolaryngology</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
A scoping review from 2022 through 2025 evaluated ambulatory AI scribing across various domains and considered implications for otolaryngology. Of the 12 articles that met inclusion criteria, nearly all studies reported modest time savings, high usability, and significant reductions in validated burnout measures, but otolaryngology‐specific experiences were not reported separately, and most measures were inconsistently reported. Future research should standardize outcomes, report AI performance consistently, and include otolaryngology populations, especially those with communication challenges.

ABSTRACT

Background/Objective
Ambient artificial intelligence scribing, “ambient AI,” is expanding across ambulatory specialties. Despite adoption, the impact on documentation efficiency, usability, and implications for otolaryngology remain poorly understood. This scoping review evaluates ambient AI utilization in multiple specialties in four areas (documentation efficiency, burnout, usability, workflow impact) to identify research gaps and apply findings from general ambulatory care to otolaryngology.


Sources of Evidence
PubMed, Web of Science, Embase, and Scopus.


Eligibility/Charting Methods
A PRISMA‐ScR compliant scoping review was conducted of studies published between January 2022 and July 2025, using search terms related to ambient AI scribe technology. Two reviewers independently screened articles and assessed quality using the Newcastle‐Ottawa Scale (NOS). Data were synthesized narratively and stratified into subcategories.


Results
We identified 164 articles and 12 met the inclusion criteria. Four studies included otolaryngology providers, but their experiences were not reported separately. Time‐saved‐per‐note and after‐hours reductions ranged from 0.2 to 2.1 and 1.6 to 15.2 min, respectively. Documentation usability scores post‐implementation were high, ranging from 69.01 to 78.8/100. Perceived workflow efficiency score improved from 3.63/7 to 5.03/7. Validated instruments showed significant burnout reduction (Stanford PFI: 4.16–3.16/10, p = 0.005; NASA‐TLX mental demand decreased 6.12 points, p &lt; 0.001).


Conclusions
Available literature on Ambient AI use in ambulatory settings does not define experiences of otolaryngologists but does report time savings, improved perceptions of usability, and reduced burnout. However, gaps must be addressed in reporting AI model performance and consistent outcome measures. Future studies must include special otolaryngology populations that have communication challenges.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/0efa81cc-cabe-42a3-a11c-37e9788b6fed/lary70625-toc-0001-m.png"
     alt="Ambient Artificial Intelligence Scribes: A Scoping Review With Implications for Otolaryngology"/&gt;
&lt;p&gt;A scoping review from 2022 through 2025 evaluated ambulatory AI scribing across various domains and considered implications for otolaryngology. Of the 12 articles that met inclusion criteria, nearly all studies reported modest time savings, high usability, and significant reductions in validated burnout measures, but otolaryngology-specific experiences were not reported separately, and most measures were inconsistently reported. Future research should standardize outcomes, report AI performance consistently, and include otolaryngology populations, especially those with communication challenges.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Background/Objective&lt;/h2&gt;
&lt;p&gt;Ambient artificial intelligence scribing, “ambient AI,” is expanding across ambulatory specialties. Despite adoption, the impact on documentation efficiency, usability, and implications for otolaryngology remain poorly understood. This scoping review evaluates ambient AI utilization in multiple specialties in &lt;i&gt;four&lt;/i&gt; areas (documentation efficiency, burnout, usability, workflow impact) to identify research gaps and apply findings from general ambulatory care to otolaryngology.&lt;/p&gt;
&lt;h2&gt;Sources of Evidence&lt;/h2&gt;
&lt;p&gt;PubMed, Web of Science, Embase, and Scopus.&lt;/p&gt;
&lt;h2&gt;Eligibility/Charting Methods&lt;/h2&gt;
&lt;p&gt;A PRISMA-ScR compliant scoping review was conducted of studies published between January 2022 and July 2025, using search terms related to ambient AI scribe technology. Two reviewers independently screened articles and assessed quality using the Newcastle-Ottawa Scale (NOS). Data were synthesized narratively and stratified into subcategories.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;We identified 164 articles and 12 met the inclusion criteria. Four studies included otolaryngology providers, but their experiences were not reported separately. Time-saved-per-note and after-hours reductions ranged from 0.2 to 2.1 and 1.6 to 15.2 min, respectively. Documentation usability scores post-implementation were high, ranging from 69.01 to 78.8/100. Perceived workflow efficiency score improved from 3.63/7 to 5.03/7. Validated instruments showed significant burnout reduction (Stanford PFI: 4.16–3.16/10, &lt;i&gt;p&lt;/i&gt; = 0.005; NASA-TLX mental demand decreased 6.12 points, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Available literature on Ambient AI use in ambulatory settings does not define experiences of otolaryngologists but does report time savings, improved perceptions of usability, and reduced burnout. However, gaps must be addressed in reporting AI model performance and consistent outcome measures. Future studies must include special otolaryngology populations that have communication challenges.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Sanjana Nallapaneni, 
Christopher L. Crafton, 
Claudia I. Cabrera, 
Crystal Mosca, 
Kenneth Rodriguez, 
Sanjeet V. Rangarajan, 
Brian D’Anza
</dc:creator>
         <category>SCOPING REVIEW</category>
         <dc:title>Ambient Artificial Intelligence Scribes: A Scoping Review With Implications for Otolaryngology</dc:title>
         <dc:identifier>10.1002/lary.70625</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70625</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70625?af=R</prism:url>
         <prism:section>SCOPING REVIEW</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70627?af=R</link>
         <pubDate>Fri, 15 May 2026 22:01:00 -0700</pubDate>
         <dc:date>2026-05-15T10:01:00-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70627</guid>
         <title>How I Do It: A Novel Case Series of Office‐Based Laser Complete Excision of Vocal Fold Cysts</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Office‐based complete excision of vocal fold cysts using Trublue laser via transnasal flexible endoscopy is a technically feasible alternative to conventional marsupialization, enabling en bloc removal under local anesthesia with excellent procedural tolerability.
</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/d60130a6-0013-4f52-b8b5-16a166fd7f38/lary70627-toc-0001-m.png"
     alt="How I Do It: A Novel Case Series of Office-Based Laser Complete Excision of Vocal Fold Cysts"/&gt;
&lt;p&gt;Office-based complete excision of vocal fold cysts using Trublue laser via transnasal flexible endoscopy is a technically feasible alternative to conventional marsupialization, enabling en bloc removal under local anesthesia with excellent procedural tolerability.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Aurora Ka Yue Tam, 
Timothy Shun Man Chu, 
Yifeng Wei, 
Zikai Wang, 
Thomas Law, 
Jason Ying Kuen Chan
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>How I Do It: A Novel Case Series of Office‐Based Laser Complete Excision of Vocal Fold Cysts</dc:title>
         <dc:identifier>10.1002/lary.70627</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70627</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70627?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70629?af=R</link>
         <pubDate>Thu, 14 May 2026 20:39:29 -0700</pubDate>
         <dc:date>2026-05-14T08:39:29-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70629</guid>
         <title>Identifying High‐Risk Children Safe for Same‐Day Discharge After Tonsillectomy</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objective
Current guidelines recommend overnight admission for children with severe obstructive sleep apnea (OSA) and obesity undergoing tonsillectomy, although most have uneventful postoperative courses. We aimed to identify low‐risk subgroups within this high‐risk population who may be candidates for same‐day discharge.


Methods
Retrospective cohort study of children aged 2–18 years with obesity (≥ 95th BMI percentile) and severe OSA (AHI ≥ 10 events/h and/or SpO2 nadir &lt; 80%) undergoing tonsillectomy at a tertiary children's hospital (2021–2024). The primary outcome was a severe perioperative event: ICU admission, prolonged hospitalization (&gt; 48 h), or need for advanced respiratory support. Bayesian logistic regression using informative priors identified predictors. Model‐based risk stratification and simplified clinical rules were evaluated using sensitivity, specificity, and negative predictive value.


Results
Among 304 children, 36 (11.8%) experienced a severe event. SpO2 nadir was the strongest predictor (β = −0.668, 95% CrI [−1.164, −0.172], directional probability 99.6%), followed by Class III obesity (97.0%) and AHI (95.0%). Model‐derived stratification identified 33% of patients with &lt; 5% predicted probability of severe events. A clinical rule combining AHI &lt; 25 events/h and SpO2 nadir &gt; 85% showed sensitivity 85.7% and negative predictive value 99.5%, corresponding to an observed event rate &lt; 5%.


Conclusion
Most obese children with severe OSA do not experience severe perioperative events. Simple polysomnographic criteria can identify very low‐risk patients who may be candidates for same‐day discharge planning. These findings support a more individualized approach to postoperative admission; prospective validation is needed before implementation.


Level of Evidence
4.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Current guidelines recommend overnight admission for children with severe obstructive sleep apnea (OSA) and obesity undergoing tonsillectomy, although most have uneventful postoperative courses. We aimed to identify low-risk subgroups within this high-risk population who may be candidates for same-day discharge.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective cohort study of children aged 2–18 years with obesity (≥ 95th BMI percentile) and severe OSA (AHI ≥ 10 events/h and/or SpO&lt;sub&gt;2&lt;/sub&gt; nadir &amp;lt; 80%) undergoing tonsillectomy at a tertiary children's hospital (2021–2024). The primary outcome was a severe perioperative event: ICU admission, prolonged hospitalization (&amp;gt; 48 h), or need for advanced respiratory support. Bayesian logistic regression using informative priors identified predictors. Model-based risk stratification and simplified clinical rules were evaluated using sensitivity, specificity, and negative predictive value.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 304 children, 36 (11.8%) experienced a severe event. SpO&lt;sub&gt;2&lt;/sub&gt; nadir was the strongest predictor (&lt;i&gt;β&lt;/i&gt; = −0.668, 95% CrI [−1.164, −0.172], directional probability 99.6%), followed by Class III obesity (97.0%) and AHI (95.0%). Model-derived stratification identified 33% of patients with &amp;lt; 5% predicted probability of severe events. A clinical rule combining AHI &amp;lt; 25 events/h and SpO&lt;sub&gt;2&lt;/sub&gt; nadir &amp;gt; 85% showed sensitivity 85.7% and negative predictive value 99.5%, corresponding to an observed event rate &amp;lt; 5%.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Most obese children with severe OSA do not experience severe perioperative events. Simple polysomnographic criteria can identify very low-risk patients who may be candidates for same-day discharge planning. These findings support a more individualized approach to postoperative admission; prospective validation is needed before implementation.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Amy Ho, 
Yann‐Fuu Kou, 
Christopher Liu, 
Cynthia S. Wang, 
Felicity Lenes‐Voit, 
Stephen R. Chorney, 
Kenneth Lee, 
Seckin Ulualp, 
Ron B. Mitchell, 
Romaine F. Johnson
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Identifying High‐Risk Children Safe for Same‐Day Discharge After Tonsillectomy</dc:title>
         <dc:identifier>10.1002/lary.70629</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70629</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70629?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70624?af=R</link>
         <pubDate>Wed, 13 May 2026 22:21:23 -0700</pubDate>
         <dc:date>2026-05-13T10:21:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70624</guid>
         <title>Trends in Industry‐Sponsored Research Payments to Otolaryngologist Principal Investigators</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Industry‐sponsored research payments (ISRPs) to otolaryngologists increased 132% from $15.6 million in 2015 to $36.2 million in 2023. The top 20 manufacturers combined accounted for 76% of all ISRPs to otolaryngologists, and 12 of the top 20 products were pharmaceuticals ($55.6 million), followed by implantable devices ($26.3 million).

ABSTRACT

Objectives
Research payments constitute the largest payment category in the Centers for Medicare and Medicaid Services (CMS) Open Payments program (OPP). We sought to characterize the distributions of and trends in industry‐sponsored research payments (ISRPs) to otolaryngologists.


Methods
OPP data was used to identify ISRPs to otolaryngologists between January 1, 2015 and December 31, 2023. ISRPs were stratified by recipient entity as covered teaching hospitals, covered physicians, and non‐covered entities (NCEs) and evaluated using descriptive analysis and multivariable linear regression.


Results
ISRPs increased 132% from $15.6 million in 2015 to $36.2 million in 2023 (p &lt; 0.001). Payments to NCEs with an otolaryngologist principal investigator (PI) constituted most payments (80%). Male otolaryngologist PIs decreased by −0.2%, while female otolaryngologist PIs increased by 86% (p &lt; 0.01). Annual median payment values per otolaryngologist PI within NCEs increased 111% from $15,239 in 2015 to $32,097 in 2023 (p &lt; 0.001). Among male otolaryngologist PIs within NCEs, total ISRPs increased 109% from $12.9 million in 2015 to $27.0 million in 2023, and median payment value per PI increased 93% from $17,144 in 2015 to $33,155 in 2023 (p &lt; 0.01). Among female otolaryngologist PIs within NCEs, total ISRPs increased 125% from $0.5 million in 2015 to $1.1 million in 2023, but median payment value per PI only increased 14% from $11,973 in 2015 to $13,614 in 2023 (p = 0.1).


Conclusions
ISRPs to otolaryngologists more than doubled from 2015 to 2023, with most payments directed to PIs within NCEs. Median payments to female otolaryngology PIs did not increase, despite an increase in female otolaryngologist PIs.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/6687bb28-606c-43e2-a152-da7858ea0b7b/lary70624-toc-0001-m.png"
     alt="Trends in Industry-Sponsored Research Payments to Otolaryngologist Principal Investigators"/&gt;
&lt;p&gt;Industry-sponsored research payments (ISRPs) to otolaryngologists increased 132% from $15.6 million in 2015 to $36.2 million in 2023. The top 20 manufacturers combined accounted for 76% of all ISRPs to otolaryngologists, and 12 of the top 20 products were pharmaceuticals ($55.6 million), followed by implantable devices ($26.3 million).&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Research payments constitute the largest payment category in the Centers for Medicare and Medicaid Services (CMS) Open Payments program (OPP). We sought to characterize the distributions of and trends in industry-sponsored research payments (ISRPs) to otolaryngologists.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;OPP data was used to identify ISRPs to otolaryngologists between January 1, 2015 and December 31, 2023. ISRPs were stratified by recipient entity as covered teaching hospitals, covered physicians, and non-covered entities (NCEs) and evaluated using descriptive analysis and multivariable linear regression.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;ISRPs increased 132% from $15.6 million in 2015 to $36.2 million in 2023 (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Payments to NCEs with an otolaryngologist principal investigator (PI) constituted most payments (80%). Male otolaryngologist PIs decreased by −0.2%, while female otolaryngologist PIs increased by 86% (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01). Annual median payment values per otolaryngologist PI within NCEs increased 111% from $15,239 in 2015 to $32,097 in 2023 (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Among male otolaryngologist PIs within NCEs, total ISRPs increased 109% from $12.9 million in 2015 to $27.0 million in 2023, and median payment value per PI increased 93% from $17,144 in 2015 to $33,155 in 2023 (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01). Among female otolaryngologist PIs within NCEs, total ISRPs increased 125% from $0.5 million in 2015 to $1.1 million in 2023, but median payment value per PI only increased 14% from $11,973 in 2015 to $13,614 in 2023 (&lt;i&gt;p&lt;/i&gt; = 0.1).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;ISRPs to otolaryngologists more than doubled from 2015 to 2023, with most payments directed to PIs within NCEs. Median payments to female otolaryngology PIs did not increase, despite an increase in female otolaryngologist PIs.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Grace Leu, 
Zeyad Hammadeh, 
Joseph G. Cheaib, 
Zhuo T. Su, 
Misop Han, 
Christine G. Gourin
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Trends in Industry‐Sponsored Research Payments to Otolaryngologist Principal Investigators</dc:title>
         <dc:identifier>10.1002/lary.70624</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70624</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70624?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70619?af=R</link>
         <pubDate>Wed, 13 May 2026 22:04:31 -0700</pubDate>
         <dc:date>2026-05-13T10:04:31-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70619</guid>
         <title>Should a Drain Be Routinely Placed After Type I Medialization Thyroplasty?</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Lauren F. Tracy, 
James A. Burns
</dc:creator>
         <category>TRIOLOGICAL SOCIETY BEST PRACTICE</category>
         <dc:title>Should a Drain Be Routinely Placed After Type I Medialization Thyroplasty?</dc:title>
         <dc:identifier>10.1002/lary.70619</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70619</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70619?af=R</prism:url>
         <prism:section>TRIOLOGICAL SOCIETY BEST PRACTICE</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70622?af=R</link>
         <pubDate>Wed, 13 May 2026 03:59:03 -0700</pubDate>
         <dc:date>2026-05-13T03:59:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70622</guid>
         <title>In Response to Validation of Non‐Soundproof Tablet Audiometry in Pediatrics: Comparison With Traditional Audiometry</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Lauren Mueller, 
Amy E. Ensing, 
David S. Lee, 
Dorina Kallogjeri, 
Judith E. C. Lieu
</dc:creator>
         <category>LETTER TO THE EDITOR</category>
         <dc:title>In Response to Validation of Non‐Soundproof Tablet Audiometry in Pediatrics: Comparison With Traditional Audiometry</dc:title>
         <dc:identifier>10.1002/lary.70622</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70622</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70622?af=R</prism:url>
         <prism:section>LETTER TO THE EDITOR</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70620?af=R</link>
         <pubDate>Wed, 13 May 2026 03:54:57 -0700</pubDate>
         <dc:date>2026-05-13T03:54:57-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70620</guid>
         <title>In Reference to Validation of Non‐Soundproof Tablet Audiometry in Pediatrics: Comparison With Traditional Audiometry</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Yi Luo, 
Conghong Zhang, 
Fuhua Chen
</dc:creator>
         <category>LETTER TO THE EDITOR</category>
         <dc:title>In Reference to Validation of Non‐Soundproof Tablet Audiometry in Pediatrics: Comparison With Traditional Audiometry</dc:title>
         <dc:identifier>10.1002/lary.70620</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70620</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70620?af=R</prism:url>
         <prism:section>LETTER TO THE EDITOR</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70617?af=R</link>
         <pubDate>Tue, 12 May 2026 21:10:38 -0700</pubDate>
         <dc:date>2026-05-12T09:10:38-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70617</guid>
         <title>How I Do It: Two Novel, Low‐Cost Phonomicrosurgery Models With Open‐Source, 3D‐Printed Laryngoscopes</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Two new vocal fold microflap models using products found in any grocery store have been developed along with publicly available 3D‐printable parts for simulating multiple laryngoscopes commonly used during laryngeal phonomicrosurgery. This represents a low cost, easily reproducible model for basic laryngeal phonomicrosurgery training.
</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/ed8b8996-df10-4121-9482-094b2cbb32b2/lary70617-toc-0001-m.png"
     alt="How I Do It: Two Novel, Low-Cost Phonomicrosurgery Models With Open-Source, 3D-Printed Laryngoscopes"/&gt;
&lt;p&gt;Two new vocal fold microflap models using products found in any grocery store have been developed along with publicly available 3D-printable parts for simulating multiple laryngoscopes commonly used during laryngeal phonomicrosurgery. This represents a low cost, easily reproducible model for basic laryngeal phonomicrosurgery training.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Sapir Pinhas, 
Ari D. Schuman, 
Itamar Pinhas, 
Aaron D. Friedman
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>How I Do It: Two Novel, Low‐Cost Phonomicrosurgery Models With Open‐Source, 3D‐Printed Laryngoscopes</dc:title>
         <dc:identifier>10.1002/lary.70617</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70617</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70617?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70613?af=R</link>
         <pubDate>Tue, 12 May 2026 21:05:16 -0700</pubDate>
         <dc:date>2026-05-12T09:05:16-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70613</guid>
         <title>Does Omitting Distal Anastomosis in Hypopharyngeal Defect Reconstruction Improve Dietary Outcomes?</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Omitting distal anastomosis did not improve dietary outcomes in total hypopharyngeal reconstruction. Free ileocolonic flaps achieved comparable or better recovery than gastric pull‐up, suggesting conduit biology outweighs anastomotic number.

ABSTRACT

Objective
Circumferential reconstruction is required for total hypopharyngeal defects to restore swallowing. Reconstructive options differ in conduit biology and anastomotic configuration, particularly the presence of a distal alimentary anastomosis. This study compared postoperative complications, dietary recovery, and survival among three reconstructive strategies.


Methods
This retrospective cohort study included 102 patients who underwent total hypopharyngeal reconstruction between 2015 and 2025 using a free anterolateral thigh (ALT) fasciocutaneous flap (n = 57), gastric pull‐up (n = 24), or free ileocolonic flap (n = 21). Postoperative complications, long‐term dietary outcomes, and 5‐year survival were evaluated. Time to regular diet was analyzed using multivariable Cox proportional hazards models adjusting for age, body mass index, length of hospitalization, and endocrine comorbidities.


Results
Baseline characteristics were similar across groups. Early pharyngocutaneous fistulas were most common in the ileocolonic flap group (23.8%), whereas late fistulas occurred mainly after gastric pull‐up reconstruction (12.5%). At 3 years, regular diet was achieved by 63.2% of ALT flap patients, compared with 100% of gastric pull‐up and 90.5% of ileocolonic flap patients. After adjustment, gastric pull‐up (adjusted HR 1.79; 95% CI, 1.05–3.07) and ileocolonic flap reconstruction (adjusted HR 2.00; 95% CI, 1.06–3.79) were independently associated with faster dietary recovery compared with ALT flaps. Five‐year survival did not differ significantly among groups.


Conclusion
Visceral reconstructions yield superior dietary recovery compared with fasciocutaneous flaps for total hypopharyngeal defects. The absence of a distal anastomosis alone did not confer a clear functional benefit, underscoring the importance of conduit biology over anastomotic number.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/8ea82375-1ca4-4b53-9998-b3353c290541/lary70613-toc-0001-m.png"
     alt="Does Omitting Distal Anastomosis in Hypopharyngeal Defect Reconstruction Improve Dietary Outcomes?"/&gt;
&lt;p&gt;Omitting distal anastomosis did not improve dietary outcomes in total hypopharyngeal reconstruction. Free ileocolonic flaps achieved comparable or better recovery than gastric pull-up, suggesting conduit biology outweighs anastomotic number.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Circumferential reconstruction is required for total hypopharyngeal defects to restore swallowing. Reconstructive options differ in conduit biology and anastomotic configuration, particularly the presence of a distal alimentary anastomosis. This study compared postoperative complications, dietary recovery, and survival among three reconstructive strategies.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective cohort study included 102 patients who underwent total hypopharyngeal reconstruction between 2015 and 2025 using a free anterolateral thigh (ALT) fasciocutaneous flap (&lt;i&gt;n&lt;/i&gt; = 57), gastric pull-up (&lt;i&gt;n&lt;/i&gt; = 24), or free ileocolonic flap (&lt;i&gt;n&lt;/i&gt; = 21). Postoperative complications, long-term dietary outcomes, and 5-year survival were evaluated. Time to regular diet was analyzed using multivariable Cox proportional hazards models adjusting for age, body mass index, length of hospitalization, and endocrine comorbidities.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Baseline characteristics were similar across groups. Early pharyngocutaneous fistulas were most common in the ileocolonic flap group (23.8%), whereas late fistulas occurred mainly after gastric pull-up reconstruction (12.5%). At 3 years, regular diet was achieved by 63.2% of ALT flap patients, compared with 100% of gastric pull-up and 90.5% of ileocolonic flap patients. After adjustment, gastric pull-up (adjusted HR 1.79; 95% CI, 1.05–3.07) and ileocolonic flap reconstruction (adjusted HR 2.00; 95% CI, 1.06–3.79) were independently associated with faster dietary recovery compared with ALT flaps. Five-year survival did not differ significantly among groups.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Visceral reconstructions yield superior dietary recovery compared with fasciocutaneous flaps for total hypopharyngeal defects. The absence of a distal anastomosis alone did not confer a clear functional benefit, underscoring the importance of conduit biology over anastomotic number.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Jian‐Xun Chen, 
Chia‐Kai Hsu, 
Shane D. Morrison, 
Mei‐Chen Lin, 
Pin‐Keng Shih
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Does Omitting Distal Anastomosis in Hypopharyngeal Defect Reconstruction Improve Dietary Outcomes?</dc:title>
         <dc:identifier>10.1002/lary.70613</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70613</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70613?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70614?af=R</link>
         <pubDate>Tue, 12 May 2026 04:48:42 -0700</pubDate>
         <dc:date>2026-05-12T04:48:42-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70614</guid>
         <title>Prognostic Significance of Lymph Node Parameters in Laryngeal Cancer After Laryngectomy</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Lymph node parameters were evaluated as prognostic factors in laryngeal cancer following laryngectomy. Metastatic lymph node count remained an independent predictor of overall survival in multivariable analysis, and an optimal lymph node ratio (LNR) cutoff of 0.045 was identified, with higher values associated with worse outcomes. These findings underscore the prognostic value of lymph node parameters in risk stratification.

ABSTRACT

Objective
The aim of this study was to evaluate the prognostic significance of lymph node yield, lymph node positivity ratio, and metastatic lymph node count in patients with laryngeal cancer undergoing laryngectomy with neck dissection, and to identify optimal cutoff values for these parameters using receiver operating characteristic (ROC) curve analysis.


Methods
This retrospective study included 48 patients who underwent partial or total laryngectomy with bilateral neck dissection at a tertiary referral center between January 2015 and December 2019. Demographic characteristics, TNM stage, lymph node parameters, pathological risk factors, recurrence, and mortality were analyzed. Neck dissection primarily bilateral involved cervical levels II–IV, with additional levels dissected when clinically or radiologically indicated.


Results
Metastatic lymph node count was significantly associated with overall survival in both univariate and multivariable Cox analyses (HR: 1.344, p &lt; 0.001; HR: 1.348, p = 0.007, respectively). An optimal lymph node ratio (LNR) cutoff of 0.045 was identified. LNR ≥ 0.045 was associated with poorer survival (log‐rank p = 0.006) and increased mortality in univariate analysis (HR: 4.815; p = 0.013), but not in multivariable analysis (p = 0.325).


Conclusions
In conclusion, the findings of this study demonstrate that lymph node‐based parameters are important prognostic indicators in laryngeal cancer. Among these, the absolute number of metastatic lymph nodes emerged as the most robust and biologically meaningful predictor of overall survival.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/1ff69555-4220-4618-acea-52b8994df327/lary70614-toc-0001-m.png"
     alt="Prognostic Significance of Lymph Node Parameters in Laryngeal Cancer After Laryngectomy"/&gt;
&lt;p&gt;Lymph node parameters were evaluated as prognostic factors in laryngeal cancer following laryngectomy. Metastatic lymph node count remained an independent predictor of overall survival in multivariable analysis, and an optimal lymph node ratio (LNR) cutoff of 0.045 was identified, with higher values associated with worse outcomes. These findings underscore the prognostic value of lymph node parameters in risk stratification.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;The aim of this study was to evaluate the prognostic significance of lymph node yield, lymph node positivity ratio, and metastatic lymph node count in patients with laryngeal cancer undergoing laryngectomy with neck dissection, and to identify optimal cutoff values for these parameters using receiver operating characteristic (ROC) curve analysis.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective study included 48 patients who underwent partial or total laryngectomy with bilateral neck dissection at a tertiary referral center between January 2015 and December 2019. Demographic characteristics, TNM stage, lymph node parameters, pathological risk factors, recurrence, and mortality were analyzed. Neck dissection primarily bilateral involved cervical levels II–IV, with additional levels dissected when clinically or radiologically indicated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Metastatic lymph node count was significantly associated with overall survival in both univariate and multivariable Cox analyses (HR: 1.344, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001; HR: 1.348, &lt;i&gt;p&lt;/i&gt; = 0.007, respectively). An optimal lymph node ratio (LNR) cutoff of 0.045 was identified. LNR ≥ 0.045 was associated with poorer survival (log-rank &lt;i&gt;p&lt;/i&gt; = 0.006) and increased mortality in univariate analysis (HR: 4.815; &lt;i&gt;p&lt;/i&gt; = 0.013), but not in multivariable analysis (&lt;i&gt;p&lt;/i&gt; = 0.325).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In conclusion, the findings of this study demonstrate that lymph node-based parameters are important prognostic indicators in laryngeal cancer. Among these, the absolute number of metastatic lymph nodes emerged as the most robust and biologically meaningful predictor of overall survival.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Melih Solhan, 
Serhan Cömertoğlu, 
Mehmet Ekrem Zorlu, 
Metin Yılmaz, 
Süleyman Cebeci, 
Utku Aydil, 
Mehmet Düzlü
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Prognostic Significance of Lymph Node Parameters in Laryngeal Cancer After Laryngectomy</dc:title>
         <dc:identifier>10.1002/lary.70614</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70614</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70614?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70611?af=R</link>
         <pubDate>Tue, 12 May 2026 03:05:11 -0700</pubDate>
         <dc:date>2026-05-12T03:05:11-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70611</guid>
         <title>Refining the Multivariable Predictive‐Prognostic PREDICTR‐OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
The PREDICTR‐OPC model is the only prognostic classifier for oropharyngeal squamous cell carcinoma (OPSCC) that also predicts surgical outcomes. This study demonstrates that removing survivin from the model preserves its prognostic and predictive performance, with comparable discrimination, calibration, and clinical utility across training and validation cohorts. The simplified three‐biomarker model offers a more cost‐effective and practical tool for guiding surgical escalation in OPSCC treatment.

ABSTRACT

Objectives
The PREDICTR‐OPC model is the only prognostic classifier for oropharyngeal squamous cell carcinoma (OPSCC) also predictive of surgical outcomes. Of the four biomarkers included, survivin contributes minimally and presents practical limitations. This study aimed to refine and simplify the model by removing survivin, then re‐assess its prognostic predictive performance compared to the original.


Methods
This retrospective cohort study analyzed a multi‐center training cohort (n = 600) and an external validation cohort (n = 385) of OPSCC patients. Tumor biopsies were stained for p16, high‐risk human papillomavirus (HR‐HPV) DNA, tumor‐infiltrating lymphocytes (TILs), and survivin and independently scored by at least three certified pathologists. Cox proportional hazards models assessed overall survival (OS), comparing three‐biomarker (p16, HR‐HPV, TILs) and four‐biomarker models. Hazard ratios (HRs) for OS were estimated in the validation cohort, adjusting for covariates. Discrimination, calibration, and decision curve analysis (DCA) evaluated performance and clinical utility.


Results
Among 985 patients (median age: 57 years), median OS = 8.8 years (95% CI: 6.9–10.5). The three‐biomarker model yielded HR = 4.10 (95% CI: 2.41–6.98, p &lt; 0.001) for high‐ vs. low‐risk groups in the validation cohort, comparable to the four‐biomarker model (HR = 4.24, p &lt; 0.001). Surgery was associated with improved OS in high‐risk (HR = 0.45, p = 0.001) but not low‐risk (HR = 0.83, p = 0.72) patients, consistent with the original model.
The models performed similarly across all metrics (e.g., Concordance Index: 0.71 vs. 0.72; Brier Score: 0.22 for both) as was model fit (Likelihood Ratio Test: p = 0.066). DCA revealed comparable clinical benefit.


Conclusion
Removing survivin preserves PREDICTR‐OPC's predictive performance, offering a more cost‐effective, easier‐to‐implement tool for OPSCC treatment recommendations.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/e5ccf61b-4a07-45a6-8575-6f16da26c409/lary70611-toc-0001-m.png"
     alt="Refining the Multivariable Predictive-Prognostic PREDICTR-OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma"/&gt;
&lt;p&gt;The PREDICTR-OPC model is the only prognostic classifier for oropharyngeal squamous cell carcinoma (OPSCC) that also predicts surgical outcomes. This study demonstrates that removing survivin from the model preserves its prognostic and predictive performance, with comparable discrimination, calibration, and clinical utility across training and validation cohorts. The simplified three-biomarker model offers a more cost-effective and practical tool for guiding surgical escalation in OPSCC treatment.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;The PREDICTR-OPC model is the only prognostic classifier for oropharyngeal squamous cell carcinoma (OPSCC) also predictive of surgical outcomes. Of the four biomarkers included, survivin contributes minimally and presents practical limitations. This study aimed to refine and simplify the model by removing survivin, then re-assess its prognostic predictive performance compared to the original.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective cohort study analyzed a multi-center training cohort (&lt;i&gt;n&lt;/i&gt; = 600) and an external validation cohort (&lt;i&gt;n&lt;/i&gt; = 385) of OPSCC patients. Tumor biopsies were stained for p16, high-risk human papillomavirus (HR-HPV) DNA, tumor-infiltrating lymphocytes (TILs), and survivin and independently scored by at least three certified pathologists. Cox proportional hazards models assessed overall survival (OS), comparing three-biomarker (p16, HR-HPV, TILs) and four-biomarker models. Hazard ratios (HRs) for OS were estimated in the validation cohort, adjusting for covariates. Discrimination, calibration, and decision curve analysis (DCA) evaluated performance and clinical utility.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 985 patients (median age: 57 years), median OS = 8.8 years (95% CI: 6.9–10.5). The three-biomarker model yielded HR = 4.10 (95% CI: 2.41–6.98, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) for high- vs. low-risk groups in the validation cohort, comparable to the four-biomarker model (HR = 4.24, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Surgery was associated with improved OS in high-risk (HR = 0.45, &lt;i&gt;p&lt;/i&gt; = 0.001) but not low-risk (HR = 0.83, &lt;i&gt;p&lt;/i&gt; = 0.72) patients, consistent with the original model.&lt;/p&gt;
&lt;p&gt;The models performed similarly across all metrics (e.g., Concordance Index: 0.71 vs. 0.72; Brier Score: 0.22 for both) as was model fit (Likelihood Ratio Test: &lt;i&gt;p&lt;/i&gt; = 0.066). DCA revealed comparable clinical benefit.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Removing survivin preserves PREDICTR-OPC's predictive performance, offering a more cost-effective, easier-to-implement tool for OPSCC treatment recommendations.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Lauren L. Zhang, 
Caroline Kristunas, 
C. Max Robinson, 
Jill M. Brooks, 
Alice J. Sitch, 
Stuart C. Winter, 
Justin Weir, 
Paul Matthews, 
Terry M. Jones, 
Keith Hunter, 
Pawel Golusinski, 
Ketan A. Shah, 
Selvam Thavaraj, 
Catharine M. West, 
Syed Haider, 
Edward Odell, 
Paul Nankivell, 
Sandra V. von Zeidler, 
Hisham Mehanna
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Refining the Multivariable Predictive‐Prognostic PREDICTR‐OPC Model for Survival in Surgical Escalation for Oropharyngeal Squamous Cell Carcinoma</dc:title>
         <dc:identifier>10.1002/lary.70611</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70611</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70611?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70608?af=R</link>
         <pubDate>Mon, 11 May 2026 23:41:49 -0700</pubDate>
         <dc:date>2026-05-11T11:41:49-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70608</guid>
         <title>Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This case report describes the use of targeted intracordal bevacizumab therapy for recurrent vocal fold hemorrhage refractory to conventional treatment. The intervention was associated with resolution of hemorrhagic episodes and sustained clinical improvement over follow‐up. These findings suggest a potential role for antiangiogenic therapy in selected cases.
</dc:description>
         <content:encoded>&lt;img src="https://onlinelibrary.wiley.com/cms/asset/2d321a48-96ae-4c05-90ba-14c51e3f5cfa/lary70608-toc-0001-m.png"
     alt="Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report"/&gt;
&lt;p&gt;This case report describes the use of targeted intracordal bevacizumab therapy for recurrent vocal fold hemorrhage refractory to conventional treatment. The intervention was associated with resolution of hemorrhagic episodes and sustained clinical improvement over follow-up. These findings suggest a potential role for antiangiogenic therapy in selected cases.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Andrés Lanas Volz, 
Camila Ramírez Pelayo
</dc:creator>
         <category>CASE REPORT</category>
         <dc:title>Targeted Bevacizumab Therapy for Recurrent Vocal Fold Hemorrhage: First Case Report</dc:title>
         <dc:identifier>10.1002/lary.70608</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70608</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70608?af=R</prism:url>
         <prism:section>CASE REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70456?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70456</guid>
         <title>In‐Office Injection for Retrograde Cricopharyngeal Dysfunction Treatment
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2681-2683, June 2026. </description>
         <dc:description>
This “How I Do It” article details an in‐office, EMG‐guided modified lateral transcervical botulinum toxin injection into the cricopharyngeus muscle for retrograde cricopharyngeal dysfunction. It highlights patient positioning, surface landmarking, and EMG confirmation of correct needle placement using swallow and sniff maneuvers. The technique provides a rapid office‐based alternative to the operating room approach and includes practical counseling on expected side effects and the common need for a planned contralateral injection when initial benefit is incomplete or wanes.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/942eaebe-6b04-4629-9764-d40ba9080d6a/lary70456-toc-0001-m.png"
     alt="In-Office Injection for Retrograde Cricopharyngeal Dysfunction Treatment&amp;#xA;"/&gt;
&lt;p&gt;This “How I Do It” article details an in-office, EMG-guided modified lateral transcervical botulinum toxin injection into the cricopharyngeus muscle for retrograde cricopharyngeal dysfunction. It highlights patient positioning, surface landmarking, and EMG confirmation of correct needle placement using swallow and sniff maneuvers. The technique provides a rapid office-based alternative to the operating room approach and includes practical counseling on expected side effects and the common need for a planned contralateral injection when initial benefit is incomplete or wanes.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Michael J. Lahiff, 
Rachel B. Kutler, 
Michael J. Pitman, 
Hayley L. Born
</dc:creator>
         <category>How I Do It</category>
         <dc:title>In‐Office Injection for Retrograde Cricopharyngeal Dysfunction Treatment
</dc:title>
         <dc:identifier>10.1002/lary.70456</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70456</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70456?af=R</prism:url>
         <prism:section>How I Do It</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70359?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70359</guid>
         <title>Upper Airway Obstruction due to Kaposi Sarcoma—Presenting Sign of HIV: Case Report and Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2631-2637, June 2026. </description>
         <dc:description>
This study presents a case of undiagnosed HIV presenting with Kaposi sarcoma (KS) of the head and neck with acute upper airway obstruction (UAO) and provides an updated scoping literature review to examine the patient characteristics, lesion characteristics, interventions, and outcomes of KS cases with UAO from the pharynx, larynx, and/or trachea.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/2fa3f2d1-cbf4-440a-9838-3c10c368870d/lary70359-toc-0001-m.png"
     alt="Upper Airway Obstruction due to Kaposi Sarcoma—Presenting Sign of HIV: Case Report and Review"/&gt;
&lt;p&gt;This study presents a case of undiagnosed HIV presenting with Kaposi sarcoma (KS) of the head and neck with acute upper airway obstruction (UAO) and provides an updated scoping literature review to examine the patient characteristics, lesion characteristics, interventions, and outcomes of KS cases with UAO from the pharynx, larynx, and/or trachea.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Zachary A. Wykoff, 
Logan F. McColl, 
Robert A. Baiocchi, 
Matthew O. Old
</dc:creator>
         <category>Case Report</category>
         <dc:title>Upper Airway Obstruction due to Kaposi Sarcoma—Presenting Sign of HIV: Case Report and Review</dc:title>
         <dc:identifier>10.1002/lary.70359</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70359</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70359?af=R</prism:url>
         <prism:section>Case Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70387?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70387</guid>
         <title>Endoscopic Repair of a Superior Orbital Roof Blow‐In Fracture: A Rare Case Report</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2499-2502, June 2026. </description>
         <dc:description>
Isolated superior orbital roof blow‐in fractures are rare and may result in functional or aesthetic impairment requiring surgical intervention. This case report demonstrates the successful endoscopic repair of such a fracture, emphasizing the advantages of endoscopic techniques in achieving adequate visualization when direct access to the fracture site is limited.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/ac7c8eea-50d7-4992-8d84-fbc8d041719e/lary70387-toc-0001-m.png"
     alt="Endoscopic Repair of a Superior Orbital Roof Blow-In Fracture: A Rare Case Report"/&gt;
&lt;p&gt;Isolated superior orbital roof blow-in fractures are rare and may result in functional or aesthetic impairment requiring surgical intervention. This case report demonstrates the successful endoscopic repair of such a fracture, emphasizing the advantages of endoscopic techniques in achieving adequate visualization when direct access to the fracture site is limited.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Ergin Eroğlu, 
Burçay Tellioğlu, 
Yasin Gökçınar, 
Serdar Özer
</dc:creator>
         <category>Case Report</category>
         <dc:title>Endoscopic Repair of a Superior Orbital Roof Blow‐In Fracture: A Rare Case Report</dc:title>
         <dc:identifier>10.1002/lary.70387</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70387</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70387?af=R</prism:url>
         <prism:section>Case Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70411?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70411</guid>
         <title>Implementing the Palatal Plate for Robin Sequence Beyond the Originating Center: How I Do It
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2801-2804, June 2026. </description>
         <dc:description>
The treatment of upper airway obstruction in newborns with Robin sequence (RS) is challenging. We report our experience implementing the minimally invasive Tübingen palatal plate in a pediatric tertiary care center, detailing a step‐by‐step protocol and clinical outcomes from our first patient series. Despite a learning curve and need for multidisciplinary coordination, the palatal plate can be safely and effectively integrated outside its center of origin.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7695ad6f-e4aa-478d-b8e2-c76e2d432b51/lary70411-toc-0001-m.png"
     alt="Implementing the Palatal Plate for Robin Sequence Beyond the Originating Center: How I Do It&amp;#xA;"/&gt;
&lt;p&gt;The treatment of upper airway obstruction in newborns with Robin sequence (RS) is challenging. We report our experience implementing the minimally invasive Tübingen palatal plate in a pediatric tertiary care center, detailing a step-by-step protocol and clinical outcomes from our first patient series. Despite a learning curve and need for multidisciplinary coordination, the palatal plate can be safely and effectively integrated outside its center of origin.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Agnès Giuseppi, 
Nancy Vegas, 
Briac Thierry, 
Véronique Soupre, 
Alexandre Donatien, 
Pauline Adnot, 
Brigitte Fauroux, 
Alexandre Lapillonne, 
Romain Luscan
</dc:creator>
         <category>How I Do It</category>
         <dc:title>Implementing the Palatal Plate for Robin Sequence Beyond the Originating Center: How I Do It
</dc:title>
         <dc:identifier>10.1002/lary.70411</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70411</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70411?af=R</prism:url>
         <prism:section>How I Do It</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70449?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70449</guid>
         <title>Plain Film Acquisition Techniques for Identification of Cochlear Implant Magnet Displacement
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2761-2764, June 2026. </description>
         <dc:description>
We describe a simple, reproducible patient‐positioning protocol to facilitate acquisition of plain film radiographs that reliably depict CI magnet orientation, thereby minimizing the need for repeat imaging or CT to determine the presence of magnet displacement. This approach leverages widely available imaging equipment and can be easily adopted in multiple patient care settings without specialized hardware or software. The image below depicts plain skull radiographs obtained using the standardized patient positioning protocol demonstrating bilateral cochlear implant magnet position before (A, B) and after (C, D) manual reduction.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/1c02f973-54eb-44c6-b6d8-b5000ff77de7/lary70449-toc-0001-m.png"
     alt="Plain Film Acquisition Techniques for Identification of Cochlear Implant Magnet Displacement&amp;#xA;"/&gt;
&lt;p&gt;We describe a simple, reproducible patient-positioning protocol to facilitate acquisition of plain film radiographs that reliably depict CI magnet orientation, thereby minimizing the need for repeat imaging or CT to determine the presence of magnet displacement. This approach leverages widely available imaging equipment and can be easily adopted in multiple patient care settings without specialized hardware or software. The image below depicts plain skull radiographs obtained using the standardized patient positioning protocol demonstrating bilateral cochlear implant magnet position before (A, B) and after (C, D) manual reduction.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Madison V. Epperson, 
Robert E. Watson Jr, 
Cindy L. Lange, 
Matthew L. Carlson
</dc:creator>
         <category>How I Do It</category>
         <dc:title>Plain Film Acquisition Techniques for Identification of Cochlear Implant Magnet Displacement
</dc:title>
         <dc:identifier>10.1002/lary.70449</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70449</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70449?af=R</prism:url>
         <prism:section>How I Do It</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70516?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70516</guid>
         <title>Piezosurgery‐Assisted Endoscopic Transpterygoid Approach for Maxillary Ameloblastoma
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2554-2557, June 2026. </description>
         <dc:description>
The use of piezoelectric instrumentation has been investigated to perform an endoscopic‐assisted transpterygoid maxillectomy for a maxillary ameloblastoma. This technology allowed safe disinsertion of the pterygoid root from the cranial base through a precise and clean osteotomy, while minimizing the risk of inadvertent soft‐tissue injury. Piezoelectric saws can represent an alternative to high‐speed endoscopic drills in selected cases. For posterior maxillary neoplasms, we recommend the employment of endoscopic‐assisted maxillectomy, as it offers improved anatomical exposure and a more accurate control of tumor margins.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/2150035e-7bb8-43cb-8e5b-b033fa83c759/lary70516-toc-0001-m.png"
     alt="Piezosurgery-Assisted Endoscopic Transpterygoid Approach for Maxillary Ameloblastoma&amp;#xA;"/&gt;
&lt;p&gt;The use of piezoelectric instrumentation has been investigated to perform an endoscopic-assisted transpterygoid maxillectomy for a maxillary ameloblastoma. This technology allowed safe disinsertion of the pterygoid root from the cranial base through a precise and clean osteotomy, while minimizing the risk of inadvertent soft-tissue injury. Piezoelectric saws can represent an alternative to high-speed endoscopic drills in selected cases. For posterior maxillary neoplasms, we recommend the employment of endoscopic-assisted maxillectomy, as it offers improved anatomical exposure and a more accurate control of tumor margins.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Alessandro Ioppi, 
Nicola Bragagna, 
Walter Decaminada, 
Giangiacomo Sanna, 
Lorenzo Trevisiol, 
Ottavio Piccin
</dc:creator>
         <category>How I Do It</category>
         <dc:title>Piezosurgery‐Assisted Endoscopic Transpterygoid Approach for Maxillary Ameloblastoma
</dc:title>
         <dc:identifier>10.1002/lary.70516</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70516</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70516?af=R</prism:url>
         <prism:section>How I Do It</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70369?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70369</guid>
         <title>Acromegaly Presenting With Cricoarytenoid Joint Arthropathy</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2678-2680, June 2026. </description>
         <dc:description>
Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.








ABSTRACT
Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/bb3dfc62-7a38-4897-a027-e12c559b956f/lary70369-toc-0001-m.png"
     alt="Acromegaly Presenting With Cricoarytenoid Joint Arthropathy"/&gt;
&lt;p&gt;Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;p&gt;Excess growth hormone in acromegaly induces characteristic acral and soft tissue overgrowth (particularly in the face and hands), arthropathies, as well as cardiovascular and metabolic complications. Similar proliferative changes can occur in the larynx, where hypertrophy of the arytenoid and cricoid cartilages may impair vocal fold mobility. We describe a rare case of acromegaly affecting the cricoarytenoid joints (CAJ), leading to proximal airway obstruction and demonstrating that these diarthrodial joints are susceptible to systemic arthropathies.&lt;/p&gt;</content:encoded>
         <dc:creator>
Samantha Salvi Cruz, 
Riley Larkin, 
Ioan Lina, 
Alexander Gelbard
</dc:creator>
         <category>Case Report</category>
         <dc:title>Acromegaly Presenting With Cricoarytenoid Joint Arthropathy</dc:title>
         <dc:identifier>10.1002/lary.70369</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70369</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70369?af=R</prism:url>
         <prism:section>Case Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70499?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70499</guid>
         <title>The Evolution in Medical Assistance in Dying for Head and Neck Cancer</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2391-2393, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Shreya Mandava, 
Andrew G. Shuman
</dc:creator>
         <category>Editorial</category>
         <dc:title>The Evolution in Medical Assistance in Dying for Head and Neck Cancer</dc:title>
         <dc:identifier>10.1002/lary.70499</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70499</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70499?af=R</prism:url>
         <prism:section>Editorial</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70519?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70519</guid>
         <title>New Frontiers in Microvascular Reconstruction of Mandibular Osteoradionecrosis</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2394-2395, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
P. Daniel Knott, 
Samuel H. Selesnick
</dc:creator>
         <category>Editorial</category>
         <dc:title>New Frontiers in Microvascular Reconstruction of Mandibular Osteoradionecrosis</dc:title>
         <dc:identifier>10.1002/lary.70519</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70519</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70519?af=R</prism:url>
         <prism:section>Editorial</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.31525?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.31525</guid>
         <title>Issue Information</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2381-2390, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator/>
         <category>Issue Information</category>
         <dc:title>Issue Information</dc:title>
         <dc:identifier>10.1002/lary.31525</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.31525</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.31525?af=R</prism:url>
         <prism:section>Issue Information</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70541?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70541</guid>
         <title>Correction to “Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID‐19”</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2827-2827, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator/>
         <category>Correction</category>
         <dc:title>Correction to “Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID‐19”</dc:title>
         <dc:identifier>10.1002/lary.70541</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70541</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70541?af=R</prism:url>
         <prism:section>Correction</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70495?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70495</guid>
         <title>Lessons in Otolaryngology: From Mentorship to Sponsorship</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2396-2397, June 2026. </description>
         <dc:description>
This study offers insight into the nuances of leadership development and emergence for female chairs in the evolving landscape of leadership in Otolaryngology‐Head and Neck Surgery. Elucidating the various pathways to leadership will assist in advancing careers and will assist in fostering diversity in surgical leadership roles.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/98659a2b-2112-4381-bf8f-19bf4c179aaa/lary70495-toc-0001-m.png"
     alt="Lessons in Otolaryngology: From Mentorship to Sponsorship"/&gt;
&lt;p&gt;This study offers insight into the nuances of leadership development and emergence for female chairs in the evolving landscape of leadership in Otolaryngology-Head and Neck Surgery. Elucidating the various pathways to leadership will assist in advancing careers and will assist in fostering diversity in surgical leadership roles.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Amanda J. Bastien, 
Janice L. Farlow, 
Mia E. Miller, 
Priya D. Krishna, 
Anca M. Barbu
</dc:creator>
         <category>Rapid Communication</category>
         <dc:title>Lessons in Otolaryngology: From Mentorship to Sponsorship</dc:title>
         <dc:identifier>10.1002/lary.70495</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70495</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70495?af=R</prism:url>
         <prism:section>Rapid Communication</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70337?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70337</guid>
         <title>Histamine 2‐Receptor Antagonists Tachyphylaxis: A Scoping Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2412-2425, June 2026. </description>
         <dc:description>
Histamine 2‐receptor antagonists (H2RAs) are commonly used to treat gastroesophageal reflux disease. However, tachyphylaxis, defined as the rapid reduction of efficacy, is frequently reported and remains poorly understood. This investigation performed a scoping review on the decrease in H2RA efficacy with consistent use.








ABSTRACT

Objective
Histamine 2‐receptor antagonists (H2RAs) commonly treat gastroesophageal reflux disease (GERD). However, tachyphylaxis, defined as the rapid reduction of efficacy, is frequently reported and remains poorly understood. This investigation performed a scoping review on the decrease in H2RA efficacy with repeat dosing.


Data Source
Following PRISMA‐ScR guidelines, we systematically searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Database through August 27, 2025.


Review Method
Two reviewers independently screened studies and extracted data on mechanisms, impact, and management strategies.


Results
While H2RAs effectively reduce gastric acid secretion, continuous dosing leads to tachyphylaxis of unclear etiology. Initial H2RA treatment increases the percentage of time intragastric pH is &gt; 4, from 8% to 38%. Tachyphylaxis begins by the second dose, 2, with an 11.2% reduction in efficacy by day 3. By day 15, tachyphylaxis results in a 13.0%–27.5% (mean: 20.3%) decrease in efficacy, after which no further reduction in effectiveness occurs. In comparison, once‐daily proton pump inhibitors maintain a daily intragastric pH of 63% above 4, with no tachyphylaxis observed after 14 days.


Conclusion
Tachyphylaxis is a well‐documented, diminished treatment effect observed across the entire class of H2RAs. It typically begins by day 2 and plateaus quickly, resulting in up to a quarter decrease in absolute efficacy. The precise mechanisms underlying H2RA tachyphylaxis remain uncertain. H2RAs should not be prescribed as first‐line agents for the management of frequent GERD or routinely added in cases of incomplete response to PPIs.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/081a5ace-973a-4436-b57b-aaaa9a4bf3ef/lary70337-toc-0001-m.png"
     alt="Histamine 2-Receptor Antagonists Tachyphylaxis: A Scoping Review"/&gt;
&lt;p&gt;Histamine 2-receptor antagonists (H2RAs) are commonly used to treat gastroesophageal reflux disease. However, tachyphylaxis, defined as the rapid reduction of efficacy, is frequently reported and remains poorly understood. This investigation performed a scoping review on the decrease in H2RA efficacy with consistent use.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Histamine 2-receptor antagonists (H2RAs) commonly treat gastroesophageal reflux disease (GERD). However, tachyphylaxis, defined as the rapid reduction of efficacy, is frequently reported and remains poorly understood. This investigation performed a scoping review on the decrease in H2RA efficacy with repeat dosing.&lt;/p&gt;
&lt;h2&gt;Data Source&lt;/h2&gt;
&lt;p&gt;Following PRISMA-ScR guidelines, we systematically searched PubMed, Embase, Scopus, Web of Science, and the Cochrane Database through August 27, 2025.&lt;/p&gt;
&lt;h2&gt;Review Method&lt;/h2&gt;
&lt;p&gt;Two reviewers independently screened studies and extracted data on mechanisms, impact, and management strategies.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;While H2RAs effectively reduce gastric acid secretion, continuous dosing leads to tachyphylaxis of unclear etiology. Initial H2RA treatment increases the percentage of time intragastric pH is &amp;gt; 4, from 8% to 38%. Tachyphylaxis begins by the second dose, 2, with an 11.2% reduction in efficacy by day 3. By day 15, tachyphylaxis results in a 13.0%–27.5% (mean: 20.3%) decrease in efficacy, after which no further reduction in effectiveness occurs. In comparison, once-daily proton pump inhibitors maintain a daily intragastric pH of 63% above 4, with no tachyphylaxis observed after 14 days.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Tachyphylaxis is a well-documented, diminished treatment effect observed across the entire class of H2RAs. It typically begins by day 2 and plateaus quickly, resulting in up to a quarter decrease in absolute efficacy. The precise mechanisms underlying H2RA tachyphylaxis remain uncertain. H2RAs should not be prescribed as first-line agents for the management of frequent GERD or routinely added in cases of incomplete response to PPIs.&lt;/p&gt;</content:encoded>
         <dc:creator>
James H. Clark, 
Zilla Hussain, 
Lee Akst, 
Stanley L. Marks, 
Peter C. Belafsky
</dc:creator>
         <category>Scoping Review</category>
         <dc:title>Histamine 2‐Receptor Antagonists Tachyphylaxis: A Scoping Review</dc:title>
         <dc:identifier>10.1002/lary.70337</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70337</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70337?af=R</prism:url>
         <prism:section>Scoping Review</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70342?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70342</guid>
         <title>Outcomes and Innervation of Gracilis for Pediatric Facial Paralysis: A Systematic Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2461-2472, June 2026. </description>
         <dc:description>
This systematic review compares innervation techniques for gracilis free muscle transfer in pediatric facial paralysis. Masseteric innervation produced the greatest commissure excursion, cross‐facial nerve grafting enabled spontaneous smiles, and dual innervation balanced both with high satisfaction and low complication rates across techniques.








ABSTRACT

Objective
This systematic review aims to describe and compare outcomes of innervation techniques for gracilis free muscle transfers for facial reanimation in the pediatric population.


Data Sources
CINAHL, PubMed, and SCOPUS were systematically queried from inception to November 18, 2025.


Review Methods
Eligible studies included pediatric patients (≤ 18 years old) who underwent free gracilis muscle transfer for facial reanimation. Outcomes extracted included commissure excursion, facial asymmetry, validated instruments, patient satisfaction, and complications. Study quality was assessed using the Joanna Briggs Institute appraisal tool.


Results
A total of 15 retrospective studies were included for review, covering cross‐facial nerve graft, masseteric innervation, and dual‐innervation. The mean age at time of surgery was 9.0 ± 0.8 years with a mean follow‐up time of 3.0 ± 0.5 years. Muscle innervation was achieved primarily with CFNG (52.1%), followed by masseteric (33.2%). Masseteric innervation generally produced the largest amount of commissure excursion (range: 6.1–8.6 mm), while CFNG also yielded moderate improvements (range: 4.6–6.9 mm). Overall satisfaction was high for all innervation techniques, ranging from 83% to 100%. Complications were infrequent and minor.


Conclusion
Gracilis free muscle transfer is safe and effective for pediatric facial reanimation. Masseteric innervation provides strong, volitional smiles, while CFNG provides spontaneous smiles, with dual‐innervation offering a balance of the two.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/1b776ab8-e8e3-404c-839f-001f9c73d1fa/lary70342-toc-0001-m.png"
     alt="Outcomes and Innervation of Gracilis for Pediatric Facial Paralysis: A Systematic Review"/&gt;
&lt;p&gt;This systematic review compares innervation techniques for gracilis free muscle transfer in pediatric facial paralysis. Masseteric innervation produced the greatest commissure excursion, cross-facial nerve grafting enabled spontaneous smiles, and dual innervation balanced both with high satisfaction and low complication rates across techniques.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;This systematic review aims to describe and compare outcomes of innervation techniques for gracilis free muscle transfers for facial reanimation in the pediatric population.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;CINAHL, PubMed, and SCOPUS were systematically queried from inception to November 18, 2025.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;Eligible studies included pediatric patients (≤ 18 years old) who underwent free gracilis muscle transfer for facial reanimation. Outcomes extracted included commissure excursion, facial asymmetry, validated instruments, patient satisfaction, and complications. Study quality was assessed using the Joanna Briggs Institute appraisal tool.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 15 retrospective studies were included for review, covering cross-facial nerve graft, masseteric innervation, and dual-innervation. The mean age at time of surgery was 9.0 ± 0.8 years with a mean follow-up time of 3.0 ± 0.5 years. Muscle innervation was achieved primarily with CFNG (52.1%), followed by masseteric (33.2%). Masseteric innervation generally produced the largest amount of commissure excursion (range: 6.1–8.6 mm), while CFNG also yielded moderate improvements (range: 4.6–6.9 mm). Overall satisfaction was high for all innervation techniques, ranging from 83% to 100%. Complications were infrequent and minor.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Gracilis free muscle transfer is safe and effective for pediatric facial reanimation. Masseteric innervation provides strong, volitional smiles, while CFNG provides spontaneous smiles, with dual-innervation offering a balance of the two.&lt;/p&gt;</content:encoded>
         <dc:creator>
Kaiwen Chen, 
Shaun A. Nguyen, 
Warren B. Chun, 
Charles M. Henry, 
Matthew H. Cheung, 
Cory Hyun‐su Kim, 
Michelle S. Hwang
</dc:creator>
         <category>Systematic Review</category>
         <dc:title>Outcomes and Innervation of Gracilis for Pediatric Facial Paralysis: A Systematic Review</dc:title>
         <dc:identifier>10.1002/lary.70342</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70342</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70342?af=R</prism:url>
         <prism:section>Systematic Review</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70368?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70368</guid>
         <title>
Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2449-2460, June 2026. </description>
         <dc:description>
PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles.








ABSTRACT

Objective
Mesna (Sodium 2‐mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond‐breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and other adhesions. This review evaluates the effectiveness and toxicity of Mesna in its various uses of otologic surgeries.


Data Sources
A comprehensive literature search was conducted with the aid of a senior medical librarian across eight databases conducted from inception until December 28, 2024: Google Scholar, Medline (Ovid), Embase (Ovid), CINAHL (Ebsco), Cochrane (Wiley), Global Health (Ovid), Web of Science (Clarivate Analytics), Africa Wide Information (Ebsco), and Global Index Medicus (WHO). No language or publication status restrictions were applied.


Review Methods
This review was reported following the PRISMA‐ScR guidelines. Studies were eligible if they investigated the use of Mesna in otology (human or animal) and reported on either efficacy or toxicity. Two reviewers independently screened all titles/abstracts and full texts, with a third resolving discrepancies. Data were charted on application methods, concentrations, outcomes, and adverse effects and synthesized qualitatively.


Results
Eighteen studies (nine human, nine animal) met inclusion criteria. Mesna was effectively used in cholesteatoma surgery, ossicular chain fixation, tympanic tube replacement, and adhesive otitis media. Four percent to one hundred percent Mesna was used, without significant signs of toxicity in animal models and clinical research.


Conclusion
Mesna could be used effectively and safely in otologic surgery. Further research is needed to optimize concentration, method of administration, time of contact, and to quantify its effect.


Level of Evidence
NA

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/c9c04b06-dd7d-4329-b305-73c1b1730c12/lary70368-toc-0001-m.png"
     alt="&amp;#xA;Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review"/&gt;
&lt;p&gt;PRISMA flow diagram indicating the process of systematic inclusion and exclusion of articles.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Mesna (Sodium 2-mercaptoethanesulfonate) is widely used as a mucolytic agent and uroprotective agent. Recently, its disulfide bond-breaking property has been applied in otologic surgery to facilitate safer dissection of cholesteatoma and other adhesions. This review evaluates the effectiveness and toxicity of Mesna in its various uses of otologic surgeries.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;A comprehensive literature search was conducted with the aid of a senior medical librarian across eight databases conducted from inception until December 28, 2024: Google Scholar, Medline (Ovid), Embase (Ovid), CINAHL (Ebsco), Cochrane (Wiley), Global Health (Ovid), Web of Science (Clarivate Analytics), Africa Wide Information (Ebsco), and Global Index Medicus (WHO). No language or publication status restrictions were applied.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;This review was reported following the PRISMA-ScR guidelines. Studies were eligible if they investigated the use of Mesna in otology (human or animal) and reported on either efficacy or toxicity. Two reviewers independently screened all titles/abstracts and full texts, with a third resolving discrepancies. Data were charted on application methods, concentrations, outcomes, and adverse effects and synthesized qualitatively.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Eighteen studies (nine human, nine animal) met inclusion criteria. Mesna was effectively used in cholesteatoma surgery, ossicular chain fixation, tympanic tube replacement, and adhesive otitis media. Four percent to one hundred percent Mesna was used, without significant signs of toxicity in animal models and clinical research.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Mesna could be used effectively and safely in otologic surgery. Further research is needed to optimize concentration, method of administration, time of contact, and to quantify its effect.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;NA&lt;/p&gt;</content:encoded>
         <dc:creator>
Kevork H. Atamian, 
Inabat Yermesheva, 
Ostap Orishchak, 
Hady Tall, 
Sam J. Daniel
</dc:creator>
         <category>Scoping Review</category>
         <dc:title>
Mesna in Otologic Surgery: Efficacy and Safety—A Scoping Review</dc:title>
         <dc:identifier>10.1002/lary.70368</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70368</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70368?af=R</prism:url>
         <prism:section>Scoping Review</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70370?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70370</guid>
         <title>Gender‐Affirming Feminization Voice Surgery: A Scoping Review of Preoperative Assessments</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2440-2448, June 2026. </description>
         <dc:description>
PRISMA flowchart.








ABSTRACT

Objective
To identify the preoperative assessments and criteria surgeons use to assess the suitability of transfeminine patients for voice feminization surgery.


Data Sources
Electronic search of Ovid MEDLINE, Ovid Embase, APA PsycINFO, Cochrane Library, CINAHL, and PubMed excluding MEDLINE records was performed on February 11, 2025 for articles that were published from inception to the search date. No language or date limits were applied.


Study Selection
The inclusion criteria were developed using the PICOTS framework. Inclusion criteria included all studies reporting (1) assessments and surgical criteria used in; (2) transfeminine adult patients who; (3) underwent feminization voice surgery. Studies involving transmasculine patients and those addressing nonsurgical interventions for voice were excluded. Non‐feminization voice surgeries were excluded.


Data Extraction
Screening and extraction followed PRISMA‐ScR guidelines by two authors. Extracted data included study type, origin, and intervention. Clinical criteria were emphasized, including voice training, acoustic and perceptual parameters, and patient‐reported outcomes. Other factors included medical/psychiatric evaluation and hormonal therapy.


Results
Of 520 studies screened, 42 met inclusion. Most were retrospective case series/reports (2000–2025) with sample sizes from 1 to 506. Acoustic parameters, especially fundamental frequency, were commonly assessed. Perceptual tools included GRBAS, CAPE‐V, and clinician judgment by speech‐language pathologists. Patient‐reported outcomes such as the Voice Handicap Index and Trans Woman Voice Questionnaire were also used. Endoscopic evaluation was frequently performed, and CT imaging was often used for cricothyroid approximation cases.


Conclusions
There is significant variability in preoperative criteria across studies, with limited reporting on key factors like prior voice training or psychological evaluation.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/560b041a-35ad-4af4-8f73-2594c547147d/lary70370-toc-0001-m.png"
     alt="Gender-Affirming Feminization Voice Surgery: A Scoping Review of Preoperative Assessments"/&gt;
&lt;p&gt;PRISMA flowchart.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To identify the preoperative assessments and criteria surgeons use to assess the suitability of transfeminine patients for voice feminization surgery.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;Electronic search of Ovid MEDLINE, Ovid Embase, APA PsycINFO, Cochrane Library, CINAHL, and PubMed excluding MEDLINE records was performed on February 11, 2025 for articles that were published from inception to the search date. No language or date limits were applied.&lt;/p&gt;
&lt;h2&gt;Study Selection&lt;/h2&gt;
&lt;p&gt;The inclusion criteria were developed using the PICOTS framework. Inclusion criteria included all studies reporting (1) assessments and surgical criteria used in; (2) transfeminine adult patients who; (3) underwent feminization voice surgery. Studies involving transmasculine patients and those addressing nonsurgical interventions for voice were excluded. Non-feminization voice surgeries were excluded.&lt;/p&gt;
&lt;h2&gt;Data Extraction&lt;/h2&gt;
&lt;p&gt;Screening and extraction followed PRISMA-ScR guidelines by two authors. Extracted data included study type, origin, and intervention. Clinical criteria were emphasized, including voice training, acoustic and perceptual parameters, and patient-reported outcomes. Other factors included medical/psychiatric evaluation and hormonal therapy.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 520 studies screened, 42 met inclusion. Most were retrospective case series/reports (2000–2025) with sample sizes from 1 to 506. Acoustic parameters, especially fundamental frequency, were commonly assessed. Perceptual tools included GRBAS, CAPE-V, and clinician judgment by speech-language pathologists. Patient-reported outcomes such as the Voice Handicap Index and Trans Woman Voice Questionnaire were also used. Endoscopic evaluation was frequently performed, and CT imaging was often used for cricothyroid approximation cases.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;There is significant variability in preoperative criteria across studies, with limited reporting on key factors like prior voice training or psychological evaluation.&lt;/p&gt;</content:encoded>
         <dc:creator>
Jadin Chahade, 
Hedieh Keshavars, 
Janice Y. Kung, 
Teresa L. D. Hardy, 
Caroline C. Jeffery
</dc:creator>
         <category>Scoping Review</category>
         <dc:title>Gender‐Affirming Feminization Voice Surgery: A Scoping Review of Preoperative Assessments</dc:title>
         <dc:identifier>10.1002/lary.70370</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70370</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70370?af=R</prism:url>
         <prism:section>Scoping Review</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70382?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70382</guid>
         <title>Algorithmic Surgical Management of Primary Hyperparathyroidism and Its Variants: A Scoping Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2426-2439, June 2026. </description>
         <dc:description>
Primary hyperparathyroidism has varied presentations that demand nuanced approaches. Our review compares the workup and management of variant (i.e., normocalcemic hyperparathyroidism and normohormonal hyperparathyroidism) to classic hyperparathyroidism, taking into account localization studies, surgical considerations, the utility of intraoperative parathyroid hormone, and surveillance. We highlight knowledge gaps that, if addressed, will improve the care of patients with variant presentations.








ABSTRACT

Objective
Primary hyperparathyroidism (PHPT) has varied presentations whose successful surgical management demands integration of the expanding literature within a comprehensive decision‐making framework. Our objective is to compare the workup and management of variant (i.e., normocalcemic hyperparathyroidism (NCPHPT) and normohormonal hyperparathyroidism (NHPHPT)) to classic hyperparathyroidism (CPHPT), taking into account localization studies, surgical considerations, utility of intraoperative parathyroid hormone (IOPTH), and surveillance to identify gaps in knowledge that limit management outcomes of variant PHPT presentations.


Data Sources
A comprehensive search of PubMed and Google Scholar was conducted from June 11, 2024, to March 17, 2025, using MeSH terms and free‐text queries focused on imaging, surgery, and outcomes in PHPT and reported using PRISMA ScR guidelines.


Review Methods
Peer‐reviewed studies addressing surgical management of PHPT in adults, published in English, were included. Two reviewers independently screened all titles, abstracts, and full texts using previously developed inclusion criteria recorded in a shared spreadsheet. Twenty‐seven studies were included. Data were synthesized into a flow diagram to identify areas in need of further guidance.


Results
Imaging accuracy was highest with 4DCT and PET scans in both classic and variant PHPT, particularly in the setting of multiglandular disease. Not obtaining ≥ 50% IOPTH drop and/or levels below 40 pg/mL are risk factors for persistence or recurrence.


Conclusions
PHPT has varied presentations that demand nuanced approaches. Our review highlights knowledge gaps that, if addressed, will improve the care of patients with variant PHPT. Further prospective validation of this algorithmic summary is warranted to improve long‐term impact and patient outcomes.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/88c370b1-2539-4979-8051-85b692c3651b/lary70382-toc-0001-m.png"
     alt="Algorithmic Surgical Management of Primary Hyperparathyroidism and Its Variants: A Scoping Review"/&gt;
&lt;p&gt;Primary hyperparathyroidism has varied presentations that demand nuanced approaches. Our review compares the workup and management of variant (i.e., normocalcemic hyperparathyroidism and normohormonal hyperparathyroidism) to classic hyperparathyroidism, taking into account localization studies, surgical considerations, the utility of intraoperative parathyroid hormone, and surveillance. We highlight knowledge gaps that, if addressed, will improve the care of patients with variant presentations.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Primary hyperparathyroidism (PHPT) has varied presentations whose successful surgical management demands integration of the expanding literature within a comprehensive decision-making framework. Our objective is to compare the workup and management of variant (i.e., normocalcemic hyperparathyroidism (NCPHPT) and normohormonal hyperparathyroidism (NHPHPT)) to classic hyperparathyroidism (CPHPT), taking into account localization studies, surgical considerations, utility of intraoperative parathyroid hormone (IOPTH), and surveillance to identify gaps in knowledge that limit management outcomes of variant PHPT presentations.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;A comprehensive search of PubMed and Google Scholar was conducted from June 11, 2024, to March 17, 2025, using MeSH terms and free-text queries focused on imaging, surgery, and outcomes in PHPT and reported using PRISMA ScR guidelines.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;Peer-reviewed studies addressing surgical management of PHPT in adults, published in English, were included. Two reviewers independently screened all titles, abstracts, and full texts using previously developed inclusion criteria recorded in a shared spreadsheet. Twenty-seven studies were included. Data were synthesized into a flow diagram to identify areas in need of further guidance.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Imaging accuracy was highest with 4DCT and PET scans in both classic and variant PHPT, particularly in the setting of multiglandular disease. Not obtaining ≥ 50% IOPTH drop and/or levels below 40 pg/mL are risk factors for persistence or recurrence.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;PHPT has varied presentations that demand nuanced approaches. Our review highlights knowledge gaps that, if addressed, will improve the care of patients with variant PHPT. Further prospective validation of this algorithmic summary is warranted to improve long-term impact and patient outcomes.&lt;/p&gt;</content:encoded>
         <dc:creator>
Fleur Kabala, 
Todd Falcone, 
Kourosh Parham
</dc:creator>
         <category>Scoping Review</category>
         <dc:title>Algorithmic Surgical Management of Primary Hyperparathyroidism and Its Variants: A Scoping Review</dc:title>
         <dc:identifier>10.1002/lary.70382</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70382</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70382?af=R</prism:url>
         <prism:section>Scoping Review</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70347?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70347</guid>
         <title>In Response to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E96-E97, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Chien‐Yi Yang, 
Shao‐Cheng Liu
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Response to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery
</dc:title>
         <dc:identifier>10.1002/lary.70347</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70347</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70347?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70319?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70319</guid>
         <title>In Response to An Evaluation of Current Trends in AI‐Generated Text in Otolaryngology Publications
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E89-E89, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Rachel B. Kutler, 
Sruthi Surapaneni, 
Sean A. Setzen, 
Anaïs Rameau
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Response to An Evaluation of Current Trends in AI‐Generated Text in Otolaryngology Publications
</dc:title>
         <dc:identifier>10.1002/lary.70319</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70319</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70319?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70320?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70320</guid>
         <title>In Reference to An Evaluation of Current Trends in AI‐Generated Text in Otolaryngology Publications
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E88-E88, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Michael E. Dunham
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Reference to An Evaluation of Current Trends in AI‐Generated Text in Otolaryngology Publications
</dc:title>
         <dc:identifier>10.1002/lary.70320</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70320</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70320?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70329?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70329</guid>
         <title>In Response to Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E86-E87, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Daniel X. Ma, 
Ali Baird, 
Peter Papagiannopoulos
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Response to Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients
</dc:title>
         <dc:identifier>10.1002/lary.70329</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70329</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70329?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70331?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70331</guid>
         <title>In Reference to Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E84-E85, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Weitao An, 
Yahong Li
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Reference to Impact of Obesity on the Structured Histopathology of Chronic Rhinosinusitis Patients
</dc:title>
         <dc:identifier>10.1002/lary.70331</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70331</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70331?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70339?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70339</guid>
         <title>In Reference to The Role of Hypoalbuminemia in the Development of Reinke's Edema: A Prospective Cohort Study
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E90-E91, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Jerome R. Lechien, 
Matteo Lazzeroni, 
Giovanni Salzano, 
Luigi A. Vaira, 
Antonino Maniaci, 
Abdul‐Latif Hamdan
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Reference to The Role of Hypoalbuminemia in the Development of Reinke's Edema: A Prospective Cohort Study
</dc:title>
         <dc:identifier>10.1002/lary.70339</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70339</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70339?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70340?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70340</guid>
         <title>In Response to The Role of Hypoalbuminemia in the Development of Reinke's Edema: A Prospective Cohort Study
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E92-E93, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Xueshi Li, 
Jilei Zhang, 
Qingyang Shi, 
Jie Tan, 
Congli Geng, 
Yuguang Wang, 
Lin Wang, 
Xingguo Zhao, 
Lihong Zhang, 
Lisheng Yu
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Response to The Role of Hypoalbuminemia in the Development of Reinke's Edema: A Prospective Cohort Study
</dc:title>
         <dc:identifier>10.1002/lary.70340</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70340</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70340?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70346?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70346</guid>
         <title>In Response to Bilateral Sudden on Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E100-E101, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Chin‐Nung Liu, 
Hong‐Yu Yan, 
Chen‐Chi Wu
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Response to Bilateral Sudden on Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations
</dc:title>
         <dc:identifier>10.1002/lary.70346</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70346</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70346?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70348?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70348</guid>
         <title>In Reference to Bilateral Sudden or Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E98-E99, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Josef Finsterer
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Reference to Bilateral Sudden or Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations</dc:title>
         <dc:identifier>10.1002/lary.70348</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70348</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70348?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70349?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70349</guid>
         <title>In Reference to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page E94-E95, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Lala Sha, 
Xiaohong Xie
</dc:creator>
         <category>Letter to the Editor</category>
         <dc:title>In Reference to Tracheostomy Dependence in Hypopharyngeal Cancer: Comparative Prognostic Impact of CRT Versus Surgery
</dc:title>
         <dc:identifier>10.1002/lary.70349</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70349</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70349?af=R</prism:url>
         <prism:section>Letter to the Editor</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70333?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70333</guid>
         <title>Identifying Risk Factors for Sialolithiasis</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2541-2546, June 2026. </description>
         <dc:description>
Sjogren's syndrome and obesity increased the odds of sialolithiasis, while essential hypertension and uncomplicated Type 2 diabetes were inversely associated. These findings suggest that disruptions in salivary flow or glandular fluid dynamics may underlie stone formation.








ABSTRACT

Objective
To investigate potential risk factors associated with the development of sialolithiasis in a database‐driven case–control study.


Methods
The All of Us database was queried for participants with sialolithiasis. These participants were matched to controls by age, race, and gender. Demographics and medical history data, such as obesity, hypertension, tonsillitis, gout, and other conditions associated with salivary stones, were extracted and compared among participants. A logistic regression model using optimized parameters was used to identify variables associated with sialolithiasis.


Results
In total, 2160 participants were included in the analysis, with 540 diagnosed with sialolithiasis and 1620 matched controls. Sjogren's syndrome (OR = 2.057, 95% CI: 1.106–3.824, p = 0.023) and obesity (OR = 1.419, 95% CI: 1.118–1.802, p = 0.004) were significantly associated with increased odds of sialolithiasis, while essential hypertension (OR = 0.279, 95% CI: 0.23–0.339, p = 0.0) and Type 2 diabetes without complication (OR = 0.771, 95% CI: 0.601–0.989, p = 0.041) were inversely associated. No significant associations were observed for dehydration, hyperparathyroidism, acute tonsillitis, alcohol abuse, smoking, hypercalcemia, gout, nephrolithiasis, gallstones, systemic lupus erythematosus, osteoporosis, or bipolar disorder.


Conclusions
This study, using a large‐scale database, aimed to identify potential risk factors associated with sialolithiasis, thereby improving our understanding of its pathogenesis and paving the way for early diagnosis and intervention. The commonality among the identified risk factors appears to be their association with reduced salivary flow or alterations in fluid dynamics and composition, which are known contributors to the formation of salivary stones.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/95aaafb3-bad9-4e52-ad4f-c84d254d161a/lary70333-toc-0001-m.png"
     alt="Identifying Risk Factors for Sialolithiasis"/&gt;
&lt;p&gt;Sjogren's syndrome and obesity increased the odds of sialolithiasis, while essential hypertension and uncomplicated Type 2 diabetes were inversely associated. These findings suggest that disruptions in salivary flow or glandular fluid dynamics may underlie stone formation.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To investigate potential risk factors associated with the development of sialolithiasis in a database-driven case–control study.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;The &lt;i&gt;All of Us&lt;/i&gt; database was queried for participants with sialolithiasis. These participants were matched to controls by age, race, and gender. Demographics and medical history data, such as obesity, hypertension, tonsillitis, gout, and other conditions associated with salivary stones, were extracted and compared among participants. A logistic regression model using optimized parameters was used to identify variables associated with sialolithiasis.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In total, 2160 participants were included in the analysis, with 540 diagnosed with sialolithiasis and 1620 matched controls. Sjogren's syndrome (OR = 2.057, 95% CI: 1.106–3.824, &lt;i&gt;p&lt;/i&gt; = 0.023) and obesity (OR = 1.419, 95% CI: 1.118–1.802, &lt;i&gt;p&lt;/i&gt; = 0.004) were significantly associated with increased odds of sialolithiasis, while essential hypertension (OR = 0.279, 95% CI: 0.23–0.339, &lt;i&gt;p&lt;/i&gt; = 0.0) and Type 2 diabetes without complication (OR = 0.771, 95% CI: 0.601–0.989, &lt;i&gt;p&lt;/i&gt; = 0.041) were inversely associated. No significant associations were observed for dehydration, hyperparathyroidism, acute tonsillitis, alcohol abuse, smoking, hypercalcemia, gout, nephrolithiasis, gallstones, systemic lupus erythematosus, osteoporosis, or bipolar disorder.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;This study, using a large-scale database, aimed to identify potential risk factors associated with sialolithiasis, thereby improving our understanding of its pathogenesis and paving the way for early diagnosis and intervention. The commonality among the identified risk factors appears to be their association with reduced salivary flow or alterations in fluid dynamics and composition, which are known contributors to the formation of salivary stones.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Karen Tawk, 
Abigail Dichter, 
Timothy Park, 
Mehdi Abouzari, 
Sepehr Oliaei
</dc:creator>
         <category>Original Report</category>
         <dc:title>Identifying Risk Factors for Sialolithiasis</dc:title>
         <dc:identifier>10.1002/lary.70333</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70333</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70333?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70343?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70343</guid>
         <title>The ENT Management of Acute Frontal Sinusitis With Intracranial Complications in Adult Patients</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2473-2480, June 2026. </description>
         <dc:description>
Sinogenic brain abscesses are rare but are associated with significant morbidity and mortality. A multicenter retrospective analysis of how adult patients with sinogenic brain abscesses were managed and how management affected outcomes. Further collaborative studies are required to identify how to optimally treat this challenging patient cohort.








ABSTRACT

Objectives
To describe how adult patients with suppurative intracranial complications of acute frontal sinusitis have been managed across three neurosurgical centers in the northwest of England, United Kingdom.


Methods
A retrospective analysis over a 5‐year period investigating adult patients (&gt; 18 years old) presenting with acute frontal sinusitis with intracranial complications.


Results
Forty two patients were identified. 76.2% were male with a mean age of 43.1 years. The most common presenting complaint was headache. Subdural collection was the most common intracranial complication. The methods of operative management varied across the cohort. There was a high rate of revision surgery (41.5%) and a significant proportion of patients developed ongoing physical (38.5%) and neurocognitive (17.9%) sequelae. Patients undergoing neurosurgical treatment alone had a higher rate of ongoing physical sequelae (p = 0.0167). Further subgroup analysis found that the type of ENT intervention performed did not impact patient outcomes. The mortality rate was 7.1% across the study.


Conclusion
To our knowledge, this is the largest multicenter study in adult patients only. Intracranial complications of frontal sinusitis are associated with significant morbidity and mortality and should be managed collaboratively between specialties. Further prospective studies are required to guide the optimal ENT intervention in this patient cohort.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/91693746-6bf3-43b6-920e-be54e1a9295b/lary70343-toc-0001-m.png"
     alt="The ENT Management of Acute Frontal Sinusitis With Intracranial Complications in Adult Patients"/&gt;
&lt;p&gt;Sinogenic brain abscesses are rare but are associated with significant morbidity and mortality. A multicenter retrospective analysis of how adult patients with sinogenic brain abscesses were managed and how management affected outcomes. Further collaborative studies are required to identify how to optimally treat this challenging patient cohort.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To describe how adult patients with suppurative intracranial complications of acute frontal sinusitis have been managed across three neurosurgical centers in the northwest of England, United Kingdom.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective analysis over a 5-year period investigating adult patients (&amp;gt; 18 years old) presenting with acute frontal sinusitis with intracranial complications.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Forty two patients were identified. 76.2% were male with a mean age of 43.1 years. The most common presenting complaint was headache. Subdural collection was the most common intracranial complication. The methods of operative management varied across the cohort. There was a high rate of revision surgery (41.5%) and a significant proportion of patients developed ongoing physical (38.5%) and neurocognitive (17.9%) sequelae. Patients undergoing neurosurgical treatment alone had a higher rate of ongoing physical sequelae (&lt;i&gt;p&lt;/i&gt; = 0.0167). Further subgroup analysis found that the type of ENT intervention performed did not impact patient outcomes. The mortality rate was 7.1% across the study.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;To our knowledge, this is the largest multicenter study in adult patients only. Intracranial complications of frontal sinusitis are associated with significant morbidity and mortality and should be managed collaboratively between specialties. Further prospective studies are required to guide the optimal ENT intervention in this patient cohort.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Ding Yang, 
Timothy Davies, 
Gabrielle Thompson, 
Stephen P. Williams, 
Haleema Nadir, 
Inga Usher, 
Smonica Kaur, 
Thomas F. C. Saunders, 
Rohini Aggarwal, 
Rajeev Advani, 
Amr Abdelhamid, 
Samuel Leong, 
John de Carpentier, 
Archana Jaiswal, 
Rajiv K. Bhalla, 
Bilal Anwar
</dc:creator>
         <category>Original Report</category>
         <dc:title>The ENT Management of Acute Frontal Sinusitis With Intracranial Complications in Adult Patients</dc:title>
         <dc:identifier>10.1002/lary.70343</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70343</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70343?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70345?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70345</guid>
         <title>Stress and Audiometric Hearing Loss in the National Hispanic Community Health Study/Study of Latinos</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2727-2734, June 2026. </description>
         <dc:description>
We used data from a cross‐sectional epidemiological study of U.S. Hispanic/Latino adults ages 18–74 years old from the first wave (2008–2011) of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) to analyze the association between hearing loss and various forms of stress. We found that hearing loss is associated with worse stress from familial/cultural conflict in U.S. Hispanic/Latino adults.








ABSTRACT

Objectives
Hearing loss (HL) has been linked to increased stress, but this relationship remains poorly characterized and often relies on subjective measures of HL, rather than more objective audiometric measures. We aimed to explore whether there is an association between stress and HL among U.S. Hispanic/Latino adults.


Methods
Cross‐sectional epidemiological study of U.S. Hispanic/Latino adults ages 18–74 years old from the first wave (2008–2011) of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). We conducted multivariable linear regressions to analyze the association between HL and various forms of stress, controlling for age, sex, education, field center, Hispanic/Latino heritage, and birth location. HL was measured by four‐frequency pure‐tone average (PTA) in the better ear and defined continuously and categorically. Stress was measured with a 17‐question version of the Hispanic Stress Inventory. The inventory was additionally used to create seven stress subscales (occupational/economic, parental, marital, immigration, familial/cultural, extrafamilial, and intrafamilial).


Results
Four thousand three hundred seventy participants had complete data. The mean age was 46.4 years (SD = 13.8 years). The mean PTA was 13.7 decibels (dB) HL (SD = 10.1 dB). On multivariable regression controlling for potential confounders, HL was associated with worse familial/cultural conflict (β = 0.15 [scale 0–3 points] per 10 dB worsening in hearing; 95% CI [0.03, 0.26]; p = 0.012). Following sensitivity analysis with survey weighting, this effect size remained similar (0.16 score increase per 10 dB) but only trended toward significance (p = 0.077). Other measures did not exhibit significant associations with HL.


Conclusions
HL is associated with worse familial/cultural conflict in U.S. Hispanic/Latino adults.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/a75b3150-1271-4aee-9213-ad30473e8a4d/lary70345-toc-0001-m.png"
     alt="Stress and Audiometric Hearing Loss in the National Hispanic Community Health Study/Study of Latinos"/&gt;
&lt;p&gt;We used data from a cross-sectional epidemiological study of U.S. Hispanic/Latino adults ages 18–74 years old from the first wave (2008–2011) of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) to analyze the association between hearing loss and various forms of stress. We found that hearing loss is associated with worse stress from familial/cultural conflict in U.S. Hispanic/Latino adults.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Hearing loss (HL) has been linked to increased stress, but this relationship remains poorly characterized and often relies on subjective measures of HL, rather than more objective audiometric measures. We aimed to explore whether there is an association between stress and HL among U.S. Hispanic/Latino adults.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Cross-sectional epidemiological study of U.S. Hispanic/Latino adults ages 18–74 years old from the first wave (2008–2011) of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). We conducted multivariable linear regressions to analyze the association between HL and various forms of stress, controlling for age, sex, education, field center, Hispanic/Latino heritage, and birth location. HL was measured by four-frequency pure-tone average (PTA) in the better ear and defined continuously and categorically. Stress was measured with a 17-question version of the Hispanic Stress Inventory. The inventory was additionally used to create seven stress subscales (occupational/economic, parental, marital, immigration, familial/cultural, extrafamilial, and intrafamilial).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Four thousand three hundred seventy participants had complete data. The mean age was 46.4 years (SD = 13.8 years). The mean PTA was 13.7 decibels (dB) HL (SD = 10.1 dB). On multivariable regression controlling for potential confounders, HL was associated with worse familial/cultural conflict (&lt;i&gt;β&lt;/i&gt; = 0.15 [scale 0–3 points] per 10 dB worsening in hearing; 95% CI [0.03, 0.26]; &lt;i&gt;p&lt;/i&gt; = 0.012). Following sensitivity analysis with survey weighting, this effect size remained similar (0.16 score increase per 10 dB) but only trended toward significance (&lt;i&gt;p&lt;/i&gt; = 0.077). Other measures did not exhibit significant associations with HL.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;HL is associated with worse familial/cultural conflict in U.S. Hispanic/Latino adults.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Michael W. Denham, 
Alexis E. Willy, 
Hannah N. W. Weinstein, 
S. Dillon Powell, 
Lauren H. Tucker, 
Justin S. Golub
</dc:creator>
         <category>Original Report</category>
         <dc:title>Stress and Audiometric Hearing Loss in the National Hispanic Community Health Study/Study of Latinos</dc:title>
         <dc:identifier>10.1002/lary.70345</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70345</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70345?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70352?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70352</guid>
         <title>Continuous Sleep Monitoring Using the Withings Sleep Mat to Assess Mean Disease Alleviation in OSA
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2805-2813, June 2026. </description>
         <dc:description>
This prospective pilot study explores the use of continuous, noninvasive home sleep monitoring with the Withings Sleep Mat to calculate mean disease alleviation (MDA) as a measure of real‐world treatment effectiveness in obstructive sleep apnea. MDA estimates derived from longitudinal nightly monitoring were lower than those calculated from single‐night studies, suggesting that night‐to‐night variability and adherence may influence treatment assessment. These findings support further investigation into the role of continuous home monitoring and integrated metrics like MDA in evaluating OSA therapies such as CPAP and hypoglossal nerve stimulation.








ABSTRACT

Objective
This pilot study aims to demonstrate the feasibility of continuous sleep monitoring using the Withings Sleep Mat (WSM) and to illustrate Mean Disease Alleviation (MDA) as a potential metric for assessing real‐world treatment effectiveness among patients with obstructive sleep apnea (OSA) treated with hypoglossal nerve stimulation (HGNS) or continuous positive airway pressure (CPAP).


Methods
Patients treated with CPAP or HGNS therapy were prospectively recruited. The WSM provided nightly estimations of sleep metrics including AHI, total sleep time, and other non‐apneic metrics over 30‐ and 90‐day periods. MDA integrating treatment efficacy and adjusted compliance was calculated as a composite measure of real‐world treatment effectiveness.


Results
A total of 29 patients (mean age 59.8 years; 66% male; 93% White) were included, with 15 treated with CPAP and 14 with HGNS. The 90‐day MDA, calculated using continuous AHI monitoring, was 36.05% for CPAP and 24.06% for HGNS (p = 0.20). Mean MDA using single‐night sleep study (HGNS) or CPAP download (CPAP) was 81.72% (14.81) among CPAP patients and 51.18% (26.69) among HGNS patients (p = 0.002). HGNS patients experienced more awakenings (3.23 vs. 2.56, p = 0.031) and snoring episodes (2.86 vs. 1.79, p = 0.029) per night during the 30‐day interval.


Conclusion
This study demonstrates the feasibility of calculating MDA through continuous, non‐invasive home monitoring using the WSA, offering a more comprehensive assessment of OSA treatment effectiveness than single‐night studies alone. These findings support further evaluation of continuous home‐based monitoring and integrated metrics like MDA to inform personalized therapy selection and long‐term management.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/538c043d-74b9-45fb-849a-3067ac8578eb/lary70352-toc-0001-m.png"
     alt="Continuous Sleep Monitoring Using the Withings Sleep Mat to Assess Mean Disease Alleviation in OSA&amp;#xA;"/&gt;
&lt;p&gt;This prospective pilot study explores the use of continuous, noninvasive home sleep monitoring with the Withings Sleep Mat to calculate mean disease alleviation (MDA) as a measure of real-world treatment effectiveness in obstructive sleep apnea. MDA estimates derived from longitudinal nightly monitoring were lower than those calculated from single-night studies, suggesting that night-to-night variability and adherence may influence treatment assessment. These findings support further investigation into the role of continuous home monitoring and integrated metrics like MDA in evaluating OSA therapies such as CPAP and hypoglossal nerve stimulation.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;This pilot study aims to demonstrate the feasibility of continuous sleep monitoring using the Withings Sleep Mat (WSM) and to illustrate Mean Disease Alleviation (MDA) as a potential metric for assessing real-world treatment effectiveness among patients with obstructive sleep apnea (OSA) treated with hypoglossal nerve stimulation (HGNS) or continuous positive airway pressure (CPAP).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Patients treated with CPAP or HGNS therapy were prospectively recruited. The WSM provided nightly estimations of sleep metrics including AHI, total sleep time, and other non-apneic metrics over 30- and 90-day periods. MDA integrating treatment efficacy and adjusted compliance was calculated as a composite measure of real-world treatment effectiveness.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 29 patients (mean age 59.8 years; 66% male; 93% White) were included, with 15 treated with CPAP and 14 with HGNS. The 90-day MDA, calculated using continuous AHI monitoring, was 36.05% for CPAP and 24.06% for HGNS (&lt;i&gt;p&lt;/i&gt; = 0.20). Mean MDA using single-night sleep study (HGNS) or CPAP download (CPAP) was 81.72% (14.81) among CPAP patients and 51.18% (26.69) among HGNS patients (&lt;i&gt;p&lt;/i&gt; = 0.002). HGNS patients experienced more awakenings (3.23 vs. 2.56, &lt;i&gt;p&lt;/i&gt; = 0.031) and snoring episodes (2.86 vs. 1.79, &lt;i&gt;p&lt;/i&gt; = 0.029) per night during the 30-day interval.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This study demonstrates the feasibility of calculating MDA through continuous, non-invasive home monitoring using the WSA, offering a more comprehensive assessment of OSA treatment effectiveness than single-night studies alone. These findings support further evaluation of continuous home-based monitoring and integrated metrics like MDA to inform personalized therapy selection and long-term management.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Praneet C. Kaki, 
Maya Childs, 
Randy Calotti, 
Jaehee Kim, 
Nicole Molin, 
Erin Creighton, 
Maurits Boon, 
Colin Huntley
</dc:creator>
         <category>Original Report</category>
         <dc:title>Continuous Sleep Monitoring Using the Withings Sleep Mat to Assess Mean Disease Alleviation in OSA
</dc:title>
         <dc:identifier>10.1002/lary.70352</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70352</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70352?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70355?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70355</guid>
         <title>A Multimodal Approach for Deep‐Learning Classification of Vocal Fold Pathologies in Stroboscopy</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2503-2510, June 2026. </description>
         <dc:description>
This study introduces a novel multimodal deep‐learning framework that integrates stroboscopic video, acoustic voice samples, and clinicodemographic data to classify vocal fold pathologies. By leveraging a gated attention mechanism to dynamically weigh these diverse data types, the multimodal classifier achieved significantly higher diagnostic accuracy (76.9%) compared to standalone image or audio models. These findings provide a foundational methodology for building efficient AI tools that more closely mirror expert clinical evaluation, offering a blueprint for future diagnostic support systems as model robustness continues to improve.








ABSTRACT

Objective
To develop and validate a multimodal deep‐learning classifier trained on stroboscopic image, voice, and clinicodemographic data, differentiating between three different vocal fold (VF) states: healthy (HVF), unilateral paralysis (UVFP), and VF lesions, including benign and malignant pathologies.


Methods
Patients with UVFP (n = 54), VF lesions (n = 42), and HVF (n = 41) were retrospectively identified. Image frames and voice samples were extracted from stroboscopic videos. Clinicodemographic variables were collected from the electronic health record. Patient‐level data was independently divided into training (80%) and testing (20%). Visual features were extracted using a transformer DINOv2 and acoustic features were extracted using Librosa. All three feature modalities were combined using a custom multilayer perceptron. Unimodality models using only image or only voice data were trained for comparison. Accuracy and F1 scores were used to validate the models.


Results
On a hold‐out test set, the multimodal classifier demonstrated stronger performance (76.9% accuracy) compared to the image classifier (61.5% accuracy) and audio classifier (65.4% accuracy). On an external dataset, the multimodal classifier accuracy dropped to 45%, though still an improvement compared to accuracies of 42% and 31% for the video‐only and audio‐only modalities, respectively.


Conclusions
In this proof‐of‐concept study, we successfully developed a multimodal dataset and classifier for VF pathology, demonstrating the potential of combining stroboscopic frames, voice and text data. The multimodal classifier achieved higher accuracy than the image‐only model and audio‐only models. Future models should validate these findings on larger datasets.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/edda1e0d-963d-4301-962f-e94e0134d6bf/lary70355-toc-0001-m.png"
     alt="A Multimodal Approach for Deep-Learning Classification of Vocal Fold Pathologies in Stroboscopy"/&gt;
&lt;p&gt;This study introduces a novel multimodal deep-learning framework that integrates stroboscopic video, acoustic voice samples, and clinicodemographic data to classify vocal fold pathologies. By leveraging a gated attention mechanism to dynamically weigh these diverse data types, the multimodal classifier achieved significantly higher diagnostic accuracy (76.9%) compared to standalone image or audio models. These findings provide a foundational methodology for building efficient AI tools that more closely mirror expert clinical evaluation, offering a blueprint for future diagnostic support systems as model robustness continues to improve.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To develop and validate a multimodal deep-learning classifier trained on stroboscopic image, voice, and clinicodemographic data, differentiating between three different vocal fold (VF) states: healthy (HVF), unilateral paralysis (UVFP), and VF lesions, including benign and malignant pathologies.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Patients with UVFP (&lt;i&gt;n&lt;/i&gt; = 54), VF lesions (&lt;i&gt;n&lt;/i&gt; = 42), and HVF (&lt;i&gt;n&lt;/i&gt; = 41) were retrospectively identified. Image frames and voice samples were extracted from stroboscopic videos. Clinicodemographic variables were collected from the electronic health record. Patient-level data was independently divided into training (80%) and testing (20%). Visual features were extracted using a transformer DINOv2 and acoustic features were extracted using Librosa. All three feature modalities were combined using a custom multilayer perceptron. Unimodality models using only image or only voice data were trained for comparison. Accuracy and &lt;i&gt;F&lt;/i&gt;1 scores were used to validate the models.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;On a hold-out test set, the multimodal classifier demonstrated stronger performance (76.9% accuracy) compared to the image classifier (61.5% accuracy) and audio classifier (65.4% accuracy). On an external dataset, the multimodal classifier accuracy dropped to 45%, though still an improvement compared to accuracies of 42% and 31% for the video-only and audio-only modalities, respectively.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In this proof-of-concept study, we successfully developed a multimodal dataset and classifier for VF pathology, demonstrating the potential of combining stroboscopic frames, voice and text data. The multimodal classifier achieved higher accuracy than the image-only model and audio-only models. Future models should validate these findings on larger datasets.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Sruthi Surapaneni, 
Rachel B. Kutler, 
Sean A. Setzen, 
Yeo Eun Kim, 
Peter Yao, 
Sana H. Siddiqui, 
Michael J. Pitman, 
Lucian Sulica, 
Olivier Elemento, 
Pegah Khosravi, 
Anaïs Rameau
</dc:creator>
         <category>Original Report</category>
         <dc:title>A Multimodal Approach for Deep‐Learning Classification of Vocal Fold Pathologies in Stroboscopy</dc:title>
         <dc:identifier>10.1002/lary.70355</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70355</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70355?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70365?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70365</guid>
         <title>Surgical Adequacy in ESS for Primary Diffuse CRS: Expert Consensus Recommendations</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2481-2490, June 2026. </description>
         <dc:description>
Fifteen internationally recognized rhinology experts participated in a two‐round Delphi process to define consensus on the extent of endoscopic sinus surgery (ESS) for primary diffuse chronic rhinosinusitis. Consensus was reached for 17 statements, providing standardized, expert‐derived recommendations to guide surgical extent in clinical practice. Standardization of ESS is essential to enable outcome comparability and to ensure equitable access to biologic therapies.








ABSTRACT

Objective
Surgical treatment represents an adjunct to medical therapy in the management of primary diffuse chronic rhinosinusitis (CRS). Despite advancement in endoscopic sinus surgery (ESS), there are currently no established guidelines delineating the appropriate surgical extent for defining adequate ESS in cases of primary diffuse CRS.


Methods
Through a modified Delphi technique, 33 statements regarding the extent of surgery for each paranasal sinus were drafted following a literature review and submitted to an expert panel composed of 15 internationally recognized ESS experts. A consensus meeting was held to discuss the results for each iteration. An additional statement was added during the meeting, and a total of 34 statements were voted on during the last round.


Results
Consensus was reached in 17 statements out of 34. Type 1 medial maxillary antrostomy, bilateral anteroposterior ethmoidectomy, and at least DRAF I frontal sinusotomy should be performed in all cases of primary diffuse CRS, with a particular focus on mucosal sparing, regardless of the likelihood of subsequently needing biologic therapy. DRAF III frontal sinusotomy should not be considered as a first‐line approach even in patients with risk factors for recurrence. Treatment of the sphenoid sinus might be avoided in cases where it is not involved by the pathology.


Conclusion
This document outlines a consensus on the appropriate surgical approach for primary diffuse CRS, aiming to promote standardization while preserving individual clinical judgment.


Level of Evidence
5.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/d00a1337-91c4-4d9e-9656-359437eaf08f/lary70365-toc-0001-m.png"
     alt="Surgical Adequacy in ESS for Primary Diffuse CRS: Expert Consensus Recommendations"/&gt;
&lt;p&gt;Fifteen internationally recognized rhinology experts participated in a two-round Delphi process to define consensus on the extent of endoscopic sinus surgery (ESS) for primary diffuse chronic rhinosinusitis. Consensus was reached for 17 statements, providing standardized, expert-derived recommendations to guide surgical extent in clinical practice. Standardization of ESS is essential to enable outcome comparability and to ensure equitable access to biologic therapies.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Surgical treatment represents an adjunct to medical therapy in the management of primary diffuse chronic rhinosinusitis (CRS). Despite advancement in endoscopic sinus surgery (ESS), there are currently no established guidelines delineating the appropriate surgical extent for defining adequate ESS in cases of primary diffuse CRS.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Through a modified Delphi technique, 33 statements regarding the extent of surgery for each paranasal sinus were drafted following a literature review and submitted to an expert panel composed of 15 internationally recognized ESS experts. A consensus meeting was held to discuss the results for each iteration. An additional statement was added during the meeting, and a total of 34 statements were voted on during the last round.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Consensus was reached in 17 statements out of 34. Type 1 medial maxillary antrostomy, bilateral anteroposterior ethmoidectomy, and at least DRAF I frontal sinusotomy should be performed in all cases of primary diffuse CRS, with a particular focus on mucosal sparing, regardless of the likelihood of subsequently needing biologic therapy. DRAF III frontal sinusotomy should not be considered as a first-line approach even in patients with risk factors for recurrence. Treatment of the sphenoid sinus might be avoided in cases where it is not involved by the pathology.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This document outlines a consensus on the appropriate surgical approach for primary diffuse CRS, aiming to promote standardization while preserving individual clinical judgment.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;5.&lt;/p&gt;</content:encoded>
         <dc:creator>
Daniela Lucidi, 
Carlotta Pipolo, 
Fabio Pagella, 
Davide Mattavelli, 
Paolo Battaglia, 
Eugenio De Corso, 
Enzo Emanuelli, 
Marco Ferrari, 
Massimiliano Garzaro, 
Luca Malvezzi, 
Daniele Marchioni, 
Ernesto Pasquini, 
Stefano Pelucchi, 
Livio Presutti, 
Mario Turri Zanoni, 
Carla Cantaffa, 
Matteo Alicandri‐Ciufelli
</dc:creator>
         <category>Original Report</category>
         <dc:title>Surgical Adequacy in ESS for Primary Diffuse CRS: Expert Consensus Recommendations</dc:title>
         <dc:identifier>10.1002/lary.70365</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70365</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70365?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70366?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70366</guid>
         <title>
TGFβ/Smad2/3‐Mediated Crosstalk Between Vocal Fold Fibroblasts and Myoblasts In Vitro</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2638-2647, June 2026. </description>
         <dc:description>
We investigated mucosa–muscle crosstalk in the vocal fold by modeling interactions between fibrotic human vocal fold fibroblasts and rat vocal fold myoblasts. TGF‐β1–stimulated fibroblasts suppressed myogenic differentiation via Smad2/3 signaling, an effect reversed by ALK4/5 inhibition, while differentiating myoblasts attenuated fibroblast fibrogenic gene expression. These findings suggest bidirectional fibroblast–myoblast interactions as a potential mechanism contributing to vocal fold pathology.








ABSTRACT

Objectives
Traditionally, disorders of the vocal fold (VF) mucosa and underlying musculature have been regarded as mutually exclusive entities. However, emerging evidence from other organ systems suggests mucosal and muscle compartments engage in reciprocal interactions with functional consequences. We hypothesized that similar crosstalk exists in the VF, whereby fibrotic mucosa influences adjacent muscle. To model this process, we stimulated human VF fibroblasts (HVOX) with TGF‐β1, a central mediator of fibrosis, and examined the effects on rat VF myoblasts (rVF‐Mbs), as well as reciprocal influences of rVF‐Mbs on fibroblasts.


Methods
HVOX fibroblasts were stimulated with 10 ng/mL TGF‐β1, and the effects on rVF‐Mbs were assessed using conditioned media and co‐culture. Myotube formation was evaluated by immunofluorescence, and nuclear localization of Smad2/3 was examined in conditioned media experiments. qRT‐PCR quantified transcripts related to myogenic differentiation and Smad2/3 signaling. ALK4/5 inhibition was performed in co‐culture to test TGF‐β/Smad2/3‐signaling pathway involvement. Reciprocal effects were examined by changes in fibrogenic gene expression in HVOX fibroblasts.


Results
Both conditioned media and co‐culture suppressed myogenic differentiation in rVF‐Mbs; increased inhibition was observed in co‐culture, as indicated by reduced myotube formation, decreased Myh2 expression, and activation of Smad2/3 signaling. ALK4/5 inhibition abrogated these effects. Differentiating rVF‐Mbs attenuated the fibrogenic phenotype of HVOX fibroblasts.


Conclusions
Fibrotic VF mucosal cells can impair myogenic differentiation through TGF‐β/Smad2/3‐mediated fibroblast–myoblast crosstalk, and myogenic cells may exert reciprocal anti‐fibrotic effects. These findings suggest mucosa–muscle interactions may contribute to VF pathology and highlight Smad2/3 as a potential therapeutic target.


Level of Evidence
NA


Study Design
In vitro.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/cbf73ebb-61e7-409a-8525-9f19612b1755/lary70366-toc-0001-m.png"
     alt="&amp;#xA;TGFβ/Smad2/3-Mediated Crosstalk Between Vocal Fold Fibroblasts and Myoblasts In Vitro"/&gt;
&lt;p&gt;We investigated mucosa–muscle crosstalk in the vocal fold by modeling interactions between fibrotic human vocal fold fibroblasts and rat vocal fold myoblasts. TGF-β1–stimulated fibroblasts suppressed myogenic differentiation via Smad2/3 signaling, an effect reversed by ALK4/5 inhibition, while differentiating myoblasts attenuated fibroblast fibrogenic gene expression. These findings suggest bidirectional fibroblast–myoblast interactions as a potential mechanism contributing to vocal fold pathology.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Traditionally, disorders of the vocal fold (VF) mucosa and underlying musculature have been regarded as mutually exclusive entities. However, emerging evidence from other organ systems suggests mucosal and muscle compartments engage in reciprocal interactions with functional consequences. We hypothesized that similar crosstalk exists in the VF, whereby fibrotic mucosa influences adjacent muscle. To model this process, we stimulated human VF fibroblasts (HVOX) with TGF-β1, a central mediator of fibrosis, and examined the effects on rat VF myoblasts (rVF-Mbs), as well as reciprocal influences of rVF-Mbs on fibroblasts.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;HVOX fibroblasts were stimulated with 10 ng/mL TGF-β1, and the effects on rVF-Mbs were assessed using conditioned media and co-culture. Myotube formation was evaluated by immunofluorescence, and nuclear localization of Smad2/3 was examined in conditioned media experiments. qRT-PCR quantified transcripts related to myogenic differentiation and Smad2/3 signaling. ALK4/5 inhibition was performed in co-culture to test TGF-β/Smad2/3-signaling pathway involvement. Reciprocal effects were examined by changes in fibrogenic gene expression in HVOX fibroblasts.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Both conditioned media and co-culture suppressed myogenic differentiation in rVF-Mbs; increased inhibition was observed in co-culture, as indicated by reduced myotube formation, decreased Myh2 expression, and activation of Smad2/3 signaling. ALK4/5 inhibition abrogated these effects. Differentiating rVF-Mbs attenuated the fibrogenic phenotype of HVOX fibroblasts.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Fibrotic VF mucosal cells can impair myogenic differentiation through TGF-β/Smad2/3-mediated fibroblast–myoblast crosstalk, and myogenic cells may exert reciprocal anti-fibrotic effects. These findings suggest mucosa–muscle interactions may contribute to VF pathology and highlight Smad2/3 as a potential therapeutic target.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;NA&lt;/p&gt;
&lt;h2&gt;Study Design&lt;/h2&gt;
&lt;p&gt;In vitro.&lt;/p&gt;</content:encoded>
         <dc:creator>
Masayoshi Yoshimatsu, 
Ryosuke Nakamura, 
Renjie Bing, 
Gary J. Gartling, 
Aaron M. Johnson, 
Ryan C. Branski
</dc:creator>
         <category>Original Report</category>
         <dc:title>
TGFβ/Smad2/3‐Mediated Crosstalk Between Vocal Fold Fibroblasts and Myoblasts In Vitro</dc:title>
         <dc:identifier>10.1002/lary.70366</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70366</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70366?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70367?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70367</guid>
         <title>Optical Coherence Tomography in Pediatric Airway Surgery: A Case Series and Focused Review</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2777-2783, June 2026. </description>
         <dc:description>
We report a four‐patient case series using intravascular optical coherence tomography (OCT) as an adjunct to bronchoscopy and cross‐sectional imaging in complex pediatric airway surgery. In each case, OCT provided high‐resolution luminal and cartilaginous detail that refined anatomic understanding and, in selected patients, informed the extent of tracheal reconstruction or stent assessment. These preliminary findings highlight the feasibility of OCT in the pediatric tracheobronchial tree and support further study of its role in perioperative airway evaluation.








ABSTRACT

Objective
To describe the role of optical coherence tomography (OCT) in the evaluation and surgical planning of pediatric patients with complex airway pathology.


Methods
We conducted a retrospective case series of four pediatric patients who underwent OCT imaging of the trachea and mainstem bronchi between 2020 and 2024 at a tertiary children's hospital. Imaging was performed intraoperatively using a microcatheter‐based OCT catheter under general anesthesia. OCT findings were reviewed in conjunction with bronchoscopy, preoperative imaging, and operative reports.


Results
In each case, OCT provided high‐resolution structural detail that refined diagnosis and informed surgical planning. OCT was instrumental in delineating the extent of stenosis, evaluating mainstem bronchial involvement, and assessing stent patency and epithelialization. OCT imaging demonstrated value both in preoperative assessment and postoperative follow‐up.


Conclusion
OCT offers a high‐resolution, radiation‐free imaging modality for pediatric airway evaluation. In this small, uncontrolled series, OCT served as a feasible adjunct that provided additional structural detail concordant with operative findings and, in selected cases, informed surgical approach. Prospective studies are needed to define workflow, performance, and impact on outcomes.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/4b66e775-a5ac-4838-8ad1-22dd0c39c101/lary70367-toc-0001-m.png"
     alt="Optical Coherence Tomography in Pediatric Airway Surgery: A Case Series and Focused Review"/&gt;
&lt;p&gt;We report a four-patient case series using intravascular optical coherence tomography (OCT) as an adjunct to bronchoscopy and cross-sectional imaging in complex pediatric airway surgery. In each case, OCT provided high-resolution luminal and cartilaginous detail that refined anatomic understanding and, in selected patients, informed the extent of tracheal reconstruction or stent assessment. These preliminary findings highlight the feasibility of OCT in the pediatric tracheobronchial tree and support further study of its role in perioperative airway evaluation.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To describe the role of optical coherence tomography (OCT) in the evaluation and surgical planning of pediatric patients with complex airway pathology.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We conducted a retrospective case series of four pediatric patients who underwent OCT imaging of the trachea and mainstem bronchi between 2020 and 2024 at a tertiary children's hospital. Imaging was performed intraoperatively using a microcatheter-based OCT catheter under general anesthesia. OCT findings were reviewed in conjunction with bronchoscopy, preoperative imaging, and operative reports.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In each case, OCT provided high-resolution structural detail that refined diagnosis and informed surgical planning. OCT was instrumental in delineating the extent of stenosis, evaluating mainstem bronchial involvement, and assessing stent patency and epithelialization. OCT imaging demonstrated value both in preoperative assessment and postoperative follow-up.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;OCT offers a high-resolution, radiation-free imaging modality for pediatric airway evaluation. In this small, uncontrolled series, OCT served as a feasible adjunct that provided additional structural detail concordant with operative findings and, in selected cases, informed surgical approach. Prospective studies are needed to define workflow, performance, and impact on outcomes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Rebecca Paquin, 
Jenny Zablah, 
Marta Kulich, 
Jacob Boyd, 
Max B. Mitchell, 
Gareth Morgan, 
Jeremy Prager
</dc:creator>
         <category>Original Report</category>
         <dc:title>Optical Coherence Tomography in Pediatric Airway Surgery: A Case Series and Focused Review</dc:title>
         <dc:identifier>10.1002/lary.70367</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70367</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70367?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70373?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70373</guid>
         <title>Hardware Exposure After Mandibular Reconstruction: Bone Versus Soft Tissue Free Flap Comparison</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2591-2597, June 2026. </description>
         <dc:description>
Hardware exposure is a significant complication after mandibular reconstruction with microvascular free tissue transfer (MFTT), but comparative data between osteocutaneous and soft tissue–only flaps are limited. In a retrospective review of 178 patients undergoing mandibular MFTT from 2011 to 2023, there was no significant difference in time to hardware exposure between osteocutaneous and soft tissue flaps at 1 or 3 years, with exposure rates increasing from ~5% to 9% at 1 year to ~14% to 17% at 3 years. Adjuvant radiation and/or chemoradiation was independently associated with a significantly increased risk of hardware exposure, while flap type was not.








ABSTRACT

Objective
Hardware exposure after microvascular free tissue transfer (MFTT) for mandibular reconstruction is a significant complication. While osteocutaneous MFTTs are the preferred option, some patients require soft tissue‐only MFTTs due to medical or anatomic limitations. Data comparing hardware exposure risk between these approaches are limited. This study compares the rate and timing of hardware exposure between osteocutaneous and soft tissue MFTTs.


Methods
We conducted a retrospective review of patients undergoing MFTT for mandibular defects at a tertiary care center (11/2011–6/2023). Patients with non‐mandibular defects or under age 18 were excluded. The primary exposure was flap type (osteocutaneous vs. soft tissue). The primary outcome was time to hardware exposure; the secondary outcome was exposure rate at defined follow‐up intervals.


Results
One hundred and seventy‐eight patients met inclusion criteria. At 1 year, hardware exposure occurred in 5.2% of osteocutaneous and 8.7% of soft tissue MFTT patients. At 3 years, exposure increased to 14.2% and 17.4%, respectively. After adjustment, there was no significant difference in time to hardware exposure between flap types at 1 year [HR 1.69 (95% CI 0.34–8.37), p = 0.520] or 3 years [HR 1.69 (95% CI 0.59–4.43), p = 0.346]. Adjuvant radiation and/or chemoradiation was associated with increased hazard of hardware exposure at 1 year [HR 7.72 (95% CI 0.97–61.4), p = 0.053] and at 3 years [HR 3.68 (95% CI 1.38–9.78), p = 0.009].


Conclusions
Flap type was not associated with differences in hardware exposure timing, but adjuvant therapy significantly increased exposure risk. Exposure rates rose by ~10% from 1 to 3 years postoperatively.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/42b4e778-e15f-4e80-889c-cc57a688a1c5/lary70373-toc-0001-m.png"
     alt="Hardware Exposure After Mandibular Reconstruction: Bone Versus Soft Tissue Free Flap Comparison"/&gt;
&lt;p&gt;Hardware exposure is a significant complication after mandibular reconstruction with microvascular free tissue transfer (MFTT), but comparative data between osteocutaneous and soft tissue–only flaps are limited. In a retrospective review of 178 patients undergoing mandibular MFTT from 2011 to 2023, there was no significant difference in time to hardware exposure between osteocutaneous and soft tissue flaps at 1 or 3 years, with exposure rates increasing from ~5% to 9% at 1 year to ~14% to 17% at 3 years. Adjuvant radiation and/or chemoradiation was independently associated with a significantly increased risk of hardware exposure, while flap type was not.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Hardware exposure after microvascular free tissue transfer (MFTT) for mandibular reconstruction is a significant complication. While osteocutaneous MFTTs are the preferred option, some patients require soft tissue-only MFTTs due to medical or anatomic limitations. Data comparing hardware exposure risk between these approaches are limited. This study compares the rate and timing of hardware exposure between osteocutaneous and soft tissue MFTTs.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We conducted a retrospective review of patients undergoing MFTT for mandibular defects at a tertiary care center (11/2011–6/2023). Patients with non-mandibular defects or under age 18 were excluded. The primary exposure was flap type (osteocutaneous vs. soft tissue). The primary outcome was time to hardware exposure; the secondary outcome was exposure rate at defined follow-up intervals.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;One hundred and seventy-eight patients met inclusion criteria. At 1 year, hardware exposure occurred in 5.2% of osteocutaneous and 8.7% of soft tissue MFTT patients. At 3 years, exposure increased to 14.2% and 17.4%, respectively. After adjustment, there was no significant difference in time to hardware exposure between flap types at 1 year [HR 1.69 (95% CI 0.34–8.37), &lt;i&gt;p&lt;/i&gt; = 0.520] or 3 years [HR 1.69 (95% CI 0.59–4.43), &lt;i&gt;p&lt;/i&gt; = 0.346]. Adjuvant radiation and/or chemoradiation was associated with increased hazard of hardware exposure at 1 year [HR 7.72 (95% CI 0.97–61.4), &lt;i&gt;p&lt;/i&gt; = 0.053] and at 3 years [HR 3.68 (95% CI 1.38–9.78), &lt;i&gt;p&lt;/i&gt; = 0.009].&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Flap type was not associated with differences in hardware exposure timing, but adjuvant therapy significantly increased exposure risk. Exposure rates rose by ~10% from 1 to 3 years postoperatively.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Hasan Abdulbaki, 
Angeline A. Truong, 
Laura Chen, 
Chase M. Heaton, 
Philip D. Knott, 
Andrea M. Park, 
Mary J. Xu, 
Katherine C. Wai
</dc:creator>
         <category>Original Report</category>
         <dc:title>Hardware Exposure After Mandibular Reconstruction: Bone Versus Soft Tissue Free Flap Comparison</dc:title>
         <dc:identifier>10.1002/lary.70373</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70373</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70373?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70388?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70388</guid>
         <title>Real‐Time Dynamic Ultrasound Characteristics of the Thyrohyoid Space in Vocal Hyperfunction Mode</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2663-2671, June 2026. </description>
         <dc:description>
This study investigates the clinical utility of real‐time ultrasound assessment of thyrohyoid space dynamics for evaluating vocal hyperfunction. Results from 260 participants indicate that ultrasound measurements offer a more precise and objective assessment than conventional palpation and vocal aerodynamic parameters. The results illustrate that real‐time ultrasound represents a viable and valuable clinical instrument for evaluating voice function.








ABSTRACT

Objective
To explore the clinical value of real‐time ultrasound measurement of thyrohyoid space dynamics in assessing vocal hyperfunction mode (VHM).


Materials and Methods
The 161 chronic laryngitis patients, 55 with vocal cord polyps, and 44 normal controls were studied at Sun Yat‐sen Memorial Hospital, Sun Yat‐sen University, from June 2024 to January 2025. Voice quality, aerodynamic parameters, and thyrohyoid space were assessed using VHI‐10, GRBAS scale, voice analysis, aerodynamic profiling, palpation scoring, and ultrasound. Data analysis was conducted using Python.


Results
Significant differences (p &lt; 0.05) in VHI‐10 scores, G, R, B, S, Jitter, and Shimmer are observed between male and female vocal cord polyp groups. Aerodynamic analysis indicates distinct variations in mean airflow rate across both genders (p &lt; 0.05), while maximum phonation time and subglottic pressure differ significantly in females alone (p &lt; 0.05). Palpation scores for the thyrohyoid space and F0 do not show substantial differences (p &gt; 0.05) between groups. Conversely, real‐time ultrasound evaluations of the thyrohyoid space, including pre‐phonation/phonation minimum distances (left/right), rates of unilateral (left/right) narrowing, and maximum narrowing rate, exhibit notable differences (p &lt; 0.05) across three groups.


Conclusion
Real‐time ultrasound measurement of the thyroid–hyoid gap is simple, feasible, and provides a more quantitative assessment of VHM than subjective palpation or vocal aerodynamic measures. It therefore represents a useful clinical tool for evaluating voice function.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/77b07619-e8e8-420f-a76d-66021a0cefc0/lary70388-toc-0001-m.png"
     alt="Real-Time Dynamic Ultrasound Characteristics of the Thyrohyoid Space in Vocal Hyperfunction Mode"/&gt;
&lt;p&gt;This study investigates the clinical utility of real-time ultrasound assessment of thyrohyoid space dynamics for evaluating vocal hyperfunction. Results from 260 participants indicate that ultrasound measurements offer a more precise and objective assessment than conventional palpation and vocal aerodynamic parameters. The results illustrate that real-time ultrasound represents a viable and valuable clinical instrument for evaluating voice function.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To explore the clinical value of real-time ultrasound measurement of thyrohyoid space dynamics in assessing vocal hyperfunction mode (VHM).&lt;/p&gt;
&lt;h2&gt;Materials and Methods&lt;/h2&gt;
&lt;p&gt;The 161 chronic laryngitis patients, 55 with vocal cord polyps, and 44 normal controls were studied at Sun Yat-sen Memorial Hospital, Sun Yat-sen University, from June 2024 to January 2025. Voice quality, aerodynamic parameters, and thyrohyoid space were assessed using VHI-10, GRBAS scale, voice analysis, aerodynamic profiling, palpation scoring, and ultrasound. Data analysis was conducted using Python.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Significant differences (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05) in VHI-10 scores, G, R, B, S, Jitter, and Shimmer are observed between male and female vocal cord polyp groups. Aerodynamic analysis indicates distinct variations in mean airflow rate across both genders (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), while maximum phonation time and subglottic pressure differ significantly in females alone (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). Palpation scores for the thyrohyoid space and F0 do not show substantial differences (&lt;i&gt;p&lt;/i&gt; &amp;gt; 0.05) between groups. Conversely, real-time ultrasound evaluations of the thyrohyoid space, including pre-phonation/phonation minimum distances (left/right), rates of unilateral (left/right) narrowing, and maximum narrowing rate, exhibit notable differences (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05) across three groups.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Real-time ultrasound measurement of the thyroid–hyoid gap is simple, feasible, and provides a more quantitative assessment of VHM than subjective palpation or vocal aerodynamic measures. It therefore represents a useful clinical tool for evaluating voice function.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Liao Fang, 
Yang Jinshan, 
Chen Wenjun, 
Ruan Jingliang, 
Liu Rongbin, 
Su Yangzhou, 
Zou Xin, 
Wei Jiayi, 
Xu Xiaolin, 
Liang Faya
</dc:creator>
         <category>Original Report</category>
         <dc:title>Real‐Time Dynamic Ultrasound Characteristics of the Thyrohyoid Space in Vocal Hyperfunction Mode</dc:title>
         <dc:identifier>10.1002/lary.70388</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70388</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70388?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70389?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70389</guid>
         <title>Disease Regression of Contralateral Reactive Lesions Following Office‐Based Laryngeal Surgery</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2672-2677, June 2026. </description>
         <dc:description>
ABSTRACT

Objective
To describe the prevalence and morphology of vocal fold contralateral reactive lesions in patients with vocal fold polyps or cysts, and to report disease regression following office‐based laryngeal surgery (OBLS).


Methods
Medical records and video recordings of patients with vocal fold polyps or cysts who underwent OBLS between November 2023 and September 2025 were reviewed. Demographic data included age, gender, history of smoking, history of reflux disease, type of vocal fold pathology, and type of office‐based laryngeal procedure. Prevalence, morphology, and disease regression of CRLs were assessed by two otolaryngologists who independently reviewed the video recordings of patients included in this study.


Results
Twenty‐six males and 19 females were included in the study. The mean age was 48.9 ± 14.9 years. The prevalence of CRLs was 60%. Most of these lesions were fibrous. Eighteen lesions were treated with ILSI, and 8 lesions were treated with the blue laser and steroid injection. Five patients were lost to follow‐up. Analysis of 21 CRLs showed complete disease regression in 52.4% of cases, and partial disease regression in 47.6% of cases. There was no statistically significant difference in disease regression between the two treatment subgroups (p = 0.284). There was a statistically significant difference in total disease regression of the primary lesion between those who had partial vs. complete disease regression of their CRL (p &lt; 0.001).


Conclusion

CRLs are common in patients with vocal fold polyps and cysts. All lesions regressed partially or completely following OBLS using the blue laser and/or steroid injection.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To describe the prevalence and morphology of vocal fold contralateral reactive lesions in patients with vocal fold polyps or cysts, and to report disease regression following office-based laryngeal surgery (OBLS).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Medical records and video recordings of patients with vocal fold polyps or cysts who underwent OBLS between November 2023 and September 2025 were reviewed. Demographic data included age, gender, history of smoking, history of reflux disease, type of vocal fold pathology, and type of office-based laryngeal procedure. Prevalence, morphology, and disease regression of CRLs were assessed by two otolaryngologists who independently reviewed the video recordings of patients included in this study.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Twenty-six males and 19 females were included in the study. The mean age was 48.9 ± 14.9 years. The prevalence of CRLs was 60%. Most of these lesions were fibrous. Eighteen lesions were treated with ILSI, and 8 lesions were treated with the blue laser and steroid injection. Five patients were lost to follow-up. Analysis of 21 CRLs showed complete disease regression in 52.4% of cases, and partial disease regression in 47.6% of cases. There was no statistically significant difference in disease regression between the two treatment subgroups (&lt;i&gt;p&lt;/i&gt; = 0.284)&lt;i&gt;.&lt;/i&gt; There was a statistically significant difference in total disease regression of the primary lesion between those who had partial vs. complete disease regression of their CRL (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;
CRLs are common in patients with vocal fold polyps and cysts. All lesions regressed partially or completely following OBLS using the blue laser and/or steroid injection.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Abdul‐Latif Hamdan, 
Lana Ghzayel, 
Lucien Khalil, 
Valerie Sarkis, 
Ghena Lababidi, 
Jad Hosri, 
Ibana Carapiperis, 
Patrick Abou Raji Feghali
</dc:creator>
         <category>Original Report</category>
         <dc:title>Disease Regression of Contralateral Reactive Lesions Following Office‐Based Laryngeal Surgery</dc:title>
         <dc:identifier>10.1002/lary.70389</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70389</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70389?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70391?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70391</guid>
         <title>Economic Evaluation of Tympanostomy Tube Placement</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2765-2768, June 2026. </description>
         <dc:description>
ABSTRACT

Objectives
The purpose of this study is to compare the economics of in‐office tympanostomy tube placement using single use devices versus standard placement in the operating room (OR).


Methods
A retrospective chart review was completed for all pediatric patients who underwent in‐office tympanostomy tube placement (CPT 69433) along with insurance and date matched patients with placement in the OR (CPT 69436) between 12/1/21–3/1/24. Financial data were compared among the public vs. private insurance cohorts using the Wilcoxon rank‐sum test with a two‐sided significance level of 5%.


Results
One hundred and thirty‐six in‐office patients were identified, 102 private versus 34 public, and compared with 136 insurance and date matched OR patients. The average total payment for both privately insured patients, $647.14 in‐office versus $6873.45 in the OR, and publicly insured patients, $312.74 in‐office versus $2656.34 in the OR, was statistically significant. The average insurance payment for both privately insured patients, $301.58 in‐office versus $5445.73 in the OR, and publicly insured patients, $310.63 in‐office versus $2258.65 in the OR, was statistically significant. For the patient payment, public insurance usually has 0 copay and is therefore excluded. The patient payment of the private insurance cohort, $308.30 in‐office versus $670.61 in the OR, was not found to be statistically significant.


Conclusion
As expected, this study demonstrates significant reductions in overall cost with in‐office tympanostomy tube placement even with the added cost of single‐use devices compared to the standard placement in the OR, particularly for insurance companies, suggesting the potential benefit of providing reimbursement for these devices.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;The purpose of this study is to compare the economics of in-office tympanostomy tube placement using single use devices versus standard placement in the operating room (OR).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective chart review was completed for all pediatric patients who underwent in-office tympanostomy tube placement (CPT 69433) along with insurance and date matched patients with placement in the OR (CPT 69436) between 12/1/21–3/1/24. Financial data were compared among the public vs. private insurance cohorts using the Wilcoxon rank-sum test with a two-sided significance level of 5%.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;One hundred and thirty-six in-office patients were identified, 102 private versus 34 public, and compared with 136 insurance and date matched OR patients. The average total payment for both privately insured patients, $647.14 in-office versus $6873.45 in the OR, and publicly insured patients, $312.74 in-office versus $2656.34 in the OR, was statistically significant. The average insurance payment for both privately insured patients, $301.58 in-office versus $5445.73 in the OR, and publicly insured patients, $310.63 in-office versus $2258.65 in the OR, was statistically significant. For the patient payment, public insurance usually has 0 copay and is therefore excluded. The patient payment of the private insurance cohort, $308.30 in-office versus $670.61 in the OR, was not found to be statistically significant.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;As expected, this study demonstrates significant reductions in overall cost with in-office tympanostomy tube placement &lt;i&gt;even with the added cost of single-use devices&lt;/i&gt; compared to the standard placement in the OR, particularly for insurance companies, suggesting the potential benefit of providing reimbursement for these devices.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Keith D. Brendes, 
Chase Beckerman, 
Andrew Ritchey, 
Nathan C. Page, 
Mark E. Gerber
</dc:creator>
         <category>Original Report</category>
         <dc:title>Economic Evaluation of Tympanostomy Tube Placement</dc:title>
         <dc:identifier>10.1002/lary.70391</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70391</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70391?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70396?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70396</guid>
         <title>Exploring Real‐Time Tracking of Vocal Fold Polyps in Video‐Stroboscopy Using Deep Learning</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2511-2518, June 2026. </description>
         <dc:description>
The study presents a deep learning based pipeline for near real‐time detection and tracking of vocal fold polyps in video‐stroboscopy. By combining frame‐level object detection with a temporal tracking module, the pipeline improves detection continuity across consecutive frames while maintaining clinically feasible processing speeds.








ABSTRACT

Objective
To develop and evaluate a deep learning object detection system for identifying vocal fold polyps in stroboscopic video frames using You Only Look Once (YOLO), and to assess the added benefit of temporal tracking on detection performance.


Methods
A retrospective dataset of 12,742 annotated frames from 55 laryngoscopy video recordings was annotated with bounding boxes identifying vocal fold polyps. Pretrained YOLO11 and YOLO12 models were fine‐tuned to detect the polyps in the frames. A temporal tracking algorithm was further developed to propagate missed detections across adjacent frames.


Results
YOLO12 outperformed YOLO11 across all metrics. On the hold‐out test set, YOLO12 reached a precision of 83.1% and an F1 score of 67.6%, with a mean average precision at 0.5 (mAP@0.5) of 64.1%. By comparison, YOLO11 achieved a precision of 67.3% and an F1 score of 56.2%, with a mAP@0.5 of 56.0%. Incorporating temporal tracking increased mAP@0.5 to 70.4% with YOLO 12, while maintaining a detection speed of 21.4 frames per second (fps), close to real time (30 fps).


Conclusions
Using YOLO 12 for vocal fold polyp detection in stroboscopy was enhanced with temporal tracking, achieving a mAP@0.5 of 70.4% with near real time performance. These results demonstrate the potential of real‐time AI‐assisted detection of vocal fold lesions.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/44bf71fb-0c49-48ef-b430-6430c7bc7436/lary70396-toc-0001-m.png"
     alt="Exploring Real-Time Tracking of Vocal Fold Polyps in Video-Stroboscopy Using Deep Learning"/&gt;
&lt;p&gt;The study presents a deep learning based pipeline for near real-time detection and tracking of vocal fold polyps in video-stroboscopy. By combining frame-level object detection with a temporal tracking module, the pipeline improves detection continuity across consecutive frames while maintaining clinically feasible processing speeds.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To develop and evaluate a deep learning object detection system for identifying vocal fold polyps in stroboscopic video frames using You Only Look Once (YOLO), and to assess the added benefit of temporal tracking on detection performance.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective dataset of 12,742 annotated frames from 55 laryngoscopy video recordings was annotated with bounding boxes identifying vocal fold polyps. Pretrained YOLO11 and YOLO12 models were fine-tuned to detect the polyps in the frames. A temporal tracking algorithm was further developed to propagate missed detections across adjacent frames.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;YOLO12 outperformed YOLO11 across all metrics. On the hold-out test set, YOLO12 reached a precision of 83.1% and an &lt;i&gt;F&lt;/i&gt;1 score of 67.6%, with a mean average precision at 0.5 (mAP@0.5) of 64.1%. By comparison, YOLO11 achieved a precision of 67.3% and an &lt;i&gt;F&lt;/i&gt;1 score of 56.2%, with a mAP@0.5 of 56.0%. Incorporating temporal tracking increased mAP@0.5 to 70.4% with YOLO 12, while maintaining a detection speed of 21.4 frames per second (fps), close to real time (30 fps).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Using YOLO 12 for vocal fold polyp detection in stroboscopy was enhanced with temporal tracking, achieving a mAP@0.5 of 70.4% with near real time performance. These results demonstrate the potential of real-time AI-assisted detection of vocal fold lesions.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Sanjana Kaza, 
Abhinita S. Mohanty, 
Aisha Serpedin, 
Jenny Yau, 
Yeo Eun Kim, 
Rachel B. Kutler, 
Olivier Elemento, 
Lucian Sulica, 
Pegah Khosravi, 
Anaïs Rameau
</dc:creator>
         <category>Original Report</category>
         <dc:title>Exploring Real‐Time Tracking of Vocal Fold Polyps in Video‐Stroboscopy Using Deep Learning</dc:title>
         <dc:identifier>10.1002/lary.70396</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70396</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70396?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70398?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70398</guid>
         <title>Nasal Air‐Jet Sensitivity Differentiates Empty Nose Syndrome and Turbinate Reduction Patients: A Pilot Study</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2491-2498, June 2026. </description>
         <dc:description>
This prospective pilot study aims to compare nasal mucosal sensitivity to air‐jet stimuli between ENS patients and patients who underwent septoplasty/turbinate reduction (septo‐turb) surgery, but without ENS symptoms. The ENS group had a significantly higher (less sensitive) threshold than the septo‐turb group for the septum opposing the center of the inferior turbinate, with regional correlation with self‐reported symptom scores.








ABSTRACT

Objectives
Abnormal nasal mucosal function has been frequently implicated in the symptomatology of empty nose syndrome (ENS), yet with limited evidence. This prospective pilot study aims to compare nasal mucosal sensitivity to air‐jet stimuli between ENS patients and patients who underwent septoplasty/turbinate reduction (septo‐turb) surgery, but without ENS symptoms.


Methods
Seven ENS and seven septo‐turb subjects were recruited through a sample of convenience (from 06/2023 to 09/2024) due to the rarity of ENS. A precise, 0.25 s air jet ranging from 0.5 to 5 L/min was delivered via a 25‐gage microcannula, with a 0.4 × 1.6 mm side opening placed 2 mm from the mucosal surface at predetermined sites that include the medial and lateral side of the nasal valve, the head and the center of inferior turbinate and their opposing septum. Detection thresholds were determined using a single‐staircase method in 0.5 L/min steps.


Results
The ENS group had a significantly higher (less sensitive) threshold than the septo‐turb group for the septum opposing the center of the inferior turbinate (ENS: 2.43 ± 1.37 L/min; septoplasty: 1.39 ± 1.27 L/min, p = 0.016); however, not for other sites. This regional threshold significantly correlated with all self‐reported symptom scores (NOSE, SNOT‐22, ENS6Q, VAS) (r = 0.45–0.54, all p &lt; 0.05).


Conclusion
Significant regional differences in air‐jet stimulus sensitivity between ENS and septoplasty patients were found that significantly correlated with symptom scores. A future larger sample size would make a more definitive conclusion.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/5f345ca3-6608-4a5a-98b6-c138edc97ec3/lary70398-toc-0001-m.png"
     alt="Nasal Air-Jet Sensitivity Differentiates Empty Nose Syndrome and Turbinate Reduction Patients: A Pilot Study"/&gt;
&lt;p&gt;This prospective pilot study aims to compare nasal mucosal sensitivity to air-jet stimuli between ENS patients and patients who underwent septoplasty/turbinate reduction (septo-turb) surgery, but without ENS symptoms. The ENS group had a significantly higher (less sensitive) threshold than the septo-turb group for the septum opposing the center of the inferior turbinate, with regional correlation with self-reported symptom scores.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Abnormal nasal mucosal function has been frequently implicated in the symptomatology of empty nose syndrome (ENS), yet with limited evidence. This prospective pilot study aims to compare nasal mucosal sensitivity to air-jet stimuli between ENS patients and patients who underwent septoplasty/turbinate reduction (septo-turb) surgery, but without ENS symptoms.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Seven ENS and seven septo-turb subjects were recruited through a sample of convenience (from 06/2023 to 09/2024) due to the rarity of ENS. A precise, 0.25 s air jet ranging from 0.5 to 5 L/min was delivered via a 25-gage microcannula, with a 0.4 × 1.6 mm side opening placed 2 mm from the mucosal surface at predetermined sites that include the medial and lateral side of the nasal valve, the head and the center of inferior turbinate and their opposing septum. Detection thresholds were determined using a single-staircase method in 0.5 L/min steps.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The ENS group had a significantly higher (less sensitive) threshold than the septo-turb group for the septum opposing the center of the inferior turbinate (ENS: 2.43 ± 1.37 L/min; septoplasty: 1.39 ± 1.27 L/min, &lt;i&gt;p&lt;/i&gt; = 0.016); however, not for other sites. This regional threshold significantly correlated with all self-reported symptom scores (NOSE, SNOT-22, ENS6Q, VAS) (&lt;i&gt;r&lt;/i&gt; = 0.45–0.54, all &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Significant regional differences in air-jet stimulus sensitivity between ENS and septoplasty patients were found that significantly correlated with symptom scores. A future larger sample size would make a more definitive conclusion.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Kanghyun Kim, 
Ahmad Odeh, 
Jack Harness, 
Nidhi Jha, 
Veronica Formanek, 
Joseph Lee, 
Bradley Otto, 
Kathleen Kelly, 
Kai Zhao
</dc:creator>
         <category>Original Report</category>
         <dc:title>Nasal Air‐Jet Sensitivity Differentiates Empty Nose Syndrome and Turbinate Reduction Patients: A Pilot Study</dc:title>
         <dc:identifier>10.1002/lary.70398</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70398</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70398?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70399?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70399</guid>
         <title>Effect of Mepolizumab on Middle Ear Disease and Hearing Outcomes in CRSwNP
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2752-2760, June 2026. </description>
         <dc:description>
Otitis media with effusion (OME), assessed by pathological tympanometry, was present in 22.8% of patients with severe CRSwNP at baseline and was associated with higher blood eosinophil levels. After 6 months of mepolizumab‐based treatment, the proportion of patients with pathological tympanometry decreased to 14% (p = 0.07), while pure tone averages remained unchanged. Patient‐reported outcomes (COMOT‐15 and SNOT‐22 ear‐related domains) improved significantly, supporting the clinical relevance of systematically assessing middle ear disease in CRSwNP.








ABSTRACT

Objective
Otitis media with effusion (OME) is frequently observed in patients with severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)—yet it remains underrecognized. Both conditions are debilitating and may share type 2 inflammatory mechanisms. This study investigates the prevalence of OME (measured by tympanometry) in patients with CRSwNP and evaluates the effect of biologic treatment with mepolizumab, with or without combined FESS, on hearing outcomes as well as otologic symptoms.


Methods
Secondary analysis of a randomized controlled trial (RCT) (n = 58) comparing FESS and mepolizumab versus mepolizumab alone in patients suffering from severe CRSwNP. Tympanometry, audiometry, and patient‐reported outcomes (SNOT‐22 and COMOT‐15) were assessed at baseline and after 6 months.


Results
At baseline, 22.8% (13/57) of patients had pathological tympanometry (OME), consistent with previous prevalence estimates. After 6 months, the proportion decreased to 14% (p = 0.07). No significant changes were observed in pure tone averages (PTA). In contrast, self‐reported outcomes improved significantly, with reductions in both COMOT‐15 and SNOT‐22 scores (p &lt; 0.05), independent of baseline tympanometry status.


Conclusion
Mepolizumab treatment was associated with a trend toward reduced middle ear symptoms and significant improvement in self‐reported otologic symptoms, supporting the concept of global type 2 airway inflammation and the clinical relevance of assessing ear disease in CRSwNP.


Level of Evidence

2.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/0ed70b66-5410-45a0-855d-8bd51baadb51/lary70399-toc-0001-m.png"
     alt="Effect of Mepolizumab on Middle Ear Disease and Hearing Outcomes in CRSwNP&amp;#xA;"/&gt;
&lt;p&gt;Otitis media with effusion (OME), assessed by pathological tympanometry, was present in 22.8% of patients with severe CRSwNP at baseline and was associated with higher blood eosinophil levels. After 6 months of mepolizumab-based treatment, the proportion of patients with pathological tympanometry decreased to 14% (&lt;i&gt;p&lt;/i&gt; = 0.07), while pure tone averages remained unchanged. Patient-reported outcomes (COMOT-15 and SNOT-22 ear-related domains) improved significantly, supporting the clinical relevance of systematically assessing middle ear disease in CRSwNP.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Otitis media with effusion (OME) is frequently observed in patients with severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)—yet it remains underrecognized. Both conditions are debilitating and may share type 2 inflammatory mechanisms. This study investigates the prevalence of OME (measured by tympanometry) in patients with CRSwNP and evaluates the effect of biologic treatment with mepolizumab, with or without combined FESS, on hearing outcomes as well as otologic symptoms.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Secondary analysis of a randomized controlled trial (RCT) (&lt;i&gt;n&lt;/i&gt; = 58) comparing FESS and mepolizumab versus mepolizumab alone in patients suffering from severe CRSwNP. Tympanometry, audiometry, and patient-reported outcomes (SNOT-22 and COMOT-15) were assessed at baseline and after 6 months.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;At baseline, 22.8% (13/57) of patients had pathological tympanometry (OME), consistent with previous prevalence estimates. After 6 months, the proportion decreased to 14% (&lt;i&gt;p&lt;/i&gt; = 0.07). No significant changes were observed in pure tone averages (PTA). In contrast, self-reported outcomes improved significantly, with reductions in both COMOT-15 and SNOT-22 scores (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), independent of baseline tympanometry status.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Mepolizumab treatment was associated with a trend toward reduced middle ear symptoms and significant improvement in self-reported otologic symptoms, supporting the concept of global type 2 airway inflammation and the clinical relevance of assessing ear disease in CRSwNP.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;
&lt;b&gt;2&lt;/b&gt;.&lt;/p&gt;</content:encoded>
         <dc:creator>
Anne‐Sophie Homøe, 
Jens Tidemandsen, 
Kasper Aanæs, 
Vibeke Backer, 
Ramon G. Jensen
</dc:creator>
         <category>Original Report</category>
         <dc:title>Effect of Mepolizumab on Middle Ear Disease and Hearing Outcomes in CRSwNP
</dc:title>
         <dc:identifier>10.1002/lary.70399</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70399</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70399?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70404?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70404</guid>
         <title>Natural History of Sensorineural Hearing Loss in Children With 
STRC
 Mutations</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2784-2791, June 2026. </description>
         <dc:description>
ABSTRACT

Introduction
The most common genes responsible for autosomal recessive nonsyndromic hearing loss (AR‐NSHL) are GJB2 and STRC. STRC mutations are associated with mild‐to‐moderate sensorineural (SNHL) hearing loss and a lack of progression. However, our institutional experience suggested otherwise, prompting this review.


Methods
A 10‐year retrospective chart review was performed at a tertiary children's hospital after the University of Iowa added STRC to its OtoSCOPER panel in 2013. Subjects with positive OtoSCOPER results underwent audiologic review. Hearing progression was defined based on pure‐tone average changes, and mutation subtypes were categorized.


Results
Of 354 subjects undergoing OtoSCOPER testing, 181 (51.1%) carried a pathogenic mutation; GJB2 (28.7%) and STRC (16.6%) were most common. The STRC cohort included 30 subjects (21 males, 9 females) with hearing loss severity classifiable in 26 subjects and the highest proportion in the mild‐to‐moderate range (n = 46 ears; 88.5%). Hearing progression was observed in 12/24 subjects (20 ears: 8 bilateral, 4 unilateral). Median annual progression was 1.1 dB (range −3.5 to 18.7 dB). Two STRC subjects had substantial progression requiring cochlear implantation (one performed, one recommended). Genetic subtyping revealed seven categories, including six males with STRC/CATSPER2 deletions (deafness‐infertility syndrome). No association between subtype and severity or progression was identified.


Discussion

STRC is the second most common cause of childhood NSHL and the leading contributor to mild‐to‐moderate SNHL. Unlike most published literature, 50% of our STRC cohort exhibited progression, and 17.6% of progressing subjects had substantial unilateral loss. We recommend long‐term audiometric monitoring and standardized genomic reporting for this population.


Level of Evidence
4.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Introduction&lt;/h2&gt;
&lt;p&gt;The most common genes responsible for autosomal recessive nonsyndromic hearing loss (AR-NSHL) are &lt;i&gt;GJB2&lt;/i&gt; and &lt;i&gt;STRC&lt;/i&gt;. &lt;i&gt;STRC&lt;/i&gt; mutations are associated with mild-to-moderate sensorineural (SNHL) hearing loss and a lack of progression. However, our institutional experience suggested otherwise, prompting this review.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A 10-year retrospective chart review was performed at a tertiary children's hospital after the University of Iowa added &lt;i&gt;STRC&lt;/i&gt; to its OtoSCOPE&lt;sup&gt;R&lt;/sup&gt; panel in 2013. Subjects with positive OtoSCOPE&lt;sup&gt;R&lt;/sup&gt; results underwent audiologic review. Hearing progression was defined based on pure-tone average changes, and mutation subtypes were categorized.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 354 subjects undergoing OtoSCOPE&lt;sup&gt;R&lt;/sup&gt; testing, 181 (51.1%) carried a pathogenic mutation; &lt;i&gt;GJB2&lt;/i&gt; (28.7%) and &lt;i&gt;STRC&lt;/i&gt; (16.6%) were most common. The &lt;i&gt;STRC&lt;/i&gt; cohort included 30 subjects (21 males, 9 females) with hearing loss severity classifiable in 26 subjects and the highest proportion in the mild-to-moderate range (&lt;i&gt;n&lt;/i&gt; = 46 ears; 88.5%). Hearing progression was observed in 12/24 subjects (20 ears: 8 bilateral, 4 unilateral). Median annual progression was 1.1 dB (range −3.5 to 18.7 dB). Two &lt;i&gt;STRC&lt;/i&gt; subjects had substantial progression requiring cochlear implantation (one performed, one recommended). Genetic subtyping revealed seven categories, including six males with &lt;i&gt;STRC/CATSPER2&lt;/i&gt; deletions (deafness-infertility syndrome). No association between subtype and severity or progression was identified.&lt;/p&gt;
&lt;h2&gt;Discussion&lt;/h2&gt;
&lt;p&gt;
&lt;i&gt;STRC&lt;/i&gt; is the second most common cause of childhood NSHL and the leading contributor to mild-to-moderate SNHL. Unlike most published literature, 50% of our STRC cohort exhibited progression, and 17.6% of progressing subjects had substantial unilateral loss. We recommend long-term audiometric monitoring and standardized genomic reporting for this population.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Kenny H. Chan, 
Emily E. Nightengale, 
Setareh Ekhteraei, 
Ericka Schicke, 
Suhong Tong, 
Austin Zhu, 
Barbara K. Burton
</dc:creator>
         <category>Original Report</category>
         <dc:title>Natural History of Sensorineural Hearing Loss in Children With 
STRC
 Mutations</dc:title>
         <dc:identifier>10.1002/lary.70404</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70404</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70404?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70414?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70414</guid>
         <title>Characterizing Secondary Velopharyngeal Surgery in Children With Cleft Palate at an Academic Center</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2792-2800, June 2026. </description>
         <dc:description>
In this retrospective study of children undergoing primary palatoplasty at a single academic institution, 10.8% required secondary surgery for velopharyngeal insufficiency. Multivariate analysis demonstrated that private insurance was associated with decreased odds of secondary surgery, while Asian race was associated with increased odds. Among patients requiring secondary intervention, the presence of 22q11.2 microdeletion syndrome was associated with the need for multiple procedures.








ABSTRACT

Objective
To identify factors associated with secondary surgery for velopharyngeal insufficiency in children following primary palatoplasty.


Methods
A retrospective review was conducted of children with cleft palate who were seen at a single academic center between August 2014 and April 2024 and underwent primary palatoplasty. Demographic and clinical data were collected, and the need for and number of secondary velopharyngeal surgeries were recorded. Univariate analyses and multivariate logistic regression were used to identify associated factors.


Results
Of 251 children who underwent primary palatoplasty, 27 (10.8%) required secondary velopharyngeal surgery. Univariate analyses revealed no association between secondary surgery and cleft type, presence of a syndrome, or timing of palatoplasty. Multivariate logistic regression controlling for race, insurance type, age at primary palatoplasty, and presence of 22q11.2 microdeletion syndrome revealed private insurance was associated with decreased odds of secondary velopharyngeal surgery (OR = 0.230, 95% CI: 0.069–0.765, p = 0.017), whereas Asian race was associated with increased odds (OR = 5.853, 95% CI: 1.105–30.998, p = 0.038). Among those requiring velopharyngeal surgery, 74.1% underwent one procedure and 25.9% underwent two. The presence of 22q11.2 microdeletion syndrome was significantly associated with needing two surgeries (p = 0.042), while female sex was associated with requiring only one surgery (p = 0.006).


Conclusions
Clinical and sociodemographic factors were predictive of secondary velopharyngeal surgery following primary palatoplasty, with different risk factors associated with the need for more than one procedure. Larger studies are warranted to corroborate these findings and guide risk stratification and family counseling.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7a271454-89de-45fc-991e-86bb4a9efb7d/lary70414-toc-0001-m.png"
     alt="Characterizing Secondary Velopharyngeal Surgery in Children With Cleft Palate at an Academic Center"/&gt;
&lt;p&gt;In this retrospective study of children undergoing primary palatoplasty at a single academic institution, 10.8% required secondary surgery for velopharyngeal insufficiency. Multivariate analysis demonstrated that private insurance was associated with decreased odds of secondary surgery, while Asian race was associated with increased odds. Among patients requiring secondary intervention, the presence of 22q11.2 microdeletion syndrome was associated with the need for multiple procedures.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To identify factors associated with secondary surgery for velopharyngeal insufficiency in children following primary palatoplasty.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective review was conducted of children with cleft palate who were seen at a single academic center between August 2014 and April 2024 and underwent primary palatoplasty. Demographic and clinical data were collected, and the need for and number of secondary velopharyngeal surgeries were recorded. Univariate analyses and multivariate logistic regression were used to identify associated factors.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 251 children who underwent primary palatoplasty, 27 (10.8%) required secondary velopharyngeal surgery. Univariate analyses revealed no association between secondary surgery and cleft type, presence of a syndrome, or timing of palatoplasty. Multivariate logistic regression controlling for race, insurance type, age at primary palatoplasty, and presence of 22q11.2 microdeletion syndrome revealed private insurance was associated with decreased odds of secondary velopharyngeal surgery (OR = 0.230, 95% CI: 0.069–0.765, &lt;i&gt;p&lt;/i&gt; = 0.017), whereas Asian race was associated with increased odds (OR = 5.853, 95% CI: 1.105–30.998, &lt;i&gt;p&lt;/i&gt; = 0.038). Among those requiring velopharyngeal surgery, 74.1% underwent one procedure and 25.9% underwent two. The presence of 22q11.2 microdeletion syndrome was significantly associated with needing two surgeries (&lt;i&gt;p&lt;/i&gt; = 0.042), while female sex was associated with requiring only one surgery (&lt;i&gt;p&lt;/i&gt; = 0.006).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Clinical and sociodemographic factors were predictive of secondary velopharyngeal surgery following primary palatoplasty, with different risk factors associated with the need for more than one procedure. Larger studies are warranted to corroborate these findings and guide risk stratification and family counseling.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Lauren E. Williamson, 
Krishna G. Patel, 
Matthew H. Cheung, 
Mathew J. Gregoski, 
Melissa S. Montiel, 
Phayvanh P. Pecha
</dc:creator>
         <category>Original Report</category>
         <dc:title>Characterizing Secondary Velopharyngeal Surgery in Children With Cleft Palate at an Academic Center</dc:title>
         <dc:identifier>10.1002/lary.70414</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70414</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70414?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70428?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70428</guid>
         <title>Fluorescence Guidance Reduces Operative Time for Sentinel Lymph Node Biopsy in the Head and Neck</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2614-2620, June 2026. </description>
         <dc:description>
Prior studies have demonstrated the feasibility of fluorescently labeled tilmanocept for sentinel lymph node biopsy (SLNB) in the oral cavity. This study demonstrated that the use of fluorescently labeled tilmanocept decreases operative time needed for SLNB compared to gamma probe, as well as reduces the amount of nonsentinel tissue removed. We additionally show the durability of the fluorescence signal up to 5 days and clear visualization of the proposed tracer with commercially available intraoperative imagers.








ABSTRACT

Objective
Prior studies have demonstrated the feasibility of fluorescently labeled tilmanocept for sentinel lymph node biopsy (SLNB) in the oral cavity. We evaluated the added value of fluorescently labeled tilmanocept in sentinel lymph node biopsy (SLNB) of the oral cavity compared to gamma probe.


Methods
Healthy male New Zealand white rabbits received oral cavity injections of radioactive (Technetium 99m) and fluorescently (IRDye800) conjugated tilmanocept followed by either fluorescence guided (n = 14) or gamma probe guided (n = 14) SLNB performed 1 h, 48 h, or 5 days postinjection. Duration of the SLNB performed by two individuals was measured and compared using the two methods.


Results
Fluorescence guidance resulted in a 1.8‐fold reduction in time of SLN removal (median 104 vs. 191 s, p = 0.05). For the fluorescence guided SLNB, 7.1% (1 of 14) had nonsentinel node tissue removed prior to the correct identification of the SLN, whereas gamma probe/radioactivity guided SLNB had 28.6% (4 of 14). When comparing operation time between attending and resident surgeon, time to identification of first SLN was not significantly different for fluorescence guided surgery (82 vs. 107 s, respectively) or with gamma probe (158 vs. 204 s); however, median times using the gamma probe were nearly double for both operators. We additionally show the durability of fluorescence signal up to 5 days and clear visualization of proposed tracer with commercially available intraoperative imagers.


Conclusion
The use of fluorescent labeled tilmanocept decreases operative time needed for SLNB as well as reduces the amount of nonsentinel tissue removed.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/2a380ca0-744a-43cc-8827-25881ddc7fb6/lary70428-toc-0001-m.png"
     alt="Fluorescence Guidance Reduces Operative Time for Sentinel Lymph Node Biopsy in the Head and Neck"/&gt;
&lt;p&gt;Prior studies have demonstrated the feasibility of fluorescently labeled tilmanocept for sentinel lymph node biopsy (SLNB) in the oral cavity. This study demonstrated that the use of fluorescently labeled tilmanocept decreases operative time needed for SLNB compared to gamma probe, as well as reduces the amount of nonsentinel tissue removed. We additionally show the durability of the fluorescence signal up to 5 days and clear visualization of the proposed tracer with commercially available intraoperative imagers.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Prior studies have demonstrated the feasibility of fluorescently labeled tilmanocept for sentinel lymph node biopsy (SLNB) in the oral cavity. We evaluated the added value of fluorescently labeled tilmanocept in sentinel lymph node biopsy (SLNB) of the oral cavity compared to gamma probe.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Healthy male New Zealand white rabbits received oral cavity injections of radioactive (Technetium 99m) and fluorescently (IRDye800) conjugated tilmanocept followed by either fluorescence guided (&lt;i&gt;n&lt;/i&gt; = 14) or gamma probe guided (&lt;i&gt;n&lt;/i&gt; = 14) SLNB performed 1 h, 48 h, or 5 days postinjection. Duration of the SLNB performed by two individuals was measured and compared using the two methods.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Fluorescence guidance resulted in a 1.8-fold reduction in time of SLN removal (median 104 vs. 191 s, &lt;i&gt;p&lt;/i&gt; = 0.05). For the fluorescence guided SLNB, 7.1% (1 of 14) had nonsentinel node tissue removed prior to the correct identification of the SLN, whereas gamma probe/radioactivity guided SLNB had 28.6% (4 of 14). When comparing operation time between attending and resident surgeon, time to identification of first SLN was not significantly different for fluorescence guided surgery (82 vs. 107 s, respectively) or with gamma probe (158 vs. 204 s); however, median times using the gamma probe were nearly double for both operators. We additionally show the durability of fluorescence signal up to 5 days and clear visualization of proposed tracer with commercially available intraoperative imagers.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The use of fluorescent labeled tilmanocept decreases operative time needed for SLNB as well as reduces the amount of nonsentinel tissue removed.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Morgan Davis Mills, 
Sophie S. Jang, 
Ryotaro Ogawa, 
Edward Ashworth, 
Christopher V. Barback, 
David J. Hall, 
David R. Vera, 
Theresa Guo
</dc:creator>
         <category>Original Report</category>
         <dc:title>Fluorescence Guidance Reduces Operative Time for Sentinel Lymph Node Biopsy in the Head and Neck</dc:title>
         <dc:identifier>10.1002/lary.70428</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70428</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70428?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70438?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70438</guid>
         <title>
ACR‐TIRADS Institution and Effect on Thyroid Surgeries in Veterans: A 10‐Year Retrospective Study</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2820-2826, June 2026. </description>
         <dc:description>
Following analysis of the adoption of ACR TI‐RADS at the VA Northern California Healthcare System, the number of thyroid ultrasounds and FNAs increased substantially, while the total number of thyroid surgeries remained relatively stable. Surgical practice trends towards more selective and less‐invasive management, with fewer total thyroidectomies for benign disease and a higher proportion of surgeries for malignancy. Overall, this stratification system for thyroid nodule disease did not appear to fully achieve the intended clinical value of decreasing FNAs, identifying more malignancy, or decreasing surgery.








ABSTRACT

Introduction
Risk stratification systems (RSSs) have had an increasing role in standardizing thyroid ultrasound reports. The VA Northern California Healthcare System (VA‐NCHCS) Radiology department adopted the American College of Radiology Thyroid Imaging Reporting and Data System (TI‐RADS) in 2018. We aimed to assess what effect the adoption of TI‐RADS at VA‐NCHCS had on thyroid surgical practices.


Methods
A 10‐year retrospective review of the VA corporate data warehouse was completed (approximately 5 years prior and 5 years after universal adoption of TI‐RADS) (i.e: 1/1/2013–7/1/2018 and 7/2/2018–12/30/2023). Using CPT and diagnosis codes, data were collected on all thyroid surgeries, including demographics, type of surgery performed, final pathology, staging of malignancy, and any incidental findings. A two‐sample t‐test with equal and unequal variances was used for comparative statistics.


Results
3985 patients (1921 PRE‐TIRADS vs. 2064 POST‐TIRADS) and 7908 thyroid ultrasounds (3411 vs. 4497) were identified. 2859 FNAs were performed (1245 vs. 1614). One hundred and ninety‐three surgeries (96 vs. 97) were performed with a decreasing trend in surgeries for benign pathology (56 vs. 45) and an increasing trend in surgeries for malignancy (39 vs. 51). We identified an increase in partial thyroidectomy surgeries for cancer diagnoses (11 vs. 18). Finally, there was a significant decrease in total thyroidectomies performed for benign pathology (30 vs. 13, p = 0.02).


Conclusion
After the institution of TIRADs at our single institution, there was a dramatic increase in the number of ultrasounds and FNAs performed, despite near stable thyroid surgical numbers. There was a significant trend towards less‐invasive surgical practices.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/355731de-aaad-4376-b377-4e8098afc3b9/lary70438-toc-0001-m.png"
     alt="&amp;#xA;ACR-TIRADS Institution and Effect on Thyroid Surgeries in Veterans: A 10-Year Retrospective Study"/&gt;
&lt;p&gt;Following analysis of the adoption of ACR TI-RADS at the VA Northern California Healthcare System, the number of thyroid ultrasounds and FNAs increased substantially, while the total number of thyroid surgeries remained relatively stable. Surgical practice trends towards more selective and less-invasive management, with fewer total thyroidectomies for benign disease and a higher proportion of surgeries for malignancy. Overall, this stratification system for thyroid nodule disease did not appear to fully achieve the intended clinical value of decreasing FNAs, identifying more malignancy, or decreasing surgery.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Introduction&lt;/h2&gt;
&lt;p&gt;Risk stratification systems (RSSs) have had an increasing role in standardizing thyroid ultrasound reports. The VA Northern California Healthcare System (VA-NCHCS) Radiology department adopted the American College of Radiology Thyroid Imaging Reporting and Data System (TI-RADS) in 2018. We aimed to assess what effect the adoption of TI-RADS at VA-NCHCS had on thyroid surgical practices.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A 10-year retrospective review of the VA corporate data warehouse was completed (approximately 5 years prior and 5 years after universal adoption of TI-RADS) (i.e: 1/1/2013–7/1/2018 and 7/2/2018–12/30/2023). Using CPT and diagnosis codes, data were collected on all thyroid surgeries, including demographics, type of surgery performed, final pathology, staging of malignancy, and any incidental findings. A two-sample &lt;i&gt;t&lt;/i&gt;-test with equal and unequal variances was used for comparative statistics.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;3985 patients (1921 PRE-TIRADS vs. 2064 POST-TIRADS) and 7908 thyroid ultrasounds (3411 vs. 4497) were identified. 2859 FNAs were performed (1245 vs. 1614). One hundred and ninety-three surgeries (96 vs. 97) were performed with a decreasing trend in surgeries for benign pathology (56 vs. 45) and an increasing trend in surgeries for malignancy (39 vs. 51). We identified an increase in partial thyroidectomy surgeries for cancer diagnoses (11 vs. 18). Finally, there was a significant decrease in total thyroidectomies performed for benign pathology (30 vs. 13, &lt;i&gt;p&lt;/i&gt; = 0.02).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;After the institution of TIRADs at our single institution, there was a dramatic increase in the number of ultrasounds and FNAs performed, despite near stable thyroid surgical numbers. There was a significant trend towards less-invasive surgical practices.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Isabella W. Leon, 
Davis S. Chong, 
Bryle Nicole G. Barrameda, 
Anusha A. Gogulapati, 
Lane D. Squires
</dc:creator>
         <category>Original Report</category>
         <dc:title>
ACR‐TIRADS Institution and Effect on Thyroid Surgeries in Veterans: A 10‐Year Retrospective Study</dc:title>
         <dc:identifier>10.1002/lary.70438</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70438</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70438?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70324?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70324</guid>
         <title>Lindsay‐Hemenway Syndrome, Acute Vertigo Followed by BPPV: A Prospective Comparative Study</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2701-2707, June 2026. </description>
         <dc:description>
Patients with Lindsay‐Hemenway syndrome showed a longer duration of vertigo and required a higher number of repositioning maneuvers to achieve symptom resolution compared with patients with idiopathic posterior canal BPPV. These findings suggest a more persistent and treatment‐resistant form of BPPV when it occurs secondary to acute unilateral vestibulopathy.








ABSTRACT

Objectives
Lindsay‐Hemenway syndrome (LHS) is characterized by an acute unilateral vestibular loss followed by ipsilateral posterior semicircular canal (PSC) benign paroxysmal positional vertigo (BPPV). Despite its clinical relevance, comparative data between LHS, isolated acute unilateral vestibulopathy (AUVP), and idiopathic PSC BPPV are uncommon. This work aims to compare vestibular function and clinical outcomes in patients diagnosed with LHS, isolated AUVP, and idiopathic PSC BPPV.


Methods
A multicenter longitudinal study was conducted between 2018 and 2025, enrolling 98 patients divided into three groups: LHS (n = 36), isolated AUVP (n = 30), and idiopathic PSC BPPV (n = 32). Vestibular evaluation was assessed through video head impulse test (vHIT), evaluation of spontaneous nystagmus, and Dix‐Hallpike maneuver. Primary outcomes included vestibular gain at baseline and 6 months, presence and characteristics of corrective saccades, number of repositioning maneuvers required, and time to symptom resolution.


Results
Patients with LHS showed significantly greater initial vestibular impairment in both affected and contralateral ears compared to isolated AUVP (p &lt; 0.05) and demonstrated slower functional recovery at 6 months. Saccade amplitude was notably larger in LHS patients (p &lt; 0.05), while latency and clustering were similar across groups. Spontaneous nystagmus persisted more frequently in the LHS cohort (OR 3.67). All LHS patients developed ipsilateral PSC BPPV, which required more repositioning maneuvers (p &lt; 0.043) and presented a longer clinical course than idiopathic PSC BPPV (p &lt; 0.05).


Conclusions
Lindsay‐Hemenway syndrome involves more severe vestibular dysfunction, slower recovery, and more persistent BPPV than isolated AUVP or idiopathic PSC BPPV.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/ac2a53ab-9707-4794-87fc-e52a9644d806/lary70324-toc-0001-m.png"
     alt="Lindsay-Hemenway Syndrome, Acute Vertigo Followed by BPPV: A Prospective Comparative Study"/&gt;
&lt;p&gt;Patients with Lindsay-Hemenway syndrome showed a longer duration of vertigo and required a higher number of repositioning maneuvers to achieve symptom resolution compared with patients with idiopathic posterior canal BPPV. These findings suggest a more persistent and treatment-resistant form of BPPV when it occurs secondary to acute unilateral vestibulopathy.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Lindsay-Hemenway syndrome (LHS) is characterized by an acute unilateral vestibular loss followed by ipsilateral posterior semicircular canal (PSC) benign paroxysmal positional vertigo (BPPV). Despite its clinical relevance, comparative data between LHS, isolated acute unilateral vestibulopathy (AUVP), and idiopathic PSC BPPV are uncommon. This work aims to compare vestibular function and clinical outcomes in patients diagnosed with LHS, isolated AUVP, and idiopathic PSC BPPV.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A multicenter longitudinal study was conducted between 2018 and 2025, enrolling 98 patients divided into three groups: LHS (&lt;i&gt;n&lt;/i&gt; = 36), isolated AUVP (&lt;i&gt;n&lt;/i&gt; = 30), and idiopathic PSC BPPV (&lt;i&gt;n&lt;/i&gt; = 32). Vestibular evaluation was assessed through video head impulse test (vHIT), evaluation of spontaneous nystagmus, and Dix-Hallpike maneuver. Primary outcomes included vestibular gain at baseline and 6 months, presence and characteristics of corrective saccades, number of repositioning maneuvers required, and time to symptom resolution.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Patients with LHS showed significantly greater initial vestibular impairment in both affected and contralateral ears compared to isolated AUVP (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05) and demonstrated slower functional recovery at 6 months. Saccade amplitude was notably larger in LHS patients (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05), while latency and clustering were similar across groups. Spontaneous nystagmus persisted more frequently in the LHS cohort (OR 3.67). All LHS patients developed ipsilateral PSC BPPV, which required more repositioning maneuvers (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.043) and presented a longer clinical course than idiopathic PSC BPPV (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Lindsay-Hemenway syndrome involves more severe vestibular dysfunction, slower recovery, and more persistent BPPV than isolated AUVP or idiopathic PSC BPPV.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Paula Morales Chacchi, 
Guillermo Coronel Touma, 
Luis Cabrera Pérez, 
Ángel Batuecas‐Caletrío, 
Eduardo Martin Sanz
</dc:creator>
         <category>Original Report</category>
         <dc:title>Lindsay‐Hemenway Syndrome, Acute Vertigo Followed by BPPV: A Prospective Comparative Study</dc:title>
         <dc:identifier>10.1002/lary.70324</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70324</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70324?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70360?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70360</guid>
         <title>Efficacy of Intracordal Trafermin Injection Using Propensity Score Matching in Age‐Related Vocal Fold Atrophy</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2655-2662, June 2026. </description>
         <dc:description>
We evaluated the efficacy of intracordal trafermin injection (ITI) compared with voice therapy (VT) in age‐related vocal fold atrophy. After excluding patients with missing data and applying propensity score matching, 185 patients were included in each group. ITI was associated with superior voice improvement compared with VT.








ABSTRACT

Hypothesis
We hypothesized that Intracordal Trafermin Injection (ITI) provides greater voice improvement than standard voice therapy (VT) in age‐related vocal fold atrophy (ARVA). To evaluate the efficacy of ITI versus VT using propensity score matching (PSM) in ARVA.


Methods
This retrospective study was conducted at the Tokyo Voice Center between July 2014 and December 2024 using medical records in ARVA. The intervention group comprised 197 of 210 patients who received ITI (mean voice recording period: 40.98 days after injection). The control group included 412 of 488 patients who underwent voice therapy (VT) between April 2015 and December 2024 (mean voice recording period: 79.91 days after initial VT). The primary outcome was defined as the improvement in VHI, calculated as the difference between post‐treatment and pre‐treatment scores. PMS was used to compare ITI and VT.


Results
Before PSM, the mean age and sex (female) were 65.30 years (standard deviation [SD], 14.01) and 48 patients (24.67%) in the ITI group and 64.81 years (SD, 14.42) and 246 patients (59.71%) in the VT group, respectively. T‐tests revealed no significant differences in outcomes. After PSM (C‐statistic = 0.746), the baseline characteristics were balanced (standardized mean difference &lt; 0.1). Post‐matching, t‐tests revealed significantly greater voice improvement in the ITI group (p = 0.023).


Conclusion
ITI appears effective for improving voice outcomes in ARVA. Future studies should include prospective interventional trials and comparative analyses with other injectable agents to determine the most effective treatment.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/4105e9e5-2b8f-482c-8886-3cea75e986a8/lary70360-toc-0001-m.png"
     alt="Efficacy of Intracordal Trafermin Injection Using Propensity Score Matching in Age-Related Vocal Fold Atrophy"/&gt;
&lt;p&gt;We evaluated the efficacy of intracordal trafermin injection (ITI) compared with voice therapy (VT) in age-related vocal fold atrophy. After excluding patients with missing data and applying propensity score matching, 185 patients were included in each group. ITI was associated with superior voice improvement compared with VT.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Hypothesis&lt;/h2&gt;
&lt;p&gt;We hypothesized that Intracordal Trafermin Injection (ITI) provides greater voice improvement than standard voice therapy (VT) in age-related vocal fold atrophy (ARVA). To evaluate the efficacy of ITI versus VT using propensity score matching (PSM) in ARVA.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective study was conducted at the Tokyo Voice Center between July 2014 and December 2024 using medical records in ARVA. The intervention group comprised 197 of 210 patients who received ITI (mean voice recording period: 40.98 days after injection). The control group included 412 of 488 patients who underwent voice therapy (VT) between April 2015 and December 2024 (mean voice recording period: 79.91 days after initial VT). The primary outcome was defined as the improvement in VHI, calculated as the difference between post-treatment and pre-treatment scores. PMS was used to compare ITI and VT.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Before PSM, the mean age and sex (female) were 65.30 years (standard deviation [SD], 14.01) and 48 patients (24.67%) in the ITI group and 64.81 years (SD, 14.42) and 246 patients (59.71%) in the VT group, respectively. &lt;i&gt;T&lt;/i&gt;-tests revealed no significant differences in outcomes. After PSM (C-statistic = 0.746), the baseline characteristics were balanced (standardized mean difference &amp;lt; 0.1). Post-matching, &lt;i&gt;t&lt;/i&gt;-tests revealed significantly greater voice improvement in the ITI group (&lt;i&gt;p&lt;/i&gt; = 0.023).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;ITI appears effective for improving voice outcomes in ARVA. Future studies should include prospective interventional trials and comparative analyses with other injectable agents to determine the most effective treatment.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Tomohiro Hasegawa, 
Yusuke Watanabe
</dc:creator>
         <category>Original Report</category>
         <dc:title>Efficacy of Intracordal Trafermin Injection Using Propensity Score Matching in Age‐Related Vocal Fold Atrophy</dc:title>
         <dc:identifier>10.1002/lary.70360</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70360</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70360?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70403?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70403</guid>
         <title>Mandibular Osteoradionecrosis: Mandibular Preservation Using Humeral Periosteal Free Flap Wrapping</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2558-2564, June 2026. </description>
         <dc:description>
The vascularized free periosteal flap can be considered as a reliable surgical option for advanced mandibular osteoradionecrosis in order to avoid an interruptive mandibulectomy.








ABSTRACT

Background
Management of mandibular osteoradionecrosis (ORN) is challenging and often requires large surgical resection. Alternatively, mandibular preservation and wrapping with a periosteal free flap may achieve healing in selected patients. Our objective was to assess the success rate and morbidity of revascularization of mandibular ORN using a humeral periosteal free flap.


Methods
A retrospective study was performed using medical records of patients who had undergone humeral periosteal free flap reconstruction for mandibular ORN. Clinical data, including age, gender, ORN site, ORN grade according to the Notani classification, clinical and radiological outcomes and complications were analyzed. The primary endpoint was ORN healing, defined as complete resolution of the main symptom (exposure, chronic infection, fistula, or fracture) at 6 months postoperatively.


Results
A total of 36 lesions in 34 patients with mandibular ORN associated with bone exposure and/or infection and/or pathologic fracture were included. ORN healing at 6 months was achieved in 64.7% (n = 22/34) of treated sites in the overall cohort and in 91.6% (n = 22/24) of patients with a viable flap.


Conclusion
The humeral periosteal free flap can be considered a reasonable surgical option for advanced mandibular ORN to avoid segmental mandibulectomy.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7e990acc-f0c5-4f33-a1db-835693749873/lary70403-toc-0001-m.png"
     alt="Mandibular Osteoradionecrosis: Mandibular Preservation Using Humeral Periosteal Free Flap Wrapping"/&gt;
&lt;p&gt;The vascularized free periosteal flap can be considered as a reliable surgical option for advanced mandibular osteoradionecrosis in order to avoid an interruptive mandibulectomy.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Background&lt;/h2&gt;
&lt;p&gt;Management of mandibular osteoradionecrosis (ORN) is challenging and often requires large surgical resection. Alternatively, mandibular preservation and wrapping with a periosteal free flap may achieve healing in selected patients. Our objective was to assess the success rate and morbidity of revascularization of mandibular ORN using a humeral periosteal free flap.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective study was performed using medical records of patients who had undergone humeral periosteal free flap reconstruction for mandibular ORN. Clinical data, including age, gender, ORN site, ORN grade according to the Notani classification, clinical and radiological outcomes and complications were analyzed. The primary endpoint was ORN healing, defined as complete resolution of the main symptom (exposure, chronic infection, fistula, or fracture) at 6 months postoperatively.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 36 lesions in 34 patients with mandibular ORN associated with bone exposure and/or infection and/or pathologic fracture were included. ORN healing at 6 months was achieved in 64.7% (&lt;i&gt;n&lt;/i&gt; = 22/34) of treated sites in the overall cohort and in 91.6% (&lt;i&gt;n&lt;/i&gt; = 22/24) of patients with a viable flap.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The humeral periosteal free flap can be considered a reasonable surgical option for advanced mandibular ORN to avoid segmental mandibulectomy.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Sandrine Vlavonou, 
Jean‐Philippe Foy, 
Mourad Benassarou, 
Chloé Bertolus, 
Thomas Schouman
</dc:creator>
         <category>Original Report</category>
         <dc:title>Mandibular Osteoradionecrosis: Mandibular Preservation Using Humeral Periosteal Free Flap Wrapping</dc:title>
         <dc:identifier>10.1002/lary.70403</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70403</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70403?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70410?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70410</guid>
         <title>Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2598-2604, June 2026. </description>
         <dc:description>
The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re‐evaluate and implement the necessary infrastructure to support the projected increase in patient demand for MAiD access.








ABSTRACT

Objective
There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care.


Methods
This is a retrospective cross‐sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada.


Results
Three hundred and fifty‐six persons received MAiD. The average age was 72.4 years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year‐by‐year increase.


Conclusion
The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/e6029af5-89cc-4c52-83e0-615e9180e03b/lary70410-toc-0001-m.png"
     alt="Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario"/&gt;
&lt;p&gt;The uptake of MAiD for head and neck cancer (HNC) has been steadily increasing since 2016, when MAiD first became available in Canada. Our study projects a substantial increase in the future use of MAiD for patients with HNC. As such, our health system needs to re-evaluate and implement the necessary infrastructure to support the projected increase in patient demand for MAiD access.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;There is a paucity of information on the uptake of Medical Assistance in Dying (MAiD) for patients with head and neck cancer (HNC). Our study reports the prevalence, disease characteristics, and nature of the desire for MAiD in patients with HNC who underwent the process in Ontario. The aim is to better understand this population and identify gaps in our current system of care.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This is a retrospective cross-sectional analysis for the period June 17, 2016 to December 31, 2022. Data were received from the Office of the Chief Coroner Ontario, Canada.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Three hundred and fifty-six persons received MAiD. The average age was 72.4 years (SD 12.22) with 260 of the patients being men (73.03%). The most common HNC primary tumor site was the oral cavity 109 (30.6%). The most reported reason was inadequate control of symptoms other than pain (79.21%) followed by inadequate pain control or concerns about it (75%). The patient's private residence (55.62%) was the most common setting. Patients were more likely to live in wealthier neighborhoods and in large urban centers. Future prediction of MAiD uptake shows a linear year-by-year increase.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The use of MAiD in HNC has been steadily increasing since its legalization and is projected to continue increasing. There is a male predominance that is aligned with the incidence and prevalence of HNC nationally. Overall, MAiD is an increasingly employed choice for HNC patients receiving treatment for disease without curative intent.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Tanika Curry, 
Emily Wener, 
Michael Odell, 
Lisa Caulley, 
Rashi Ramchandani, 
Alyssa Grant, 
Kednapa Thavorn, 
Andrea Lasso, 
Shaun Kilty
</dc:creator>
         <category>Original Report</category>
         <dc:title>Choice and Death: Analysis of Medical Assistance in Dying for Head and Neck Cancer in Ontario</dc:title>
         <dc:identifier>10.1002/lary.70410</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70410</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70410?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70416?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70416</guid>
         <title>Anterolateral‐Thigh Fascia Lata Free Flap Versus Fibula Free Flap for Mandibular Osteoradionecrosis</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2565-2572, June 2026. </description>
         <dc:description>
The anterolateral thigh fascia lata “rescue” free flap has been employed as a novel tool in the treatment of advanced partial thickness mandibular osteoradionecrosis. Compared with the traditional fibula free flap for the same indication, the “rescue” flap provides similar outcomes in terms of disease resolution, superior functional outcomes, and reduced operative time and post‐operative hospitalization duration.








ABSTRACT

Objectives
While standard treatments for mandibular osteoradionecrosis (MORN) exist for mild/superficial and severe/full thickness disease, there is no consensus on treatment for advanced, partial thickness disease. In this niche, the anterolateral thigh fascia lata (ALTFL) “rescue” flap has managed MORN successfully. This study aimed to compare ALTFL with fibula free flap (FFF) reconstruction to determine differences in outcomes, complications, and postoperative logistics.


Methods
A retrospective chart review of patients undergoing ALTFL or FFF for MORN between 2008 and 2024 was carried out.


Results
Fifty‐one patients with Grade III (n = 26) or IV (n = 25) MORN underwent FFF (n = 22) or ALTFL (n = 29). ALTFL patients were older but did not differ in preoperative MORN treatment or risk factors compared to FFF. Median operative time for ALTFL was significantly less than FFF in both Grade III (298 min vs. 516 min) and IV (298 min vs. 599 min), without differences in subsites of mandible involved. Hospitalization for ALTFL was significantly shorter than FFF for both Grade III (2 days vs. 7 days) and IV (4.5 days vs. 7 days) without differences in peri‐operative complications, flap failure or MORN resolution. Tracheotomy was performed more often for patients undergoing FFF for Grade III MORN. Patients who underwent ALTFL were more likely to return to a diet beyond soft within the follow‐up period.


Conclusions
The ALTFL rescue flap offers reduced morbidity and improved resource allocation compared to FFF for the treatment of advanced, partial thickness MORN with similar outcomes.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/bec115a2-f259-4634-8e0c-8b8484458873/lary70416-toc-0001-m.png"
     alt="Anterolateral-Thigh Fascia Lata Free Flap Versus Fibula Free Flap for Mandibular Osteoradionecrosis"/&gt;
&lt;p&gt;The anterolateral thigh fascia lata “rescue” free flap has been employed as a novel tool in the treatment of advanced partial thickness mandibular osteoradionecrosis. Compared with the traditional fibula free flap for the same indication, the “rescue” flap provides similar outcomes in terms of disease resolution, superior functional outcomes, and reduced operative time and post-operative hospitalization duration.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;While standard treatments for mandibular osteoradionecrosis (MORN) exist for mild/superficial and severe/full thickness disease, there is no consensus on treatment for advanced, partial thickness disease. In this niche, the anterolateral thigh fascia lata (ALTFL) “rescue” flap has managed MORN successfully. This study aimed to compare ALTFL with fibula free flap (FFF) reconstruction to determine differences in outcomes, complications, and postoperative logistics.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective chart review of patients undergoing ALTFL or FFF for MORN between 2008 and 2024 was carried out.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Fifty-one patients with Grade III (&lt;i&gt;n&lt;/i&gt; = 26) or IV (&lt;i&gt;n&lt;/i&gt; = 25) MORN underwent FFF (&lt;i&gt;n&lt;/i&gt; = 22) or ALTFL (&lt;i&gt;n&lt;/i&gt; = 29). ALTFL patients were older but did not differ in preoperative MORN treatment or risk factors compared to FFF. Median operative time for ALTFL was significantly less than FFF in both Grade III (298 min vs. 516 min) and IV (298 min vs. 599 min), without differences in subsites of mandible involved. Hospitalization for ALTFL was significantly shorter than FFF for both Grade III (2 days vs. 7 days) and IV (4.5 days vs. 7 days) without differences in peri-operative complications, flap failure or MORN resolution. Tracheotomy was performed more often for patients undergoing FFF for Grade III MORN. Patients who underwent ALTFL were more likely to return to a diet beyond soft within the follow-up period.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;The ALTFL rescue flap offers reduced morbidity and improved resource allocation compared to FFF for the treatment of advanced, partial thickness MORN with similar outcomes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Conrad K. Blunck, 
Alexander Havens, 
Michael A. Fritz, 
Brandon L. Prendes, 
Derek J. Vos, 
Amani Alvi, 
Sara Liu, 
Dane J. Genther, 
Peter J. Ciolek
</dc:creator>
         <category>Original Report</category>
         <dc:title>Anterolateral‐Thigh Fascia Lata Free Flap Versus Fibula Free Flap for Mandibular Osteoradionecrosis</dc:title>
         <dc:identifier>10.1002/lary.70416</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70416</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70416?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70440?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70440</guid>
         <title>
ALT Rescue Flap With Iliac Crest Bone Graft and Spanning Plate for Mandibular ORN
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2573-2580, June 2026. </description>
         <dc:description>
In select patients with focal full‐thickness mandibular ORN defects, the use of ALTFL in conjunction with ICBG and a spanning reconstructive plate appears to offer clinical and radiographic arrest of ORN. This technique has considerably lower morbidity than osteocutaneous reconstruction, with abbreviated hospital stays, a low complication rate, and no tracheostomy need, without precluding future reconstruction with osteocutaneous free flap if necessary. As a result, consideration of this technique is reasonable in select patients, particularly those with comorbidities that preclude more extensive and morbid reconstructive techniques.








ABSTRACT

Objective
The mainstay of treatment for full‐thickness mandibular osteoradionecrosis (ORN) is segmental mandibulectomy followed by osteocutaneous free flap. We have found success in combining anterolateral thigh rescue flaps with iliac crest bone graft (ICBG) and spanning reconstructive plate for select patients. Our objective is to therefore describe the use, indications, and outcomes of this technique.


Methods
Retrospective chart review of patients at our institution from 1/1/2017 to 10/1/2025.


Results
Eight patients (median age: 67, 87.5% male) were included. Pre‐operative fracture was noted in six patients; two patients had full thickness destruction evident after debridement. Following the procedure, the median length of stay was 3 days (range: 2–6). There were no episodes of flap takeback or failure. Cessation of symptoms of ORN at most recent follow‐up was noted in most patients (n = 6, 75%), with most patients (n = 6, 75%) also demonstrating bony union on follow‐up imaging. The median lengths of clinical and radiographic follow up were 25.4 months (range 12.9–84) and 25.2 months (range 6–57.1), respectively.


Conclusion
Early experience with ALT rescue flap, ICBG, and spanning plate appears to offer an alternative to osteocutaneous free flap reconstruction in select patients with full‐thickness mandibular ORN, with low morbidity and abbreviated hospital stays.


Level of Evidence
4

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7cce829d-4237-4adb-afd7-847ce95e4dae/lary70440-toc-0001-m.png"
     alt="&amp;#xA;ALT Rescue Flap With Iliac Crest Bone Graft and Spanning Plate for Mandibular ORN&amp;#xA;"/&gt;
&lt;p&gt;In select patients with focal full-thickness mandibular ORN defects, the use of ALTFL in conjunction with ICBG and a spanning reconstructive plate appears to offer clinical and radiographic arrest of ORN. This technique has considerably lower morbidity than osteocutaneous reconstruction, with abbreviated hospital stays, a low complication rate, and no tracheostomy need, without precluding future reconstruction with osteocutaneous free flap if necessary. As a result, consideration of this technique is reasonable in select patients, particularly those with comorbidities that preclude more extensive and morbid reconstructive techniques.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;The mainstay of treatment for full-thickness mandibular osteoradionecrosis (ORN) is segmental mandibulectomy followed by osteocutaneous free flap. We have found success in combining anterolateral thigh rescue flaps with iliac crest bone graft (ICBG) and spanning reconstructive plate for select patients. Our objective is to therefore describe the use, indications, and outcomes of this technique.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective chart review of patients at our institution from 1/1/2017 to 10/1/2025.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Eight patients (median age: 67, 87.5% male) were included. Pre-operative fracture was noted in six patients; two patients had full thickness destruction evident after debridement. Following the procedure, the median length of stay was 3 days (range: 2–6). There were no episodes of flap takeback or failure. Cessation of symptoms of ORN at most recent follow-up was noted in most patients (&lt;i&gt;n&lt;/i&gt; = 6, 75%), with most patients (&lt;i&gt;n&lt;/i&gt; = 6, 75%) also demonstrating bony union on follow-up imaging. The median lengths of clinical and radiographic follow up were 25.4 months (range 12.9–84) and 25.2 months (range 6–57.1), respectively.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Early experience with ALT rescue flap, ICBG, and spanning plate appears to offer an alternative to osteocutaneous free flap reconstruction in select patients with full-thickness mandibular ORN, with low morbidity and abbreviated hospital stays.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4&lt;/p&gt;</content:encoded>
         <dc:creator>
Derek J. Vos, 
Sara W. Liu, 
Peter J. Ciolek, 
Brandon L. Prendes, 
Michael A. Fritz
</dc:creator>
         <category>Original Report</category>
         <dc:title>
ALT Rescue Flap With Iliac Crest Bone Graft and Spanning Plate for Mandibular ORN
</dc:title>
         <dc:identifier>10.1002/lary.70440</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70440</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70440?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70475?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70475</guid>
         <title>Transoral Minimal Access Mandibular Reconstruction Using Fibula Free Flap in Osteoradionecrosis</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2581-2590, June 2026. </description>
         <dc:description>
We conducted a retrospective review of 9 patients with mandibular ORN at our institution who underwent a limited transoral approach for segmental mandibulectomy reconstruction with fibula free flap and minimal access vessel isolation and anastomoses. This technique may be safely utilized in patients with irradiated and previously operated surgical fields who require free vascularized bone for reconstruction of mandibular ORN defects. Compared with the traditional transcervical approach, this technique may offer a reduction in patient morbidity and abbreviations in hospital stay.








ABSTRACT

Objective
To describe the use, indications, and outcomes of a limited transoral approach for segmental mandibulectomy reconstruction with minimal access vessel isolation and anastomoses in patients with mandibular osteoradionecrosis.


Methods
Retrospective review of patients who have undergone FFF reconstruction of segmental mandibulectomy via transoral plating and inset at our institution from 2022 to 2024.


Results
Nine patients (median age of 66, 100% male) with mandibular ORN underwent FFF reconstruction via transoral approach with minimal access vessels isolation. The majority of patients failed conservative management of ORN, with eight patients receiving prior antibiotic therapy and seven undergoing hyperbaric oxygen therapy. Preoperative fracture/nonunion and fistula were noted in seven and four patients, respectively. The median length of hospitalization following this procedure was 6 days (range: 4–9). One patient developed nonunion in the postoperative period and required revision with anterolateral thigh fascia lata free flap and iliac crest bone grafting. An additional patient required takeback for hematoma and successful vascular salvage; however, complications were otherwise minimal, with no other patients experiencing operating room takeback, readmission within 30 days, hematoma, fistulas, or flap compromise. All patients demonstrated clinical and radiographic arrest of ORN at most recent follow‐up. Median follow‐up length was 13.9 months (range 7.7–34).


Conclusion
Mandibular reconstruction using a transoral approach with FFF provides a promising alternative to the traditional transcervical approach for patients with osteoradionecrosis, potentially reducing morbidity and improving outcomes.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/a0e3f45f-6d84-4465-80a3-9e3778d64d42/lary70475-toc-0001-m.png"
     alt="Transoral Minimal Access Mandibular Reconstruction Using Fibula Free Flap in Osteoradionecrosis"/&gt;
&lt;p&gt;We conducted a retrospective review of 9 patients with mandibular ORN at our institution who underwent a limited transoral approach for segmental mandibulectomy reconstruction with fibula free flap and minimal access vessel isolation and anastomoses. This technique may be safely utilized in patients with irradiated and previously operated surgical fields who require free vascularized bone for reconstruction of mandibular ORN defects. Compared with the traditional transcervical approach, this technique may offer a reduction in patient morbidity and abbreviations in hospital stay.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To describe the use, indications, and outcomes of a limited transoral approach for segmental mandibulectomy reconstruction with minimal access vessel isolation and anastomoses in patients with mandibular osteoradionecrosis.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective review of patients who have undergone FFF reconstruction of segmental mandibulectomy via transoral plating and inset at our institution from 2022 to 2024.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Nine patients (median age of 66, 100% male) with mandibular ORN underwent FFF reconstruction via transoral approach with minimal access vessels isolation. The majority of patients failed conservative management of ORN, with eight patients receiving prior antibiotic therapy and seven undergoing hyperbaric oxygen therapy. Preoperative fracture/nonunion and fistula were noted in seven and four patients, respectively. The median length of hospitalization following this procedure was 6 days (range: 4–9). One patient developed nonunion in the postoperative period and required revision with anterolateral thigh fascia lata free flap and iliac crest bone grafting. An additional patient required takeback for hematoma and successful vascular salvage; however, complications were otherwise minimal, with no other patients experiencing operating room takeback, readmission within 30 days, hematoma, fistulas, or flap compromise. All patients demonstrated clinical and radiographic arrest of ORN at most recent follow-up. Median follow-up length was 13.9 months (range 7.7–34).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Mandibular reconstruction using a transoral approach with FFF provides a promising alternative to the traditional transcervical approach for patients with osteoradionecrosis, potentially reducing morbidity and improving outcomes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Derek J. Vos, 
Emily Zhang, 
Neil N. Patel, 
Sara W. Liu, 
Peter J. Ciolek, 
Brandon L. Prendes, 
Eric D. Lamarre, 
Michael A. Fritz
</dc:creator>
         <category>Original Report</category>
         <dc:title>Transoral Minimal Access Mandibular Reconstruction Using Fibula Free Flap in Osteoradionecrosis</dc:title>
         <dc:identifier>10.1002/lary.70475</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70475</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70475?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70316?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70316</guid>
         <title>In Vivo Imaging of Cochlear Implant Electrode Orientation Relative to Scalar Tilt</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2694-2700, June 2026. </description>
         <dc:description>
We used in vivo flat‐panel CT imaging in cochlear implant users to quantify individual electrode contact orientation relative to the scala tympani's dynamic anatomical tilt. Flexible lateral wall arrays demonstrated rotational alignment with scala tilt throughout much of the insertion trajectory, indicating that electrode contacts conform to the cochlea's “roller‐coaster” geometry in vivo. These findings offer new insight into electrode–cochlea biomechanics with potential implications for structure preservation and anatomically guided programming.








ABSTRACT

Objective
Visualization of cochlear implant (CI) electrode contact position offers insights into electrode–cochlea biomechanics. Prior in vivo imaging studies have assessed electrode distances to a fixed modiolar axis, but electrodes' orientation within the cochlear canal and their relationship to the scala tympani's dynamic anatomical tilt have not been investigated. This study employed in vivo flat‐panel computed tomography (FPCT) imaging to examine the flexibility and dynamic behavior of lateral wall arrays.


Methods
This retrospective cohort study included eight MED‐EL FLEX28 CI users. FPCT images were acquired, and reconstructions were aligned to a standardized cochlear coordinate system. Vectors perpendicular to electrode contacts were used to estimate contact orientation using mid‐modiolar image slices and 3D renderings. Anatomical landmarks were used to calculate scalar tilt.


Results
A significant correlation was observed between scalar tilt and contact orientation (r = −0.44, p &lt; 0.0001). The scala tympani exhibited its greatest tilt relative to the X–Y plane in the hook region, then transitioned to a parallel orientation at approximately 180° angular depth before increasing tilt again between 180° and 360°. Electrode arrays demonstrated rotational alignment with the scala between 180° and 360° angular insertion depth.


Conclusion
Flexible lateral wall electrode arrays accommodate the natural anatomical tilt of the scala tympani, with contact orientation aligning to cochlear structures for much of the insertion trajectory. This in vivo analysis provides new insights into the biomechanical interactions of electrode arrays within the cochlea and may have implications for structure preservation, spectral resolution, and CI stimulation patterns.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/8c781d71-c018-422f-8fe5-a601971d5a36/lary70316-toc-0001-m.png"
     alt="In Vivo Imaging of Cochlear Implant Electrode Orientation Relative to Scalar Tilt"/&gt;
&lt;p&gt;We used in vivo flat-panel CT imaging in cochlear implant users to quantify individual electrode contact orientation relative to the scala tympani's dynamic anatomical tilt. Flexible lateral wall arrays demonstrated rotational alignment with scala tilt throughout much of the insertion trajectory, indicating that electrode contacts conform to the cochlea's “roller-coaster” geometry in vivo. These findings offer new insight into electrode–cochlea biomechanics with potential implications for structure preservation and anatomically guided programming.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Visualization of cochlear implant (CI) electrode contact position offers insights into electrode–cochlea biomechanics. Prior in vivo imaging studies have assessed electrode distances to a fixed modiolar axis, but electrodes' orientation within the cochlear canal and their relationship to the scala tympani's dynamic anatomical tilt have not been investigated. This study employed in vivo flat-panel computed tomography (FPCT) imaging to examine the flexibility and dynamic behavior of lateral wall arrays.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective cohort study included eight MED-EL FLEX28 CI users. FPCT images were acquired, and reconstructions were aligned to a standardized cochlear coordinate system. Vectors perpendicular to electrode contacts were used to estimate contact orientation using mid-modiolar image slices and 3D renderings. Anatomical landmarks were used to calculate scalar tilt.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A significant correlation was observed between scalar tilt and contact orientation (r = −0.44, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). The scala tympani exhibited its greatest tilt relative to the X–Y plane in the hook region, then transitioned to a parallel orientation at approximately 180° angular depth before increasing tilt again between 180° and 360°. Electrode arrays demonstrated rotational alignment with the scala between 180° and 360° angular insertion depth.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Flexible lateral wall electrode arrays accommodate the natural anatomical tilt of the scala tympani, with contact orientation aligning to cochlear structures for much of the insertion trajectory. This in vivo analysis provides new insights into the biomechanical interactions of electrode arrays within the cochlea and may have implications for structure preservation, spectral resolution, and CI stimulation patterns.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Nicole T. Jiam, 
Luke Helpard, 
Melanie L. Gilbert, 
Ana Marija Sola, 
Patpong Jiradejvong, 
Charles J. Limb
</dc:creator>
         <category>Original Report</category>
         <dc:title>In Vivo Imaging of Cochlear Implant Electrode Orientation Relative to Scalar Tilt</dc:title>
         <dc:identifier>10.1002/lary.70316</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70316</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70316?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70322?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70322</guid>
         <title>Regenerative Treatment of Middle Ear Mucosa With Topical Retinoid Administration</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2684-2693, June 2026. </description>
         <dc:description>
Topical administration of retinoids markedly enhanced regeneration of the damaged middle ear mucosa in this animal study, resulting in epithelial recovery with immunohistological and functional characteristics comparable to normal ciliated epithelium. In the retinoid‐treated group, 83% of ears exhibited complete or partial healing of the middle ear mucosa without evidence of ototoxicity, whereas no regeneration was observed in the control group. These findings suggest that retinoids may represent a promising and safe therapeutic approach for promoting middle ear mucosal regeneration.








ABSTRACT

Objective
Dysfunction of the middle ear can lead to hearing loss and the development of diseases such as cholesteatoma. Although radical treatment for cholesteatoma involves complete removal of the lesion, incomplete regeneration of the middle ear mucosa may contribute to hearing loss and recurrence of the cholesteatoma. This study aimed to evaluate the regenerative potential of topical retinoid therapy for damaged middle ear mucosa.


Methods
We used a guinea pig model to investigate the regenerative effects of topical retinoids on middle ear mucosal damage. Retinoids, which are known to promote nasal mucosal epithelium regeneration, were applied to the middle ear. Histological analysis was performed to assess epithelial recovery, and auditory function testing was conducted to detect any signs of ototoxicity.


Results
The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids. In the retinoid group, five of six ears (83%) demonstrated complete or partial healing, whereas none in the control group showed regeneration (p = 0.0183). The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids.


Conclusion
Topical retinoids may be an effective and novel therapeutic option for promoting the regeneration of middle ear mucosa without inducing ototoxic effects. Further investigations are required prior to clinical application in humans.


Level of Evidence
NA.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7a5b18d5-18e1-426e-bfea-9fc0e0a0bd55/lary70322-toc-0001-m.png"
     alt="Regenerative Treatment of Middle Ear Mucosa With Topical Retinoid Administration"/&gt;
&lt;p&gt;Topical administration of retinoids markedly enhanced regeneration of the damaged middle ear mucosa in this animal study, resulting in epithelial recovery with immunohistological and functional characteristics comparable to normal ciliated epithelium. In the retinoid-treated group, 83% of ears exhibited complete or partial healing of the middle ear mucosa without evidence of ototoxicity, whereas no regeneration was observed in the control group. These findings suggest that retinoids may represent a promising and safe therapeutic approach for promoting middle ear mucosal regeneration.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Dysfunction of the middle ear can lead to hearing loss and the development of diseases such as cholesteatoma. Although radical treatment for cholesteatoma involves complete removal of the lesion, incomplete regeneration of the middle ear mucosa may contribute to hearing loss and recurrence of the cholesteatoma. This study aimed to evaluate the regenerative potential of topical retinoid therapy for damaged middle ear mucosa.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We used a guinea pig model to investigate the regenerative effects of topical retinoids on middle ear mucosal damage. Retinoids, which are known to promote nasal mucosal epithelium regeneration, were applied to the middle ear. Histological analysis was performed to assess epithelial recovery, and auditory function testing was conducted to detect any signs of ototoxicity.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids. In the retinoid group, five of six ears (83%) demonstrated complete or partial healing, whereas none in the control group showed regeneration (&lt;i&gt;p&lt;/i&gt; = 0.0183). The regenerated mucosa exhibited histological and functional characteristics comparable to those of normal ciliated epithelium. Furthermore, no ototoxicity was observed following the administration of retinoids.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Topical retinoids may be an effective and novel therapeutic option for promoting the regeneration of middle ear mucosa without inducing ototoxic effects. Further investigations are required prior to clinical application in humans.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;NA.&lt;/p&gt;</content:encoded>
         <dc:creator>
Sayuri Terada, 
Chikako Shinkawa, 
Yutaka Koizumi, 
Motoyasu Sugiyama, 
Akiko Amano, 
Seiji Kakehata, 
Tsukasa Ito
</dc:creator>
         <category>Original Report</category>
         <dc:title>Regenerative Treatment of Middle Ear Mucosa With Topical Retinoid Administration</dc:title>
         <dc:identifier>10.1002/lary.70322</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70322</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70322?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70327?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70327</guid>
         <title>Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2708-2718, June 2026. </description>
         <dc:description>
Sudden sensorineural hearing loss is traditionally treated with steroids, either orally and/or via intratympanic injections, and hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The study has not found any additional treatment benefit with adjunctive concurrent HBOT; however, HBOT might be of value to patients refractory to steroid treatment. In addition, no beneficial treatment effect in receiving more than 23 HBOT dives was observed.








ABSTRACT

Objectives
The pathophysiology of sudden sensorineural hearing loss (SSNHL) is still unknown, and therefore treatment strategies are often debated. Traditionally, SSNHL is treated with steroids, either orally (OCS) and/or via intratympanic injection (ITSI). Hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The present study investigated the additive effect of HBOT to traditional steroid treatment for SSNHL.


Methods
Retrospective study comparing treatment effect (pure tone average–PTA; speech recognition threshold–SRT; word recognition score–WRS) between HBOT + ITSI and ITSI treated patients. Sub‐analysis of responders and nonresponders, treatment delay, and number of injection/dives.


Results
One hundred nineteen patients were divided into ITSI (n = 73) and HBOT + ITSI (n = 46) groups. While there was a significant pre‐to‐posttreatment improvement in PTA, SRT, and WRS (p &lt; 0.001) within each group, there was no difference between groups in pre‐to‐postimprovement for PTA, SRT, or WRS (p = 0.49, 0.07, or 0.55, respectively). Of responders to treatment, 4.1% did not receive OCS compared to 24.4% of nonresponders (p &lt; 0.001). In HBOT responders, audiogram improvement was demonstrated within 10.9 ± 6.5 (max 23) sessions. 25.8% of HBOT responders showed no response after completing ITSI and then subsequently demonstrated audiometric response after 17.5 ± 4.0 HBOT dives.


Conclusion
No additional treatment benefit was found with adjunctive concurrent HBOT. HBOT might be of value to patients refractory to steroid treatment. No beneficial treatment effect in receiving more than 23 HBOT dives was observed. However, evaluating treatment effect in SSNHL loss is always biased by the well‐known confounders that are linked to the condition.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/09ba4160-17e2-4a3e-8b07-3e035a471446/lary70327-toc-0001-m.png"
     alt="Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?"/&gt;
&lt;p&gt;Sudden sensorineural hearing loss is traditionally treated with steroids, either orally and/or via intratympanic injections, and hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The study has not found any additional treatment benefit with adjunctive concurrent HBOT; however, HBOT might be of value to patients refractory to steroid treatment. In addition, no beneficial treatment effect in receiving more than 23 HBOT dives was observed.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;The pathophysiology of sudden sensorineural hearing loss (SSNHL) is still unknown, and therefore treatment strategies are often debated. Traditionally, SSNHL is treated with steroids, either orally (OCS) and/or via intratympanic injection (ITSI). Hyperbaric oxygen treatment (HBOT) has resurged in popularity as an adjunctive therapy. The present study investigated the additive effect of HBOT to traditional steroid treatment for SSNHL.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective study comparing treatment effect (pure tone average–PTA; speech recognition threshold–SRT; word recognition score–WRS) between HBOT + ITSI and ITSI treated patients. Sub-analysis of responders and nonresponders, treatment delay, and number of injection/dives.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;One hundred nineteen patients were divided into ITSI (&lt;i&gt;n&lt;/i&gt; = 73) and HBOT + ITSI (&lt;i&gt;n&lt;/i&gt; = 46) groups. While there was a significant pre-to-posttreatment improvement in PTA, SRT, and WRS (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) within each group, there was no difference between groups in pre-to-postimprovement for PTA, SRT, or WRS (&lt;i&gt;p&lt;/i&gt; = 0.49, 0.07, or 0.55, respectively). Of responders to treatment, 4.1% did not receive OCS compared to 24.4% of nonresponders (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). In HBOT responders, audiogram improvement was demonstrated within 10.9 ± 6.5 (max 23) sessions. 25.8% of HBOT responders showed no response after completing ITSI and then subsequently demonstrated audiometric response after 17.5 ± 4.0 HBOT dives.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;No additional treatment benefit was found with adjunctive concurrent HBOT. HBOT might be of value to patients refractory to steroid treatment. No beneficial treatment effect in receiving more than 23 HBOT dives was observed. However, evaluating treatment effect in SSNHL loss is always biased by the well-known confounders that are linked to the condition.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Jennifer L. Spiegel, 
Michael J. De Biasio, 
Gianluca Sampieri, 
Omer J. Ungar, 
Munir D. Bajin, 
Vincent Y. W. Lin, 
Joseph M. Chen, 
Chris Idestrup, 
Jordan Tarshis, 
Trung N. Le
</dc:creator>
         <category>Original Report</category>
         <dc:title>Adjunctive Hyperbaric Oxygen Therapy or Intratympanic Steroids in Sudden Sensorineural Hearing Loss?</dc:title>
         <dc:identifier>10.1002/lary.70327</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70327</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70327?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70335?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70335</guid>
         <title>Beyond the Milestones: Data and Decision‐Making in Otolaryngology Clinical Competency Committees</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2547-2553, June 2026. </description>
         <dc:description>
This qualitative study of otolaryngology clinical competency committee (CCC) members found that committees rely on a heterogeneous mix of formal and informal assessment data, with narrative feedback often outweighing structured metrics. Decision‐making is challenged by unused data, inconsistent faculty engagement and preparation for assessment, and a predominant focus on identifying struggling residents rather than supporting development across all trainees. Recommended strategies for maximizing the effectiveness of CCCs are outlined.








ABSTRACT

Objective
The decision‐making processes of Clinical Competency Committees (CCCs) in otolaryngology‐head and neck surgery (OHNS) are poorly understood. This study explores how CCCs collect, interpret, and use assessment data to evaluate resident performance and progress.


Methods
We conducted a cross‐sectional qualitative study using focus groups with OHNS faculty who serve on CCCs at the November 2024 Society of University Otolaryngologists meeting. Discussions explored the types of assessment data gathered and how this information is interpreted and applied. Audio recordings were transcribed, de‐identified, and analyzed using thematic analysis.


Results
Twenty‐one CCC members participated in three seven‐person focus groups. Thematic analysis revealed the following findings related to CCC decision‐making: (1) There is substantial heterogeneity in the types of data collected and used; (2) Narrative and verbal feedback outweighed structured data; (3) Challenges emerged due to a need to transform informal feedback into documented, defensible data for high‐stakes decisions. Gaps in the CCC process included: (1) Collection of data that is ultimately unused in decision‐making; (2) A lack of structured mechanisms to encourage faculty engagement and development for performing assessments; and (3) A focus on identifying struggling residents rather than fostering development across all levels of trainee performance.


Conclusions
OHNS CCCs rely on a heterogeneous mix of formal and informal data, with narrative feedback often the most influential in decision‐making. The process is challenged by data overload, variable faculty engagement, and a lack of standardization. Addressing such challenges may improve the quality, equity, and transparency of resident assessment and progression decisions.


Level of Evidence
5.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/e1272ee4-5def-4f08-a9ad-9a7496de168d/lary70335-toc-0001-m.png"
     alt="Beyond the Milestones: Data and Decision-Making in Otolaryngology Clinical Competency Committees"/&gt;
&lt;p&gt;This qualitative study of otolaryngology clinical competency committee (CCC) members found that committees rely on a heterogeneous mix of formal and informal assessment data, with narrative feedback often outweighing structured metrics. Decision-making is challenged by unused data, inconsistent faculty engagement and preparation for assessment, and a predominant focus on identifying struggling residents rather than supporting development across all trainees. Recommended strategies for maximizing the effectiveness of CCCs are outlined.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;The decision-making processes of Clinical Competency Committees (CCCs) in otolaryngology-head and neck surgery (OHNS) are poorly understood. This study explores how CCCs collect, interpret, and use assessment data to evaluate resident performance and progress.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We conducted a cross-sectional qualitative study using focus groups with OHNS faculty who serve on CCCs at the November 2024 Society of University Otolaryngologists meeting. Discussions explored the types of assessment data gathered and how this information is interpreted and applied. Audio recordings were transcribed, de-identified, and analyzed using thematic analysis.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Twenty-one CCC members participated in three seven-person focus groups. Thematic analysis revealed the following findings related to CCC decision-making: (1) There is substantial heterogeneity in the types of data collected and used; (2) Narrative and verbal feedback outweighed structured data; (3) Challenges emerged due to a need to transform informal feedback into documented, defensible data for high-stakes decisions. Gaps in the CCC process included: (1) Collection of data that is ultimately unused in decision-making; (2) A lack of structured mechanisms to encourage faculty engagement and development for performing assessments; and (3) A focus on identifying struggling residents rather than fostering development across all levels of trainee performance.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;OHNS CCCs rely on a heterogeneous mix of formal and informal data, with narrative feedback often the most influential in decision-making. The process is challenged by data overload, variable faculty engagement, and a lack of standardization. Addressing such challenges may improve the quality, equity, and transparency of resident assessment and progression decisions.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;5.&lt;/p&gt;</content:encoded>
         <dc:creator>
Taylor S. Erickson, 
Jenny X. Chen, 
Tiffany N. Chao, 
Sarah N. Bowe, 
Nina W. Zhao
</dc:creator>
         <category>Original Report</category>
         <dc:title>Beyond the Milestones: Data and Decision‐Making in Otolaryngology Clinical Competency Committees</dc:title>
         <dc:identifier>10.1002/lary.70335</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70335</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70335?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70361?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70361</guid>
         <title>Effects of Anesthetic Depth Using the Bispectral Index During Sleep Endoscopy With PAP Titration</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2814-2819, June 2026. </description>
         <dc:description>
In this study, patients underwent sleep endoscopy with positive airway pressure (PAP) titration, at both deep‐and light‐sedation. We found that the Pharyngeal opening pressure (PhOP) correlated with the sedation depth. The Airway collapsibility at the velum and epiglottis appeared to be the most sensitive to depth of sedation.








ABSTRACT

Objectives
Airway collapsibility varies with the level of anesthetic depth during drug‐induced sleep endoscopy (DISE). Bispectral index (BIS) monitoring uses EEG signals to quantify anesthetic depth. We conducted a prospective study to examine changes in VOTE scores and pharyngeal opening pressure (PhOP) during DISE with positive airway pressure (DISE‐PAP), at light and deep sedation.


Methods
Anesthetic depth was monitored using BIS during DISE‐PAP for 17 patients. We classified BIS ≥ 55 as light sedation and &lt; 55 as deep sedation. The DISE exam was performed and subsequently PAP applied to assess PhOP at both light and deep sedation. We defined PhOP as the minimum pressure wherein all areas of the airway were opened. A blinded evaluation of the procedure video was performed by either one of two sleep surgery fellows or an attending sleep surgeon to create a VOTE score for the DISE exam and PhOP.


Results
All n = 17 patients enrolled had OSA with a mean AHI of 30.5 and standard deviation 17.8. PhOP significantly correlated with BIS readings (rho = −0.45, p = 0.0328) but VOTE classification did not significantly correlate with BIS level (rho = 0.18, p = 0.189). The velum and epiglottis had opening pressures that correlated to BIS level (rho = −0.398; p = 0.044) and (rho = −0.426; p = 0.038), respectively.


Conclusions
Anesthetic depth measured by BIS correlates with airway resistance as measured by PhOP. PAP appears to be a useful tool during DISE as it gives a highly titratable and immediate measurement of pharyngeal collapsibility.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/32da079e-8d69-46c3-b6fb-3fd891ce96f5/lary70361-toc-0001-m.png"
     alt="Effects of Anesthetic Depth Using the Bispectral Index During Sleep Endoscopy With PAP Titration"/&gt;
&lt;p&gt;In this study, patients underwent sleep endoscopy with positive airway pressure (PAP) titration, at both deep-and light-sedation. We found that the Pharyngeal opening pressure (PhOP) correlated with the sedation depth. The Airway collapsibility at the velum and epiglottis appeared to be the most sensitive to depth of sedation.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Airway collapsibility varies with the level of anesthetic depth during drug-induced sleep endoscopy (DISE). Bispectral index (BIS) monitoring uses EEG signals to quantify anesthetic depth. We conducted a prospective study to examine changes in VOTE scores and pharyngeal opening pressure (PhOP) during DISE with positive airway pressure (DISE-PAP), at light and deep sedation.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Anesthetic depth was monitored using BIS during DISE-PAP for 17 patients. We classified BIS ≥ 55 as light sedation and &amp;lt; 55 as deep sedation. The DISE exam was performed and subsequently PAP applied to assess PhOP at both light and deep sedation. We defined PhOP as the minimum pressure wherein all areas of the airway were opened. A blinded evaluation of the procedure video was performed by either one of two sleep surgery fellows or an attending sleep surgeon to create a VOTE score for the DISE exam and PhOP.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;All &lt;i&gt;n =&lt;/i&gt; 17 patients enrolled had OSA with a mean AHI of 30.5 and standard deviation 17.8. PhOP significantly correlated with BIS readings (rho = −0.45, &lt;i&gt;p&lt;/i&gt; = 0.0328) but VOTE classification did not significantly correlate with BIS level (rho = 0.18, &lt;i&gt;p&lt;/i&gt; = 0.189). The velum and epiglottis had opening pressures that correlated to BIS level (rho = −0.398; &lt;i&gt;p&lt;/i&gt; = 0.044) and (rho = −0.426; &lt;i&gt;p&lt;/i&gt; = 0.038), respectively.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Anesthetic depth measured by BIS correlates with airway resistance as measured by PhOP. PAP appears to be a useful tool during DISE as it gives a highly titratable and immediate measurement of pharyngeal collapsibility.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Jefferson DeKloe, 
Erin Creighton, 
Jay Trivedi, 
Nicole Molin, 
Patrick Hunt, 
Maurits Boon, 
Colin Huntley
</dc:creator>
         <category>Original Report</category>
         <dc:title>Effects of Anesthetic Depth Using the Bispectral Index During Sleep Endoscopy With PAP Titration</dc:title>
         <dc:identifier>10.1002/lary.70361</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70361</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70361?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70363?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70363</guid>
         <title>Assessment of 7‐Item Eustachian Tube Dysfunction Questionnaire in a Clinical Population</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2745-2751, June 2026. </description>
         <dc:description>
The 7‐item Eustachian Tube Dysfunction Questionnaire (ETDQ‐7) is a widely used clinical tool for diagnosing Eustachian tube disorders. Although initial validation studies reported near‐perfect sensitivity and specificity in prestratified patient populations, the questionnaire performs poorly when applied to more representative clinical cohorts. Using retrospective clinical data, we further demonstrate that the total ETDQ‐7 score correlates more strongly with tinnitus bothersomeness than with Eustachian tube dysfunction itself.








ABSTRACT

Objective
Eustachian tube dysfunction (ETD) is a common condition among patients presenting to audiology clinics, often accompanied by nonspecific symptoms that complicate diagnosis. The 7‐item Eustachian Tube Dysfunction Questionnaire (ETDQ‐7) was developed to aid in identifying ETD; however, despite its widespread clinical use, its diagnostic validity has not been consistently demonstrated across patient populations. We evaluate ETDQ‐7 performance in a diverse group of patients seen in an audiology clinic and compare it to an objective test of ETD based on modified impedance audiometry.


Methods
This retrospective study analyzed ETDQ‐7 scores, responses to a custom tinnitus quality questionnaire, pure‐tone audiometry, and tympanometry with pressure manipulation in a clinical sample of 300 patients. ETD‐positive cases were identified based on the absence of a significant shift in tympanometric peak pressure during swallowing or the Valsalva maneuver.


Results
The total ETDQ‐7 score showed low sensitivity and specificity in detecting objectively confirmed ETD, even when the analysis was limited to patients without hearing loss. ETDQ‐7 scores did not differ significantly between patients with normal hearing and those with hearing impairment, regardless of ETD status. However, among patients reporting tinnitus, ETDQ‐7 scores were positively correlated with the reported bothersomeness of tinnitus—even after excluding the “ringing in the ears” item from the total score.


Conclusions
In patients with tinnitus, ETDQ‐7 scores appear to reflect general subjective discomfort caused by tinnitus rather than the presence or severity of ETD. These findings raise concerns about the ETDQ‐7's utility as a stand‐alone diagnostic tool for ETD in heterogeneous clinical populations.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/d9f00e5d-9f7a-4b01-9a86-88b21bca1904/lary70363-toc-0001-m.png"
     alt="Assessment of 7-Item Eustachian Tube Dysfunction Questionnaire in a Clinical Population"/&gt;
&lt;p&gt;The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) is a widely used clinical tool for diagnosing Eustachian tube disorders. Although initial validation studies reported near-perfect sensitivity and specificity in prestratified patient populations, the questionnaire performs poorly when applied to more representative clinical cohorts. Using retrospective clinical data, we further demonstrate that the total ETDQ-7 score correlates more strongly with tinnitus bothersomeness than with Eustachian tube dysfunction itself.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Eustachian tube dysfunction (ETD) is a common condition among patients presenting to audiology clinics, often accompanied by nonspecific symptoms that complicate diagnosis. The 7-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) was developed to aid in identifying ETD; however, despite its widespread clinical use, its diagnostic validity has not been consistently demonstrated across patient populations. We evaluate ETDQ-7 performance in a diverse group of patients seen in an audiology clinic and compare it to an objective test of ETD based on modified impedance audiometry.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective study analyzed ETDQ-7 scores, responses to a custom tinnitus quality questionnaire, pure-tone audiometry, and tympanometry with pressure manipulation in a clinical sample of 300 patients. ETD-positive cases were identified based on the absence of a significant shift in tympanometric peak pressure during swallowing or the Valsalva maneuver.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The total ETDQ-7 score showed low sensitivity and specificity in detecting objectively confirmed ETD, even when the analysis was limited to patients without hearing loss. ETDQ-7 scores did not differ significantly between patients with normal hearing and those with hearing impairment, regardless of ETD status. However, among patients reporting tinnitus, ETDQ-7 scores were positively correlated with the reported bothersomeness of tinnitus—even after excluding the “ringing in the ears” item from the total score.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In patients with tinnitus, ETDQ-7 scores appear to reflect general subjective discomfort caused by tinnitus rather than the presence or severity of ETD. These findings raise concerns about the ETDQ-7's utility as a stand-alone diagnostic tool for ETD in heterogeneous clinical populations.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Amina Khan, 
Lawrence Wang, 
John Parsons, 
Karolina Charaziak
</dc:creator>
         <category>Original Report</category>
         <dc:title>Assessment of 7‐Item Eustachian Tube Dysfunction Questionnaire in a Clinical Population</dc:title>
         <dc:identifier>10.1002/lary.70363</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70363</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70363?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70371?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70371</guid>
         <title>Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2735-2744, June 2026. </description>
         <dc:description>
This study compared prognostic factors and therapeutic efficacy in 219 pediatric and 1728 adult patients with unilateral idiopathic sudden sensorineural hearing loss (SSNHL). We found that the two groups shared major prognostic factors. Furthermore, after 1:1 propensity score matching, therapeutic efficacy was shown to be comparable between the pediatric and adult groups.








ABSTRACT

Objective
To identify prognostic factors for unilateral idiopathic sudden sensorineural hearing loss (SSNHL) in pediatric and adult patients, and to compare therapeutic efficacy between these age groups:


Methods
This retrospective cohort study included 1947 hospitalized patients (219 pediatric, 1728 adult) with unilateral idiopathic SSNHL from January 2008 to December 2022. All patients received inpatient therapy following the Chinese Guidelines for SSNHL, with pediatric dosing adjusted for age and weight. To compare therapeutic outcomes, multivariable logistic regression, full propensity score matching (PSM), restricted cubic spline (RCS), and machine learning algorithms were employed.


Results
Baseline median ages were 13 (IQR, 10–15) years for pediatric and 43 (IQR, 33–50) years for adult patients. Shared independent prognostic factors in both groups included audiogram configuration, degree of hearing loss, and treatment‐onset time. Furthermore, after matching, pediatric and adult patients had comparable complete recovery (18.7% vs. 16.4%) and overall efficacy rates (52.5% vs. 54.1%). The therapeutic window was identified as 14 days for children and 15 days for adults. Consistent with this, treatment‐onset time emerged as the most influential feature in predictive models, with pediatric outcomes achieving an area under the curve (AUC) of 0.849 and adult outcomes an AUC of 0.901.


Conclusions
Pediatric and adult patients with unilateral idiopathic SSNHL share major prognostic factors. Therapeutic efficacy is comparable between groups when appropriate treatment is provided. Early intervention, ideally within 2 weeks of symptom onset, is critical to maximize auditory recovery.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/ea015216-c5fe-40cd-a3f7-92634e34cdf3/lary70371-toc-0001-m.png"
     alt="Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss"/&gt;
&lt;p&gt;This study compared prognostic factors and therapeutic efficacy in 219 pediatric and 1728 adult patients with unilateral idiopathic sudden sensorineural hearing loss (SSNHL). We found that the two groups shared major prognostic factors. Furthermore, after 1:1 propensity score matching, therapeutic efficacy was shown to be comparable between the pediatric and adult groups.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To identify prognostic factors for unilateral idiopathic sudden sensorineural hearing loss (SSNHL) in pediatric and adult patients, and to compare therapeutic efficacy between these age groups:&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective cohort study included 1947 hospitalized patients (219 pediatric, 1728 adult) with unilateral idiopathic SSNHL from January 2008 to December 2022. All patients received inpatient therapy following the Chinese Guidelines for SSNHL, with pediatric dosing adjusted for age and weight. To compare therapeutic outcomes, multivariable logistic regression, full propensity score matching (PSM), restricted cubic spline (RCS), and machine learning algorithms were employed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Baseline median ages were 13 (IQR, 10–15) years for pediatric and 43 (IQR, 33–50) years for adult patients. Shared independent prognostic factors in both groups included audiogram configuration, degree of hearing loss, and treatment-onset time. Furthermore, after matching, pediatric and adult patients had comparable complete recovery (18.7% vs. 16.4%) and overall efficacy rates (52.5% vs. 54.1%). The therapeutic window was identified as 14 days for children and 15 days for adults. Consistent with this, treatment-onset time emerged as the most influential feature in predictive models, with pediatric outcomes achieving an area under the curve (AUC) of 0.849 and adult outcomes an AUC of 0.901.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Pediatric and adult patients with unilateral idiopathic SSNHL share major prognostic factors. Therapeutic efficacy is comparable between groups when appropriate treatment is provided. Early intervention, ideally within 2 weeks of symptom onset, is critical to maximize auditory recovery.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Changshuo Shan, 
Jiao Zhang, 
Xin Zhou, 
Xiaonan Wu, 
Guohui Chen, 
Chunyan Liu, 
Jing Guan, 
Yun Gao, 
Dayong Wang, 
Qiuju Wang
</dc:creator>
         <category>Original Report</category>
         <dc:title>Comparable Outcomes in Pediatric and Adult Patients With Sudden Sensorineural Hearing Loss</dc:title>
         <dc:identifier>10.1002/lary.70371</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70371</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70371?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70374?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70374</guid>
         <title>Preoperative SGLT2 Inhibitors and Postoperative Complications After Tracheostomy in Type 2 Diabetes</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2528-2540, June 2026. </description>
         <dc:description>
ABSTRACT

Objective
To evaluate whether preoperative sodium‐glucose cotransporter 2 inhibitor (SGLT2i) use is associated with postoperative complications in adults with type 2 diabetes mellitus (T2DM) undergoing open surgical tracheostomy (OST)


Methods
We performed a retrospective cohort study using a multi‐institutional electronic health record network. Adults with T2DM who underwent OST between 2013 and 2024 were identified using CPT and ICD‐10‐PCS codes. Exposure was defined as an SGLT2i prescription within 180 days before surgery. One‐to‐one propensity score matching on demographics, comorbidities, preoperative ventilator dependence, medications, and laboratory values generated balanced SGLT2i and non‐SGLT2i cohorts. Ninety‐ and 180‐day postoperative complications were compared using odds ratios (ORs) with 95% confidence intervals, with Benjamini‐Hochberg false discovery rate (FDR) correction.


Results
Of 36,840 eligible adults (1329 SGLT2i; 35,511 non‐SGLT2i), 1327 patients remained in each cohort after matching. At 90 days, SGLT2i use was associated with higher odds of heart failure exacerbation (OR 1.70, 95% CI 1.36–2.14), which remained significant after FDR adjustment. At 180 days, SGLT2i use was associated with increased odds of hypoglycemia (OR 2.01, 95% CI 1.30–3.13) and heart failure exacerbation (OR 1.61, 95% CI 1.30–1.99), both significant after FDR correction. Signals for surgical site infection, tracheostomy stoma malfunction, and dizziness/vertigo did not remain significant after adjustment.


Conclusion
In adults with T2DM undergoing OST, preoperative SGLT2i use was associated with increased postoperative hypoglycemia and heart failure exacerbation. These findings support careful perioperative management of SGLT2is in high‐risk airway surgery and justify prospective studies to define optimal discontinuation strategies.


Level of Evidence
3

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To evaluate whether preoperative sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with postoperative complications in adults with type 2 diabetes mellitus (T2DM) undergoing open surgical tracheostomy (OST)&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We performed a retrospective cohort study using a multi-institutional electronic health record network. Adults with T2DM who underwent OST between 2013 and 2024 were identified using CPT and ICD-10-PCS codes. Exposure was defined as an SGLT2i prescription within 180 days before surgery. One-to-one propensity score matching on demographics, comorbidities, preoperative ventilator dependence, medications, and laboratory values generated balanced SGLT2i and non-SGLT2i cohorts. Ninety- and 180-day postoperative complications were compared using odds ratios (ORs) with 95% confidence intervals, with Benjamini-Hochberg false discovery rate (FDR) correction.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 36,840 eligible adults (1329 SGLT2i; 35,511 non-SGLT2i), 1327 patients remained in each cohort after matching. At 90 days, SGLT2i use was associated with higher odds of heart failure exacerbation (OR 1.70, 95% CI 1.36–2.14), which remained significant after FDR adjustment. At 180 days, SGLT2i use was associated with increased odds of hypoglycemia (OR 2.01, 95% CI 1.30–3.13) and heart failure exacerbation (OR 1.61, 95% CI 1.30–1.99), both significant after FDR correction. Signals for surgical site infection, tracheostomy stoma malfunction, and dizziness/vertigo did not remain significant after adjustment.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;In adults with T2DM undergoing OST, preoperative SGLT2i use was associated with increased postoperative hypoglycemia and heart failure exacerbation. These findings support careful perioperative management of SGLT2is in high-risk airway surgery and justify prospective studies to define optimal discontinuation strategies.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Sohil Singh, 
Sagar Singh Matharu, 
Ankit Choudhury, 
Ryan Puccia
</dc:creator>
         <category>Original Report</category>
         <dc:title>Preoperative SGLT2 Inhibitors and Postoperative Complications After Tracheostomy in Type 2 Diabetes</dc:title>
         <dc:identifier>10.1002/lary.70374</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70374</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70374?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70422?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70422</guid>
         <title>Role of Pediatric Otolaryngologist in Pediatric Tracheostomy Code Blue Cases: A New Safety Initiative</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2769-2776, June 2026. </description>
         <dc:description>
ABSTRACT

Objective
A “Code Blue” is a term to activate an alarm for the resuscitation team for a patient who has a cardiopulmonary arrest. The role of a pediatric otolaryngologist in a tracheostomy‐related code blue case is not clearly defined. We aim to describe the role of pediatric otolaryngologists in pediatric tracheostomy code blue (PTCB) cases.


Methods
This retrospective study analyzed pediatric code blue cases in a tertiary care hospital from January 2019 to December 2022, before and after the implementation of a standardized PTCB that includes a pediatric otolaryngologist in the resuscitation team. Primary outcome variables included response time and survival‐to‐discharge of patients.


Results
The most common reason for code activation was reduced oxygen saturation. The leading cause for the otolaryngology consultation was tube blockage. Tracheostomy tube change was the most common intervention performed. The mean time of otolaryngology arrival was significantly decreased from 14.0 min pre‐implementation to 4.0 min post‐implementation (p &lt; 0.001). While including all 48 PTCB events, pediatric otolaryngologist involvement was significantly associated with higher survival‐to‐discharge (94.4% vs. 66.7%, p = 0.028). While comparing post‐PTCB protocol implementation versus pre‐implementation, mortality declined from 23.8% to 3.7% with increased discharge rates, although this did not reach statistical significance (p = 0.073).


Conclusion
Inclusion of a pediatric otolaryngologist in the resuscitation team reduces time‐to‐arrival of the pediatric otolaryngologist to the code blue activation site. Reduced time to pediatric otolaryngologist arrival and completion of interventions by pediatric otolaryngologist are associated with reduced mortality in PTCB events.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;A “Code Blue” is a term to activate an alarm for the resuscitation team for a patient who has a cardiopulmonary arrest. The role of a pediatric otolaryngologist in a tracheostomy-related code blue case is not clearly defined. We aim to describe the role of pediatric otolaryngologists in pediatric tracheostomy code blue (PTCB) cases.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This retrospective study analyzed pediatric code blue cases in a tertiary care hospital from January 2019 to December 2022, before and after the implementation of a standardized PTCB that includes a pediatric otolaryngologist in the resuscitation team. Primary outcome variables included response time and survival-to-discharge of patients.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The most common reason for code activation was reduced oxygen saturation. The leading cause for the otolaryngology consultation was tube blockage. Tracheostomy tube change was the most common intervention performed. The mean time of otolaryngology arrival was significantly decreased from 14.0 min pre-implementation to 4.0 min post-implementation (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). While including all 48 PTCB events, pediatric otolaryngologist involvement was significantly associated with higher survival-to-discharge (94.4% vs. 66.7%, &lt;i&gt;p&lt;/i&gt; = 0.028). While comparing post-PTCB protocol implementation versus pre-implementation, mortality declined from 23.8% to 3.7% with increased discharge rates, although this did not reach statistical significance (&lt;i&gt;p&lt;/i&gt; = 0.073).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Inclusion of a pediatric otolaryngologist in the resuscitation team reduces time-to-arrival of the pediatric otolaryngologist to the code blue activation site. Reduced time to pediatric otolaryngologist arrival and completion of interventions by pediatric otolaryngologist are associated with reduced mortality in PTCB events.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Deepa Shivnani, 
Miles Jonathan Klimara, 
M. S. Shruthi, 
Dnyanesh Balkrishna Amle, 
Matthew Ern Lin, 
Ian Kim, 
R. N. Ashwath Ram, 
Eswaran Venkat Raman, 
Gnanam Aram, 
Mallikarjun Ravi Kobal, 
Olivia E. Speed, 
Maie A. St. John, 
Dinesh Chhetri
</dc:creator>
         <category>Original Report</category>
         <dc:title>Role of Pediatric Otolaryngologist in Pediatric Tracheostomy Code Blue Cases: A New Safety Initiative</dc:title>
         <dc:identifier>10.1002/lary.70422</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70422</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70422?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70424?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70424</guid>
         <title>Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT
</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2605-2613, June 2026. </description>
         <dc:description>
T2N0M0 glottic cancers with impaired vocal cord mobility (VCM) have worse outcomes than T2N0M0 tumors with normal VCM, but still fare better than T3N0M0 disease. These findings support subdivision of T2 glottic cancer into T2a (normal VCM) and T2b (impaired VCM) in future TNM revisions. Prospective studies are needed to determine whether treatment intensification can improve outcomes for T2 disease with impaired VCM.








ABSTRACT

Objectives
To evaluate the prognostic importance of impaired vocal cord mobility (VCM) in T2N0 glottic cancer.


Methods
All patients with T2N0 glottic cancer treated with partial laryngeal IMRT in 2009–2021 in our institution were retrospectively reviewed. For comparison, cohorts with T1N0 and T3N0 disease were also included. Locoregional failure (LRF), disease‐free survival (DFS), and overall survival (OS) were compared among T1N0, T2N0 with normal VCM (T2‐Normal‐VCM), T2N0 with impaired VCM (T2‐Impaired‐VCM), and T3N0 groups. Multivariable analysis (MVA) assessed the prognostic value of VCM within the T2N0 group.


Results
A total of 642 cases were included: 288 T1N0, 224 T2N0 (147 T2‐Normal‐VCM, 77 T2‐Impaired‐VCM), and 130 T3N0. Median follow‐up was 5.0 years (IQR 3.4–6.2). Five‐year LRF for T1N0, T2‐Normal‐VCM, T2‐Impaired‐VCM, and T3N0 were 4% (95% CI 2–6), 9% (5–15), 27% (17–38), and 35% (27–44), respectively. Corresponding DFS was 83% (78–88), 80% (73–87), 55% (45–68), and 50% (41–60), while OS was 85% (80–90), 86% (80–92), 71% (61–83), and 59% (50–69), respectively. In T2N0, MVA confirmed that impaired VCM was associated with higher LRF (aHR 3.72 [95% CI 1.79–7.71], p &lt; 0.001), lower DFS (aHR 2.74 [1.68–4.45], p &lt; 0.001), and lower OS (aHR 2.07 [1.17–3.67], p = 0.013).


Conclusions
In this contemporary cohort, LRF rates increased stepwise from T1N0 to T2‐Normal‐VCM, T2‐Impaired‐VCM, and T3N0 glottic cancer. Within T2N0 disease, impaired VCM is an adverse prognostic factor, supporting subdivision into T2a (normal VCM) and T2b (impaired VCM) in future TNM revisions. Prospective studies are warranted to assess whether treatment intensification can improve outcomes for T2‐Impaired‐VCM disease.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/10416b6b-bb7d-4ace-b8d5-b572e7d91525/lary70424-toc-0001-m.png"
     alt="Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT&amp;#xA;"/&gt;
&lt;p&gt;T2N0M0 glottic cancers with impaired vocal cord mobility (VCM) have worse outcomes than T2N0M0 tumors with normal VCM, but still fare better than T3N0M0 disease. These findings support subdivision of T2 glottic cancer into T2a (normal VCM) and T2b (impaired VCM) in future TNM revisions. Prospective studies are needed to determine whether treatment intensification can improve outcomes for T2 disease with impaired VCM.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To evaluate the prognostic importance of impaired vocal cord mobility (VCM) in T2N0 glottic cancer.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;All patients with T2N0 glottic cancer treated with partial laryngeal IMRT in 2009–2021 in our institution were retrospectively reviewed. For comparison, cohorts with T1N0 and T3N0 disease were also included. Locoregional failure (LRF), disease-free survival (DFS), and overall survival (OS) were compared among T1N0, T2N0 with normal VCM (T2-Normal-VCM), T2N0 with impaired VCM (T2-Impaired-VCM), and T3N0 groups. Multivariable analysis (MVA) assessed the prognostic value of VCM within the T2N0 group.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 642 cases were included: 288 T1N0, 224 T2N0 (147 T2-Normal-VCM, 77 T2-Impaired-VCM), and 130 T3N0. Median follow-up was 5.0 years (IQR 3.4–6.2). Five-year LRF for T1N0, T2-Normal-VCM, T2-Impaired-VCM, and T3N0 were 4% (95% CI 2–6), 9% (5–15), 27% (17–38), and 35% (27–44), respectively. Corresponding DFS was 83% (78–88), 80% (73–87), 55% (45–68), and 50% (41–60), while OS was 85% (80–90), 86% (80–92), 71% (61–83), and 59% (50–69), respectively. In T2N0, MVA confirmed that impaired VCM was associated with higher LRF (aHR 3.72 [95% CI 1.79–7.71], &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), lower DFS (aHR 2.74 [1.68–4.45], &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), and lower OS (aHR 2.07 [1.17–3.67], &lt;i&gt;p&lt;/i&gt; = 0.013).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In this contemporary cohort, LRF rates increased stepwise from T1N0 to T2-Normal-VCM, T2-Impaired-VCM, and T3N0 glottic cancer. Within T2N0 disease, impaired VCM is an adverse prognostic factor, supporting subdivision into T2a (normal VCM) and T2b (impaired VCM) in future TNM revisions. Prospective studies are warranted to assess whether treatment intensification can improve outcomes for T2-Impaired-VCM disease.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Alexander Rühle, 
Ranjan Subramani, 
Jie Su, 
Brian O'Sullivan, 
John N. Waldron, 
Andrew Hope, 
Andrew Bayley, 
Andrew McPartlin, 
Nauman Malik, 
Scott V. Bratman, 
Ali Hosni, 
John Kim, 
Ian Witterick, 
John R. de Almeida, 
Christopher Yao, 
Anna Spreafico, 
C. Jillian Tsai, 
Li Tong, 
Wei Xu, 
Shao Hui Huang, 
Ezra Hahn
</dc:creator>
         <category>Original Report</category>
         <dc:title>Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT
</dc:title>
         <dc:identifier>10.1002/lary.70424</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70424</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70424?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70452?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70452</guid>
         <title>Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2621-2630, June 2026. </description>
         <dc:description>
Cohort selection flow diagram.








ABSTRACT

Objective
Although current NCCN guidelines do not recommend surgical resection for T4b sinonasal tumors, recent studies report that up to 80% of patients undergo surgery as part of their treatment. This discrepancy between guideline‐based recommendations and real‐world clinical practice led us to investigate the clinical, demographic, and institutional factors associated with undergoing surgery among patients with clinically staged T4b sinonasal cancer.


Methods
We analyzed data from the National Cancer Database (2004–2022) to identify patients diagnosed with clinical T4b sinonasal malignancies. Patients were grouped by treatment approach: surgery with adjuvant therapy vs. definitive chemoradiation. Multivariable logistic regression assessed clinical, demographic, and institutional predictors of surgery.


Results
Of 2244 patients, 57.5% received surgery as part of treatment. Surgical management was more likely among patients with private insurance (aOR 1.56, 95% CI 1.17–2.08), those treated in the Northeast (aOR 1.55, 95% CI 1.12–2.16), and patients traveling more than 100 miles for care (aOR 1.89, 95% CI 1.35–2.63). Histologic subtypes such as melanoma (aOR 13.37), neuroectodermal tumors (aOR 11.79), adenoid cystic carcinoma (aOR 2.98), and adenocarcinoma (aOR 2.99) were more likely to receive surgery. Node positivity was negatively associated with surgery (aOR 0.49).


Conclusion
Despite guideline recommendations, surgery remains common for T4b sinonasal cancer. Surgical selection appears driven by tumor biology as well as access‐ and system‐level factors. These findings highlight the evolving and context‐dependent definition of unresectability in clinical practice.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/1e74f362-45a2-4dfc-abcb-807271cfa9e0/lary70452-toc-0001-m.png"
     alt="Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer"/&gt;
&lt;p&gt;Cohort selection flow diagram.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Although current NCCN guidelines do not recommend surgical resection for T4b sinonasal tumors, recent studies report that up to 80% of patients undergo surgery as part of their treatment. This discrepancy between guideline-based recommendations and real-world clinical practice led us to investigate the clinical, demographic, and institutional factors associated with undergoing surgery among patients with clinically staged T4b sinonasal cancer.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We analyzed data from the National Cancer Database (2004–2022) to identify patients diagnosed with clinical T4b sinonasal malignancies. Patients were grouped by treatment approach: surgery with adjuvant therapy vs. definitive chemoradiation. Multivariable logistic regression assessed clinical, demographic, and institutional predictors of surgery.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 2244 patients, 57.5% received surgery as part of treatment. Surgical management was more likely among patients with private insurance (aOR 1.56, 95% CI 1.17–2.08), those treated in the Northeast (aOR 1.55, 95% CI 1.12–2.16), and patients traveling more than 100 miles for care (aOR 1.89, 95% CI 1.35–2.63). Histologic subtypes such as melanoma (aOR 13.37), neuroectodermal tumors (aOR 11.79), adenoid cystic carcinoma (aOR 2.98), and adenocarcinoma (aOR 2.99) were more likely to receive surgery. Node positivity was negatively associated with surgery (aOR 0.49).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Despite guideline recommendations, surgery remains common for T4b sinonasal cancer. Surgical selection appears driven by tumor biology as well as access- and system-level factors. These findings highlight the evolving and context-dependent definition of unresectability in clinical practice.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Valentina Montanez‐Azcarate, 
Zoha Syed, 
Felipe Porto‐Gutierrez, 
Brett Campbell, 
Alexa Kacin, 
Ernest Gomez, 
Scharukh Jalisi
</dc:creator>
         <category>Original Report</category>
         <dc:title>Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer</dc:title>
         <dc:identifier>10.1002/lary.70452</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70452</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70452?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70338?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70338</guid>
         <title>Mastoid Surgery Does Not Normalize Tympanometric Middle Ear Pressure in Children With Cholesteatoma</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2719-2726, June 2026. </description>
         <dc:description>
Conflicting mechanism‐based hypotheses have been used to promote selection of different approaches to management of the mastoid in order to optimize middle ear pressure homeostasis after removal of cholesteatoma. For example: (a) conservation of mastoid mucosa and opening of ventilation pathways endoscopically to normalize function, (b) removal of mastoid mucosa with canal wall up tympanomastoidectomy to create a larger air‐volume reservoir as a pressure buffer, or exenterating gas absorption from the mastoid with (c) canal wall down surgery or (d) mastoid obliteration. Analysis of children with cholesteatoma shows that average tympanometric middle ear pressure remains below normal post‐operatively and that pressure does not differ between these techniques, so questioning the validity of the proposed mechanisms.








ABSTRACT

Objective
To determine whether transcanal surgery without mastoidectomy, canal wall up (CWU), canal wall down (CWD), or CWU mastoid obliteration (MO) surgery for pediatric cholesteatoma has a more favorable effect on middle ear pressure (MEP) homeostasis.


Methods
Data from children having mastoid surgery for acquired cholesteatoma were collected prospectively. Tympanometric values of MEP were compared after transcanal, CWU, CWD, and MO surgery analyzing (i) a single measure per ear from last clinic visit, and (ii) linear mixed‐effects modeling (LMEM) to control for multiple measures, surgeries, age, and cholesteatoma severity (EAONO‐JOS stage).


Results
742 surgeries on 471 ears and 2382 tympanograms were completed. At last visit, (average age 15.6 years [6.0–19.3]), Type a tympanograms were present in 80/173 (46%) of transcanal surgeries, 64/132 (48%) CWU, 15/32 (47%) CWD, and 11/25 (44%) MO (Chi‐square, p = 0.19), but 185/209 (89%) contralateral ears without cholesteatoma (Chi‐square: p = 1.08 × 10−7). Median MEP was −47 daPa (IQR: 133) after transcanal, −65 daPa (IQR: 156) after CWU, −90 daPa (IQR: 151) after CWD, and −31 daPa (IQR: 151) after MO surgery and (Kruskal–Wallis: p = 0.4) but 5 daPa (IQR: 45) in normal contralateral ears (Wilcoxon: p = 7.92 × 10−13). LMEM showed MEP was dependent on age (p = 6.3 × 10−7) but not type of mastoid surgery (p = 0.70) or EAONO‐JOS stage (p = 0.51).


Conclusion
MEP after surgery for pediatric cholesteatoma is similar after transcanal, CWU, CWD, or MO surgery and remains lower than normal. Hypotheses that propose beneficial effects of these different surgical approaches on MEP homeostasis are not supported, so should not be used to influence choice of surgical approach.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/380fdf83-10c9-4354-99d4-22669ef97c47/lary70338-toc-0001-m.png"
     alt="Mastoid Surgery Does Not Normalize Tympanometric Middle Ear Pressure in Children With Cholesteatoma"/&gt;
&lt;p&gt;Conflicting mechanism-based hypotheses have been used to promote selection of different approaches to management of the mastoid in order to optimize middle ear pressure homeostasis after removal of cholesteatoma. For example: (a) conservation of mastoid mucosa and opening of ventilation pathways endoscopically to normalize function, (b) removal of mastoid mucosa with canal wall up tympanomastoidectomy to create a larger air-volume reservoir as a pressure buffer, or exenterating gas absorption from the mastoid with (c) canal wall down surgery or (d) mastoid obliteration. Analysis of children with cholesteatoma shows that average tympanometric middle ear pressure remains below normal post-operatively and that pressure does not differ between these techniques, so questioning the validity of the proposed mechanisms.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To determine whether transcanal surgery without mastoidectomy, canal wall up (CWU), canal wall down (CWD), or CWU mastoid obliteration (MO) surgery for pediatric cholesteatoma has a more favorable effect on middle ear pressure (MEP) homeostasis.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Data from children having mastoid surgery for acquired cholesteatoma were collected prospectively. Tympanometric values of MEP were compared after transcanal, CWU, CWD, and MO surgery analyzing (i) a single measure per ear from last clinic visit, and (ii) linear mixed-effects modeling (LMEM) to control for multiple measures, surgeries, age, and cholesteatoma severity (EAONO-JOS stage).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;742 surgeries on 471 ears and 2382 tympanograms were completed. At last visit, (average age 15.6 years [6.0–19.3]), Type a tympanograms were present in 80/173 (46%) of transcanal surgeries, 64/132 (48%) CWU, 15/32 (47%) CWD, and 11/25 (44%) MO (Chi-square, &lt;i&gt;p&lt;/i&gt; = 0.19), but 185/209 (89%) contralateral ears without cholesteatoma (Chi-square: &lt;i&gt;p&lt;/i&gt; = 1.08 × 10&lt;sup&gt;−7&lt;/sup&gt;). Median MEP was −47 daPa (IQR: 133) after transcanal, −65 daPa (IQR: 156) after CWU, −90 daPa (IQR: 151) after CWD, and −31 daPa (IQR: 151) after MO surgery and (Kruskal–Wallis: &lt;i&gt;p&lt;/i&gt; = 0.4) but 5 daPa (IQR: 45) in normal contralateral ears (Wilcoxon: &lt;i&gt;p&lt;/i&gt; = 7.92 × 10&lt;sup&gt;−13&lt;/sup&gt;). LMEM showed MEP was dependent on age (&lt;i&gt;p&lt;/i&gt; = 6.3 × 10&lt;sup&gt;−7&lt;/sup&gt;) but not type of mastoid surgery (&lt;i&gt;p&lt;/i&gt; = 0.70) or EAONO-JOS stage (&lt;i&gt;p&lt;/i&gt; = 0.51).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;MEP after surgery for pediatric cholesteatoma is similar after transcanal, CWU, CWD, or MO surgery and remains lower than normal. Hypotheses that propose beneficial effects of these different surgical approaches on MEP homeostasis are not supported, so should not be used to influence choice of surgical approach.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Adrian L. James
</dc:creator>
         <category>Original Report</category>
         <dc:title>Mastoid Surgery Does Not Normalize Tympanometric Middle Ear Pressure in Children With Cholesteatoma</dc:title>
         <dc:identifier>10.1002/lary.70338</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70338</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70338?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70372?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70372</guid>
         <title>Dysphonia Is Associated With Anxiety and Depression in the All of Us Research Program</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2648-2654, June 2026. </description>
         <dc:description>
ABSTRACT

Objectives
Previous studies have examined the relationship between dysphonia and mental health, but often in small samples and not across age groups. In this large national epidemiological study, we examine if dysphonia is related to anxiety and depression generally and across cohorts of different ages.


Methods
This is a cross‐sectional analysis of adults ≥ 18 years old in the All of Us dataset. The exposure was dysphonia (ICD‐10 code R49.0), and the outcomes were anxiety (ICD‐10 F41) and depression (ICD‐10 F32‐33). We performed multivariable logistic regression analyses, controlling for age, gender, race, ethnicity, insurance, education, smoking history, alcohol use, and medical comorbidities. A sub‐analysis compared depression and anxiety odds across two and five age groups.


Results
Of 283,137 adults in our sample, the mean age was 56 years (standard deviation 16 years). Sixty‐one percent identified as female. Controlling for covariates, those with dysphonia had 1.34 times (95% CI 1.27–1.41) the odds of depression and 1.44 times (1.37–1.52) the odds of anxiety compared to their non‐dysphonia counterparts. After stratifying by age, the odds of depression and anxiety were 2.36 times (1.67–3.35) and 1.62 (1.14–2.30) respectively for participants ≥ 18–30 years old, 1.61 (1.37–1.89) and 1.75 (1.49–2.07) for &gt; 30–45 year olds, 1.38 (1.23–1.55) and 1.46 (1.33–1.67) for &gt; 45–60 year olds, 1.33 (1.23–1.44) and 1.46 (1.35–1.58) for &gt; 60–75 year olds, and 1.22 (1.09–1.35) and 1.36 (1.22–1.51) for &gt; 75 year olds.


Conclusions
Those with dysphonia had higher odds of depression and anxiety. Following stratification by age, the odds for each were highest for the youngest age group.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Previous studies have examined the relationship between dysphonia and mental health, but often in small samples and not across age groups. In this large national epidemiological study, we examine if dysphonia is related to anxiety and depression generally and across cohorts of different ages.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This is a cross-sectional analysis of adults ≥ 18 years old in the All of Us dataset. The exposure was dysphonia (ICD-10 code R49.0), and the outcomes were anxiety (ICD-10 F41) and depression (ICD-10 F32-33). We performed multivariable logistic regression analyses, controlling for age, gender, race, ethnicity, insurance, education, smoking history, alcohol use, and medical comorbidities. A sub-analysis compared depression and anxiety odds across two and five age groups.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 283,137 adults in our sample, the mean age was 56 years (standard deviation 16 years). Sixty-one percent identified as female. Controlling for covariates, those with dysphonia had 1.34 times (95% CI 1.27–1.41) the odds of depression and 1.44 times (1.37–1.52) the odds of anxiety compared to their non-dysphonia counterparts. After stratifying by age, the odds of depression and anxiety were 2.36 times (1.67–3.35) and 1.62 (1.14–2.30) respectively for participants ≥ 18–30 years old, 1.61 (1.37–1.89) and 1.75 (1.49–2.07) for &amp;gt; 30–45 year olds, 1.38 (1.23–1.55) and 1.46 (1.33–1.67) for &amp;gt; 45–60 year olds, 1.33 (1.23–1.44) and 1.46 (1.35–1.58) for &amp;gt; 60–75 year olds, and 1.22 (1.09–1.35) and 1.36 (1.22–1.51) for &amp;gt; 75 year olds.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Those with dysphonia had higher odds of depression and anxiety. Following stratification by age, the odds for each were highest for the youngest age group.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Hannah N. W. Weinstein, 
Michael W. Denham, 
Lauren H. Tucker, 
Justin S. Golub, 
Hayley L. Born
</dc:creator>
         <category>Original Report</category>
         <dc:title>Dysphonia Is Associated With Anxiety and Depression in the All of Us Research Program</dc:title>
         <dc:identifier>10.1002/lary.70372</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70372</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70372?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70393?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70393</guid>
         <title>Decoding Gender in Cough Sounds: A Transformer‐Based Analysis</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2519-2527, June 2026. </description>
         <dc:description>
Transformer‐based analysis of cough sounds demonstrates that non‐speech respiratory acoustics encode gender‐discriminative features. Using a HuBERT model with attention‐based interpretability, we show improved gender classification with cough series and consistent model attention to the explosive phase of the cough. These findings highlight the relevance of involuntary respiratory sounds in audiomics and gender‐affirming voice care.








ABSTRACT

Objective
Various components of speech, such as pitch, volume, and resonance, influence gender perception, but little is known about gender differences in non‐speech upper airway sounds such as cough. This gap has implications for gender‐affirming voice care, as coughs are harder to modulate. We aimed to explore how cough acoustics differ by gender using a transformer model with self‐attention to identify salient cough features for gender classification.


Methods
We analyzed 327 cough recordings (154 male, 173 female) from the Coswara dataset, using a 70/15/15 split for model training, validation, and testing. Preprocessing included resampling, silence removal, normalization, and trimming to uniform length. The HuBERT transformer model was used for its ability to handle unstructured audio. Gender balance was verified through SMD (standardized mean difference) screening across seven variables, all of which showed negligible imbalance.


Results
On the held‐out test set, the model achieved an accuracy of 84.0% with an F1 score of 0.8462 when classifying gender from cough series, compared to 71.4% accuracy and an F1 score of 0.7308 when using single‐cough/first‐cough samples. Attention‐aligned cough visualization revealed the highest attention on the explosive phases of the cough, suggesting that these segments encapsulate the most salient gender‐distinct acoustic cues.


Conclusion
Cough sounds contain gender‐discriminative features detectable by transformer models. Attention to specific cough phases reveals physiologically meaningful segments in cough sounds supporting gender classification. These insights may inform gender‐affirming interventions, particularly for non‐speech sound production. Future research should explore further socio‐demographic factors shaping cough acoustics.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/b725c2cc-2b71-4609-8b5c-cd7c1b5ac6f4/lary70393-toc-0001-m.png"
     alt="Decoding Gender in Cough Sounds: A Transformer-Based Analysis"/&gt;
&lt;p&gt;Transformer-based analysis of cough sounds demonstrates that non-speech respiratory acoustics encode gender-discriminative features. Using a HuBERT model with attention-based interpretability, we show improved gender classification with cough series and consistent model attention to the explosive phase of the cough. These findings highlight the relevance of involuntary respiratory sounds in audiomics and gender-affirming voice care.
&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Various components of speech, such as pitch, volume, and resonance, influence gender perception, but little is known about gender differences in non-speech upper airway sounds such as cough. This gap has implications for gender-affirming voice care, as coughs are harder to modulate. We aimed to explore how cough acoustics differ by gender using a transformer model with self-attention to identify salient cough features for gender classification.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We analyzed 327 cough recordings (154 male, 173 female) from the Coswara dataset, using a 70/15/15 split for model training, validation, and testing. Preprocessing included resampling, silence removal, normalization, and trimming to uniform length. The HuBERT transformer model was used for its ability to handle unstructured audio. Gender balance was verified through SMD (standardized mean difference) screening across seven variables, all of which showed negligible imbalance.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;On the held-out test set, the model achieved an accuracy of 84.0% with an F1 score of 0.8462 when classifying gender from cough series, compared to 71.4% accuracy and an F1 score of 0.7308 when using single-cough/first-cough samples. Attention-aligned cough visualization revealed the highest attention on the explosive phases of the cough, suggesting that these segments encapsulate the most salient gender-distinct acoustic cues.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Cough sounds contain gender-discriminative features detectable by transformer models. Attention to specific cough phases reveals physiologically meaningful segments in cough sounds supporting gender classification. These insights may inform gender-affirming interventions, particularly for non-speech sound production. Future research should explore further socio-demographic factors shaping cough acoustics.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Linh He, 
Haomiao Li, 
Siyan Wang, 
Eunice Baik, 
Sarah Kervin, 
Robin Zhao, 
John M. Ramos, 
Bridge2AI‐Voice Consortium, 
Yael E. Bensoussan, 
Olivier Elemento, 
Jean‐Christophe Bélisle‐Pipon, 
David Dorr, 
Satrajit Ghosh, 
Alistair Johnson, 
Phillip Payne, 
Maria E. Powell, 
Anaïs Rameau, 
Vardit Ravitsky, 
Alexandros Sigaras, 
Joseph Colonel, 
Anaïs Rameau
</dc:creator>
         <category>Original Report</category>
         <dc:title>Decoding Gender in Cough Sounds: A Transformer‐Based Analysis</dc:title>
         <dc:identifier>10.1002/lary.70393</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70393</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70393?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.32420?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.32420</guid>
         <title>Do Children With Cochlear Nerve Deficiency Benefit From Cochlear Implantation?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2400-2402, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Rishi K. Vas, 
Divya A. Chari, 
Anil K. Lalwani
</dc:creator>
         <category>Triological Society Best Practice</category>
         <dc:title>Do Children With Cochlear Nerve Deficiency Benefit From Cochlear Implantation?</dc:title>
         <dc:identifier>10.1002/lary.32420</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.32420</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.32420?af=R</prism:url>
         <prism:section>Triological Society Best Practice</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70026?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70026</guid>
         <title>Is Open Repair of Congenital Tracheoesophageal Fistula Preferred Over Endoscopic Approach?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2410-2411, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Saad Akhtar, 
Sukgi Choi
</dc:creator>
         <category>Triological Society Best Practice</category>
         <dc:title>Is Open Repair of Congenital Tracheoesophageal Fistula Preferred Over Endoscopic Approach?</dc:title>
         <dc:identifier>10.1002/lary.70026</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70026</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70026?af=R</prism:url>
         <prism:section>Triological Society Best Practice</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.32461?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.32461</guid>
         <title>Does Degree of Resection Improve Survival in Laryngeal Chondrosarcomas?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2403-2405, June 2026. </description>
         <dc:description>
Survival outcomes after resection of laryngeal chondrosarcoma are generally excellent, and contemporary management should aim to optimize laryngeal function and tailor the surgical approach based on subsite (accessibility of resection), initial extent of disease (when and how much to resect), and histologic grade. R0 resection does not appear to improve overall survival and should not usually be prioritized over preserving laryngeal function, especially in cases with a less aggressive oncologic profile.







</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/432663ff-62ff-4234-83a4-14b0d7c643dd/lary32461-toc-0001-m.png"
     alt="Does Degree of Resection Improve Survival in Laryngeal Chondrosarcomas?"/&gt;
&lt;p&gt;Survival outcomes after resection of laryngeal chondrosarcoma are generally excellent, and contemporary management should aim to optimize laryngeal function and tailor the surgical approach based on subsite (accessibility of resection), initial extent of disease (when and how much to resect), and histologic grade. &lt;i&gt;R&lt;/i&gt;0 resection does not appear to improve overall survival and should not usually be prioritized over preserving laryngeal function, especially in cases with a less aggressive oncologic profile.
&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Nrusheel Kattar, 
Alison Hawkins, 
Karuna Dewan, 
Cherie Ann Nathan
</dc:creator>
         <category>Triological Society Best Practice</category>
         <dc:title>Does Degree of Resection Improve Survival in Laryngeal Chondrosarcomas?</dc:title>
         <dc:identifier>10.1002/lary.32461</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.32461</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.32461?af=R</prism:url>
         <prism:section>Triological Society Best Practice</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.32441?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.32441</guid>
         <title>Do Aspirin and Antiplatelets Need to Be Held for Most Otolaryngologic/Head and Neck Surgery?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2398-2399, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Elizabeth A. Borowiec, 
Richard V. Smith
</dc:creator>
         <category>Triological Society Best Practice</category>
         <dc:title>Do Aspirin and Antiplatelets Need to Be Held for Most Otolaryngologic/Head and Neck Surgery?</dc:title>
         <dc:identifier>10.1002/lary.32441</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.32441</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.32441?af=R</prism:url>
         <prism:section>Triological Society Best Practice</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70022?af=R</link>
         <pubDate>Mon, 11 May 2026 01:46:03 -0700</pubDate>
         <dc:date>2026-05-11T01:46:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70022</guid>
         <title>
GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?</title>
         <description>The Laryngoscope, Volume 136, Issue 6, Page 2406-2409, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Alina Zgardau, 
Ryan Chin Taw Cheong, 
Kenny Peter Pang, 
Brian W. Rotenberg
</dc:creator>
         <category>Triological Society Best Practice</category>
         <dc:title>
GLP‐1 Receptor Agonists for Obstructive Sleep Apnea: An Otolaryngologist's Prescription?</dc:title>
         <dc:identifier>10.1002/lary.70022</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70022</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70022?af=R</prism:url>
         <prism:section>Triological Society Best Practice</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>6</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70602?af=R</link>
         <pubDate>Mon, 11 May 2026 01:38:06 -0700</pubDate>
         <dc:date>2026-05-11T01:38:06-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70602</guid>
         <title>Issue Information</title>
         <description>The Laryngoscope, Volume 136, Issue S3, Page S1-S5, June 2026. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator/>
         <category>Issue Information</category>
         <dc:title>Issue Information</dc:title>
         <dc:identifier>10.1002/lary.70602</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70602</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70602?af=R</prism:url>
         <prism:section>Issue Information</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>S3</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70431?af=R</link>
         <pubDate>Mon, 11 May 2026 01:38:06 -0700</pubDate>
         <dc:date>2026-05-11T01:38:06-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDate>
         <prism:coverDisplayDate>Mon, 01 Jun 2026 00:00:00 -0700</prism:coverDisplayDate>
         <guid isPermaLink="false">10.1002/lary.70431</guid>
         <title>Gender and Academic Rank Disparities in Electronic Health Record Burden Among Otolaryngologists</title>
         <description>The Laryngoscope, Volume 136, Issue S3, Page S7-S20, June 2026. </description>
         <dc:description>
In academic otolaryngology, junior and female faculty have a higher electronic health record burden (EHR). At the extremes, female assistant professors spent nearly twice as much time as their male full professor counterparts did in the EHR completing tasks related to ambulatory patient care. The differential likelihood of faculty receiving help with notes and orders may play a role in this disparity.

ABSTRACT

Objectives
The electronic health record (EHR) has benefits but also adds documentation burden that is not equally shared between academic faculty. We hypothesize that male gender and senior academic rank are associated with decreased EHR burden compared to female and junior faculty.


Methods
Demographics from faculty at participating organizations were combined with 3 years of provider efficiency data. Multivariate analyses were performed to evaluate the differences in EHR burden between genders and academic ranks, clustering for otolaryngologist and institution.


Results
Forty‐six institutions with 914 otolaryngologists (female, n = 283, 31%) were included for analysis. Median hours per day (h/d) spent in EHR tasks related to outpatient visits were 4.3, 3.5, and 3.4 h/d for female assistant, associate, and full professors, respectively; and 3.4, 2.7, and 2.3 h/d for males, likewise in ascending academic rank. These differences between median h/d in ambulatory time were significant across all six subgroups of gender and academic rank (p &lt; 0.002). Academic seniority, but not gender, was associated with less time in ambulatory tasks after work and on days without scheduled appointments (p &lt; 0.002). Males and otolaryngologists with higher academic rank were more likely to receive help with notes and orders (p &lt; 0.002).


Conclusions
For a typical clinic day, female assistant professors in academic otolaryngology spent nearly twice as much time as their male full professor counterparts did in the EHR completing tasks related to ambulatory patient care. The differential likelihood of faculty receiving help with notes and orders may play a role in this disparity.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/ad0fe87f-89c2-4914-bbae-8e0bce3ea353/lary70431-toc-0001-m.png"
     alt="Gender and Academic Rank Disparities in Electronic Health Record Burden Among Otolaryngologists"/&gt;
&lt;p&gt;In academic otolaryngology, junior and female faculty have a higher electronic health record burden (EHR). At the extremes, female assistant professors spent nearly twice as much time as their male full professor counterparts did in the EHR completing tasks related to ambulatory patient care. The differential likelihood of faculty receiving help with notes and orders may play a role in this disparity.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;The electronic health record (EHR) has benefits but also adds documentation burden that is not equally shared between academic faculty. We hypothesize that male gender and senior academic rank are associated with decreased EHR burden compared to female and junior faculty.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Demographics from faculty at participating organizations were combined with 3 years of provider efficiency data. Multivariate analyses were performed to evaluate the differences in EHR burden between genders and academic ranks, clustering for otolaryngologist and institution.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Forty-six institutions with 914 otolaryngologists (female, &lt;i&gt;n&lt;/i&gt; = 283, 31%) were included for analysis. Median hours per day (h/d) spent in EHR tasks related to outpatient visits were 4.3, 3.5, and 3.4 h/d for female assistant, associate, and full professors, respectively; and 3.4, 2.7, and 2.3 h/d for males, likewise in ascending academic rank. These differences between median h/d in ambulatory time were significant across all six subgroups of gender and academic rank (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.002). Academic seniority, but not gender, was associated with less time in ambulatory tasks after work and on days without scheduled appointments (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.002). Males and otolaryngologists with higher academic rank were more likely to receive help with notes and orders (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.002).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;For a typical clinic day, female assistant professors in academic otolaryngology spent nearly twice as much time as their male full professor counterparts did in the EHR completing tasks related to ambulatory patient care. The differential likelihood of faculty receiving help with notes and orders may play a role in this disparity.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Theresa Kim, 
Yassmeen Abdel‐Aty, 
Sarah R. Akkina, 
Greg Ator, 
Megan Ballard, 
Mihir K. Bhayani, 
Lauren A. Bohm, 
Hayley Born, 
Paul Bryson, 
Thomas L. Carroll, 
Orly Coblens, 
Alissa Collins, 
Christine E. DeMason, 
Karuna Dewan, 
Colin Edwards, 
Christina H. Fang, 
Nyssa Fox Farrell, 
Meha Goyal Fox, 
Katie Geelan‐Hansen, 
Carla Giannoni, 
Jennifer Gross, 
Anna H. Grosz, 
Elizabeth Guardiani, 
Agnes Hurtuk, 
Hongzhao Ji, 
Richard Kelley, 
Ashley Elizabeth Kita, 
Natalie A. Krane, 
Priya Krishna, 
Maggie Kuhn, 
Brian C. Lobo, 
Lyndsay L. Madden, 
Stephanie Misono, 
Nadia Moyhuddin, 
Matthew R. Naunheim, 
Miriam O'Leary, 
Sachin Pawar, 
Nicholas C. Purdy, 
Mindy Rabinowitz, 
Anaïs Rameau, 
Katherine Rieth, 
Jose W. Ruiz, 
Melissa Scholes, 
Alice L. Tang, 
Neelu Tummala, 
Andrew M. Vahabzadeh‐Hagh, 
James Wang, 
Lyndy Wilcox, 
Kathleen Yaremchuk, 
Vivian Yu, 
John Paul Giliberto
</dc:creator>
         <category>Original Report</category>
         <dc:title>Gender and Academic Rank Disparities in Electronic Health Record Burden Among Otolaryngologists</dc:title>
         <dc:identifier>10.1002/lary.70431</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70431</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70431?af=R</prism:url>
         <prism:section>Original Report</prism:section>
         <prism:volume>136</prism:volume>
         <prism:number>S3</prism:number>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70621?af=R</link>
         <pubDate>Fri, 08 May 2026 19:54:51 -0700</pubDate>
         <dc:date>2026-05-08T07:54:51-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70621</guid>
         <title>Does Xylitol Have Additional Benefit Over Saline for Nasal Irrigation in Chronic Rhinosinusitis?</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Shahid Iqbal, 
Adam DeConde, 
Deborah Watson
</dc:creator>
         <category>TRIOLOGICAL SOCIETY BEST PRACTICE</category>
         <dc:title>Does Xylitol Have Additional Benefit Over Saline for Nasal Irrigation in Chronic Rhinosinusitis?</dc:title>
         <dc:identifier>10.1002/lary.70621</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70621</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70621?af=R</prism:url>
         <prism:section>TRIOLOGICAL SOCIETY BEST PRACTICE</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70583?af=R</link>
         <pubDate>Fri, 08 May 2026 18:44:58 -0700</pubDate>
         <dc:date>2026-05-08T06:44:58-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70583</guid>
         <title>Objective Structured Assessment of Technical Skills in Mastoidectomy Using 3D‐Printed Temporal Bones</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study validated a 3D‐printed temporal bone model combined with final product analysis as an objective assessment tool for mastoidectomy surgical skills in otolaryngology residency. Performance scores improved significantly with training level, with excellent inter‐rater reliability. This approach supports competency‐based surgical education through standardized, reliable skills assessment.

ABSTRACT

Objective
To evaluate the use of three‐dimensional (3D) printed temporal bone models combined with final product analysis as an objective structured assessment of technical skills tool to assess mastoidectomy performance across levels of otolaryngology residency training.


Methods
In this prospective observational study conducted at a single academic otolaryngology residency program, 32 residents performed 64 mastoidectomies on 3D‐printed temporal bone models over a three‐year period. Three expert faculty independently and anonymously evaluated each performance using a validated 14‐item final product analysis checklist. Statistical analyses included linear regression, ANOVA, Mann–Whitney U, Wilcoxon signed‐rank tests, and intraclass correlation coefficient (ICC) for inter‐rater reliability.


Results
Median scores improved steadily with training level, from 35.0 in postgraduate year (PGY) 1 to 53.7 in PGY 5 out of 70. Linear regression demonstrated a significant positive association between both training level and duration in residency with performance. Senior residents (PGY 4–5, median score 54.0) significantly outperformed junior residents (PGY 1–3, median score 38.0; p = 0.012). Across all training levels, median scores improved from 43.2 on the first attempt to 52.5 on the third, though this difference was not statistically significant. Inter‐rater reliability was excellent (ICC = 0.9210, p &lt; 0.0001). A proficiency cutoff score of 45/70 was established using the contrasting groups method.


Conclusion
The consistency of 3D‐printed temporal bones judged by final product analysis allows for fair, objective, and reliable assessment for formative and summative evaluations. By longitudinally tracking skill improvement and differentiating performance across training levels, it supports the transition to competency‐based surgical education.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/88fac805-f9c9-40aa-a926-517a5ab5a012/lary70583-toc-0001-m.png"
     alt="Objective Structured Assessment of Technical Skills in Mastoidectomy Using 3D-Printed Temporal Bones"/&gt;
&lt;p&gt;This study validated a 3D-printed temporal bone model combined with final product analysis as an objective assessment tool for mastoidectomy surgical skills in otolaryngology residency. Performance scores improved significantly with training level, with excellent inter-rater reliability. This approach supports competency-based surgical education through standardized, reliable skills assessment.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To evaluate the use of three-dimensional (3D) printed temporal bone models combined with final product analysis as an objective structured assessment of technical skills tool to assess mastoidectomy performance across levels of otolaryngology residency training.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;In this prospective observational study conducted at a single academic otolaryngology residency program, 32 residents performed 64 mastoidectomies on 3D-printed temporal bone models over a three-year period. Three expert faculty independently and anonymously evaluated each performance using a validated 14-item final product analysis checklist. Statistical analyses included linear regression, ANOVA, Mann–Whitney U, Wilcoxon signed-rank tests, and intraclass correlation coefficient (ICC) for inter-rater reliability.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Median scores improved steadily with training level, from 35.0 in postgraduate year (PGY) 1 to 53.7 in PGY 5 out of 70. Linear regression demonstrated a significant positive association between both training level and duration in residency with performance. Senior residents (PGY 4–5, median score 54.0) significantly outperformed junior residents (PGY 1–3, median score 38.0; &lt;i&gt;p&lt;/i&gt; = 0.012). Across all training levels, median scores improved from 43.2 on the first attempt to 52.5 on the third, though this difference was not statistically significant. Inter-rater reliability was excellent (ICC = 0.9210, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). A proficiency cutoff score of 45/70 was established using the contrasting groups method.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The consistency of 3D-printed temporal bones judged by final product analysis allows for fair, objective, and reliable assessment for formative and summative evaluations. By longitudinally tracking skill improvement and differentiating performance across training levels, it supports the transition to competency-based surgical education.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Vanessa Helou, 
Lucien Khalil, 
Philip L. Perez, 
Andrew A. McCall, 
Noel Jabbour
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Objective Structured Assessment of Technical Skills in Mastoidectomy Using 3D‐Printed Temporal Bones</dc:title>
         <dc:identifier>10.1002/lary.70583</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70583</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70583?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70605?af=R</link>
         <pubDate>Fri, 08 May 2026 18:28:47 -0700</pubDate>
         <dc:date>2026-05-08T06:28:47-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70605</guid>
         <title>Effect of Smoking in Oropharyngeal Cancer Treated With TORS: Systematic Review and Meta‐Analysis</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
In a systematic review of 12 studies including 2079 patients with predominantly HPV‐associated OPSCC treated with TORS, meta‐analysis demonstrated no significant difference in recurrence‐free survival or disease‐specific survival between individuals with and without a smoking history. Individuals with a smoking history appeared to have worse overall survival, although only five studies reported on this outcome.

ABSTRACT

Objective
While smoking has been implicated as a risk factor for recurrence in HPV‐associated oropharyngeal squamous cell cancer (OPSCC) treated with definitive chemoradiation, its prognostic impact on surgically treated OPSCC is less clear.


Data Sources
MEDLINE, Embase, CENTRAL, and Scopus.


Review Methods
Articles describing patients with HPV‐associated OPSCC treated with transoral robotic surgery (TORS), which reported oncologic outcomes by smoking history, were included.


Results
2079 patients were included across 12 studies. Median age was 58.5 years, and 1808 (87.0%) were male. HPV‐associated disease was reported in 1681 (80.9%) patients. T stage was most commonly T2 in 831 (40.0%) and T1 in 764 (36.7%). N stage was N2 in 854 (41.1%), N1 in 544 (26.2%), and N0 in 307 (14.8%). 931 (44.8%) were considered individuals with a smoking history, while 1045 (50.3%) were considered without a smoking history. Median follow up was 33.7 months. Meta‐analysis using a fixed effects model demonstrated an overall hazard ratio of 1.4 (95% confidence interval 1.0–2.0) for disease recurrence, 2.7 (95% confidence interval 1.5–4.8) for overall survival, and 1.4 (95% confidence interval 0.4–4.6) for disease specific survival.


Conclusions
In this population of predominantly HPV‐associated OPSCC treated with TORS, meta‐analysis demonstrated no significant difference in recurrence‐free survival or disease‐specific survival between individuals with and without a smoking history. Individuals with a smoking history appeared to have worse overall survival, although only five studies reported on this outcome. Further research is required to clarify the prognostic influence of smoking on OPSCC treated with TORS.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/4e949f90-023d-4efa-a3ef-3a02451ac2a8/lary70605-toc-0001-m.png"
     alt="Effect of Smoking in Oropharyngeal Cancer Treated With TORS: Systematic Review and Meta-Analysis"/&gt;
&lt;p&gt;In a systematic review of 12 studies including 2079 patients with predominantly HPV-associated OPSCC treated with TORS, meta-analysis demonstrated no significant difference in recurrence-free survival or disease-specific survival between individuals with and without a smoking history. Individuals with a smoking history appeared to have worse overall survival, although only five studies reported on this outcome.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;While smoking has been implicated as a risk factor for recurrence in HPV-associated oropharyngeal squamous cell cancer (OPSCC) treated with definitive chemoradiation, its prognostic impact on surgically treated OPSCC is less clear.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;MEDLINE, Embase, CENTRAL, and Scopus.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;Articles describing patients with HPV-associated OPSCC treated with transoral robotic surgery (TORS), which reported oncologic outcomes by smoking history, were included.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;2079 patients were included across 12 studies. Median age was 58.5 years, and 1808 (87.0%) were male. HPV-associated disease was reported in 1681 (80.9%) patients. T stage was most commonly T2 in 831 (40.0%) and T1 in 764 (36.7%). N stage was N2 in 854 (41.1%), N1 in 544 (26.2%), and N0 in 307 (14.8%). 931 (44.8%) were considered individuals with a smoking history, while 1045 (50.3%) were considered without a smoking history. Median follow up was 33.7 months. Meta-analysis using a fixed effects model demonstrated an overall hazard ratio of 1.4 (95% confidence interval 1.0–2.0) for disease recurrence, 2.7 (95% confidence interval 1.5–4.8) for overall survival, and 1.4 (95% confidence interval 0.4–4.6) for disease specific survival.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In this population of predominantly HPV-associated OPSCC treated with TORS, meta-analysis demonstrated no significant difference in recurrence-free survival or disease-specific survival between individuals with and without a smoking history. Individuals with a smoking history appeared to have worse overall survival, although only five studies reported on this outcome. Further research is required to clarify the prognostic influence of smoking on OPSCC treated with TORS.&lt;/p&gt;</content:encoded>
         <dc:creator>
Jane Y. Tong, 
Neha Amin, 
Cailin Cruess, 
Emilie Ludeman, 
Kelly Moyer, 
Jeffrey Wolf, 
Rodney Taylor, 
Jason K. Molitoris, 
Matthew J. Ferris, 
Ranee Mehra, 
Kyle M. Hatten
</dc:creator>
         <category>SYSTEMATIC REVIEW</category>
         <dc:title>Effect of Smoking in Oropharyngeal Cancer Treated With TORS: Systematic Review and Meta‐Analysis</dc:title>
         <dc:identifier>10.1002/lary.70605</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70605</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70605?af=R</prism:url>
         <prism:section>SYSTEMATIC REVIEW</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70604?af=R</link>
         <pubDate>Thu, 07 May 2026 19:20:23 -0700</pubDate>
         <dc:date>2026-05-07T07:20:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70604</guid>
         <title>How Should Thyroid Nodules and Risk of Thyroid Cancer Be Managed in Patients on GLP‐1 Receptor Agonists?</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Cassidy Anderson, 
Richard V. Smith, 
Carolyn Debiase
</dc:creator>
         <category>TRIOLOGICAL SOCIETY BEST PRACTICE</category>
         <dc:title>How Should Thyroid Nodules and Risk of Thyroid Cancer Be Managed in Patients on GLP‐1 Receptor Agonists?</dc:title>
         <dc:identifier>10.1002/lary.70604</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70604</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70604?af=R</prism:url>
         <prism:section>TRIOLOGICAL SOCIETY BEST PRACTICE</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70606?af=R</link>
         <pubDate>Wed, 06 May 2026 23:19:40 -0700</pubDate>
         <dc:date>2026-05-06T11:19:40-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70606</guid>
         <title>The Utility of Macrolide Therapy for Neutrophilic CRSsNP Based on Structured Histopathology</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Alison J. Yu, 
Sanjena Venkatesh, 
Jadyn Wilensky, 
Alan D. Workman, 
Jeremy Chang, 
Maria Espinosa, 
Jennifer E. Douglas, 
James N. Palmer, 
Nithin D. Adappa, 
Michael A. Kohanski
</dc:creator>
         <category>RAPID COMMUNICATION</category>
         <dc:title>The Utility of Macrolide Therapy for Neutrophilic CRSsNP Based on Structured Histopathology</dc:title>
         <dc:identifier>10.1002/lary.70606</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70606</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70606?af=R</prism:url>
         <prism:section>RAPID COMMUNICATION</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70603?af=R</link>
         <pubDate>Wed, 06 May 2026 21:27:05 -0700</pubDate>
         <dc:date>2026-05-06T09:27:05-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70603</guid>
         <title>Finite Element Analysis of Upper Airway in Ansa Cervicalis Stimulation for Obstructive Sleep Apnea</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We developed a subject‐specific FE model to investigate how ACS stabilizes the upper airway in OSA. Simulations demonstrate that caudal traction applied through the hyolaryngeal complex produces coordinated multilevel airway stabilization, with pronounced effects at the retropalatal and retro‐epiglottic regions under physiologic loading. This proof‐of‐concept modeling framework provides mechanistic insight into ACS and supports further hypothesis‐driven investigation of neurostimulation‐based airway therapies.

ABSTRACT

Objective
To develop a subject‐specific, three‐dimensional finite element (FE) model of the human upper airway and evaluate how ansa cervicalis stimulation (ACS), a novel neurostimulation for obstructive sleep apnea (OSA), alters upper airway anatomy under physiologic loading.


Methods
Upper airway anatomy was reconstructed from a head‐and‐neck CT of an adult female using a semi‐automated pipeline, including segmentation, smoothing, tetrahedral meshing, and registration. Linear elastic material properties were assigned from the literature. ACS was simulated as a caudal load on the anterior thyroid cartilage, and inspiratory collapse tendency was mimicked with a −70 Pa luminal negative pressure. Structural displacement and cross‐sectional area (CSA) changes were quantified at the soft palate, lateral pharyngeal wall, tongue base, and epiglottis.


Results
ACS produced caudal displacement of the thyroid cartilage by approximately 10 mm with coordinated motion of the hyolaryngeal complex and longitudinal pharyngeal wall strain. It also tilted the epiglottis antero–inferiorly and increased its curvature, reducing posterior–inferior motion under negative pressure by more than 50% (5.0 to 2.2 mm). Retro‐epiglottic CSA increased by 68.8% without negative pressure (42.43 to 71.63 mm2) and by 2980.3% with negative pressure (0.79 to 24.19 mm2). Retropalatal CSA improved by 34.4% without negative pressure (65.04 to 87.42 mm2) and by 20.3% with negative pressure (16.98 to 20.43 mm2).


Conclusion
This proof‐of‐concept, subject‐specific FE model shows that ACS imparts caudal traction through the hyolaryngeal complex, producing multilevel anatomic stabilization under physiologic loading. The findings establish a quantitative, hypothesis‐generating framework for interrogating ACS‐mediated airway stabilization mechanisms and support further investigation across broader OSA populations and collapse phenotypes.


Level of Evidence
N/A

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/93878526-166a-43d0-bf35-02abccffabeb/lary70603-toc-0001-m.png"
     alt="Finite Element Analysis of Upper Airway in Ansa Cervicalis Stimulation for Obstructive Sleep Apnea"/&gt;
&lt;p&gt;We developed a subject-specific FE model to investigate how ACS stabilizes the upper airway in OSA. Simulations demonstrate that caudal traction applied through the hyolaryngeal complex produces coordinated multilevel airway stabilization, with pronounced effects at the retropalatal and retro-epiglottic regions under physiologic loading. This proof-of-concept modeling framework provides mechanistic insight into ACS and supports further hypothesis-driven investigation of neurostimulation-based airway therapies.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To develop a subject-specific, three-dimensional finite element (FE) model of the human upper airway and evaluate how ansa cervicalis stimulation (ACS), a novel neurostimulation for obstructive sleep apnea (OSA), alters upper airway anatomy under physiologic loading.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Upper airway anatomy was reconstructed from a head-and-neck CT of an adult female using a semi-automated pipeline, including segmentation, smoothing, tetrahedral meshing, and registration. Linear elastic material properties were assigned from the literature. ACS was simulated as a caudal load on the anterior thyroid cartilage, and inspiratory collapse tendency was mimicked with a −70 Pa luminal negative pressure. Structural displacement and cross-sectional area (CSA) changes were quantified at the soft palate, lateral pharyngeal wall, tongue base, and epiglottis.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;ACS produced caudal displacement of the thyroid cartilage by approximately 10 mm with coordinated motion of the hyolaryngeal complex and longitudinal pharyngeal wall strain. It also tilted the epiglottis antero–inferiorly and increased its curvature, reducing posterior–inferior motion under negative pressure by more than 50% (5.0 to 2.2 mm). Retro-epiglottic CSA increased by 68.8% without negative pressure (42.43 to 71.63 mm&lt;sup&gt;2&lt;/sup&gt;) and by 2980.3% with negative pressure (0.79 to 24.19 mm&lt;sup&gt;2&lt;/sup&gt;). Retropalatal CSA improved by 34.4% without negative pressure (65.04 to 87.42 mm&lt;sup&gt;2&lt;/sup&gt;) and by 20.3% with negative pressure (16.98 to 20.43 mm&lt;sup&gt;2&lt;/sup&gt;).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This proof-of-concept, subject-specific FE model shows that ACS imparts caudal traction through the hyolaryngeal complex, producing multilevel anatomic stabilization under physiologic loading. The findings establish a quantitative, hypothesis-generating framework for interrogating ACS-mediated airway stabilization mechanisms and support further investigation across broader OSA populations and collapse phenotypes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A&lt;/p&gt;</content:encoded>
         <dc:creator>
Mukund Gupta, 
Songrui Li, 
Haoxiang Luo, 
David T. Kent, 
Yike Li
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Finite Element Analysis of Upper Airway in Ansa Cervicalis Stimulation for Obstructive Sleep Apnea</dc:title>
         <dc:identifier>10.1002/lary.70603</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70603</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70603?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70575?af=R</link>
         <pubDate>Wed, 06 May 2026 21:25:47 -0700</pubDate>
         <dc:date>2026-05-06T09:25:47-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70575</guid>
         <title>In Reference to Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence Tomography</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
K. V. Vijay Kumar, 
Pankaj Kshirsagar, 
Mansi Mishra, 
Surbhi Panwar
</dc:creator>
         <category>LETTER TO THE EDITOR</category>
         <dc:title>In Reference to Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence Tomography</dc:title>
         <dc:identifier>10.1002/lary.70575</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70575</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70575?af=R</prism:url>
         <prism:section>LETTER TO THE EDITOR</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70612?af=R</link>
         <pubDate>Wed, 06 May 2026 21:00:19 -0700</pubDate>
         <dc:date>2026-05-06T09:00:19-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70612</guid>
         <title>Peri‐ and Post‐Menopausal Hormone Replacement Therapy and Voice Disorder Risk: A TriNetX Study</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objectives
The aim of this study was to elucidate the risk of developing voice disorders among peri‐ and post‐menopausal female hormone replacement therapy (HRT) users.


Methods
A retrospective cohort study was conducted using the TriNetX Global Collaborative Network. Females aged 40–60 years old were included and stratified into two cohorts: HRT users (n = 16,586) and HRT non‐users (n = 248,725) while excluding for head and neck radiation/neoplasms, smoking, benign laryngeal lesions, thyroid disorders, gender dysphoria, and any other systemic hormone use. Voice and resonance disorders (VRD) and dysphonia were separately assessed at 3‐month intervals post‐HRT initiation after propensity score‐matching for age, sex, race, and ethnicity. Odds ratios (ORs) with 95% confidence intervals (CIs) and risk differences (RD) were generated to compare outcomes.


Results
HRT users had significantly higher odds of dysphonia, but not VRD, within 0–9 months (OR 1.72; 95% CI (1.01–2.95), OR 1.66; 95% CI (0.99–2.79), respectively). For HRT users with elevated BMI, the 1‐year VRD incidence was not significantly different than non‐HRT users (RD 0.19%, p = 0.069). Overall, the incidence of VRD and dysphonia within 1 year in both groups was &lt; 0.5% and showed no significant difference at most times between groups.


Conclusions
HRT may not have any significant clinical impact on the peri‐ and post‐menopausal voice. Although higher odds were noted earlier after treatment, HRT users did not have higher odds of voice issues after 1 year. This study highlights the lack of consensus in literature and urges future research to fully understand the impact of HRT on peri‐ and post‐menopausal voice.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;The aim of this study was to elucidate the risk of developing voice disorders among peri- and post-menopausal female hormone replacement therapy (HRT) users.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective cohort study was conducted using the TriNetX Global Collaborative Network. Females aged 40–60 years old were included and stratified into two cohorts: HRT users (&lt;i&gt;n&lt;/i&gt; = 16,586) and HRT non-users (&lt;i&gt;n&lt;/i&gt; = 248,725) while excluding for head and neck radiation/neoplasms, smoking, benign laryngeal lesions, thyroid disorders, gender dysphoria, and any other systemic hormone use. Voice and resonance disorders (VRD) and dysphonia were separately assessed at 3-month intervals post-HRT initiation after propensity score-matching for age, sex, race, and ethnicity. Odds ratios (ORs) with 95% confidence intervals (CIs) and risk differences (RD) were generated to compare outcomes.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;HRT users had significantly higher odds of dysphonia, but not VRD, within 0–9 months (OR 1.72; 95% CI (1.01–2.95), OR 1.66; 95% CI (0.99–2.79), respectively). For HRT users with elevated BMI, the 1-year VRD incidence was not significantly different than non-HRT users (RD 0.19%, &lt;i&gt;p&lt;/i&gt; = 0.069). Overall, the incidence of VRD and dysphonia within 1 year in both groups was &amp;lt; 0.5% and showed no significant difference at most times between groups.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;HRT may not have any significant clinical impact on the peri- and post-menopausal voice. Although higher odds were noted earlier after treatment, HRT users did not have higher odds of voice issues after 1 year. This study highlights the lack of consensus in literature and urges future research to fully understand the impact of HRT on peri- and post-menopausal voice.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
David Kayekjian, 
Warren B. Chun, 
Shaun A. Nguyen, 
Ashli K. O'Rourke, 
Kirsten D. Meenan
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Peri‐ and Post‐Menopausal Hormone Replacement Therapy and Voice Disorder Risk: A TriNetX Study</dc:title>
         <dc:identifier>10.1002/lary.70612</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70612</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70612?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70610?af=R</link>
         <pubDate>Wed, 06 May 2026 20:55:42 -0700</pubDate>
         <dc:date>2026-05-06T08:55:42-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70610</guid>
         <title>Neighborhood Deprivation and Voice and Reflux Symptom Burden in a Tertiary Laryngology Cohort</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objective
The voice handicap index‐10 (VHI‐10) and reflux symptoms index (RSI) are validated, patient‐reported outcome measures (PROMs) commonly used in laryngology to assess the subjective impact of voice disorders and severity of symptoms associated with laryngopharyngeal reflux, respectively. This study aims to evaluate the relationship between neighborhood‐level socioeconomic disadvantage, as measured by the area deprivation index (ADI), and patient‐reported laryngeal outcomes.


Methods
An analysis of 1310 adult patients who were referred to a tertiary care laryngology clinic between January and December 2024 was conducted. Patient addresses were geocoded and matched to corresponding ADI national percentile scores, and internally derived ADI quartiles were formed. Median VHI‐10 and RSI scores by ADI quartile were compared using the Kruskal‐Wallis test. Multivariable linear regression was performed to investigate the association between ADI and VHI‐10 or RSI scores, adjusting for sociodemographic (race, sex, and age) and clinical (comorbidities, depression/anxiety, insurance status, BMI, and primary diagnosis) factors.


Results
Patients living in the least deprived ADI quartile had significantly lower median VHI‐10 and RSI Scores, compared to patients in the most deprived ADI quartile (10 vs. 14, and 15 vs. 20, respectively). In adjusted analysis, living in a higher ADI area was significantly associated with a higher VHI‐10 (β = 0.04, 95% confidence interval [CI]: 0.008–0.06) or RSI (β = 0.04, 95% CI: 0.01–0.07) score.


Conclusions
Higher neighborhood socioeconomic deprivation is significantly associated with higher VHI‐10 and RSI scores. Patients living in more deprived areas may face barriers to accessing care, including low health literacy and limited resources.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;The voice handicap index-10 (VHI-10) and reflux symptoms index (RSI) are validated, patient-reported outcome measures (PROMs) commonly used in laryngology to assess the subjective impact of voice disorders and severity of symptoms associated with laryngopharyngeal reflux, respectively. This study aims to evaluate the relationship between neighborhood-level socioeconomic disadvantage, as measured by the area deprivation index (ADI), and patient-reported laryngeal outcomes.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;An analysis of 1310 adult patients who were referred to a tertiary care laryngology clinic between January and December 2024 was conducted. Patient addresses were geocoded and matched to corresponding ADI national percentile scores, and internally derived ADI quartiles were formed. Median VHI-10 and RSI scores by ADI quartile were compared using the Kruskal-Wallis test. Multivariable linear regression was performed to investigate the association between ADI and VHI-10 or RSI scores, adjusting for sociodemographic (race, sex, and age) and clinical (comorbidities, depression/anxiety, insurance status, BMI, and primary diagnosis) factors.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Patients living in the least deprived ADI quartile had significantly lower median VHI-10 and RSI Scores, compared to patients in the most deprived ADI quartile (10 vs. 14, and 15 vs. 20, respectively). In adjusted analysis, living in a higher ADI area was significantly associated with a higher VHI-10 (&lt;i&gt;β&lt;/i&gt; = 0.04, 95% confidence interval [CI]: 0.008–0.06) or RSI (&lt;i&gt;β&lt;/i&gt; = 0.04, 95% CI: 0.01–0.07) score.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Higher neighborhood socioeconomic deprivation is significantly associated with higher VHI-10 and RSI scores. Patients living in more deprived areas may face barriers to accessing care, including low health literacy and limited resources.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Sandra Stinnett, 
Shirley X. Liu, 
Katie M. Carlson, 
Leah Helou, 
Libby Smith, 
Chloe Santa Maria, 
Angela L. Mazul
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Neighborhood Deprivation and Voice and Reflux Symptom Burden in a Tertiary Laryngology Cohort</dc:title>
         <dc:identifier>10.1002/lary.70610</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70610</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70610?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70584?af=R</link>
         <pubDate>Tue, 05 May 2026 22:46:43 -0700</pubDate>
         <dc:date>2026-05-05T10:46:43-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70584</guid>
         <title>Impact of Co‐Morbid Immunocompromise in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Among patients with surgically resected Human Papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), immunocompromised patients had significantly worse overall survival compared to the non‐compromised group; however, these exploratory findings should be interpreted cautiously.

ABSTRACT

Objectives
To characterize the survival and morbidity associated with immunocompromised status in patients with surgically resected Human Papillomavirus positive oropharyngeal squamous cell carcinoma (HPV + OPSCC).


Methods
We reviewed patients with surgically resected HPV + OPSCC at a tertiary institution between 2000 and 2023. The survival and morbidity associated with an immunocompromised status were assessed with multivariable Cox proportional hazards models controlling for patient, tumor, and treatment characteristics.


Results
Among 278 patients with HPV+ OPSCC that met inclusion criteria, 14 patients were immunocompromised. Causes of immunocompromise: 4, leukemia or lymphoma; 3, organ transplantation; 3, medically immunosuppressed; 2, HIV; 2, myelodysplastic syndrome and pancytopenia. Adjusting for covariates, the immunocompromised patient group had significantly worse overall survival (64.3% vs. 91.7%; HR 4.12, 95% CI: 1.14–14.90, p &lt; 0.005) compared to the non‐compromised group. The immunocompromised patient group did not have a significantly different postoperative length of stay (3.96 vs. 3.5 days; aβ 0.66, 95% CI: −1.30 to 2.64).


Conclusions
In this small, heterogeneous cohort of surgically resected HPV + OPSCC, immunocompromised status was associated with significantly worse overall survival; however, these exploratory findings should be interpreted cautiously.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7bb88588-e33d-4765-acb4-9f7bcc79d82a/lary70584-toc-0001-m.png"
     alt="Impact of Co-Morbid Immunocompromise in HPV-Associated Oropharyngeal Squamous Cell Carcinoma"/&gt;
&lt;p&gt;Among patients with surgically resected Human Papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC), immunocompromised patients had significantly worse overall survival compared to the non-compromised group; however, these exploratory findings should be interpreted cautiously.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To characterize the survival and morbidity associated with immunocompromised status in patients with surgically resected Human Papillomavirus positive oropharyngeal squamous cell carcinoma (HPV + OPSCC).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We reviewed patients with surgically resected HPV + OPSCC at a tertiary institution between 2000 and 2023. The survival and morbidity associated with an immunocompromised status were assessed with multivariable Cox proportional hazards models controlling for patient, tumor, and treatment characteristics.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 278 patients with HPV+ OPSCC that met inclusion criteria, 14 patients were immunocompromised. Causes of immunocompromise: 4, leukemia or lymphoma; 3, organ transplantation; 3, medically immunosuppressed; 2, HIV; 2, myelodysplastic syndrome and pancytopenia. Adjusting for covariates, the immunocompromised patient group had significantly worse overall survival (64.3% vs. 91.7%; HR 4.12, 95% CI: 1.14–14.90, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.005) compared to the non-compromised group. The immunocompromised patient group did not have a significantly different postoperative length of stay (3.96 vs. 3.5 days; aβ 0.66, 95% CI: −1.30 to 2.64).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In this small, heterogeneous cohort of surgically resected HPV + OPSCC, immunocompromised status was associated with significantly worse overall survival; however, these exploratory findings should be interpreted cautiously.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Maxwell L. Weng, 
Tereza Vitkovska, 
Song Hon Hwang, 
Lauran K. Evans, 
Hong‐Ho Yang, 
Christopher Dann, 
Dipti Sajed, 
Maie A. St. John
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Impact of Co‐Morbid Immunocompromise in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma</dc:title>
         <dc:identifier>10.1002/lary.70584</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70584</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70584?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70607?af=R</link>
         <pubDate>Tue, 05 May 2026 20:01:01 -0700</pubDate>
         <dc:date>2026-05-05T08:01:01-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70607</guid>
         <title>Structural Phenotype of High‐Frequency Recurrent Facial Palsy</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study identifies a specific “structural phenotype” in high‐frequency recurrent facial palsy, characterized by fixed bony constraints and secondary inflammatory remodeling of the geniculate ganglion. These findings suggest that identifying such anatomical variations on HRCT may enhance the prediction of recurrence risk and inform clinical strategies for managing patients with complex recurrent patterns.

ABSTRACT

Objectives
High‐frequency recurrence of peripheral facial palsy suggests an underlying structural predisposition. We aimed to identify the anatomical phenotype associated with ≥ 3 recurrences using high‐resolution CT (HRCT).


Methods
We retrospectively analyzed 63 patients with high‐frequency recurrence (mean 3.5 episodes) and 62 normal controls. Four HRCT parameters were quantified: geniculate ganglion (GG) enlargement, labyrinthine segment (LS) constriction, intracanalicular bony exostosis, and greater superficial petrosal nerve (GSPN) thickening. Inter‐parameter correlations were also evaluated.


Results
The mean age at the first attack was young (22.1 years). Intracanalicular bony exostosis was identified as the most potent predictor of recurrence (39.7% vs. 9.7%; OR: 7.39, p &lt; 0.001). GG enlargement and GSPN thickening were significantly more prevalent in the recurrent group (p &lt; 0.01) and showed a strong positive correlation (ρ = 0.58, p &lt; 0.001), supporting a retrograde inflammatory spread mechanism. Overall, 63.5% of the recurrent group exhibited at least one structural or secondary finding (p &lt; 0.001).


Conclusion
High‐frequency recurrent facial palsy is associated with a structural phenotype, where fixed bony constraints like exostosis exacerbate chronic secondary inflammatory changes in the GG and GSPN. Recognizing these features on HRCT may help predict individuals at risk for recurrence and assist in planning targeted surgical decompression.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/94772150-c385-45b8-b3e9-7734a7749abf/lary70607-toc-0001-m.png"
     alt="Structural Phenotype of High-Frequency Recurrent Facial Palsy"/&gt;
&lt;p&gt;This study identifies a specific “structural phenotype” in high-frequency recurrent facial palsy, characterized by fixed bony constraints and secondary inflammatory remodeling of the geniculate ganglion. These findings suggest that identifying such anatomical variations on HRCT may enhance the prediction of recurrence risk and inform clinical strategies for managing patients with complex recurrent patterns.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;High-frequency recurrence of peripheral facial palsy suggests an underlying structural predisposition. We aimed to identify the anatomical phenotype associated with ≥ 3 recurrences using high-resolution CT (HRCT).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We retrospectively analyzed 63 patients with high-frequency recurrence (mean 3.5 episodes) and 62 normal controls. Four HRCT parameters were quantified: geniculate ganglion (GG) enlargement, labyrinthine segment (LS) constriction, intracanalicular bony exostosis, and greater superficial petrosal nerve (GSPN) thickening. Inter-parameter correlations were also evaluated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The mean age at the first attack was young (22.1 years). Intracanalicular bony exostosis was identified as the most potent predictor of recurrence (39.7% vs. 9.7%; OR: 7.39, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). GG enlargement and GSPN thickening were significantly more prevalent in the recurrent group (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and showed a strong positive correlation (ρ = 0.58, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), supporting a retrograde inflammatory spread mechanism. Overall, 63.5% of the recurrent group exhibited at least one structural or secondary finding (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;High-frequency recurrent facial palsy is associated with a structural phenotype, where fixed bony constraints like exostosis exacerbate chronic secondary inflammatory changes in the GG and GSPN. Recognizing these features on HRCT may help predict individuals at risk for recurrence and assist in planning targeted surgical decompression.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Yeso Choi, 
Il‐Seok Park, 
Sung Jun Han, 
Jihae Lee, 
Jin Kim
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Structural Phenotype of High‐Frequency Recurrent Facial Palsy</dc:title>
         <dc:identifier>10.1002/lary.70607</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70607</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70607?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70609?af=R</link>
         <pubDate>Tue, 05 May 2026 19:50:14 -0700</pubDate>
         <dc:date>2026-05-05T07:50:14-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70609</guid>
         <title>Carbon Dioxide Laser‐Assisted Stiffening for Primary Epiglottic Collapse: A Preliminary Experience</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We present a modification of the traditional Epiglottis Stiffening Operation technique for the management of primary epiglottic collapse in OSA, introducing carbon dioxide (CO2) laser application to promote anterior repositioning of the epiglottis. The use of laser yielded promising improvements in polysomnographic parameters compared to baseline and allowed for modulable thermal effects on target tissues by adjusting power, spot size, and exposure time, thereby reducing the risk of cartilage injury from excessive collateral heat.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/021526cd-26d2-4cce-b39c-be1d88fa2774/lary70609-toc-0001-m.png"
     alt="Carbon Dioxide Laser-Assisted Stiffening for Primary Epiglottic Collapse: A Preliminary Experience"/&gt;
&lt;p&gt;We present a modification of the traditional Epiglottis Stiffening Operation technique for the management of primary epiglottic collapse in OSA, introducing carbon dioxide (CO&lt;sub&gt;2&lt;/sub&gt;) laser application to promote anterior repositioning of the epiglottis. The use of laser yielded promising improvements in polysomnographic parameters compared to baseline and allowed for modulable thermal effects on target tissues by adjusting power, spot size, and exposure time, thereby reducing the risk of cartilage injury from excessive collateral heat.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Francesco Giombi, 
Gian Marco Pace, 
Michele Cerasuolo, 
Giuseppe Spriano, 
Luca Malvezzi
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>Carbon Dioxide Laser‐Assisted Stiffening for Primary Epiglottic Collapse: A Preliminary Experience</dc:title>
         <dc:identifier>10.1002/lary.70609</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70609</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70609?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70599?af=R</link>
         <pubDate>Tue, 05 May 2026 03:54:49 -0700</pubDate>
         <dc:date>2026-05-05T03:54:49-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70599</guid>
         <title>Location Matters for Proximal Hilar Submandibular Stone Removal: Position Relative to the Mylohyoid</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This retrospective cohort study demonstrates that larger stone diameter and sialendoscopic visibility are independent predictors of successful sialendoscopy‐assisted removal of submandibular proximal hilar stones. The majority of cases required a transoral incision for removal and all glands were preserved. Stones located superior to or at the mylohyoid plane were associated with higher successful removal rates compared to stones located inferior to the mylohyoid.

ABSTRACT

Objective
To identify imaging predictors for successful sialendoscopy‐assisted removal of proximal/hilar submandibular stones.


Methods
Retrospective cohort study of patients with sialolithiasis near the hilum of the submandibular gland (SMG). Two independent reviewers measured CT images for stone size, number, location relative to the mylohyoid, and distance from the inferior mandible.


Results
Seventy‐six patients were evaluated. Stones were located at the mylohyoid plane in 52 patients (68.4%), superior to the mylohyoid in 9 (11.8%), and inferior to the mylohyoid in 15 (19.7%). A combined transoral approach was required in 65 (85.5%) patients. Proximal/hilar SMG stones were successfully removed in 82.9% (n = 63), with higher removal rates in patients with stones located superior to the mylohyoid line (100.0%) compared to at (84.6%) or inferior (60.0%, p = 0.038). Shorter average distance between the inferior border of the mandible and the stone was associated with successful removal (p &lt; 0.001). Maximum stone diameter was significantly larger in successful cases compared to unsuccessful cases (8.0 vs. 5.4 mm; p = 0.043). Stones visible with sialendoscopy (n = 55, 72.4%) were associated with higher successful removal rates than for stones not seen with sialendoscopy.


Conclusions
Gland preservation techniques for proximal/hilar submandibular sialolithiasis required proximal transoral incision in 85.5% of cases. Imaging characteristics, including stone position superior to or at the mylohyoid plane and larger stone size, were predictors of successful sialendoscopy‐assisted transoral removal. Imaging findings can assist with surgical planning for proximal/hilar submandibular stones.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/f2ef812c-f999-4ed3-84a4-7e57451b6ce5/lary70599-toc-0001-m.png"
     alt="Location Matters for Proximal Hilar Submandibular Stone Removal: Position Relative to the Mylohyoid"/&gt;
&lt;p&gt;This retrospective cohort study demonstrates that larger stone diameter and sialendoscopic visibility are independent predictors of successful sialendoscopy-assisted removal of submandibular proximal hilar stones. The majority of cases required a transoral incision for removal and all glands were preserved. Stones located superior to or at the mylohyoid plane were associated with higher successful removal rates compared to stones located inferior to the mylohyoid.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To identify imaging predictors for successful sialendoscopy-assisted removal of proximal/hilar submandibular stones.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective cohort study of patients with sialolithiasis near the hilum of the submandibular gland (SMG). Two independent reviewers measured CT images for stone size, number, location relative to the mylohyoid, and distance from the inferior mandible.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Seventy-six patients were evaluated. Stones were located at the mylohyoid plane in 52 patients (68.4%), superior to the mylohyoid in 9 (11.8%), and inferior to the mylohyoid in 15 (19.7%). A combined transoral approach was required in 65 (85.5%) patients. Proximal/hilar SMG stones were successfully removed in 82.9% (&lt;i&gt;n&lt;/i&gt; = 63), with higher removal rates in patients with stones located superior to the mylohyoid line (100.0%) compared to at (84.6%) or inferior (60.0%, &lt;i&gt;p&lt;/i&gt; = 0.038). Shorter average distance between the inferior border of the mandible and the stone was associated with successful removal (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Maximum stone diameter was significantly larger in successful cases compared to unsuccessful cases (8.0 vs. 5.4 mm; &lt;i&gt;p&lt;/i&gt; = 0.043). Stones visible with sialendoscopy (&lt;i&gt;n&lt;/i&gt; = 55, 72.4%) were associated with higher successful removal rates than for stones not seen with sialendoscopy.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Gland preservation techniques for proximal/hilar submandibular sialolithiasis required proximal transoral incision in 85.5% of cases. Imaging characteristics, including stone position superior to or at the mylohyoid plane and larger stone size, were predictors of successful sialendoscopy-assisted transoral removal. Imaging findings can assist with surgical planning for proximal/hilar submandibular stones.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Tiffany Husman, 
Ashley Stone, 
Jolie L. Chang
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Location Matters for Proximal Hilar Submandibular Stone Removal: Position Relative to the Mylohyoid</dc:title>
         <dc:identifier>10.1002/lary.70599</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70599</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70599?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70592?af=R</link>
         <pubDate>Tue, 05 May 2026 03:45:58 -0700</pubDate>
         <dc:date>2026-05-05T03:45:58-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70592</guid>
         <title>Multi‐Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
A novel multi‐frequency electrocochleography (ECochG) algorithm used during cochlear implant electrode insertion is associated with fewer drop alarms and an increase in optimal insertion track patterns. Multi‐frequency ECochG may provide a more accurate assessment of the cochlear microenvironment when compared to single‐frequency ECochG.

ABSTRACT

Objective
To evaluate intracochlear electrocochleography (ECochG) amplitude parameters during cochlear implantation (CI) using a novel multi‐frequency ECochG algorithm.


Methods
A multi‐institutional, prospective cohort study was performed at 18 high‐volume CI centers. The inclusion criteria were adults with sensorineural hearing loss and audiometric thresholds of ≤ 90 dB hearing level at 500 Hz undergoing CI with Advanced Bionics (Valencia, CA) Ultra 3D devices between 2024 and 2025. ECochG recordings were performed with simultaneous multi‐frequency stimulation of four frequencies between 125 and 4000 Hz during cochlear implant insertion. Concurrent multi‐frequency recording allowed extraction of amplitude and phase of each frequency individually. Post hoc analysis was performed to determine the difference in the number of drop alarms between single‐ and multi‐frequency ECochG. An ECochG amplitude drop of 6 dB was defined as a drop alarm. Insertion track patterns were compared between single‐ and multi‐frequency ECochG.


Results
One hundred ninety‐five ears were included. Mean number of drop alarms for the single‐frequency algorithm was 1.72 (95% CI: 1.52, 1.92; median 1) compared to 0.42 (95% CI: 0.31, 0.53; median 0) for multi‐frequency; p &lt; 0.001. The number of Type C patterns (rise in amplitude during insertion followed by a drop) decreased with the multi‐frequency ECochG algorithm compared to the single‐frequency ECochG algorithm. The number of Type D patterns (no‐response) decreased, indicating that multi‐frequency ECochG generated more responses across the cochlea than single‐frequency ECochG.


Conclusions
A novel multi‐frequency ECochG algorithm during CI is associated with fewer drop alarms and altered insertion track patterns, which may provide a more accurate assessment of the cochlear microenvironment.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/00ea149d-37d7-4d90-a36d-e332f062464b/lary70592-toc-0001-m.png"
     alt="Multi-Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion"/&gt;
&lt;p&gt;A novel multi-frequency electrocochleography (ECochG) algorithm used during cochlear implant electrode insertion is associated with fewer drop alarms and an increase in optimal insertion track patterns. Multi-frequency ECochG may provide a more accurate assessment of the cochlear microenvironment when compared to single-frequency ECochG.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To evaluate intracochlear electrocochleography (ECochG) amplitude parameters during cochlear implantation (CI) using a novel multi-frequency ECochG algorithm.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A multi-institutional, prospective cohort study was performed at 18 high-volume CI centers. The inclusion criteria were adults with sensorineural hearing loss and audiometric thresholds of ≤ 90 dB hearing level at 500 Hz undergoing CI with Advanced Bionics (Valencia, CA) Ultra 3D devices between 2024 and 2025. ECochG recordings were performed with simultaneous multi-frequency stimulation of four frequencies between 125 and 4000 Hz during cochlear implant insertion. Concurrent multi-frequency recording allowed extraction of amplitude and phase of each frequency individually. Post hoc analysis was performed to determine the difference in the number of drop alarms between single- and multi-frequency ECochG. An ECochG amplitude drop of 6 dB was defined as a drop alarm. Insertion track patterns were compared between single- and multi-frequency ECochG.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;One hundred ninety-five ears were included. Mean number of drop alarms for the single-frequency algorithm was 1.72 (95% CI: 1.52, 1.92; median 1) compared to 0.42 (95% CI: 0.31, 0.53; median 0) for multi-frequency; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001. The number of Type C patterns (rise in amplitude during insertion followed by a drop) decreased with the multi-frequency ECochG algorithm compared to the single-frequency ECochG algorithm. The number of Type D patterns (no-response) decreased, indicating that multi-frequency ECochG generated more responses across the cochlea than single-frequency ECochG.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;A novel multi-frequency ECochG algorithm during CI is associated with fewer drop alarms and altered insertion track patterns, which may provide a more accurate assessment of the cochlear microenvironment.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Mana Espahbodi, 
Ali Syed, 
Alex Tu, 
Michael D. Seidman, 
Christopher J. Danner, 
Kyle P. Allen, 
Loren J. Bartels, 
Syed F. Ahsan, 
Courtney C.J. Voelker, 
Nicholas L. Deep, 
Jacob B. Hunter, 
Rebecca C. Chiffer, 
Elias M. Michaelides, 
Mohamed Elrakhawy, 
Matthew W. Miller, 
Harrison W. Lin, 
Hamid R. Djalilian, 
Esther X. Vivas, 
Simon I. Angeli, 
Michael Hoa, 
H. Jeffrey Kim, 
Mark H. Widick, 
Katrina R. Stidham, 
Neil S. Patel, 
Richard K. Gurgel, 
Karl W. Doerfer, 
Kanthaiah Koka, 
Michael S. Harris
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Multi‐Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion</dc:title>
         <dc:identifier>10.1002/lary.70592</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70592</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70592?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70587?af=R</link>
         <pubDate>Thu, 30 Apr 2026 23:05:08 -0700</pubDate>
         <dc:date>2026-04-30T11:05:08-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70587</guid>
         <title>Insomnia as a Clinical Predictor of Hypoglossal Nerve Stimulation Settings and Treatment Success</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
In 80 adult obstructive sleep apnea (OSA) patients who received hypoglossal nerve stimulation (HNS) surgery, 35.5% (n = 30) had comorbid insomnia with OSA (COMISA). COMISA patients had lower mean HNS stimulation level changes from baseline (0.8 V (COMISA) vs. 1.01 V, p &lt; 0.05) compared to non‐COMISA patients. Further, fewer COMISA patients met Sher15 criteria (33.3% (n = 10) (COMISA) vs. 62.0% (n = 31), p = 0.02).

ABSTRACT

Objectives
To examine the impact of comorbid insomnia and obstructive sleep apnea (COMISA) on hypoglossal nerve stimulation (HNS) stimulation levels and rates of therapeutic success.


Methods
A retrospective chart review included adult OSA patients who received HNS surgery. Demographic information, baseline Insomnia Severity Index (ISI), pre and post implant sleep studies, and HNS stimulation data were collected. HNS therapy success was evaluated as ≥ 50% AHI reduction and AHI ≤ 15 (Sher15 criteria) and based on HNS treatment pathways using AHI symptoms and adherence.


Results
The cohort included 80 OSA patients treated with HNS therapy including 35.5% (n = 30) with pre‐surgery COMISA based on ISI score ≥ 15. COMISA patients had lower therapeutic HNS stimulation levels (1.5 V (COMISA) vs. 1.9 V, p &lt; 0.01) and lower mean HNS stimulation level change from baseline (0.8 V (COMISA) vs. 1.01 V, p &lt; 0.05) compared to non‐COMISA patients. Fewer COMISA patients met Sher15 criteria (33.3% (n = 10) (COMISA) vs. 62.0% (n = 31), p = 0.02). When classifying COMISA and non‐COMISA patients by post‐operative HNS pathways, 60.0% (n = 18) of COMISA patients were within the Yellow Pathway Type 2 (adequate adherence, Sher15 nonresponse) compared to 32.0% (n = 16) of non‐COMISA (p = 0.02), with no significant differences in rates within the other pathways.


Conclusion
COMISA patients have lower therapeutic HNS stimulation levels, fewer stimulation level changes, and reduced rates of achieving Sher15 success criteria compared to those without COMISA. Managing expectations during stimulation uptitration and balancing implant stimulation tolerance and effectivness are required to optimize HNS outcomes.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/6ff088f1-694c-4b6c-a7fe-d74502e4658a/lary70587-toc-0001-m.png"
     alt="Insomnia as a Clinical Predictor of Hypoglossal Nerve Stimulation Settings and Treatment Success"/&gt;
&lt;p&gt;In 80 adult obstructive sleep apnea (OSA) patients who received hypoglossal nerve stimulation (HNS) surgery, 35.5% (&lt;i&gt;n&lt;/i&gt; = 30) had comorbid insomnia with OSA (COMISA). COMISA patients had lower mean HNS stimulation level changes from baseline (0.8 V (COMISA) vs. 1.01 V, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05) compared to non-COMISA patients. Further, fewer COMISA patients met Sher15 criteria (33.3% (&lt;i&gt;n&lt;/i&gt; = 10) (COMISA) vs. 62.0% (&lt;i&gt;n&lt;/i&gt; = 31), &lt;i&gt;p&lt;/i&gt; = 0.02).&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To examine the impact of comorbid insomnia and obstructive sleep apnea (COMISA) on hypoglossal nerve stimulation (HNS) stimulation levels and rates of therapeutic success.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective chart review included adult OSA patients who received HNS surgery. Demographic information, baseline Insomnia Severity Index (ISI), pre and post implant sleep studies, and HNS stimulation data were collected. HNS therapy success was evaluated as ≥ 50% AHI reduction and AHI &lt;i&gt;≤&lt;/i&gt; 15 (Sher15 criteria) and based on HNS treatment pathways using AHI symptoms and adherence.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The cohort included 80 OSA patients treated with HNS therapy including 35.5% (&lt;i&gt;n&lt;/i&gt; = 30) with pre-surgery COMISA based on ISI score ≥ 15. COMISA patients had lower therapeutic HNS stimulation levels (1.5 V (COMISA) vs. 1.9 V, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and lower mean HNS stimulation level change from baseline (0.8 V (COMISA) vs. 1.01 V, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05) compared to non-COMISA patients. Fewer COMISA patients met Sher15 criteria (33.3% (&lt;i&gt;n&lt;/i&gt; = 10) (COMISA) vs. 62.0% (&lt;i&gt;n&lt;/i&gt; = 31), &lt;i&gt;p&lt;/i&gt; = 0.02). When classifying COMISA and non-COMISA patients by post-operative HNS pathways, 60.0% (&lt;i&gt;n&lt;/i&gt; = 18) of COMISA patients were within the Yellow Pathway Type 2 (adequate adherence, Sher15 nonresponse) compared to 32.0% (&lt;i&gt;n&lt;/i&gt; = 16) of non-COMISA (&lt;i&gt;p&lt;/i&gt; = 0.02), with no significant differences in rates within the other pathways.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;COMISA patients have lower therapeutic HNS stimulation levels, fewer stimulation level changes, and reduced rates of achieving Sher15 success criteria compared to those without COMISA. Managing expectations during stimulation uptitration and balancing implant stimulation tolerance and effectivness are required to optimize HNS outcomes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Pearl Doan, 
Megan L. Durr, 
Jolie L. Chang
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Insomnia as a Clinical Predictor of Hypoglossal Nerve Stimulation Settings and Treatment Success</dc:title>
         <dc:identifier>10.1002/lary.70587</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70587</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70587?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70600?af=R</link>
         <pubDate>Thu, 30 Apr 2026 20:44:30 -0700</pubDate>
         <dc:date>2026-04-30T08:44:30-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70600</guid>
         <title>Effect of Preoperative Systemic Steroids on Tissue Eosinophils in CRSwNP: Meta‐Analysis</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This meta‐analysis shows that preoperative systemic corticosteroids significantly reduced tissue eosinophil counts by 36.57 cells/HPF in patients with CRSwNP. These findings suggest that intraoperative biopsy after systemic steroid exposure may underestimate tissue eosinophilia and potentially affect histologic endotyping.

ABSTRACT

Objective
Preoperative systemic corticosteroids are frequently used in chronic rhinosinusitis with nasal polyps (CRSwNP). This meta‐analysis aimed to evaluate the effect of preoperative systemic steroids on tissue eosinophil count (TEC) in CRSwNP.


Data Sources
PubMed, EMBASE, and Cochrane Library.


Review Methods
Systematic searches were conducted through March 2026 for studies assessing TEC following preoperative systemic steroids in adult CRSwNP patients. Eligible designs included randomized controlled trials, cohort studies, and pre‐post studies. TEC was reported as cells per high‐power field (TEC/HPF) or as a percentage of eosinophils among inflammatory cells (%TEC). Pooled mean differences (MD) were calculated using random‐effects models.


Results
Seventeen studies (930 participants) were included, of which 13 were eligible for quantitative synthesis. Systemic steroids significantly reduced TEC/HPF (MD −36.57; 95% CI: −43.94 to −29.20) and %TEC (MD −18.14; 95% CI: −24.88 to −11.39). Reductions were consistent across steroid dose, duration, and concomitant intranasal steroid use. However, low dose (4.2–18.6 mg/day) given in ≤ 7‐day regimens showed a non‐significant reduction (MD −17.78; 95% CI: −62.62 to 27.05). Adverse events were not statistically different between the steroid and control groups (5.60% vs. 1.12%, odds ratio = 5.22, p = 0.12). No adverse events were reported in studies using low‐dose or tapering regimens.


Conclusion
Preoperative systemic corticosteroids significantly reduce TEC in CRSwNP, regardless of the quantifying method. This effect may interfere with histologic assessment when biopsy is taken intraoperatively. To avoid misinterpretation, clinicians may consider either withholding preoperative systemic corticosteroids, using a less suppressive regimen, or obtaining a biopsy prior to steroid initiation.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/03090476-e9d7-4302-b385-f49379a37832/lary70600-toc-0001-m.png"
     alt="Effect of Preoperative Systemic Steroids on Tissue Eosinophils in CRSwNP: Meta-Analysis"/&gt;
&lt;p&gt;This meta-analysis shows that preoperative systemic corticosteroids significantly reduced tissue eosinophil counts by 36.57 cells/HPF in patients with CRSwNP. These findings suggest that intraoperative biopsy after systemic steroid exposure may underestimate tissue eosinophilia and potentially affect histologic endotyping.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Preoperative systemic corticosteroids are frequently used in chronic rhinosinusitis with nasal polyps (CRSwNP). This meta-analysis aimed to evaluate the effect of preoperative systemic steroids on tissue eosinophil count (TEC) in CRSwNP.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;PubMed, EMBASE, and Cochrane Library.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;Systematic searches were conducted through March 2026 for studies assessing TEC following preoperative systemic steroids in adult CRSwNP patients. Eligible designs included randomized controlled trials, cohort studies, and pre-post studies. TEC was reported as cells per high-power field (TEC/HPF) or as a percentage of eosinophils among inflammatory cells (%TEC). Pooled mean differences (MD) were calculated using random-effects models.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Seventeen studies (930 participants) were included, of which 13 were eligible for quantitative synthesis. Systemic steroids significantly reduced TEC/HPF (MD −36.57; 95% CI: −43.94 to −29.20) and %TEC (MD −18.14; 95% CI: −24.88 to −11.39). Reductions were consistent across steroid dose, duration, and concomitant intranasal steroid use. However, low dose (4.2–18.6 mg/day) given in ≤ 7-day regimens showed a non-significant reduction (MD −17.78; 95% CI: −62.62 to 27.05). Adverse events were not statistically different between the steroid and control groups (5.60% vs. 1.12%, odds ratio = 5.22, &lt;i&gt;p&lt;/i&gt; = 0.12). No adverse events were reported in studies using low-dose or tapering regimens.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Preoperative systemic corticosteroids significantly reduce TEC in CRSwNP, regardless of the quantifying method. This effect may interfere with histologic assessment when biopsy is taken intraoperatively. To avoid misinterpretation, clinicians may consider either withholding preoperative systemic corticosteroids, using a less suppressive regimen, or obtaining a biopsy prior to steroid initiation.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Wirach Chitsuthipakorn, 
Vorachai Pooldum, 
Minh P. Hoang, 
Dichapong Kanjanawasee, 
Kachorn Seresirikachorn, 
Kornkiat Snidvongs
</dc:creator>
         <category>SYSTEMATIC REVIEW</category>
         <dc:title>Effect of Preoperative Systemic Steroids on Tissue Eosinophils in CRSwNP: Meta‐Analysis</dc:title>
         <dc:identifier>10.1002/lary.70600</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70600</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70600?af=R</prism:url>
         <prism:section>SYSTEMATIC REVIEW</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70590?af=R</link>
         <pubDate>Thu, 30 Apr 2026 03:58:18 -0700</pubDate>
         <dc:date>2026-04-30T03:58:18-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70590</guid>
         <title>Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
COVID‐19 is associated with an increased incidence of new‐onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ventilation, and vaccination status. These findings highlight the need for long‐term surveillance and evaluation of laryngeal symptoms in patients with prior COVID‐19 infection.

ABSTRACT

Objective(s)
Long COVID affects multiple organ systems, yet the incidence and risk factors for post–COVID‐19 laryngeal dysfunction remain underexplored. This study evaluated the incidence of laryngeal dysfunction following COVID‐19.


Methods
A retrospective cohort study was performed using the TriNetX Global Collaborative EHR Network (&gt; 180 million records). Adults without prior laryngeal dysfunction or major comorbidities were stratified by COVID‐19 exposure and compared with uninfected controls. Outcomes included chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, assessed up to 5 years post‐infection. After propensity score matching, odds ratios (OR) and risk differences (RD) with 95% confidence intervals (CI) were calculated.


Results
COVID‐19 was associated with significantly increased odds of chronic cough (peak OR 7.12; RD 0.33%, p &lt; 0.0001), dysphagia (peak OR 2.71; RD 0.36%, p &lt; 0.0001), voice disorders (peak OR 3.25; RD 0.12%, p &lt; 0.0001), vocal fold paralysis (peak OR 2.17; RD 0.01%, p &lt; 0.0001), and laryngeal spasm (peak OR 2.79; RD 0.003%, p &lt; 0.0001). Incidence peaked at 1–2 years for most outcomes and at 2–3 years for laryngeal spasm. Hospitalization and mechanical ventilation were associated with increased rates of dysphagia (HR 2.63; HR 5.26), voice disorders (HR 1.15; HR 4.45), and vocal cord paralysis (HR 2.09; HR 9.35), but reduced rates of chronic cough (HR 0.68; HR 0.45). Vaccinated patients showed higher rates of chronic cough (HR 1.36) and voice disorders (HR 1.22).


Conclusion
COVID‐19 is associated with increased incidence of new‐onset laryngeal dysfunction, most commonly peaking 1–2 years after infection and influenced by hospitalization, mechanical ventilation, and vaccination status.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/597d1a98-1fd4-4ae6-8d2e-347e6c40d60c/lary70590-toc-0001-m.png"
     alt="Laryngeal Dysfunction Following COVID-19: A TriNetX Retrospective Cohort Study"/&gt;
&lt;p&gt;COVID-19 is associated with an increased incidence of new-onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ventilation, and vaccination status. These findings highlight the need for long-term surveillance and evaluation of laryngeal symptoms in patients with prior COVID-19 infection.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective(s)&lt;/h2&gt;
&lt;p&gt;Long COVID affects multiple organ systems, yet the incidence and risk factors for post–COVID-19 laryngeal dysfunction remain underexplored. This study evaluated the incidence of laryngeal dysfunction following COVID-19.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective cohort study was performed using the TriNetX Global Collaborative EHR Network (&amp;gt; 180 million records). Adults without prior laryngeal dysfunction or major comorbidities were stratified by COVID-19 exposure and compared with uninfected controls. Outcomes included chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, assessed up to 5 years post-infection. After propensity score matching, odds ratios (OR) and risk differences (RD) with 95% confidence intervals (CI) were calculated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;COVID-19 was associated with significantly increased odds of chronic cough (peak OR 7.12; RD 0.33%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001), dysphagia (peak OR 2.71; RD 0.36%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001), voice disorders (peak OR 3.25; RD 0.12%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001), vocal fold paralysis (peak OR 2.17; RD 0.01%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001), and laryngeal spasm (peak OR 2.79; RD 0.003%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). Incidence peaked at 1–2 years for most outcomes and at 2–3 years for laryngeal spasm. Hospitalization and mechanical ventilation were associated with increased rates of dysphagia (HR 2.63; HR 5.26), voice disorders (HR 1.15; HR 4.45), and vocal cord paralysis (HR 2.09; HR 9.35), but reduced rates of chronic cough (HR 0.68; HR 0.45). Vaccinated patients showed higher rates of chronic cough (HR 1.36) and voice disorders (HR 1.22).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;COVID-19 is associated with increased incidence of new-onset laryngeal dysfunction, most commonly peaking 1–2 years after infection and influenced by hospitalization, mechanical ventilation, and vaccination status.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Cali Loblundo, 
Warren B. Chun, 
Shaun A. Nguyen, 
Kirsten Meenan, 
Ashli K. O'Rourke
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study</dc:title>
         <dc:identifier>10.1002/lary.70590</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70590</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70590?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70597?af=R</link>
         <pubDate>Thu, 30 Apr 2026 00:00:00 -0700</pubDate>
         <dc:date>2026-04-30T12:00:00-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70597</guid>
         <title>Primary Language Spoken at Home and Speech Outcomes Among Children With Cleft Palate</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objectives
Following cleft palate repair, early detection of maladaptive compensatory mechanisms and hypernasality may determine the need for additional intervention. Our goal is to understand if primary language influences rates of subsequent intervention among children with cleft palate in the United States.


Methods
Within a single urban cleft team, patients with a history of palate repair evaluated at least 2 years postoperatively were analyzed using Fisher's exact test.


Results
There were 124 patients representing 6 languages: 101 English, 9 Spanish, and 14 other (Vietnamese, Haitian Creole, Portuguese, and Tamil). Some patients were repaired elsewhere and presented to our clinic secondarily for evaluation. Among English and non‐English speaking children, similar rates of symptomatic and asymptomatic postoperative fistula (17.8% vs. 17.4%, p = 1.00), hypernasality and/or audible nasal emissions (ANEs) (44.6% vs. 30.4%, p = 0.25), persistent hypernasality/ANE after speech therapy (ST) (22.8% vs. 13.0%, p = 0.40), and revision surgery (33.7% vs. 17.4%, p = 0.14) were observed. However, higher rates of hypernasality/ANE (45.5% vs. 14.3%, p = 0.04), persistent hypernasality/ANE after ST (23.6% vs. 0.0%, p = 0.04), and revision surgery (33.6% vs. 7.1%, p = 0.06) were noted among English and Spanish speakers. [Correction added on 08 May 2026, after first online publication: The preceding sentence has been revised in this version.]


Conclusion
Within a single urban practice in the United States, lower rates of hypernasality and revision surgery were observed among non‐English and non‐Spanish speaking patients. Such findings may suggest disparities in resources available for detecting speech abnormalities in this population.


Level of Evidence
3.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Following cleft palate repair, early detection of maladaptive compensatory mechanisms and hypernasality may determine the need for additional intervention. Our goal is to understand if primary language influences rates of subsequent intervention among children with cleft palate in the United States.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Within a single urban cleft team, patients with a history of palate repair evaluated at least 2 years postoperatively were analyzed using Fisher's exact test.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;There were 124 patients representing 6 languages: 101 English, 9 Spanish, and 14 other (Vietnamese, Haitian Creole, Portuguese, and Tamil). Some patients were repaired elsewhere and presented to our clinic secondarily for evaluation. Among English and non-English speaking children, similar rates of symptomatic and asymptomatic postoperative fistula (17.8% vs. 17.4%, &lt;i&gt;p&lt;/i&gt; = 1.00), hypernasality and/or audible nasal emissions (ANEs) (44.6% vs. 30.4%, &lt;i&gt;p&lt;/i&gt; = 0.25), persistent hypernasality/ANE after speech therapy (ST) (22.8% vs. 13.0%, &lt;i&gt;p&lt;/i&gt; = 0.40), and revision surgery (33.7% vs. 17.4%, &lt;i&gt;p&lt;/i&gt; = 0.14) were observed. However, higher rates of hypernasality/ANE (45.5% vs. 14.3%, &lt;i&gt;p&lt;/i&gt; = 0.04), persistent hypernasality/ANE after ST (23.6% vs. 0.0%, &lt;i&gt;p&lt;/i&gt; = 0.04), and revision surgery (33.6% vs. 7.1%, &lt;i&gt;p&lt;/i&gt; = 0.06) were noted among English and Spanish speakers. [Correction added on 08 May 2026, after first online publication: The preceding sentence has been revised in this version.]&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Within a single urban practice in the United States, lower rates of hypernasality and revision surgery were observed among non-English and non-Spanish speaking patients. Such findings may suggest disparities in resources available for detecting speech abnormalities in this population.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Amanda E. Du, 
Olivia Lopes, 
Nicole Mastacouris, 
Craig W. Hanna, 
Andrew R. Scott
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Primary Language Spoken at Home and Speech Outcomes Among Children With Cleft Palate</dc:title>
         <dc:identifier>10.1002/lary.70597</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70597</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70597?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70596?af=R</link>
         <pubDate>Wed, 29 Apr 2026 04:48:43 -0700</pubDate>
         <dc:date>2026-04-29T04:48:43-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70596</guid>
         <title>Ménière's Disease: A Tri‐Decade Scoping Review of Treatment Trends and Evidence Quality</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This tri‐decade scoping review of Ménière's disease literature reveals a significant increase in high‐level evidence and a clinical pivot toward hearing‐preserving interventions, such as intratympanic steroids and cochlear implants. However, a significant quality paradox has emerged, where adherence to standardized AAO‐HNS reporting and diagnostic criteria has declined to 34% and 73%, respectively. The findings emphasize that enforcing standardized reporting is essential to safeguard the integrity of clinical advancements in the field.

ABSTRACT

Introduction
Ménière's disease (MD) is a complex inner ear disorder defined by endolymphatic hydrops and a triad of episodic vertigo, fluctuating hearing loss, and tinnitus. Despite AAO‐HNS diagnostic guidelines, disease heterogeneity and lack of treatment consensus persist.


Objective
This study conducts a tri‐decade scoping review (1994–2024) to evaluate the MD evidence base, shifts in management, and methodological rigor regarding AAO‐HNS and CONSORT compliance.


Materials and Methods
A systematic search of PubMed, CINAHL, and Cochrane (2014–2024) identified English‐language RCTs and prospective cohorts involving adults. Studies were graded via the Oxford CEBM system, with guideline compliance analyzed using IBM SPSS v29.0. A scoping review framework was adopted to map the “Quality Paradox” between evidence hierarchy and reporting standards.


Results
From 1344 publications, 257 studies met inclusion criteria. While research volume surged—with Level 2 studies quadrupling (p &lt; 0.01) and Level 3 studies tripling (p &lt; 0.05)—reporting standards significantly declined. Adherence to AAO‐HNS diagnostic and treatment‐outcome criteria dropped to 73% and 34%, respectively. Clinically, management shifted toward preservation‐focused interventions, including hydrops‐visualizing MRI, intratympanic steroids over gentamicin, and increased cochlear implantation, alongside a decline in positive‐pressure device use.


Conclusion
The MD evidence base increasingly favors non‐ablative, patient‐centered interventions. However, the validity of these advancements is threatened by a significant decline in reporting compliance. To safeguard the evidence base, journals must enforce standardized reporting as a nonnegotiable prerequisite for publication.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7437cd60-321e-494a-9559-70f4adb0097a/lary70596-toc-0001-m.png"
     alt="Ménière's Disease: A Tri-Decade Scoping Review of Treatment Trends and Evidence Quality"/&gt;
&lt;p&gt;This tri-decade scoping review of Ménière's disease literature reveals a significant increase in high-level evidence and a clinical pivot toward hearing-preserving interventions, such as intratympanic steroids and cochlear implants. However, a significant quality paradox has emerged, where adherence to standardized AAO-HNS reporting and diagnostic criteria has declined to 34% and 73%, respectively. The findings emphasize that enforcing standardized reporting is essential to safeguard the integrity of clinical advancements in the field.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Introduction&lt;/h2&gt;
&lt;p&gt;Ménière's disease (MD) is a complex inner ear disorder defined by endolymphatic hydrops and a triad of episodic vertigo, fluctuating hearing loss, and tinnitus. Despite AAO-HNS diagnostic guidelines, disease heterogeneity and lack of treatment consensus persist.&lt;/p&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;This study conducts a tri-decade scoping review (1994–2024) to evaluate the MD evidence base, shifts in management, and methodological rigor regarding AAO-HNS and CONSORT compliance.&lt;/p&gt;
&lt;h2&gt;Materials and Methods&lt;/h2&gt;
&lt;p&gt;A systematic search of PubMed, CINAHL, and Cochrane (2014–2024) identified English-language RCTs and prospective cohorts involving adults. Studies were graded via the Oxford CEBM system, with guideline compliance analyzed using IBM SPSS v29.0. A scoping review framework was adopted to map the “Quality Paradox” between evidence hierarchy and reporting standards.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;From 1344 publications, 257 studies met inclusion criteria. While research volume surged—with Level 2 studies quadrupling (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01) and Level 3 studies tripling (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05)—reporting standards significantly declined. Adherence to AAO-HNS diagnostic and treatment-outcome criteria dropped to 73% and 34%, respectively. Clinically, management shifted toward preservation-focused interventions, including hydrops-visualizing MRI, intratympanic steroids over gentamicin, and increased cochlear implantation, alongside a decline in positive-pressure device use.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The MD evidence base increasingly favors non-ablative, patient-centered interventions. However, the validity of these advancements is threatened by a significant decline in reporting compliance. To safeguard the evidence base, journals must enforce standardized reporting as a nonnegotiable prerequisite for publication.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Ofir Zavdy, 
Teeraya Piyajarawong, 
Seamus Boyle, 
Ross O'Shea, 
John Rutka
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Ménière's Disease: A Tri‐Decade Scoping Review of Treatment Trends and Evidence Quality</dc:title>
         <dc:identifier>10.1002/lary.70596</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70596</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70596?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70593?af=R</link>
         <pubDate>Wed, 29 Apr 2026 04:30:35 -0700</pubDate>
         <dc:date>2026-04-29T04:30:35-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70593</guid>
         <title>Long‐Term Outcomes of Patients Undergoing Cricothyrotomy at a Tertiary Care Level One Trauma Center</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This retrospective study of 48 patients undergoing emergent cricothyrotomy (2014–2025) evaluated short‐ and long‐term outcomes and complications. Common complications included dysphagia, pneumonia, and dysphonia, with delayed conversion to tracheostomy associated with increased pneumonia risk; long‐term issues included persistent dysphagia, subglottic stenosis, and vocal fold injury. Cricothyrotomy is a critical life‐saving procedure but carries substantial morbidity, underscoring the importance of timely tracheostomy conversion and careful postoperative management.

ABSTRACT

Objective(s)
To identify short‐term and long‐term outcomes and complications for patients who underwent cricothyrotomy.


Methods
A retrospective review was conducted for all patients who underwent cricothyrotomy between 2014 and 2025. Data included demographics, procedural details such as time to tracheostomy conversion and success rates, hospital course, short‐term complications (e.g., dysphagia, pneumonia, vocal cord paralysis), and long‐term complications (e.g., subglottic stenosis, vocal fold injury).


Results
Forty‐eight patients underwent emergent cricothyrotomy. 72.9% were male and the mean age was 57.7 years. Common short‐term complications included dysphagia (35.4%), pneumonia (31.3%), and dysphonia (27.1%). Planned conversion to tracheostomy occurred in 83.3% of patients, on average 2.3 days post‐cricothyrotomy. Time to tracheostomy was significantly longer in patients who developed pneumonia (3.9 vs. 1.4 days, p = 0.005). In‐hospital mortality was 20.8% and 90‐day mortality was 29.2%. The mean post‐cricothyrotomy hospital length of stay was 19.4 days. Long‐term complications included persistent dysphagia (18.8%), subglottic stenosis (12.5%), and vocal fold injury (10.4%). Thirty‐day return to the ED visits occurred in 20.8% of patients, with both airway and comorbidity‐related presentations. Twenty patients (41.7%) ultimately had their tracheostomy tube removed with a mean time to decannulation of 83.7 days.


Conclusion
Cricothyrotomy remains a vital, life‐saving intervention in the difficult airway algorithm but carries a risk of significant post‐procedural complications, including dysphagia, pneumonia, dysphonia, subglottic stenosis, and vocal fold injury. These findings highlight the importance of meticulous postoperative care, particularly respiratory management, to reduce delays in conversion to tracheostomy and optimize long‐term outcomes.


Level of Evidence
4.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/15a086b1-c74f-47a4-b369-5806ed877860/lary70593-toc-0001-m.png"
     alt="Long-Term Outcomes of Patients Undergoing Cricothyrotomy at a Tertiary Care Level One Trauma Center"/&gt;
&lt;p&gt;This retrospective study of 48 patients undergoing emergent cricothyrotomy (2014–2025) evaluated short- and long-term outcomes and complications. Common complications included dysphagia, pneumonia, and dysphonia, with delayed conversion to tracheostomy associated with increased pneumonia risk; long-term issues included persistent dysphagia, subglottic stenosis, and vocal fold injury. Cricothyrotomy is a critical life-saving procedure but carries substantial morbidity, underscoring the importance of timely tracheostomy conversion and careful postoperative management.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective(s)&lt;/h2&gt;
&lt;p&gt;To identify short-term and long-term outcomes and complications for patients who underwent cricothyrotomy.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective review was conducted for all patients who underwent cricothyrotomy between 2014 and 2025. Data included demographics, procedural details such as time to tracheostomy conversion and success rates, hospital course, short-term complications (e.g., dysphagia, pneumonia, vocal cord paralysis), and long-term complications (e.g., subglottic stenosis, vocal fold injury).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Forty-eight patients underwent emergent cricothyrotomy. 72.9% were male and the mean age was 57.7 years. Common short-term complications included dysphagia (35.4%), pneumonia (31.3%), and dysphonia (27.1%). Planned conversion to tracheostomy occurred in 83.3% of patients, on average 2.3 days post-cricothyrotomy. Time to tracheostomy was significantly longer in patients who developed pneumonia (3.9 vs. 1.4 days, &lt;i&gt;p&lt;/i&gt; = 0.005). In-hospital mortality was 20.8% and 90-day mortality was 29.2%. The mean post-cricothyrotomy hospital length of stay was 19.4 days. Long-term complications included persistent dysphagia (18.8%), subglottic stenosis (12.5%), and vocal fold injury (10.4%). Thirty-day return to the ED visits occurred in 20.8% of patients, with both airway and comorbidity-related presentations. Twenty patients (41.7%) ultimately had their tracheostomy tube removed with a mean time to decannulation of 83.7 days.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Cricothyrotomy remains a vital, life-saving intervention in the difficult airway algorithm but carries a risk of significant post-procedural complications, including dysphagia, pneumonia, dysphonia, subglottic stenosis, and vocal fold injury. These findings highlight the importance of meticulous postoperative care, particularly respiratory management, to reduce delays in conversion to tracheostomy and optimize long-term outcomes.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;4.&lt;/p&gt;</content:encoded>
         <dc:creator>
Shivani Raizada, 
Yekaterina Shapiro, 
Reshma Modi, 
Bailey Balouch, 
Kathy Zhang, 
John Chovanes, 
Donald Solomon
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Long‐Term Outcomes of Patients Undergoing Cricothyrotomy at a Tertiary Care Level One Trauma Center</dc:title>
         <dc:identifier>10.1002/lary.70593</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70593</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70593?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70601?af=R</link>
         <pubDate>Wed, 29 Apr 2026 00:00:00 -0700</pubDate>
         <dc:date>2026-04-29T12:00:00-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70601</guid>
         <title>The Statistical Fragility of Saline Nasal Irrigation for Rhinosinusitis: A Systematic Review</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This systematic review evaluated the statistical robustness of randomized controlled trials assessing high‐volume saline nasal irrigation for rhinosinusitis using fragility analysis. Across eight trials and 38 dichotomous outcomes, results demonstrated moderate‐to‐high fragility, with a median fragility index of 5, indicating that small changes in outcomes could reverse statistical significance. These findings suggest that current evidence supporting saline nasal irrigation should be interpreted cautiously, highlighting the need for larger, more rigorous trials with improved methodological design.

ABSTRACT

Objective
To assess the statistical fragility of randomized controlled trials (RCTs) evaluating high‐volume saline nasal irrigation (SNI) for rhinosinusitis using fragility analysis.


Data Sources
PubMed, MEDLINE, and Embase were searched for RCTs published between May 1976 and January 2026.


Review Methods
This study was reported as per PRISMA guidelines. RCTs that compared high‐volume SNI to non‐irrigation standard care for acute, recurrent, or chronic rhinosinusitis, and reported ≥ 1 dichotomous outcome, were included. Fragility index (FI), the minimum number of event reversals needed to alter statistical significance, and fragility quotient (FQ), FI normalized to sample size, were calculated for statistically significant dichotomous outcomes. Reverse FI (rFI) and reverse FQ (rFQ) were calculated for non‐significant outcomes.


Results
Eight RCTs were included, yielding 38 dichotomous outcomes. Eight outcomes (21.1%) were statistically significant. The overall combined median FI was 5 (FQ 0.062), with similar FI values between significant and non‐significant outcomes. In over one‐fifth of outcomes, loss to follow‐up exceeded FI. Analysis of principal dichotomous outcomes from studies demonstrated a median FI of 6 (FQ 0.092), with five of eight (62.5%) outcomes non‐significant.


Conclusion
RCTs evaluating SNI for rhinosinusitis exhibit moderate‐to‐high statistical fragility, with small outcome changes capable of reversing study conclusions. Because fragility analysis was limited to dichotomous outcomes while many primary endpoints were continuous, our findings should be interpreted as complementary rather than comprehensive appraisals of RCTs. Future RCTs with larger sample sizes, reduced bias, and pre‐specified fragility considerations are needed to better define the clinical role of SNI.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/1f5c2fb8-943b-44c4-808d-f8e5acdb28c0/lary70601-toc-0001-m.png"
     alt="The Statistical Fragility of Saline Nasal Irrigation for Rhinosinusitis: A Systematic Review"/&gt;
&lt;p&gt;This systematic review evaluated the statistical robustness of randomized controlled trials assessing high-volume saline nasal irrigation for rhinosinusitis using fragility analysis. Across eight trials and 38 dichotomous outcomes, results demonstrated moderate-to-high fragility, with a median fragility index of 5, indicating that small changes in outcomes could reverse statistical significance. These findings suggest that current evidence supporting saline nasal irrigation should be interpreted cautiously, highlighting the need for larger, more rigorous trials with improved methodological design.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To assess the statistical fragility of randomized controlled trials (RCTs) evaluating high-volume saline nasal irrigation (SNI) for rhinosinusitis using fragility analysis.&lt;/p&gt;
&lt;h2&gt;Data Sources&lt;/h2&gt;
&lt;p&gt;PubMed, MEDLINE, and Embase were searched for RCTs published between May 1976 and January 2026.&lt;/p&gt;
&lt;h2&gt;Review Methods&lt;/h2&gt;
&lt;p&gt;This study was reported as per PRISMA guidelines. RCTs that compared high-volume SNI to non-irrigation standard care for acute, recurrent, or chronic rhinosinusitis, and reported ≥ 1 dichotomous outcome, were included. Fragility index (FI), the minimum number of event reversals needed to alter statistical significance, and fragility quotient (FQ), FI normalized to sample size, were calculated for statistically significant dichotomous outcomes. Reverse FI (rFI) and reverse FQ (rFQ) were calculated for non-significant outcomes.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Eight RCTs were included, yielding 38 dichotomous outcomes. Eight outcomes (21.1%) were statistically significant. The overall combined median FI was 5 (FQ 0.062), with similar FI values between significant and non-significant outcomes. In over one-fifth of outcomes, loss to follow-up exceeded FI. Analysis of principal dichotomous outcomes from studies demonstrated a median FI of 6 (FQ 0.092), with five of eight (62.5%) outcomes non-significant.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;RCTs evaluating SNI for rhinosinusitis exhibit moderate-to-high statistical fragility, with small outcome changes capable of reversing study conclusions. Because fragility analysis was limited to dichotomous outcomes while many primary endpoints were continuous, our findings should be interpreted as complementary rather than comprehensive appraisals of RCTs. Future RCTs with larger sample sizes, reduced bias, and pre-specified fragility considerations are needed to better define the clinical role of SNI.&lt;/p&gt;</content:encoded>
         <dc:creator>
Ronit Sethi, 
Kaan Oral, 
Rahul Guda, 
Shiven Sharma, 
Sujay Ratna, 
Olivia First, 
Shreya Deshmukh, 
Chris Choi, 
Mohemmed N. Khan
</dc:creator>
         <category>SYSTEMATIC REVIEW</category>
         <dc:title>The Statistical Fragility of Saline Nasal Irrigation for Rhinosinusitis: A Systematic Review</dc:title>
         <dc:identifier>10.1002/lary.70601</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70601</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70601?af=R</prism:url>
         <prism:section>SYSTEMATIC REVIEW</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70598?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:45:32 -0700</pubDate>
         <dc:date>2026-04-28T06:45:32-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70598</guid>
         <title>Diagnosis and Treatment of Refractory Chronic Cough: An American Broncho‐Esophagological Association Expert Consensus Statement</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objective
To develop an expert consensus statement (ECS) on the diagnosis and treatment of refractory chronic cough (RCC) in adults. RCC was defined as cough lasting longer than 8 weeks and refractory to standard management of pulmonary, gastrointestinal, sinonasal, and medication‐induced etiologies.


Methods
An expert panel of otolaryngologists used published consensus statement methodology to develop statements guiding the diagnosis and management of RCC from an otolaryngologic perspective. A modified Delphi method was used to iteratively select, eliminate, and refine statements based upon accepted methodology until consensus was achieved.


Results
Three iterative Delphi surveys were performed with discussion rounds between each of the voting sessions. Twenty‐seven statements met consensus while six statements did not. The clinical statements were grouped into 9 categories: operational definition, pathophysiology, assessment of prior work‐up, phenomenology and symptomatology, four treatment categories (neuromodulators, superior laryngeal nerve blocks, behavioral cough suppression, and emerging treatments), and overall treatment approaches.


Conclusion
The panel reached consensus for 27 statements related to the diagnosis and treatment of adults with RCC from an otolaryngologic perspective. These statements may be used to standardize evaluation and improve quality of care, while also identifying areas for future investigation in the management of RCC.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To develop an expert consensus statement (ECS) on the diagnosis and treatment of refractory chronic cough (RCC) in adults. RCC was defined as cough lasting longer than 8 weeks and refractory to standard management of pulmonary, gastrointestinal, sinonasal, and medication-induced etiologies.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;An expert panel of otolaryngologists used published consensus statement methodology to develop statements guiding the diagnosis and management of RCC from an otolaryngologic perspective. A modified Delphi method was used to iteratively select, eliminate, and refine statements based upon accepted methodology until consensus was achieved.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Three iterative Delphi surveys were performed with discussion rounds between each of the voting sessions. Twenty-seven statements met consensus while six statements did not. The clinical statements were grouped into 9 categories: operational definition, pathophysiology, assessment of prior work-up, phenomenology and symptomatology, four treatment categories (neuromodulators, superior laryngeal nerve blocks, behavioral cough suppression, and emerging treatments), and overall treatment approaches.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The panel reached consensus for 27 statements related to the diagnosis and treatment of adults with RCC from an otolaryngologic perspective. These statements may be used to standardize evaluation and improve quality of care, while also identifying areas for future investigation in the management of RCC.&lt;/p&gt;</content:encoded>
         <dc:creator>
Ronit E. Malka, 
Anirudh Saraswathula, 
Gabriela Lilly, 
Marisa A. Ryan, 
Andrew Bowen, 
Kenneth W. Altman, 
Milan Amin, 
Laura Matrka, 
Ashli K. O'Rourke, 
C. Blake Simpson, 
Jonathan Bock, 
Paul C. Bryson, 
Thomas L. Carroll, 
Lee M. Akst
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Diagnosis and Treatment of Refractory Chronic Cough: An American Broncho‐Esophagological Association Expert Consensus Statement</dc:title>
         <dc:identifier>10.1002/lary.70598</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70598</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70598?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70594?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:39:38 -0700</pubDate>
         <dc:date>2026-04-28T06:39:38-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70594</guid>
         <title>Electrode Contacts in the Functional Hearing Region for Pediatric Cochlear Implant Recipients</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study reviewed the incidence of electrode contacts within the functional acoustic hearing region in pediatric cochlear implant recipients. Of 69 ears, 90% had at least one electrode contact in this region. For those with speech recognition data, word recognition in quiet was not significantly associated with proximity within the functional acoustic hearing region. Research is needed to understand the effects of electrode contact placement within this region on speech recognition in noise and the long‐term effects on hearing preservation.

ABSTRACT

Objectives
Examine the incidence of one or more electrode contacts placed within the region of functional acoustic hearing and the potential influence of electrode positioning on speech recognition for pediatric cochlear implant (CI) recipients.


Methods
A retrospective review for pediatric CI recipients of straight electrode arrays with preserved low‐frequency hearing (an unaided threshold of ≤ 80 dB HL at 250 Hz) was conducted at a tertiary referral center. Intraoperative X‐rays were used to determine the angular insertion depth (AID) of each electrode. Proximity of contacts to the functional acoustic hearing region was calculated using AID and postoperative unaided thresholds. For electric‐acoustic stimulation (EAS) users, the association between proximity values and CNC word recognition in quiet was reviewed at 3‐, 6‐, and 12‐months post‐activation.


Results
Among 69 ears, 90% had at least one electrode contact within the functional acoustic hearing region. Proximity values ranged from −131° to 450° (mean: 100°, SD: 120°). For EAS users with speech recognition data (n = 29), proximity values were not significantly associated with post‐activation CNC scores (p ≥ 0.212).


Conclusions
Most pediatric CI recipients with hearing preservation had at least one electrode contact in the region of functional acoustic hearing. Proximity was not significantly associated with word recognition in quiet for EAS users, though this subgroup was limited in sample size. Further studies in pediatric EAS users are needed to understand the potential relationship with speech recognition in noise and to determine the benefits of individualizing array selection and/or EAS mapping.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/e35d1966-529d-407c-a4e9-c5bd22640597/lary70594-toc-0001-m.png"
     alt="Electrode Contacts in the Functional Hearing Region for Pediatric Cochlear Implant Recipients"/&gt;
&lt;p&gt;This study reviewed the incidence of electrode contacts within the functional acoustic hearing region in pediatric cochlear implant recipients. Of 69 ears, 90% had at least one electrode contact in this region. For those with speech recognition data, word recognition in quiet was not significantly associated with proximity within the functional acoustic hearing region. Research is needed to understand the effects of electrode contact placement within this region on speech recognition in noise and the long-term effects on hearing preservation.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Examine the incidence of one or more electrode contacts placed within the region of functional acoustic hearing and the potential influence of electrode positioning on speech recognition for pediatric cochlear implant (CI) recipients.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective review for pediatric CI recipients of straight electrode arrays with preserved low-frequency hearing (an unaided threshold of ≤ 80 dB HL at 250 Hz) was conducted at a tertiary referral center. Intraoperative X-rays were used to determine the angular insertion depth (AID) of each electrode. Proximity of contacts to the functional acoustic hearing region was calculated using AID and postoperative unaided thresholds. For electric-acoustic stimulation (EAS) users, the association between proximity values and CNC word recognition in quiet was reviewed at 3-, 6-, and 12-months post-activation.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 69 ears, 90% had at least one electrode contact within the functional acoustic hearing region. Proximity values ranged from −131° to 450° (mean: 100°, SD: 120°). For EAS users with speech recognition data (&lt;i&gt;n&lt;/i&gt; = 29), proximity values were not significantly associated with post-activation CNC scores (&lt;i&gt;p&lt;/i&gt; ≥ 0.212).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Most pediatric CI recipients with hearing preservation had at least one electrode contact in the region of functional acoustic hearing. Proximity was not significantly associated with word recognition in quiet for EAS users, though this subgroup was limited in sample size. Further studies in pediatric EAS users are needed to understand the potential relationship with speech recognition in noise and to determine the benefits of individualizing array selection and/or EAS mapping.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Elena Quinonez Del Cid, 
Margaret T. Dillon, 
Lisa R. Park, 
Kevin D. Brown, 
Nicholas J. Thompson
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Electrode Contacts in the Functional Hearing Region for Pediatric Cochlear Implant Recipients</dc:title>
         <dc:identifier>10.1002/lary.70594</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70594</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70594?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70595?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:36:05 -0700</pubDate>
         <dc:date>2026-04-28T06:36:05-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70595</guid>
         <title>The Hidden Hazards of Vaping</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
A 31 year old male presented with a penetrating oropharyngeal injury following a motor vehicle collision and was found to have a retained metallic foreign body suspected to be part of a vape pen. The foreign body was abutting the carotid artery and was removed via a combined transoral and transcervical approach. This case highlights a novel mechanism of head and neck trauma and emphasizes the importance of understanding a wide spectrum of unique injuries.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/0d869e57-1dc7-49ec-b167-c2c11ad61445/lary70595-toc-0001-m.png"
     alt="The Hidden Hazards of Vaping"/&gt;
&lt;p&gt;A 31 year old male presented with a penetrating oropharyngeal injury following a motor vehicle collision and was found to have a retained metallic foreign body suspected to be part of a vape pen. The foreign body was abutting the carotid artery and was removed via a combined transoral and transcervical approach. This case highlights a novel mechanism of head and neck trauma and emphasizes the importance of understanding a wide spectrum of unique injuries.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Ayaantuu F. Usman, 
Sobia F. Khaja
</dc:creator>
         <category>CASE REPORT</category>
         <dc:title>The Hidden Hazards of Vaping</dc:title>
         <dc:identifier>10.1002/lary.70595</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70595</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70595?af=R</prism:url>
         <prism:section>CASE REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70566?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:29:23 -0700</pubDate>
         <dc:date>2026-04-28T06:29:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70566</guid>
         <title>Disparities in Hearing Screening Practices in Minnesota Elementary Schools</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
ABSTRACT

Objective
Identifying and addressing pediatric hearing loss is critical to supporting a child's development. School‐based hearing screening is a mainstay of timely identification of hearing loss. The objectives of this study were to characterize the current hearing screening practices in public, charter, and private elementary schools in Minnesota.


Methods
This was a cross‐sectional survey with data collected between March and June 2023. Surveys assessed the presence of standardized hearing screening processes and compliance with American Academy of Audiology (AAA) or Minnesota Department of Health (MDH) guidelines.


Results
About 146 public schools, 43 charter schools, and 60 private schools met inclusion criteria and responded to the survey. There was a statistically significant difference in the rate of standardized screening between school types (χ2 = 18.06; p &lt; 0.001). Only 10.44% (n = 26) of schools completed hearing screenings per AAA guidelines, and even fewer, 4.82% (n = 12), completed hearing screenings according to MDH guidelines. The odds of screening per AAA or MDH guidelines were 3.50 times higher in charter schools compared to public schools (95% CI: 1.14, 10.73) and 4.61 times higher in private schools compared to public schools (95% CI: 1.73, 12.26).


Conclusion
There is a lack of standardization in hearing screening processes in Minnesota elementary schools. Adherence to screening per AAA or MDH recommendations is low in all types of elementary schools. Charter and private schools were more likely than public schools to screen per AAA or MDH guidelines. Overall, our data demonstrate an opportunity for improvement in school‐based hearing screening.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Identifying and addressing pediatric hearing loss is critical to supporting a child's development. School-based hearing screening is a mainstay of timely identification of hearing loss. The objectives of this study were to characterize the current hearing screening practices in public, charter, and private elementary schools in Minnesota.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This was a cross-sectional survey with data collected between March and June 2023. Surveys assessed the presence of standardized hearing screening processes and compliance with American Academy of Audiology (AAA) or Minnesota Department of Health (MDH) guidelines.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;About 146 public schools, 43 charter schools, and 60 private schools met inclusion criteria and responded to the survey. There was a statistically significant difference in the rate of standardized screening between school types (&lt;i&gt;χ&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 18.06; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Only 10.44% (&lt;i&gt;n&lt;/i&gt; = 26) of schools completed hearing screenings per AAA guidelines, and even fewer, 4.82% (&lt;i&gt;n&lt;/i&gt; = 12), completed hearing screenings according to MDH guidelines. The odds of screening per AAA or MDH guidelines were 3.50 times higher in charter schools compared to public schools (95% CI: 1.14, 10.73) and 4.61 times higher in private schools compared to public schools (95% CI: 1.73, 12.26).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;There is a lack of standardization in hearing screening processes in Minnesota elementary schools. Adherence to screening per AAA or MDH recommendations is low in all types of elementary schools. Charter and private schools were more likely than public schools to screen per AAA or MDH guidelines. Overall, our data demonstrate an opportunity for improvement in school-based hearing screening.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Autefeh Sajjadi, 
Elizabeth Kim, 
Kathryn S. Marcus, 
Soorya Todatry, 
Nicholas Hable, 
Brianne Roby, 
Abby C. Meyer, 
Andrew Redmann, 
Hannah Herd, 
Rebecca Maher, 
Siva Chinnadurai, 
Amanda Nickel, 
Asitha Jayawardena
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Disparities in Hearing Screening Practices in Minnesota Elementary Schools</dc:title>
         <dc:identifier>10.1002/lary.70566</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70566</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70566?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70586?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:25:32 -0700</pubDate>
         <dc:date>2026-04-28T06:25:32-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70586</guid>
         <title>The Impact of Etiology on Time to Vocal Fold Motion Recovery in Unilateral Vocal Fold Paralysis</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
The time course of vocal fold motion recovery in UVFP reflects the underlying etiologies. This study showed that there was no difference in the time to recovery between UVFP from cardiothoracic versus thyroid/parathyroid surgeries, challenging the long‐held assumption that recovery time is proportional to the distance between injury site and larynx. The findings support a model in which the severity of neural injury, not the location of injury, is the principal determinant of time to recovery.

ABSTRACT

Objectives
Spontaneous recovery of vocal fold (VF) motion in unilateral vocal fold paralysis (UVFP) has been shown to follow a bimodal time distribution for peripheral, nonidiopathic etiologies, but recovery time dependencies on UVFP etiology are incompletely characterized. This study aimed to (1) determine recovery time differences between surgically induced, idiopathic, and intubation‐related UVFP, and (2) investigate the impact of distance of injury from larynx on recovery time in surgically induced UVFP.


Methods
Retrospective study of 1425 UVFP patients over a 16‐year period identified 736 patients with recovery of VF motion. The time to the first laryngoscopic sign of VF motion recovery in surgically induced, idiopathic, or intubation‐related UVFP was fit to a bimodal or unimodal mathematical model. Time course of VF motion recovery was also compared using Kaplan–Meier estimates.


Results
Surgically induced UVFP demonstrated a bimodal time‐to‐recovery distribution, consistent with a previously described two‐phase model of recovery. Both idiopathic and intubation‐related UVFP followed unimodal recovery patterns. Among surgically induced cases, Kaplan–Meier recovery curves for thyroid/parathyroid and cardiothoracic surgeries were nearly identical despite differing injury locations along the recurrent laryngeal nerve.


Conclusion
Differences in the time course of VF motion recovery in UVFP reflect the underlying etiologies. Among surgically induced UVFP, the recovery time did not correlate with the distance between the injury site and the larynx, challenging a long‐held assumption. The findings support a model in which the severity of neural injury, not the location of injury, is the principal determinant of time to recovery.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/c0db2519-db45-4dc0-85cf-0f6379212fcb/lary70586-toc-0001-m.png"
     alt="The Impact of Etiology on Time to Vocal Fold Motion Recovery in Unilateral Vocal Fold Paralysis"/&gt;
&lt;p&gt;The time course of vocal fold motion recovery in UVFP reflects the underlying etiologies. This study showed that there was no difference in the time to recovery between UVFP from cardiothoracic versus thyroid/parathyroid surgeries, challenging the long-held assumption that recovery time is proportional to the distance between injury site and larynx. The findings support a model in which the severity of neural injury, not the location of injury, is the principal determinant of time to recovery.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Spontaneous recovery of vocal fold (VF) motion in unilateral vocal fold paralysis (UVFP) has been shown to follow a bimodal time distribution for peripheral, nonidiopathic etiologies, but recovery time dependencies on UVFP etiology are incompletely characterized. This study aimed to (1) determine recovery time differences between surgically induced, idiopathic, and intubation-related UVFP, and (2) investigate the impact of distance of injury from larynx on recovery time in surgically induced UVFP.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Retrospective study of 1425 UVFP patients over a 16-year period identified 736 patients with recovery of VF motion. The time to the first laryngoscopic sign of VF motion recovery in surgically induced, idiopathic, or intubation-related UVFP was fit to a bimodal or unimodal mathematical model. Time course of VF motion recovery was also compared using Kaplan–Meier estimates.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Surgically induced UVFP demonstrated a bimodal time-to-recovery distribution, consistent with a previously described two-phase model of recovery. Both idiopathic and intubation-related UVFP followed unimodal recovery patterns. Among surgically induced cases, Kaplan–Meier recovery curves for thyroid/parathyroid and cardiothoracic surgeries were nearly identical despite differing injury locations along the recurrent laryngeal nerve.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Differences in the time course of VF motion recovery in UVFP reflect the underlying etiologies. Among surgically induced UVFP, the recovery time did not correlate with the distance between the injury site and the larynx, challenging a long-held assumption. The findings support a model in which the severity of neural injury, not the location of injury, is the principal determinant of time to recovery.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Rishi Suresh, 
Ted Mau
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>The Impact of Etiology on Time to Vocal Fold Motion Recovery in Unilateral Vocal Fold Paralysis</dc:title>
         <dc:identifier>10.1002/lary.70586</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70586</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70586?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70580?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:20:06 -0700</pubDate>
         <dc:date>2026-04-28T06:20:06-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70580</guid>
         <title>Multi‐Task Assessment of Context‐Specific Gait Changes to Virtual Reality‐Based Visual Perturbations</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We developed an immersive virtual reality (VR)‐based gait assessment platform incorporating a 10‐item multi‐task battery to systematically probe balance under controlled visual perturbations. Compared with unperturbed VR conditions, optic flow and flickering light environments elicited context‐specific alterations in mediolateral stability, temporal consistency, and spatial gait adaptation, revealing changes that may not be captured by conventional overground walking assessments. This multi‐task, perturbation‐based framework may therefore enhance sensitivity to subtle gait instability by exposing context‐dependent limits of balance control.

ABSTRACT

Objective
Conventional gait assessments often fail to detect early, subclinical balance abnormalities that may become apparent under sensory conflict, such as visual perturbations. We investigated whether instrumented gait analysis combined with virtual reality (VR)‐delivered visual perturbations can reveal task‐dependent gait adaptations in healthy adults exposed to discordant sensory information.


Methods
Ten healthy adults completed a purpose‐designed battery of 10 walking tasks spanning steady‐state and balance‐challenging conditions (e.g., tandem gait, obstacle negotiation, Timed Up and Go) on an instrumented walkway under four visual conditions: no virtual reality, unperturbed VR, optic flow‐perturbed VR, and flickering light‐perturbed VR. Spatiotemporal gait parameters were quantified to assess task‐ and condition‐specific changes in dynamic gait control.


Results
Visual perturbations elicited task‐dependent gait adaptations rather than uniform effects across the battery. Compared to unperturbed walking, optic flow was associated with selective increases in stride width during tasks involving rapid reorientation and rotational head movements, including pivot turning (0.10 vs. 0.06, p = 0.045) and horizontal head turns (0.12 vs. 0.08, p = 0.027). Temporal and spatial gait variability increased during tandem gait under optic flow (step time variability: 32.23 vs. 12.75, p = 0.036; stride length variability: 27.96 vs. 8.08, p = 0.041), reflecting impaired cycle‐to‐cycle consistency under heightened precision demands.


Conclusion
VR‐delivered visual perturbations revealed task‐specific alterations in mediolateral stability, temporal consistency, and spatial gait scaling that were absent during unperturbed walking. A multi‐task, perturbation‐based assessment framework may therefore enhance sensitivity to subtle gait instability by exposing context‐dependent limits of balance control.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/af9149d7-8760-4067-bc23-00aa6f0eb62e/lary70580-toc-0001-m.png"
     alt="Multi-Task Assessment of Context-Specific Gait Changes to Virtual Reality-Based Visual Perturbations"/&gt;
&lt;p&gt;We developed an immersive virtual reality (VR)-based gait assessment platform incorporating a 10-item multi-task battery to systematically probe balance under controlled visual perturbations. Compared with unperturbed VR conditions, optic flow and flickering light environments elicited context-specific alterations in mediolateral stability, temporal consistency, and spatial gait adaptation, revealing changes that may not be captured by conventional overground walking assessments. This multi-task, perturbation-based framework may therefore enhance sensitivity to subtle gait instability by exposing context-dependent limits of balance control.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Conventional gait assessments often fail to detect early, subclinical balance abnormalities that may become apparent under sensory conflict, such as visual perturbations. We investigated whether instrumented gait analysis combined with virtual reality (VR)-delivered visual perturbations can reveal task-dependent gait adaptations in healthy adults exposed to discordant sensory information.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Ten healthy adults completed a purpose-designed battery of 10 walking tasks spanning steady-state and balance-challenging conditions (e.g., tandem gait, obstacle negotiation, Timed Up and Go) on an instrumented walkway under four visual conditions: no virtual reality, unperturbed VR, optic flow-perturbed VR, and flickering light-perturbed VR. Spatiotemporal gait parameters were quantified to assess task- and condition-specific changes in dynamic gait control.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Visual perturbations elicited task-dependent gait adaptations rather than uniform effects across the battery. Compared to unperturbed walking, optic flow was associated with selective increases in stride width during tasks involving rapid reorientation and rotational head movements, including pivot turning (0.10 vs. 0.06, &lt;i&gt;p&lt;/i&gt; = 0.045) and horizontal head turns (0.12 vs. 0.08, &lt;i&gt;p&lt;/i&gt; = 0.027). Temporal and spatial gait variability increased during tandem gait under optic flow (step time variability: 32.23 vs. 12.75, &lt;i&gt;p&lt;/i&gt; = 0.036; stride length variability: 27.96 vs. 8.08, &lt;i&gt;p&lt;/i&gt; = 0.041), reflecting impaired cycle-to-cycle consistency under heightened precision demands.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;VR-delivered visual perturbations revealed task-specific alterations in mediolateral stability, temporal consistency, and spatial gait scaling that were absent during unperturbed walking. A multi-task, perturbation-based assessment framework may therefore enhance sensitivity to subtle gait instability by exposing context-dependent limits of balance control.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Catherine Gbekie, 
Siddharth Bhardwaj, 
Hana Ro, 
Anil K. Lalwani, 
Sunil K. Agrawal
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Multi‐Task Assessment of Context‐Specific Gait Changes to Virtual Reality‐Based Visual Perturbations</dc:title>
         <dc:identifier>10.1002/lary.70580</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70580</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70580?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70591?af=R</link>
         <pubDate>Tue, 28 Apr 2026 18:13:06 -0700</pubDate>
         <dc:date>2026-04-28T06:13:06-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70591</guid>
         <title>Should Superior Laryngeal Nerve Block Be Performed for Neurogenic Cough?</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
SLN block may be offered as a treatment for neurogenic cough after guideline‐directed evaluation and treatment for other causes have been attempted. There is an ~80% success rate which may require multiple injections. Risks appear limited; however, long‐term benefit is not yet determined.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/72d7f394-232d-4750-abca-48f244f1e6f0/lary70591-toc-0001-m.png"
     alt="Should Superior Laryngeal Nerve Block Be Performed for Neurogenic Cough?"/&gt;
&lt;p&gt;SLN block may be offered as a treatment for neurogenic cough after guideline-directed evaluation and treatment for other causes have been attempted. There is an ~80% success rate which may require multiple injections. Risks appear limited; however, long-term benefit is not yet determined.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Lauren F. Tracy, 
J. Pieter Noordzij
</dc:creator>
         <category>TRIOLOGICAL SOCIETY BEST PRACTICE</category>
         <dc:title>Should Superior Laryngeal Nerve Block Be Performed for Neurogenic Cough?</dc:title>
         <dc:identifier>10.1002/lary.70591</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70591</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70591?af=R</prism:url>
         <prism:section>TRIOLOGICAL SOCIETY BEST PRACTICE</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70588?af=R</link>
         <pubDate>Mon, 27 Apr 2026 20:45:23 -0700</pubDate>
         <dc:date>2026-04-27T08:45:23-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70588</guid>
         <title>National Trends and Risk Factors for Dysphagia After Anterior Cervical Discectomy and Fusion</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
From 2016 to 2023, inpatient anterior cervical discectomy and fusion (ACDF) volume declined 52.2% while postoperative dysphagia rates increased 11.4% annually. Analysis of 496,425 cases demonstrated that dysphagia risk varied markedly by surgical indication, with cervical diffuse idiopathic skeletal hyperostosis, cervical spine fracture, and pseudoarthrosis emerging as the strongest independent predictors, alongside multilevel surgery and greater comorbidity burden. These findings informed the development of a predictive nomogram and underscore the need for individualized perioperative risk stratification in ACDF candidates.

ABSTRACT

Background
Dysphagia remains one of the most common complications following anterior cervical discectomy and fusion (ACDF), yet recent national trends and risk factors across surgical indications have not been fully characterized.


Objective
To evaluate national trends in ACDF and dysphagia rates and to identify patient, surgical, and indication‐specific risk factors for postoperative dysphagia.


Methods
A retrospective analysis of the Nationwide Inpatient Sample identified adult patients undergoing elective ACDF from 2016 to 2022. Multivariable logistic regression was used to determine independent risk factors for dysphagia and develop a predictive nomogram. Separate models were also constructed for single‐ and multilevel ACDF.


Results
Among 496,425 hospitalizations, dysphagia occurred in 7.7% of patients. Despite a 57.3% decline in ACDF, the odds of dysphagia increased at an estimated 11.4% annually (OR: 1.11, 95% CI: 1.09–1.13; p &lt; 0.001). Cervical diffuse idiopathic skeletal hyperostosis (OR: 5.41; 95% CI: 3.81–7.67), cervical spine fracture (OR: 1.73; 95% CI: 1.31–2.30), and pseudoarthrosis (OR: 1.36; 95% CI: 1.15–1.61) were strong independent predictors of dysphagia. Additional risk factors included racial minority status, higher comorbidity burden, and care at urban teaching hospitals. Risk factors differed between single‐ and multilevel ACDF. Dysphagia was associated with higher rates of complications, including aspiration pneumonia, percutaneous endoscopic gastrostomy placement, and tracheostomy (all p &lt; 0.001).


Conclusions
These findings represent the first national analysis to demonstrate a decline in inpatient ACDF volumes yet rising postoperative dysphagia rates. Selective surgical indications emerged as key predictors, informing the development of a nomogram for risk stratification and preoperative optimization in ACDF patients.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/65a815b8-8b1e-4d61-b64d-b16fdb7dd5d2/lary70588-toc-0001-m.png"
     alt="National Trends and Risk Factors for Dysphagia After Anterior Cervical Discectomy and Fusion"/&gt;
&lt;p&gt;From 2016 to 2023, inpatient anterior cervical discectomy and fusion (ACDF) volume declined 52.2% while postoperative dysphagia rates increased 11.4% annually. Analysis of 496,425 cases demonstrated that dysphagia risk varied markedly by surgical indication, with cervical diffuse idiopathic skeletal hyperostosis, cervical spine fracture, and pseudoarthrosis emerging as the strongest independent predictors, alongside multilevel surgery and greater comorbidity burden. These findings informed the development of a predictive nomogram and underscore the need for individualized perioperative risk stratification in ACDF candidates.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Background&lt;/h2&gt;
&lt;p&gt;Dysphagia remains one of the most common complications following anterior cervical discectomy and fusion (ACDF), yet recent national trends and risk factors across surgical indications have not been fully characterized.&lt;/p&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To evaluate national trends in ACDF and dysphagia rates and to identify patient, surgical, and indication-specific risk factors for postoperative dysphagia.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective analysis of the Nationwide Inpatient Sample identified adult patients undergoing elective ACDF from 2016 to 2022. Multivariable logistic regression was used to determine independent risk factors for dysphagia and develop a predictive nomogram. Separate models were also constructed for single- and multilevel ACDF.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 496,425 hospitalizations, dysphagia occurred in 7.7% of patients. Despite a 57.3% decline in ACDF, the odds of dysphagia increased at an estimated 11.4% annually (OR: 1.11, 95% CI: 1.09–1.13; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Cervical diffuse idiopathic skeletal hyperostosis (OR: 5.41; 95% CI: 3.81–7.67), cervical spine fracture (OR: 1.73; 95% CI: 1.31–2.30), and pseudoarthrosis (OR: 1.36; 95% CI: 1.15–1.61) were strong independent predictors of dysphagia. Additional risk factors included racial minority status, higher comorbidity burden, and care at urban teaching hospitals. Risk factors differed between single- and multilevel ACDF. Dysphagia was associated with higher rates of complications, including aspiration pneumonia, percutaneous endoscopic gastrostomy placement, and tracheostomy (all &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;These findings represent the first national analysis to demonstrate a decline in inpatient ACDF volumes yet rising postoperative dysphagia rates. Selective surgical indications emerged as key predictors, informing the development of a nomogram for risk stratification and preoperative optimization in ACDF patients.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Caryn J. Ha, 
Sraavya G. Anne, 
Sara Morgan, 
Fadar Oliver Otite, 
Kenneth Yan
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>National Trends and Risk Factors for Dysphagia After Anterior Cervical Discectomy and Fusion</dc:title>
         <dc:identifier>10.1002/lary.70588</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70588</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70588?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70589?af=R</link>
         <pubDate>Mon, 27 Apr 2026 18:55:03 -0700</pubDate>
         <dc:date>2026-04-27T06:55:03-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70589</guid>
         <title>Virtual Reality Mastoidectomy as Precadaver Training for Novices: A Randomized Crossover Study</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Virtual reality mastoidectomy training produced significantly lower relative reaction times than cadaveric dissection, indicating reduced cognitive load among novice learners and improved subsequent cadaveric performance. In this randomized crossover study, trainees who completed VR first achieved higher cadaveric mastoidectomy scores, despite similar cognitive load trajectories across modalities. These findings support VR mastoidectomy as a cognitively efficient precadaver training modality that enhances early learning in otologic surgery.

ABSTRACT

Objectives
To compare cognitive load during virtual reality (VR) simulation and cadaveric dissection (CD) mastoidectomy training in novice learners. To determine whether training order influences cognitive load, characterize cognitive load progression during the procedure, and assess whether VR training improves subsequent cadaveric performance.


Methods
In this randomized crossover study, 24 core surgical trainees with no prior mastoidectomy experience performed a cortical mastoidectomy in both VR and CD settings. Participants were randomized to either VR‐first or CD‐first training sequences. Cognitive load was measured using a bespoke auditory reaction‐time device at baseline and 10, 30, and 50 min. Relative reaction time (RRT) served as an objective index of cognitive load. Cadaveric performance was assessed using the Modified Welling Scale by two blinded otologists.


Results
Cognitive load was significantly lower during VR than CD, with mean RRT rising 26% from baseline in VR versus 60% in CD (p &lt; 0.001). Training order did not affect cognitive load in either modality, and RRT increased progressively throughout mastoidectomy in both VR and CD. Participants who began with VR achieved significantly higher cadaveric performance scores than those who began with CD (mean 9.50 vs. 4.96; p &lt; 0.001), and inter‐rater reliability for performance scoring was high.


Conclusion
VR mastoidectomy reduces cognitive load and enhances subsequent cadaveric performance in novice trainees, supporting its role as a cognitively optimized precadaver training modality that complements, rather than replaces, cadaveric dissection. These findings suggest VR enhances early learning efficiency and resource utilization in novice otolaryngology training.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/1d9cc5fa-bebf-4c78-877f-381883ad29ad/lary70589-toc-0001-m.png"
     alt="Virtual Reality Mastoidectomy as Precadaver Training for Novices: A Randomized Crossover Study"/&gt;
&lt;p&gt;Virtual reality mastoidectomy training produced significantly lower relative reaction times than cadaveric dissection, indicating reduced cognitive load among novice learners and improved subsequent cadaveric performance. In this randomized crossover study, trainees who completed VR first achieved higher cadaveric mastoidectomy scores, despite similar cognitive load trajectories across modalities. These findings support VR mastoidectomy as a cognitively efficient precadaver training modality that enhances early learning in otologic surgery.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To compare cognitive load during virtual reality (VR) simulation and cadaveric dissection (CD) mastoidectomy training in novice learners. To determine whether training order influences cognitive load, characterize cognitive load progression during the procedure, and assess whether VR training improves subsequent cadaveric performance.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;In this randomized crossover study, 24 core surgical trainees with no prior mastoidectomy experience performed a cortical mastoidectomy in both VR and CD settings. Participants were randomized to either VR-first or CD-first training sequences. Cognitive load was measured using a bespoke auditory reaction-time device at baseline and 10, 30, and 50 min. Relative reaction time (RRT) served as an objective index of cognitive load. Cadaveric performance was assessed using the Modified Welling Scale by two blinded otologists.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Cognitive load was significantly lower during VR than CD, with mean RRT rising 26% from baseline in VR versus 60% in CD (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Training order did not affect cognitive load in either modality, and RRT increased progressively throughout mastoidectomy in both VR and CD. Participants who began with VR achieved significantly higher cadaveric performance scores than those who began with CD (mean 9.50 vs. 4.96; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), and inter-rater reliability for performance scoring was high.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;VR mastoidectomy reduces cognitive load and enhances subsequent cadaveric performance in novice trainees, supporting its role as a cognitively optimized precadaver training modality that complements, rather than replaces, cadaveric dissection. These findings suggest VR enhances early learning efficiency and resource utilization in novice otolaryngology training.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Hazem Nijim, 
Wai Sam Cho, 
Elizabeth Marsh, 
Jason Evans, 
Raguwinder Bindy Sahota, 
Owen Judd
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Virtual Reality Mastoidectomy as Precadaver Training for Novices: A Randomized Crossover Study</dc:title>
         <dc:identifier>10.1002/lary.70589</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70589</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70589?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70512?af=R</link>
         <pubDate>Mon, 27 Apr 2026 18:48:14 -0700</pubDate>
         <dc:date>2026-04-27T06:48:14-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70512</guid>
         <title>Integrating Augmented Reality Into Otologic Cadaveric Surgical Training</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This pilot study developed and implemented a specimen‐specific augmented reality (AR) workflow for cadaveric temporal bone dissection, using CT‐derived 3D models registered to each specimen and viewed intermittently through a Microsoft HoloLens 2 headset. Four otolaryngology residents completed seven dissections with high dissection performance and favorable user feedback for anatomical orientation, supporting the feasibility of integrating this workflow into a cadaveric dissection course.

ABSTRACT

Objective
Temporal bone dissection poses a significant challenge due to its intricate three‐dimensional (3D) anatomy. Traditional learning methods involving cadaver dissections are limited by practical constraints. Augmented reality (AR) offers a potential solution by providing 3D anatomical visualization of key anatomical landmarks based on computed tomography (CT) scans, superimposed directly onto the cadaver specimen. This pilot study evaluated the feasibility of integrating AR to support temporal bone dissection of cadavers and enhance otolaryngology residents' grasp of anatomy.


Methods
Four otolaryngology residents performed a total of seven temporal bone dissections during a dedicated dissection course. AR models were developed using specimen‐specific CT data and overlaid onto cadaveric specimens using the Microsoft HoloLens 2 headset. Participants' dissection accuracy and efficiency were evaluated using predefined metrics, and their feedback was collected through questionnaires to assess the system's contribution to learning.


Results
In this pilot feasibility study, the AR system was successfully integrated into the dissection workflow, with participants reporting improved understanding of these complex anatomical structures as well as enhanced spatial orientation. Dissection quality was high, and the participants expressed overall satisfaction with the course.


Conclusion
AR technology shows significant potential as an adjunct to traditional temporal bone dissection training by providing enhanced visualization that leads to greater anatomical understanding.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/4ba81f95-fd04-46fc-a13d-ae982cd69d42/lary70512-toc-0001-m.png"
     alt="Integrating Augmented Reality Into Otologic Cadaveric Surgical Training"/&gt;
&lt;p&gt;This pilot study developed and implemented a specimen-specific augmented reality (AR) workflow for cadaveric temporal bone dissection, using CT-derived 3D models registered to each specimen and viewed intermittently through a Microsoft HoloLens 2 headset. Four otolaryngology residents completed seven dissections with high dissection performance and favorable user feedback for anatomical orientation, supporting the feasibility of integrating this workflow into a cadaveric dissection course.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;Temporal bone dissection poses a significant challenge due to its intricate three-dimensional (3D) anatomy. Traditional learning methods involving cadaver dissections are limited by practical constraints. Augmented reality (AR) offers a potential solution by providing 3D anatomical visualization of key anatomical landmarks based on computed tomography (CT) scans, superimposed directly onto the cadaver specimen. This pilot study evaluated the feasibility of integrating AR to support temporal bone dissection of cadavers and enhance otolaryngology residents' grasp of anatomy.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Four otolaryngology residents performed a total of seven temporal bone dissections during a dedicated dissection course. AR models were developed using specimen-specific CT data and overlaid onto cadaveric specimens using the Microsoft HoloLens 2 headset. Participants' dissection accuracy and efficiency were evaluated using predefined metrics, and their feedback was collected through questionnaires to assess the system's contribution to learning.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In this pilot feasibility study, the AR system was successfully integrated into the dissection workflow, with participants reporting improved understanding of these complex anatomical structures as well as enhanced spatial orientation. Dissection quality was high, and the participants expressed overall satisfaction with the course.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;AR technology shows significant potential as an adjunct to traditional temporal bone dissection training by providing enhanced visualization that leads to greater anatomical understanding.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Yuval Mizrakli, 
Dor Hadida Barzilai, 
Netanel Nagar, 
Nir Cohen, 
Oliana Vazhgovsky, 
Rona Bourla, 
Shai Tejman‐Yarden, 
Haim Gavriel, 
Yael Garti
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Integrating Augmented Reality Into Otologic Cadaveric Surgical Training</dc:title>
         <dc:identifier>10.1002/lary.70512</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70512</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70512?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70581?af=R</link>
         <pubDate>Mon, 27 Apr 2026 03:34:35 -0700</pubDate>
         <dc:date>2026-04-27T03:34:35-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70581</guid>
         <title>Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Adjuvant therapy with the bacterial lysate OM‐85 significantly reduced postoperative polyp recurrence at 12 months (8.82% vs. 27.91%) and improved symptoms, L‐K endoscopic and SNOT‐22 scores in patients with nasal polyps following endoscopic sinus surgery. These clinical benefits were associated with elevated white blood cell and lymphocyte counts, suggesting that OM‐85 may reduce recurrence through enhanced systemic immune function.

ABSTRACT

Objective
This study aimed to investigate the potential role of OM‐85 in reducing polyp recurrence (PR).


Methods
A single‐center randomized, prospective study was performed to compare the inter‐group PR rate, patient‐reported outcome measures (PROMs), CT and endoscopic scores. Hundred patients were randomized to receive either add‐on OM‐85 (34/50) or control group (43/50); 77 participants completed the 12‐month follow‐up. The OM‐85 group received oral treatment for 10 days, followed by a 20‐day washout (Months 1–3 and 7–9). Primary outcome was the PR rate. Secondary outcomes included PROMs, Lund‐Kennedy (L‐K) scores, Lund‐Mackay (L‐M) scores, and complete blood count (CBC) parameters.


Results
The PR rate was significantly lower in the OM‐85 group (8.82%) than in the control group (27.91%, χ2 = 4.408, p = 0.036). Univariable analysis identified pre‐operative Lund‐Mackay (L‐M) score (p = 0.008) and hyposmia VAS score (p = 0.031) as significant predictors of PR. In multivariable analysis, the L‐M score remained an independent predictor (OR = 1.15, p = 0.012), with an optimal cutoff of 10. The OM‐85 group showed significant improvements in nasal obstruction, olfactory dysfunction, and mucopurulent discharge at 6 and 12 months (p &lt; 0.05). Lund‐Kennedy (L‐K) score and 22‐item Sinonasal Outcome Test (SNOT‐22) score were also significantly improved (p &lt; 0.05). Furthermore, the OM‐85 group exhibited elevated white blood cell counts and lymphocyte percentages from 6 months onward (p &lt; 0.05).


Conclusion
Adjuvant OM‐85 may reduce postoperative PR, with improved endoscopic and symptom scores, potentially mediated by enhanced systemic immune function.


Level of Evidence
2.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/6c9fec02-5ece-48b7-b4ad-25fc87b7879a/lary70581-toc-0001-m.png"
     alt="Bacterial Lysates Add-On Therapy to Reduce Postoperative Recurrence in Nasal Polyps"/&gt;
&lt;p&gt;Adjuvant therapy with the bacterial lysate OM-85 significantly reduced postoperative polyp recurrence at 12 months (8.82% vs. 27.91%) and improved symptoms, L-K endoscopic and SNOT-22 scores in patients with nasal polyps following endoscopic sinus surgery. These clinical benefits were associated with elevated white blood cell and lymphocyte counts, suggesting that OM-85 may reduce recurrence through enhanced systemic immune function.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;This study aimed to investigate the potential role of OM-85 in reducing polyp recurrence (PR).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A single-center randomized, prospective study was performed to compare the inter-group PR rate, patient-reported outcome measures (PROMs), CT and endoscopic scores. Hundred patients were randomized to receive either add-on OM-85 (34/50) or control group (43/50); 77 participants completed the 12-month follow-up. The OM-85 group received oral treatment for 10 days, followed by a 20-day washout (Months 1–3 and 7–9). Primary outcome was the PR rate. Secondary outcomes included PROMs, Lund-Kennedy (L-K) scores, Lund-Mackay (L-M) scores, and complete blood count (CBC) parameters.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The PR rate was significantly lower in the OM-85 group (8.82%) than in the control group (27.91%, &lt;i&gt;χ&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 4.408, &lt;i&gt;p&lt;/i&gt; = 0.036). Univariable analysis identified pre-operative Lund-Mackay (L-M) score (&lt;i&gt;p&lt;/i&gt; = 0.008) and hyposmia VAS score (&lt;i&gt;p&lt;/i&gt; = 0.031) as significant predictors of PR. In multivariable analysis, the L-M score remained an independent predictor (OR = 1.15, &lt;i&gt;p&lt;/i&gt; = 0.012), with an optimal cutoff of 10. The OM-85 group showed significant improvements in nasal obstruction, olfactory dysfunction, and mucopurulent discharge at 6 and 12 months (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). Lund-Kennedy (L-K) score and 22-item Sinonasal Outcome Test (SNOT-22) score were also significantly improved (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). Furthermore, the OM-85 group exhibited elevated white blood cell counts and lymphocyte percentages from 6 months onward (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Adjuvant OM-85 may reduce postoperative PR, with improved endoscopic and symptom scores, potentially mediated by enhanced systemic immune function.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;2.&lt;/p&gt;</content:encoded>
         <dc:creator>
Huiyi Deng, 
Huijun Qiu, 
Tian Yuan, 
Shuo Wu, 
Qintai Yang
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Bacterial Lysates Add‐On Therapy to Reduce Postoperative Recurrence in Nasal Polyps</dc:title>
         <dc:identifier>10.1002/lary.70581</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70581</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70581?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70585?af=R</link>
         <pubDate>Sat, 25 Apr 2026 22:05:13 -0700</pubDate>
         <dc:date>2026-04-25T10:05:13-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70585</guid>
         <title>Validation of the TruBlue Light Laser for Laryngeal Somatosensory and Perturbation Testing</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study validates a blue light laser method for assessing laryngeal somatosensory function by measuring perceptual thresholds, reflexive responses, discrimination acuity, and vocal perturbations in healthy adults. Results demonstrate that the method provides precise, reliable stimulation and yields quantifiable sensory and acoustic responses, including graded perception, reflex activation, and measurable perturbations in fundamental frequency. Overall, blue light laser stimulation is a feasible, low‐risk, and clinically promising tool for evaluating laryngeal sensorimotor function.

ABSTRACT

Objectives
Clinical assessment of laryngeal somatosensation is limited by the lack of precise tools to directly stimulate the larynx and quantify sensorimotor responses. This study validated a blue light laser method for laryngeal somatosensory testing in vocally healthy adults and developed acoustic measures to quantify vocal responses to controlled laryngeal perturbations.


Methods
In this prospective validation study, a 445‐nm diode blue light laser was delivered through a channeled flexible laryngoscope to the arytenoid mucosa. Single subablative pulses (1–10 W, 30 ms) were applied during quiet breathing or sustained phonation to determine perceptual and reflexive sensory thresholds, discrimination acuity, and laryngeal perturbation responses. Acoustic recordings during perturbations were analyzed in Praat using custom software to extract continuous fundamental frequency variability and quantify perturbation magnitude and recovery.


Results
Participants demonstrated reliable perceptual detection and laryngeal reflexive responses to laser stimulation. Mean perceptual sensory threshold was 1.46 W (SD = 1.17) and mean laryngeal response threshold was 4.62 W (SD = 2.04). Sensory ratings were higher during stimulation than foil trials (p &lt; 0.001). Sensory perception increased with stimulation intensity (~0.3 points per 1 W; p &lt; 0.001), and higher wattage increased odds of eliciting a laryngeal response (OR = 1.38; p &lt; 0.001). Discrimination accuracy averaged 78.5% (OR = 1.45; p = 0.002). Laser stimulation during phonation produced measurable acoustic perturbations (peak SD(f0) = 19.35 Hz; recovery = 0.48 s).


Conclusion
Blue light laser stimulation is a feasible and precise method for evaluating laryngeal somatosensation and vocal sensorimotor responses.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/77898124-6eef-42cb-ab3f-8b5d6acfa66c/lary70585-toc-0001-m.png"
     alt="Validation of the TruBlue Light Laser for Laryngeal Somatosensory and Perturbation Testing"/&gt;
&lt;p&gt;This study validates a blue light laser method for assessing laryngeal somatosensory function by measuring perceptual thresholds, reflexive responses, discrimination acuity, and vocal perturbations in healthy adults. Results demonstrate that the method provides precise, reliable stimulation and yields quantifiable sensory and acoustic responses, including graded perception, reflex activation, and measurable perturbations in fundamental frequency. Overall, blue light laser stimulation is a feasible, low-risk, and clinically promising tool for evaluating laryngeal sensorimotor function.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;Clinical assessment of laryngeal somatosensation is limited by the lack of precise tools to directly stimulate the larynx and quantify sensorimotor responses. This study validated a blue light laser method for laryngeal somatosensory testing in vocally healthy adults and developed acoustic measures to quantify vocal responses to controlled laryngeal perturbations.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;In this prospective validation study, a 445-nm diode blue light laser was delivered through a channeled flexible laryngoscope to the arytenoid mucosa. Single subablative pulses (1–10 W, 30 ms) were applied during quiet breathing or sustained phonation to determine perceptual and reflexive sensory thresholds, discrimination acuity, and laryngeal perturbation responses. Acoustic recordings during perturbations were analyzed in Praat using custom software to extract continuous fundamental frequency variability and quantify perturbation magnitude and recovery.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Participants demonstrated reliable perceptual detection and laryngeal reflexive responses to laser stimulation. Mean perceptual sensory threshold was 1.46 W (SD = 1.17) and mean laryngeal response threshold was 4.62 W (SD = 2.04). Sensory ratings were higher during stimulation than foil trials (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Sensory perception increased with stimulation intensity (~0.3 points per 1 W; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), and higher wattage increased odds of eliciting a laryngeal response (OR = 1.38; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Discrimination accuracy averaged 78.5% (OR = 1.45; &lt;i&gt;p&lt;/i&gt; = 0.002). Laser stimulation during phonation produced measurable acoustic perturbations (peak SD(&lt;i&gt;f&lt;/i&gt;
&lt;sub&gt;0&lt;/sub&gt;) = 19.35 Hz; recovery = 0.48 s).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Blue light laser stimulation is a feasible and precise method for evaluating laryngeal somatosensation and vocal sensorimotor responses.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Adrianna C. Shembel, 
Ted Mau, 
Youri Maryn, 
Elizabeth Young, 
Julianna Smeltzer, 
Lesley Childs, 
Shumon Dhar
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Validation of the TruBlue Light Laser for Laryngeal Somatosensory and Perturbation Testing</dc:title>
         <dc:identifier>10.1002/lary.70585</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70585</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70585?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70582?af=R</link>
         <pubDate>Fri, 24 Apr 2026 18:43:02 -0700</pubDate>
         <dc:date>2026-04-24T06:43:02-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70582</guid>
         <title>Educational Benefit of Hospitalist Consult Experience During Otolaryngology Training</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
The flagship consult service is both clinically active and a formative clinical rotation for residents. Fifty trainees from over four institutions who participated in both a hospitalist faculty model and rotating coverage for the consult service were surveyed about the quality of their educational experience and workflow efficiency. Trainees reported significantly better global experiences, instruction, clarity of plans, and timeliness of surgeries with the hospitalist model compared to the rotating model.

ABSTRACT

Objective(s)
To evaluate the consult and emergency care experience of Otolaryngology—Head and Neck Surgery (OHNS) trainees with a hospitalist faculty model.


Methods
An anonymous survey was distributed to OHNS residents across institutions with hospitalist models. Each respondent reported trainee and institutional details and completed a 12‐item five‐point Likert‐scale questionnaire rating resident experiences working with (1) faculty hospitalist and (2) rotating on‐call coverage models across three domains: educational features, workflow efficiency, and global experience. Subgroup analyses were conducted stratifying by training level (junior vs. senior) and degree of hospitalist experience (≥ 60% vs. &lt; 60%).


Results
Among 50 respondents (response rate 39.7%), the hospitalist model demonstrated superior performance across all domains. More respondents reported favorable education‐to‐service ratios with hospitalist supervision (58.0%) versus rotating coverage (14.0%, p &lt; 0.001). The hospitalist model had higher ratings for quality of clinical instruction (mean difference = 0.58, p &lt; 0.001), surgical instruction (0.37, p = 0.035), and managing emergencies (0.45, p &lt; 0.001). Notably, 64.0% of residents reported rarely or never feeling rushed in the OR with hospitalist supervision, compared to 36.0% with rotating coverage (p &lt; 0.001). Workflow advantages of the hospitalist model included improved procedural timeliness (p = 0.022), handoff efficiency (p = 0.002), and treatment plan clarity (p &lt; 0.001). Training level did not significantly modulate responses. Residents with more hospitalist experience (≥ 60%) reported significantly greater advantages in clinical instruction (p = 0.026) and surgical teaching (p = 0.008) compared to those with less experience.


Conclusion
The hospitalist model provides educational advantages and operational efficiency. These findings support the curricular and systemic value of a hospitalist role in enhancing overall satisfaction and potentially mitigating trainee burnout.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/65f9111f-8995-48f0-920e-68960f4e6a1c/lary70582-toc-0001-m.png"
     alt="Educational Benefit of Hospitalist Consult Experience During Otolaryngology Training"/&gt;
&lt;p&gt;The flagship consult service is both clinically active and a formative clinical rotation for residents. Fifty trainees from over four institutions who participated in both a hospitalist faculty model and rotating coverage for the consult service were surveyed about the quality of their educational experience and workflow efficiency. Trainees reported significantly better global experiences, instruction, clarity of plans, and timeliness of surgeries with the hospitalist model compared to the rotating model.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective(s)&lt;/h2&gt;
&lt;p&gt;To evaluate the consult and emergency care experience of Otolaryngology—Head and Neck Surgery (OHNS) trainees with a hospitalist faculty model.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;An anonymous survey was distributed to OHNS residents across institutions with hospitalist models. Each respondent reported trainee and institutional details and completed a 12-item five-point Likert-scale questionnaire rating resident experiences working with (1) faculty hospitalist and (2) rotating on-call coverage models across three domains: educational features, workflow efficiency, and global experience. Subgroup analyses were conducted stratifying by training level (junior vs. senior) and degree of hospitalist experience (≥ 60% vs. &amp;lt; 60%).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 50 respondents (response rate 39.7%), the hospitalist model demonstrated superior performance across all domains. More respondents reported favorable education-to-service ratios with hospitalist supervision (58.0%) versus rotating coverage (14.0%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). The hospitalist model had higher ratings for quality of clinical instruction (mean difference = 0.58, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), surgical instruction (0.37, &lt;i&gt;p&lt;/i&gt; = 0.035), and managing emergencies (0.45, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Notably, 64.0% of residents reported rarely or never feeling rushed in the OR with hospitalist supervision, compared to 36.0% with rotating coverage (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Workflow advantages of the hospitalist model included improved procedural timeliness (&lt;i&gt;p&lt;/i&gt; = 0.022), handoff efficiency (&lt;i&gt;p&lt;/i&gt; = 0.002), and treatment plan clarity (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Training level did not significantly modulate responses. Residents with more hospitalist experience (≥ 60%) reported significantly greater advantages in clinical instruction (&lt;i&gt;p&lt;/i&gt; = 0.026) and surgical teaching (&lt;i&gt;p&lt;/i&gt; = 0.008) compared to those with less experience.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The hospitalist model provides educational advantages and operational efficiency. These findings support the curricular and systemic value of a hospitalist role in enhancing overall satisfaction and potentially mitigating trainee burnout.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Alexandra T. Bourdillon, 
Alyssa M. Civantos, 
Ran A. Wang, 
Elizabeth Willingham, 
Natalie E. Kadin, 
Phillip G. Allen, 
Caroline Schlocker, 
Tyler W. Crosby, 
Steven D. Pletcher
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Educational Benefit of Hospitalist Consult Experience During Otolaryngology Training</dc:title>
         <dc:identifier>10.1002/lary.70582</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70582</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70582?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70563?af=R</link>
         <pubDate>Thu, 23 Apr 2026 21:01:33 -0700</pubDate>
         <dc:date>2026-04-23T09:01:33-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70563</guid>
         <title>A Simple Technique for Probe‐Based NIRAF‐Guided Parathyroid Identification in TOETVA</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We describe a technique for probe‐based near‐infrared autofluorescence (NIRAF)‐guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real‐time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote‐access thyroid surgery.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/6e404c3c-dbea-4458-a27e-ec66ae259ba1/lary70563-toc-0001-m.png"
     alt="A Simple Technique for Probe-Based NIRAF-Guided Parathyroid Identification in TOETVA"/&gt;
&lt;p&gt;We describe a technique for probe-based near-infrared autofluorescence (NIRAF)-guided parathyroid identification during TOETVA. The probe is mounted on a suction cannula and introduced via the central port, allowing real-time confirmation of parathyroid tissue without device modification. This approach enables integration of NIRAF into remote-access thyroid surgery.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Prachya Maneeprasopchoke, 
Aimpat Aungsusiripong, 
Paveena Pithuksurachai, 
Angkoon Anuwong, 
Marika D. Russell, 
Amr H. Abdelhamid Ahmed, 
Gregory W. Randolph
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>A Simple Technique for Probe‐Based NIRAF‐Guided Parathyroid Identification in TOETVA</dc:title>
         <dc:identifier>10.1002/lary.70563</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70563</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70563?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70576?af=R</link>
         <pubDate>Wed, 22 Apr 2026 21:40:08 -0700</pubDate>
         <dc:date>2026-04-22T09:40:08-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70576</guid>
         <title>Middle Ear Bacterial Colonization and Recurrence of Radiation‐Induced OME: A Prospective Study</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This study investigated the bacteriological features of radiation‐induced otitis media with effusion (RI‐OME) in nasopharyngeal carcinoma patients after radiotherapy and its association with early recurrence. Compared with non‐radiation‐induced OME patients, RI‐OME patients showed significantly higher middle ear effusion bacterial positivity, with more opportunistic and drug‐resistant pathogens. While bacterial colonization was linked to early recurrence within 4 weeks, it did not serve as an independent prognostic factor for overall recurrence over 24 weeks, suggesting the need for further studies on targeted antibacterial interventions.

ABSTRACT

Objective
To define the bacteriological characteristics of otitis media with effusion (OME) in nasopharyngeal carcinoma (NPC) patients following radiotherapy and determine whether bacterial colonization in the middle ear was associated with a higher risk of early recurrence of radiation‐induced OME (RI‐OME).


Methods
This prospective multicenter cohort enrolled patients with OME (with or without a history of radiotherapy for NPC) undergoing tympanocentesis. Middle ear effusion (MEE) samples were cultured and patients with RI‐OME were followed up for 24 weeks. Data on demographics, radiotherapy history, treatment, comorbidities, and effusion characteristics were collected. Recurrence patterns were characterized descriptively throughout the 24‐week post‐tympanocentesis follow‐up.


Results
A total of 93 RI‐OME patients and 115 non‐radiation‐induced (NRI)‐OME patients were included. RI‐OME patients had a 4.843‐fold higher risk of MEE bacterial culture positivity compared to NRI‐OME patients (OR = 4.843, p = 0.006). MEE cultures in RI‐OME patients showed higher proportions of opportunistic pathogens and drug‐resistant bacteria. Mucoid effusion was a significant risk factor for bacterial positivity in RI‐OME (OR = 8.553, p = 0.002). Male sex (OR = 12.120, p = 0.002) and bacterial colonization (OR = 10.239, p = 0.035) were associated with early recurrence (≤ 4 weeks post‐tympanocentesis) in RI‐OME patients; however, neither factor remained an independent predictor over the full 24‐week period.


Conclusion
RI‐OME patients demonstrated significantly higher MEE bacterial culture positivity rates than NRI‐OME patients. Although MEE bacterial colonization significantly impacted early recurrence, it lacked independent prognostic value for overall 24‐week recurrence. Thus, whether targeted antibacterial therapy can reduce recurrence rates warrants further investigation.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/34577f87-aadc-4bc7-a1a1-22d18e366878/lary70576-toc-0001-m.png"
     alt="Middle Ear Bacterial Colonization and Recurrence of Radiation-Induced OME: A Prospective Study"/&gt;
&lt;p&gt;This study investigated the bacteriological features of radiation-induced otitis media with effusion (RI-OME) in nasopharyngeal carcinoma patients after radiotherapy and its association with early recurrence. Compared with non-radiation-induced OME patients, RI-OME patients showed significantly higher middle ear effusion bacterial positivity, with more opportunistic and drug-resistant pathogens. While bacterial colonization was linked to early recurrence within 4 weeks, it did not serve as an independent prognostic factor for overall recurrence over 24 weeks, suggesting the need for further studies on targeted antibacterial interventions.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;To define the bacteriological characteristics of otitis media with effusion (OME) in nasopharyngeal carcinoma (NPC) patients following radiotherapy and determine whether bacterial colonization in the middle ear was associated with a higher risk of early recurrence of radiation-induced OME (RI-OME).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This prospective multicenter cohort enrolled patients with OME (with or without a history of radiotherapy for NPC) undergoing tympanocentesis. Middle ear effusion (MEE) samples were cultured and patients with RI-OME were followed up for 24 weeks. Data on demographics, radiotherapy history, treatment, comorbidities, and effusion characteristics were collected. Recurrence patterns were characterized descriptively throughout the 24-week post-tympanocentesis follow-up.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 93 RI-OME patients and 115 non-radiation-induced (NRI)-OME patients were included. RI-OME patients had a 4.843-fold higher risk of MEE bacterial culture positivity compared to NRI-OME patients (OR = 4.843, &lt;i&gt;p&lt;/i&gt; = 0.006). MEE cultures in RI-OME patients showed higher proportions of opportunistic pathogens and drug-resistant bacteria. Mucoid effusion was a significant risk factor for bacterial positivity in RI-OME (OR = 8.553, &lt;i&gt;p&lt;/i&gt; = 0.002). Male sex (OR = 12.120, &lt;i&gt;p&lt;/i&gt; = 0.002) and bacterial colonization (OR = 10.239, &lt;i&gt;p&lt;/i&gt; = 0.035) were associated with early recurrence (≤ 4 weeks post-tympanocentesis) in RI-OME patients; however, neither factor remained an independent predictor over the full 24-week period.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;RI-OME patients demonstrated significantly higher MEE bacterial culture positivity rates than NRI-OME patients. Although MEE bacterial colonization significantly impacted early recurrence, it lacked independent prognostic value for overall 24-week recurrence. Thus, whether targeted antibacterial therapy can reduce recurrence rates warrants further investigation.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
Minjun Chen, 
Minjian Wu, 
Jin Chen, 
Lingwen Xie, 
Chuxuan Yang, 
Yuejia Su, 
Hao Xiong
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Middle Ear Bacterial Colonization and Recurrence of Radiation‐Induced OME: A Prospective Study</dc:title>
         <dc:identifier>10.1002/lary.70576</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70576</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70576?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70579?af=R</link>
         <pubDate>Wed, 22 Apr 2026 21:17:40 -0700</pubDate>
         <dc:date>2026-04-22T09:17:40-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70579</guid>
         <title>Identifying Stimulation Lead Malfunction After Hypoglossal Nerve Stimulation Implantion</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
This case series describes four obstructive sleep apnea patients who underwent hypoglossal nerve stimulation implant surgery. After a period of OSA resolution with therapy, these patients presented with symptoms of increased snoring and reduced tongue sensation with implant activation. Impedance testing showed abnormally elevated values on bipolar electrode settings, and electrode reprogramming led to restored therapeutic benefit.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/d511538a-4816-450a-9f52-5e8e2f882296/lary70579-toc-0001-m.png"
     alt="Identifying Stimulation Lead Malfunction After Hypoglossal Nerve Stimulation Implantion"/&gt;
&lt;p&gt;This case series describes four obstructive sleep apnea patients who underwent hypoglossal nerve stimulation implant surgery. After a period of OSA resolution with therapy, these patients presented with symptoms of increased snoring and reduced tongue sensation with implant activation. Impedance testing showed abnormally elevated values on bipolar electrode settings, and electrode reprogramming led to restored therapeutic benefit.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Pearl Doan, 
Megan L. Durr, 
Jolie L. Chang
</dc:creator>
         <category>CASE REPORT</category>
         <dc:title>Identifying Stimulation Lead Malfunction After Hypoglossal Nerve Stimulation Implantion</dc:title>
         <dc:identifier>10.1002/lary.70579</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70579</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70579?af=R</prism:url>
         <prism:section>CASE REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70577?af=R</link>
         <pubDate>Wed, 22 Apr 2026 21:09:49 -0700</pubDate>
         <dc:date>2026-04-22T09:09:49-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70577</guid>
         <title>In Response to Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence Tomography</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description/>
         <content:encoded/>
         <dc:creator>
Owen P. Wischhoff, 
Michael Kuang, 
Brady D. Prosser, 
Jakob R. Holm, 
Jack J. Jiang
</dc:creator>
         <category>LETTER TO THE EDITOR</category>
         <dc:title>In Response to Quantifying Dehydration Effects of Porcine Vocal Fold Attenuation With Optical Coherence Tomography</dc:title>
         <dc:identifier>10.1002/lary.70577</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70577</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70577?af=R</prism:url>
         <prism:section>LETTER TO THE EDITOR</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70578?af=R</link>
         <pubDate>Tue, 21 Apr 2026 21:00:31 -0700</pubDate>
         <dc:date>2026-04-21T09:00:31-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70578</guid>
         <title>Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Within TriNetX, there is an association between migraine and MD. Migraine patients receiving migraine treatment are more likely to develop MD compared to non‐migraine patients. These results affirm the proposed pathophysiological link between migraine and MD, supporting how treatments for migraine may also help MD‐related symptoms.

ABSTRACT

Objectives
To observe the incidence of Meniere's disease (MD) and MD‐related symptoms (i.e., aural fullness, tinnitus, hearing loss, and vertigo) between (a) non‐migraine and migraine patients and (b) migraine untreated and migraine treated patients within the TriNetX database.


Methods
We conducted a retrospective cohort study of (a) non‐migraine and migraine patients and (b) migraine treated and untreated patients within the TriNetX database from 2013 till 2025. Patients underwent propensity score matching for sex, age, race, and known lifestyle/disease confounders for MD. Incidence of MD and MD‐related symptoms were evaluated 5 years post index date and beyond 5 years post index date.


Results
Migraine patients demonstrated a greater incidence of MD and MD‐related symptoms 5 years and more than 5 years post index date. Amongst migraine patients, those not receiving treatment demonstrated a lesser predilection (risk ratio [RR] = 0.43, 95% CI: 0.28–0.66) of developing MD than patients receiving treatment. There was no significant difference in the incidence of hearing loss or aural fullness between migraine untreated and treated subgroups. Migraine patients not receiving treatment had an increased risk of experiencing tinnitus (RR = 1.11, 95% CI: 1.03–1.19).


Conclusions
There exists a connection between migraine and MD. Migraine patients receiving migraine treatment are statistically significantly more likely to develop MD compared to non‐migraine patients. These results support the findings of preceding studies that have demonstrated a pathophysiological link between migraine and vestibulocochlear dysfunction.


Level of Evidence
3

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/bed0ef0f-4a2f-4c3a-bebc-514a8b9a306e/lary70578-toc-0001-m.png"
     alt="Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease"/&gt;
&lt;p&gt;Within TriNetX, there is an association between migraine and MD. Migraine patients receiving migraine treatment are more likely to develop MD compared to non-migraine patients. These results affirm the proposed pathophysiological link between migraine and MD, supporting how treatments for migraine may also help MD-related symptoms.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To observe the incidence of Meniere's disease (MD) and MD-related symptoms (i.e., aural fullness, tinnitus, hearing loss, and vertigo) between (a) non-migraine and migraine patients and (b) migraine untreated and migraine treated patients within the TriNetX database.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We conducted a retrospective cohort study of (a) non-migraine and migraine patients and (b) migraine treated and untreated patients within the TriNetX database from 2013 till 2025. Patients underwent propensity score matching for sex, age, race, and known lifestyle/disease confounders for MD. Incidence of MD and MD-related symptoms were evaluated 5 years post index date and beyond 5 years post index date.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Migraine patients demonstrated a greater incidence of MD and MD-related symptoms 5 years and more than 5 years post index date. Amongst migraine patients, those not receiving treatment demonstrated a lesser predilection (risk ratio [RR] = 0.43, 95% CI: 0.28–0.66) of developing MD than patients receiving treatment. There was no significant difference in the incidence of hearing loss or aural fullness between migraine untreated and treated subgroups. Migraine patients not receiving treatment had an increased risk of experiencing tinnitus (RR = 1.11, 95% CI: 1.03–1.19).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;There exists a connection between migraine and MD. Migraine patients receiving migraine treatment are statistically significantly more likely to develop MD compared to non-migraine patients. These results support the findings of preceding studies that have demonstrated a pathophysiological link between migraine and vestibulocochlear dysfunction.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3&lt;/p&gt;</content:encoded>
         <dc:creator>
Khushi Bhatt, 
Yueqi Ren, 
Charlotte Chan, 
Marianne Rara, 
Hamid R. Djalilian, 
Mehdi Abouzari
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Meniere's Disease and Migraine: Effect of Migraine Medications on Symptoms of Meniere's Disease</dc:title>
         <dc:identifier>10.1002/lary.70578</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70578</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70578?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70574?af=R</link>
         <pubDate>Tue, 21 Apr 2026 04:03:05 -0700</pubDate>
         <dc:date>2026-04-21T04:03:05-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70574</guid>
         <title>Endoscopic Marsupialization With Periodic Debridement for Petrous Apex Cholesteatoma</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
In cases where an expanded cholesteatoma has extensively eroded the petroclival bones, marsupialization of the cholesteatoma cavity without matrix removal through an endoscopic transsphenoidal approach is a feasible and safe option. This approach avoids CSF rhinorrhea and injury to critical structures which may be underlying and adherent to the cholesteatoma matrix, and periodic debridements address the disease satisfactorily.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/f8bfe35b-9b0c-4242-8587-4f0a228c6260/lary70574-toc-0001-m.png"
     alt="Endoscopic Marsupialization With Periodic Debridement for Petrous Apex Cholesteatoma"/&gt;
&lt;p&gt;In cases where an expanded cholesteatoma has extensively eroded the petroclival bones, marsupialization of the cholesteatoma cavity without matrix removal through an endoscopic transsphenoidal approach is a feasible and safe option. This approach avoids CSF rhinorrhea and injury to critical structures which may be underlying and adherent to the cholesteatoma matrix, and periodic debridements address the disease satisfactorily.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Emily G. Hardy, 
Michael A. Cirelli Jr, 
Nitish Kumar, 
Naresh P. Patel, 
Devyani Lal
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>Endoscopic Marsupialization With Periodic Debridement for Petrous Apex Cholesteatoma</dc:title>
         <dc:identifier>10.1002/lary.70574</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70574</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70574?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70568?af=R</link>
         <pubDate>Fri, 17 Apr 2026 23:39:00 -0700</pubDate>
         <dc:date>2026-04-17T11:39:00-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70568</guid>
         <title>Bronchoscopic Internal Traction for Airway Foreign Body Removal via Tracheotomy Under ECMO</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We present a technique utilizing internal traction‐assisted mobilization to effectively retrieve objects, such as pen caps, that lack an external grasping surface and resist conventional rigid bronchoscopy. In this case, tracheotomy served as an alternative extraction route for impacted foreign bodies that failed to pass across the glottis or subglottic region. Concurrently, ECMO maintains oxygenation during complex airway manipulation and reduces the risk of hypoxia.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/7e744d9e-ed7c-4103-8784-f2089bcc7c02/lary70568-toc-0001-m.png"
     alt="Bronchoscopic Internal Traction for Airway Foreign Body Removal via Tracheotomy Under ECMO"/&gt;
&lt;p&gt;We present a technique utilizing internal traction-assisted mobilization to effectively retrieve objects, such as pen caps, that lack an external grasping surface and resist conventional rigid bronchoscopy. In this case, tracheotomy served as an alternative extraction route for impacted foreign bodies that failed to pass across the glottis or subglottic region. Concurrently, ECMO maintains oxygenation during complex airway manipulation and reduces the risk of hypoxia.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Ko‐Chun Fang, 
Hua Chiang, 
Jyun‐Hong Jiang, 
Ching‐Nung Wu, 
Sheng‐Dean Luo, 
Wei‐Chih Chen
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>Bronchoscopic Internal Traction for Airway Foreign Body Removal via Tracheotomy Under ECMO</dc:title>
         <dc:identifier>10.1002/lary.70568</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70568</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70568?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70570?af=R</link>
         <pubDate>Fri, 17 Apr 2026 21:09:57 -0700</pubDate>
         <dc:date>2026-04-17T09:09:57-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70570</guid>
         <title>Efficient Suprahyoid Muscle Contraction by Combined Modulated Currents in Mice</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
The composite wave stimulation, combining amplitude‐modulated alternating current with pulse stimulation, facilitated suprahyoid muscle contraction. The effects occurred without a marked reduction in discomfort threshold current intensities.

ABSTRACT

Objective
This study aimed to optimize electrical stimulation modalities for the suprahyoid muscles to improve swallowing function. We hypothesized that novel stimulus patterns (amplitude‐modulated, mid‐frequency sinusoidal, exponentially amplified, and short‐pulse waveforms) would enhance contraction efficiency.


Methods
We delivered 80‐Hz rectangular pulse, 2‐kHz alternating current (AC) with nth‐power sinusoidal modulation (n = 1, 5, 7, 9, 11), and 4‐ and 8‐kHz sine waves. We also tested 2‐kHz AC with nth‐power sinusoidal modulation combined with short‐pulsed currents. These were applied via subcutaneously embedded Ag–AgCl ball electrodes targeting the suprahyoid muscles in anesthetized mice. Threshold intensities were determined using isometric contraction measurements. Discomfort levels for each stimulus were then assessed in awake conditions.


Results
Increasing the power of sinusoidal modulation in AC significantly reduced muscle contraction thresholds. Waveforms combining amplitude‐modulated sinusoids and short pulse trains (20 μs duration) further lowered thresholds over non‐pulsed stimuli. Discomfort thresholds did not differ significantly across AC and composite stimulation.


Conclusion
Our findings reveal an exponential relationship between amplitude‐modulated AC and suprahyoid muscle contraction efficiency, and show that integrating pulsed current with sinusoidal stimulation synergistically optimizes activation. These results provide a foundation for advanced neuromuscular electrical stimulation strategies for swallowing rehabilitation.


Level of Evidence
N/A.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/65230616-0634-4280-9171-a79c7f697045/lary70570-toc-0001-m.png"
     alt="Efficient Suprahyoid Muscle Contraction by Combined Modulated Currents in Mice"/&gt;
&lt;p&gt;The composite wave stimulation, combining amplitude-modulated alternating current with pulse stimulation, facilitated suprahyoid muscle contraction. The effects occurred without a marked reduction in discomfort threshold current intensities.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objective&lt;/h2&gt;
&lt;p&gt;This study aimed to optimize electrical stimulation modalities for the suprahyoid muscles to improve swallowing function. We hypothesized that novel stimulus patterns (amplitude-modulated, mid-frequency sinusoidal, exponentially amplified, and short-pulse waveforms) would enhance contraction efficiency.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We delivered 80-Hz rectangular pulse, 2-kHz alternating current (AC) with &lt;i&gt;n&lt;/i&gt;th-power sinusoidal modulation (&lt;i&gt;n&lt;/i&gt; = 1, 5, 7, 9, 11), and 4- and 8-kHz sine waves. We also tested 2-kHz AC with &lt;i&gt;n&lt;/i&gt;th-power sinusoidal modulation combined with short-pulsed currents. These were applied via subcutaneously embedded Ag–AgCl ball electrodes targeting the suprahyoid muscles in anesthetized mice. Threshold intensities were determined using isometric contraction measurements. Discomfort levels for each stimulus were then assessed in awake conditions.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Increasing the power of sinusoidal modulation in AC significantly reduced muscle contraction thresholds. Waveforms combining amplitude-modulated sinusoids and short pulse trains (20 μs duration) further lowered thresholds over non-pulsed stimuli. Discomfort thresholds did not differ significantly across AC and composite stimulation.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Our findings reveal an exponential relationship between amplitude-modulated AC and suprahyoid muscle contraction efficiency, and show that integrating pulsed current with sinusoidal stimulation synergistically optimizes activation. These results provide a foundation for advanced neuromuscular electrical stimulation strategies for swallowing rehabilitation.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;N/A.&lt;/p&gt;</content:encoded>
         <dc:creator>
Tomoya Ishida, 
Yoichiro Sugiyama, 
Yuki Sato, 
Taichi Kitamura, 
Hiroyuki Shuto, 
Eriko Shimazaki, 
Akimichi Minesaki
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Efficient Suprahyoid Muscle Contraction by Combined Modulated Currents in Mice</dc:title>
         <dc:identifier>10.1002/lary.70570</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70570</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70570?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70572?af=R</link>
         <pubDate>Fri, 17 Apr 2026 20:56:49 -0700</pubDate>
         <dc:date>2026-04-17T08:56:49-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70572</guid>
         <title>Ear Piercing Complications: Comparing Cartilage and Soft Tissue Piercings in a Large Survey Cohort</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
Cartilage ear piercings were associated with significantly higher complication rates than lobule piercings and remained an independent predictor of complications after multivariate analysis. Cartilage site also independently predicted piercing removal, with higher removal rates observed compared to lobule piercings.

ABSTRACT

Objectives
To compare complication and removal rates between cartilage and lobule ear piercings in a large adult population.


Methods
An anonymous electronic survey was distributed to all individuals with a University of Iowa email address. Respondents reported demographic characteristics, piercing site, age at piercing, technique, personnel, and specific complications. Multivariate logistic regression evaluated complication and removal rates between cartilage and lobule sites.


Results
Data were analyzed on 9016 ear piercings from 3270 respondents, including 6275 (69.6%) lobule piercings and 2741 (30.4%) auricular cartilage piercings. Complications were reported in 40.2% of cartilage piercings versus 25.4% of lobule piercings (odds ratio [OR] 1.98, p &lt; 0.0001). Infection occurred in 30.3% of cartilage piercings versus 23.8% of lobule piercings (OR 1.39, p &lt; 0.0001). Additionally, cartilage site and presence of any complication each independently predicted piercing removal (OR 1.62, p &lt; 0.0001; OR 12.82, p &lt; 0.0001).


Conclusion
Cartilage piercings carried significantly greater odds of complication and removal compared to lobule piercings. These findings underscore the importance of thorough counseling and informed consent, especially when piercing through auricular cartilage.


Level of Evidence
3.

</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/572a7212-68f8-4282-97ac-fe84e423ace3/lary70572-toc-0001-m.png"
     alt="Ear Piercing Complications: Comparing Cartilage and Soft Tissue Piercings in a Large Survey Cohort"/&gt;
&lt;p&gt;Cartilage ear piercings were associated with significantly higher complication rates than lobule piercings and remained an independent predictor of complications after multivariate analysis. Cartilage site also independently predicted piercing removal, with higher removal rates observed compared to lobule piercings.&lt;/p&gt;
&lt;br/&gt;
&lt;h2&gt;ABSTRACT&lt;/h2&gt;
&lt;h2&gt;Objectives&lt;/h2&gt;
&lt;p&gt;To compare complication and removal rates between cartilage and lobule ear piercings in a large adult population.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;An anonymous electronic survey was distributed to all individuals with a University of Iowa email address. Respondents reported demographic characteristics, piercing site, age at piercing, technique, personnel, and specific complications. Multivariate logistic regression evaluated complication and removal rates between cartilage and lobule sites.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Data were analyzed on 9016 ear piercings from 3270 respondents, including 6275 (69.6%) lobule piercings and 2741 (30.4%) auricular cartilage piercings. Complications were reported in 40.2% of cartilage piercings versus 25.4% of lobule piercings (odds ratio [OR] 1.98, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). Infection occurred in 30.3% of cartilage piercings versus 23.8% of lobule piercings (OR 1.39, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). Additionally, cartilage site and presence of any complication each independently predicted piercing removal (OR 1.62, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001; OR 12.82, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Cartilage piercings carried significantly greater odds of complication and removal compared to lobule piercings. These findings underscore the importance of thorough counseling and informed consent, especially when piercing through auricular cartilage.&lt;/p&gt;
&lt;h2&gt;Level of Evidence&lt;/h2&gt;
&lt;p&gt;3.&lt;/p&gt;</content:encoded>
         <dc:creator>
John P. Ziegler, 
Nitin A. Pagedar, 
McKay Moline, 
Kathryn Marcus, 
Zachary G. Tanenbaum, 
Henry T. Hoffman, 
Scott R. Owen
</dc:creator>
         <category>ORIGINAL REPORT</category>
         <dc:title>Ear Piercing Complications: Comparing Cartilage and Soft Tissue Piercings in a Large Survey Cohort</dc:title>
         <dc:identifier>10.1002/lary.70572</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70572</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70572?af=R</prism:url>
         <prism:section>ORIGINAL REPORT</prism:section>
      </item>
      <item>
         <link>https://onlinelibrary.wiley.com/doi/10.1002/lary.70533?af=R</link>
         <pubDate>Thu, 16 Apr 2026 21:10:37 -0700</pubDate>
         <dc:date>2026-04-16T09:10:37-07:00</dc:date>
         <source url="https://onlinelibrary.wiley.com/journal/15314995?af=R">Wiley: The Laryngoscope: Table of Contents</source>
         <prism:coverDate/>
         <prism:coverDisplayDate/>
         <guid isPermaLink="false">10.1002/lary.70533</guid>
         <title>Endoscopic‐Assisted Transcervical Excision of Second Branchial Cleft Anomalies in Young Children</title>
         <description>The Laryngoscope, EarlyView. </description>
         <dc:description>
We describe an endoscopic‐assisted transcervical technique for excision of second branchial cleft anomalies in young children. In three cases (ages 2–8), this approach allowed safe identification and ligation of the tracts while providing improved visualization and allowing smaller incisions. Endoscopic assistance may be an effective alternative to traditional wide transcervical excision.
</dc:description>
         <content:encoded>&lt;img src="https://pericles.pericles-prod.literatumonline.com/cms/asset/aabb2007-01c9-46fc-b4cf-984c61dcb30d/lary70533-toc-0001-m.png"
     alt="Endoscopic-Assisted Transcervical Excision of Second Branchial Cleft Anomalies in Young Children"/&gt;
&lt;p&gt;We describe an endoscopic-assisted transcervical technique for excision of second branchial cleft anomalies in young children. In three cases (ages 2–8), this approach allowed safe identification and ligation of the tracts while providing improved visualization and allowing smaller incisions. Endoscopic assistance may be an effective alternative to traditional wide transcervical excision.&lt;/p&gt;
&lt;br/&gt;
</content:encoded>
         <dc:creator>
Thinh T. Kieu, 
Hosam H. Alkhatib, 
Shaunak Amin, 
Sheng Zhou, 
Kaalan Johnson
</dc:creator>
         <category>HOW I DO IT</category>
         <dc:title>Endoscopic‐Assisted Transcervical Excision of Second Branchial Cleft Anomalies in Young Children</dc:title>
         <dc:identifier>10.1002/lary.70533</dc:identifier>
         <prism:publicationName>The Laryngoscope</prism:publicationName>
         <prism:doi>10.1002/lary.70533</prism:doi>
         <prism:url>https://onlinelibrary.wiley.com/doi/10.1002/lary.70533?af=R</prism:url>
         <prism:section>HOW I DO IT</prism:section>
      </item>
   </channel>
</rss>
